However_RB up_IN to_TO now_RB ,_, there_EX has_VBZ not_RB been_VBN any_DT published_VBN systematic_JJ assessment_NN of_IN its_PRP$ performance_NN to_TO guide_VB further_JJ policy_NN decisions_NNS ._.
However_RB ,_, BsAbs_NNS indiscriminately_RB bind_VBP all_DT CD3_NN +_CC T-cells_NNS and_CC trigger_VB TCR_NN activation_NN in_IN the_DT absence_NN of_IN parallel_JJ costimulatory_JJ signals_NNS required_VBN to_TO overcome_VB T-cell_NN unresponsiveness_NN or_CC anergy_NN ._.
However_RB ,_, the_DT availability_NN of_IN utility_NN scores_NNS for_IN these_DT newer_JJR interventions_NNS is_VBZ limited_VBN ._.
However_RB ,_, it_PRP is_VBZ unclear_JJ why_WRB respiratory_JJ drive_NN does_VBZ not_RB prevent_VB CO2_NN retention_NN ._.
However_RB ,_, students_NNS '_POS ward_NN internship_NN is_VBZ partially_RB problematic_JJ due_JJ to_TO condensed_JJ workflows_NNS on_IN the_DT ward_NN and_CC the_DT high_JJ workload_NN of_IN supervising_VBG physicians_NNS ._.
However_RB ,_, since_IN INT_CD ,_, we_PRP have_VBP been_VBN developing_VBG new_JJ devices_NNS to_TO achieve_VB a_DT bar_NN dislocation_NN rate_NN of_IN zero_CD ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT degree_NN of_IN traction_NN injury_NN that_WDT causes_VBZ loss_NN of_IN signal_NN ._.
However_RB ,_, the_DT fate_NN of_IN its_PRP$ antioxidants_NNS after_IN oral_JJ consumption_NN is_VBZ not_RB yet_RB reported_VBN ._.
However_RB ,_, there_EX have_VBP been_VBN no_DT investigations_NNS of_IN the_DT manner_NN in_IN which_WDT aging_NN and_CC radiation_NN treatment_NN effects_NNS combine_VBP to_TO impact_VB tongue_NN muscles_NNS ,_, which_WDT are_VBP critical_JJ effectors_NNS of_IN the_DT oropharyngeal_NN swallow_VB ._.
However_RB ,_, the_DT application_NN of_IN these_DT new_JJ agents_NNS increases_VBZ treatment_NN costs_NNS considerably_RB ._.
However_RB ,_, it_PRP is_VBZ not_RB clear_JJ whether_IN the_DT increase_NN in_IN thyroid_NN cancer_NN rate_NN is_VBZ reducing_VBG the_DT extent_NN of_IN thyroid_NN surgeries_NNS ._.
However_RB ,_, the_DT predictive_JJ value_NN of_IN the_DT HCAP_NN model_NN is_VBZ limited_JJ and_CC data_NNS suggest_VBP that_IN outcomes_NNS are_VBP not_RB improved_VBN using_VBG HCAP_NN guideline-concordant_JJ therapy_NN ._.
However_RB ,_, no_DT study_NN has_VBZ examined_VBN sperm_NN quality_NN using_VBG different_JJ processing_NN media_NNS simultaneously_RB and_CC under_IN identical_JJ conditions_NNS ._.
However_RB ,_, the_DT references_NNS may_MD not_RB apply_VB to_TO rural_JJ children_NNS because_IN of_IN the_DT differences_NNS between_IN urban_JJ and_CC rural_JJ areas_NNS ,_, such_JJ as_IN economy_NN ,_, culture_NN ,_, and_CC dietary_JJ habits_NNS ._.
However_RB ,_, the_DT contrast_NN dispersion_NN pattern_NN during_IN ultrasound-guided_JJ pararadicular_JJ injection_NN has_VBZ not_RB been_VBN reported_VBN ._.
However_RB ,_, it_PRP is_VBZ unclear_JJ if_IN individuals_NNS with_IN other_JJ psychoses_NNS -LRB-_-LRB- e.g._FW ,_, mood_NN disorders_NNS or_CC substance_NN abuse_NN with_IN psychotic_JJ features_NNS -RRB-_-RRB- also_RB show_VBP this_DT impairment_NN ,_, and_CC whether_IN N400_NN reduction_NN relates_VBZ to_TO real-world_JJ functioning_VBG and_CC recovery_NN ._.
However_RB ,_, due_JJ to_TO inconsistent_JJ definitions_NNS of_IN response_NN ,_, variable_JJ rates_NNS of_IN long_JJ term_NN response_NN have_VBP been_VBN reported_VBN ._.
However_RB ,_, there_EX have_VBP been_VBN few_JJ studies_NNS reporting_VBG on_IN the_DT learning_NN curve_NN of_IN endoscopic_JJ thyroidectomy_NN ._.
However_RB ,_, very_RB few_JJ data_NNS are_VBP available_JJ about_IN its_PRP$ value_NN in_IN predicting_VBG sustained_JJ virologic_JJ response_NN -LRB-_-LRB- SVR_NN -RRB-_-RRB- in_IN patients_NNS with_IN cirrhosis_NN ,_, and_CC whether_IN IFN-λ3_NN genotype_NN influences_VBZ liver_NN disease_NN progression_NN remains_VBZ unclear_JJ ._.
However_RB ,_, the_DT information_NN about_IN synonymous_JJ codon_NN usage_NN pattern_NN of_IN T._FW saginata_FW genome_NN remains_VBZ unclear_JJ ._.
However_RB ,_, it_PRP is_VBZ not_RB known_VBN whether_IN such_JJ predictive_JJ effect_NN is_VBZ independent_JJ of_IN HRQOL_NN at_IN INT_CD month_NN after_IN stroke_NN ._.
However_RB ,_, concomitant_JJ vaccination_NN could_MD potentially_RB compromise_VB immunogenicity_NN and/or_CC safety_NN of_IN the_DT individual_JJ vaccines_NNS and_CC ,_, therefore_RB ,_, possible_JJ vaccine_NN interferences_NNS should_MD be_VB carefully_RB assessed_VBN ._.
However_RB ,_, it_PRP is_VBZ technically_RB challenging_JJ ,_, and_CC the_DT optimal_JJ SEMS_NNS for_IN the_DT procedure_NN remains_VBZ unknown_JJ ._.
However_RB ,_, it_PRP is_VBZ currently_RB unknown_JJ if_IN the_DT complexity_NN of_IN the_DT surgical_JJ procedure_NN influences_VBZ the_DT type_NN of_IN anesthesia-related_JJ risks_NNS that_WDT patients_NNS wish_VBP disclosed_VBN ._.
However_RB ,_, the_DT antitumor_JJ effects_NNS of_IN CaM_NN antagonists_NNS on_IN MM_NN are_VBP poorly_RB understood_VBN ._.
However_RB ,_, in_IN many_JJ patients_NNS ,_, neurophysiological_JJ disturbances_NNS are_VBP not_RB associated_VBN with_IN catastrophic_JJ cell_NN depletion_NN despite_IN prolonged_JJ alcohol_NN abuse_NN ._.
However_RB ,_, the_DT effects_NNS on_IN end-organ_JJ perfusion_NN ,_, including_VBG cerebral_JJ autoregulation_NN ,_, are_VBP unclear_JJ in_IN the_DT presence_NN of_IN reduced_VBN pulsatility_NN ._.
However_RB ,_, there_EX are_VBP also_RB reported_VBN cases_NNS of_IN diarrhea_NN with_IN sitagliptin_NN use_NN ._.
However_RB ,_, the_DT role_NN of_IN this_DT hypoxia-related_JJ protein_NN in_IN radiotherapy_NN of_IN lung_NN cancer_NN is_VBZ unclear_JJ ._.
However_RB ,_, up_IN to_TO now_RB limited_JJ research_NN guided_VBN by_IN this_DT perspective_NN has_VBZ been_VBN done_VBN in_IN Norway_NNP ._.
However_RB ,_, the_DT molecular_JJ mechanisms_NNS involved_VBN in_IN the_DT association_NN between_IN obesity_NN and_CC reproductive_JJ disorders_NNS remain_VBP unclear_JJ ._.
However_RB ,_, telephone_NN assessment_NN is_VBZ a_DT more_RBR time-efficient_JJ way_NN to_TO obtain_VB an_DT mRS_NN grade_NN than_IN a_DT face-to-face_JJ interview_NN ._.
However_RB ,_, very_RB little_JJ is_VBZ known_VBN about_IN the_DT extent_NN of_IN this_DT use_NN ,_, the_DT body_NN parts_NNS that_WDT are_VBP used_VBN and_CC the_DT ailments_NNS these_DT practices_NNS are_VBP attempting_VBG to_TO cure_VB or_CC alleviate_VB ._.
However_RB IKT_NNP is_VBZ not_RB widely_RB practiced_VBN due_JJ to_TO numerous_JJ challenges_NNS ._.
However_RB ,_, two_CD closely-timed_JJ cellular_JJ collections_NNS are_VBP not_RB usually_RB available_JJ in_IN the_DT unrelated_JJ donor_NN setting_NN ,_, which_WDT limits_VBZ the_DT accessibility_NN of_IN anti-viral_JJ cells_NNS for_IN adoptive_JJ immunotherapy_NN ._.
However_RB ,_, established_JJ research_NN has_VBZ not_RB investigated_VBN the_DT longer-term_JJ outcomes_NNS including_VBG mortality_NN and_CC hospitalisation_NN in_IN light_NN of_IN the_DT contemporary_JJ management_NN of_IN HF_NN ._.
However_RB ,_, surgical_JJ treatment_NN sometimes_RB causes_VBZ some_DT discomforts_NNS and_CC complications_NNS to_TO patients_NNS ._.
However_RB ,_, analyses_NNS of_IN serological_JJ data_NNS that_WDT use_VBP a_DT cut-off_JJ value_NN to_TO classify_VB individuals_NNS as_IN seropositive_JJ are_VBP prone_JJ to_TO misclassification_NN bias_NN ,_, in_IN particular_JJ when_WRB studying_VBG infections_NNS with_IN a_DT weak_JJ serological_JJ response_NN ,_, such_JJ as_IN the_DT sexually_RB transmitted_VBN human_JJ papillomavirus_NN -LRB-_-LRB- HPV_NN -RRB-_-RRB- ._.
However_RB ,_, their_PRP$ validation_NN in_IN predicting_VBG tropism_NN of_IN viral_JJ isolates_NNS belonging_VBG to_TO group_NN M_NN non-B_JJ subtypes_NNS remains_VBZ challenging_JJ ._.
However_RB ,_, a_DT relatively_RB high_JJ concentration_NN of_IN hyaluronic_JJ acid_NN was_VBD also_RB seen_VBN in_IN the_DT pleural_JJ fluid_NN of_IN patients_NNS with_IN benign_JJ inflammatory_JJ diseases_NNS ._.
However_RB ,_, how_WRB the_DT spleen_NN microenvironment_NN distinctly_RB affects_VBZ T-ALL_NN cells_NNS as_IN opposed_VBN to_TO bone_NN marrow_NN -LRB-_-LRB- BM_NN -RRB-_-RRB- microenvironment_NN has_VBZ not_RB been_VBN addressed_VBN ._.
However_RB ,_, evidence_NN about_IN which_WDT patients_NNS benefiting_VBG most_RBS from_IN the_DT interventions_NNS is_VBZ limited_VBN ._.
However_RB ,_, the_DT optimal_JJ surgical_JJ approach_NN to_TO laparoscopic_JJ bilateral_JJ adrenalectomy_NN has_VBZ not_RB been_VBN clearly_RB defined_VBN ._.
However_RB ,_, the_DT identities_NNS of_IN the_DT immune_JJ cells_NNS that_WDT infiltrate_VBP non-asthmatic_JJ nasal_JJ polyps_NNS remain_VBP unclear_JJ ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT footwear_NN advice_NN people_NNS receive_VBP from_IN healthcare_NN professionals_NNS ,_, or_CC the_DT beliefs_NNS and_CC footwear_NN habits_NNS of_IN people_NNS with_IN knee_NN OA_NN ._.
However_RB ,_, it_PRP has_VBZ been_VBN found_VBN that_IN the_DT mechanical_JJ properties_NNS of_IN animals_NNS '_POS arteries_NNS may_MD not_RB have_VB similar_JJ mechanical_JJ properties_NNS to_TO that_DT of_IN human_JJ coronary_JJ arteries_NNS and_CC ,_, consequently_RB ,_, may_MD invoke_VB a_DT substantial_JJ underestimation_NN of_IN stresses_NNS induced_VBN on_IN the_DT arterial_JJ and_CC plaque_NN walls_NNS ._.
However_RB few_JJ studies_NNS have_VBP been_VBN conducted_VBN on_IN rats_NNS ._.
However_RB ,_, there_EX have_VBP been_VBN few_JJ studies_NNS regarding_VBG the_DT molecular_JJ epidemiology_NN of_IN Cryptosporidium_NN in_IN human_JJ infections_NNS in_IN China_NNP ._.
However_RB ,_, it_PRP is_VBZ unclear_JJ to_TO which_WDT extent_NN the_DT costs_NNS of_IN developing_VBG and_CC implementing_VBG DMPs_NNS are_VBP included_VBN in_IN this_DT price_NN ._.
However_RB ,_, no_DT studies_NNS have_VBP been_VBN conducted_VBN in_IN Japan_NNP on_IN this_DT issue_NN ._.
However_RB ,_, some_DT subjects_NNS may_MD have_VB a_DT markedly_RB narrowed_VBN canal_NN without_IN any_DT symptoms_NNS ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT impact_NN of_IN drug_NN mixing_VBG in_IN markets_NNS dominated_VBN by_IN black_JJ tar_NN heroin_NN and_CC methamphetamine_NN ,_, such_JJ as_IN the_DT western_JJ United_NNP States_NNPS ._.
However_RB ,_, head_NN bandages_NNS are_VBP often_RB troublesome_JJ for_IN patients_NNS and_CC can_MD lead_VB to_TO serious_JJ complications_NNS ._.
However_RB ,_, there_EX has_VBZ not_RB yet_RB been_VBN a_DT systematic_JJ ,_, randomized_VBN ,_, controlled_VBN study_NN to_TO demonstrate_VB its_PRP$ effect_NN on_IN the_DT vitality_NN and_CC postoperative_JJ fat_JJ survival_NN of_IN fresh_JJ lipoaspirates_NNS ._.
However_RB ,_, the_DT literature_NN is_VBZ diverse_JJ and_CC hence_RB difficult_JJ to_TO review_VB ._.
However_RB ,_, data_NN analysis_NN of_IN numerous_JJ AD-specific_JJ miRNAs_NNS derived_VBN from_IN small_JJ RNA-sequencing_NN -LRB-_-LRB- RNA-Seq_NN -RRB-_-RRB- is_VBZ most_RBS often_RB laborious_JJ ._.
However_RB ,_, uncertainty_NN exists_VBZ regarding_VBG the_DT association_NN of_IN INPP4B_NN expression_NN and_CC biochemical_JJ and_CC clinical_JJ relapse_NN of_IN prostate_NN carcinoma_NN ._.
However_RB ,_, the_DT relationships_NNS may_MD be_VB affected_VBN by_IN bias_NN and_CC confounding_NN ._.
However_RB ,_, the_DT exact_JJ mechanisms_NNS that_WDT underlie_VBP palmitate-induced_JJ pancreatic_JJ β-cell_JJ apoptosis_NN and_CC through_IN which_WDT pathway_NN Bcl-2_NN executes_VBZ the_DT protective_JJ effect_NN are_VBP still_RB unclear_JJ ._.
However_RB ,_, modeling_NN and_CC experimental_JJ studies_NNS on_IN the_DT intravenous_JJ anesthetic_JJ propofol_NN indicate_VBP that_IN potentiation_NN of_IN γ-aminobutyric_JJ acid_NN receptors_NNS leads_VBZ to_TO a_DT state_NN of_IN thalamocortical_JJ synchrony_NN ,_, observed_VBN as_IN coherent_JJ frontal_JJ alpha_NN oscillations_NNS ,_, associated_VBN with_IN unconsciousness_NN ._.
However_RB ,_, in_IN humans_NNS ,_, sevoflurane-induced_JJ coherent_JJ frontal_JJ alpha_NN oscillations_NNS have_VBP not_RB been_VBN well_RB detailed_VBN ._.
However_RB ,_, the_DT dynamics_NNS of_IN these_DT transitions_NNS in_IN relation_NN to_TO the_DT duration_NN of_IN residence_NN in_IN the_DT new_JJ environment_NN are_VBP not_RB clearly_RB defined_VBN ._.
However_RB ,_, the_DT predictors_NNS for_IN the_DT development_NN of_IN MD_NN after_IN chronic_JJ right_JJ ventricular_JJ -LRB-_-LRB- RV_NN -RRB-_-RRB- pacing_NN are_VBP not_RB well_RB known_VBN ._.
However_RB ,_, the_DT value_NN of_IN different_JJ bridging_VBG modalities_NNS for_IN these_DT patients_NNS is_VBZ controversial_JJ ._.
However_RB ,_, few_JJ studies_NNS have_VBP evaluated_VBN the_DT effects_NNS of_IN the_DT present_JJ air_NN pollution_NN on_IN the_DT health_NN of_IN Chinese_JJ children_NNS ._.
However_RB ,_, the_DT reliability_NN of_IN these_DT tests_NNS is_VBZ uncertain_JJ ,_, due_JJ to_TO unresolved_JJ methodological_JJ issues_NNS ._.
However_RB ,_, the_DT significance_NN of_IN single_JJ nucleotide_NN polymorphisms_NNS -LRB-_-LRB- SNPs_NNS -RRB-_-RRB- in_IN genes_NNS encoding_VBG these_DT key_JJ enzymes_NNS has_VBZ not_RB been_VBN investigated_VBN in_IN hepatocellular_JJ carcinoma_NN -LRB-_-LRB- HCC_NN -RRB-_-RRB- ._.
However_RB ,_, the_DT precise_JJ effect_NN of_IN this_DT chemotherapeutic_JJ regimen_NN on_IN tumour_NN volume_NN is_VBZ unclear_JJ ._.
However_RB ,_, few_JJ studies_NNS have_VBP investigated_VBN the_DT relationship_NN between_IN Apo_NN B/Apo_NN A-1_NN ratio_NN and_CC arterial_JJ stiffness_NN ,_, thus_RB we_PRP investigated_VBD the_DT relationships_NNS between_IN Apo_NN B/Apo_NN A-1_NN and_CC arterial_JJ stiffness_NN in_IN patients_NNS with_IN metabolic_JJ syndrome_NN -LRB-_-LRB- MetS_NN -RRB-_-RRB- ._.
However_RB ,_, this_DT outcome_NN has_VBZ not_RB been_VBN evaluated_VBN because_IN of_IN the_DT lack_NN of_IN validated_VBN health-related_JJ empowerment_NN questionnaires_NNS in_IN the_DT cancer_NN context_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN how_WRB these_DT methods_NNS of_IN assessment_NN might_MD influence_VB reporting_NN of_IN SMCs_NNS ._.
However_RB ,_, the_DT extent_NN to_TO which_WDT combat_NN exposure_NN per_FW se_FW ,_, depression_NN ,_, or_CC early_JJ life_NN trauma_NN ,_, all_DT of_IN which_WDT are_VBP associated_VBN with_IN combat_NN PTSD_NN ,_, may_MD confound_VB the_DT relationship_NN between_IN PTSD_NN and_CC inflammation_NN is_VBZ unclear_JJ ._.
However_RB ,_, prospective_JJ data_NNS concerning_VBG the_DT relation_NN between_IN circulating_VBG soluble_JJ tumor_NN necrosis_NN factor_NN receptor-1_NN -LRB-_-LRB- sTNFR1_NN -RRB-_-RRB- and_CC mortality_NN in_IN humans_NNS are_VBP lacking_VBG ._.
However_RB ,_, GABA_NN alteration_NN has_VBZ been_VBN explored_VBN in_IN only_RB one_CD study_NN on_IN trigeminal_JJ neuropathic_JJ pain_NN ._.
However_RB ,_, contemporary_JJ series_NN have_VBP demonstrated_VBN improved_JJ outcomes_NNS following_VBG a_DT combination_NN of_IN cytoreductive_JJ surgery_NN and_CC intraperitoneal_JJ chemotherapy_NN ._.
However_RB ,_, there_EX continues_VBZ to_TO be_VB a_DT wide_JJ variation_NN in_IN the_DT previously_RB reported_VBN incidence_NN rates_NNS of_IN postoperative_JJ nausea_NN and_CC vomiting_NN ._.
However_RB ,_, using_VBG survival_NN analysis_NN with_IN Cox_NN regression_NN ,_, and_CC thus_RB factoring_VBG in_IN these_DT time_NN effects_NNS ,_, may_MD solve_VB this_DT statistical_JJ limitation_NN and_CC reveal_VBP risk_NN factors_NNS related_VBN to_TO the_DT occurrence_NN of_IN postoperative_JJ nausea_NN and_CC vomiting_VBG in_IN the_DT following_JJ period_NN ._.
However_RB ,_, there_EX are_VBP very_RB few_JJ studies_NNS to_TO apply_VB those_DT techniques_NNS for_IN pediatric_JJ diseases_NNS ._.
However_RB ,_, it_PRP is_VBZ unclear_JJ if_IN sensory_JJ deficits_NNS exist_VBP in_IN mild_JJ scars_NNS ._.
However_RB ,_, excluding_VBG small_JJ bowel_NN disease_NN remains_VBZ a_DT challenge_NN ._.
However_RB ,_, there_EX are_VBP no_DT lesion_NN studies_NNS including_VBG a_DT sufficient_JJ number_NN of_IN patients_NNS ,_, which_WDT would_MD reinforce_VB the_DT functional_JJ imaging_NN data_NNS obtained_VBN from_IN healthy_JJ subjects_NNS ._.
However_RB ,_, a_DT more_RBR detailed_JJ examination_NN of_IN the_DT attributional_JJ model_NN of_IN EE_NN has_VBZ not_RB been_VBN reported_VBN ._.
However_RB ,_, degradation_NN by_IN monoamine_NN oxidase-A_NN -LRB-_-LRB- MAO-A_NN -RRB-_-RRB- reduces_VBZ retention_NN and_CC the_DT contrast_NN to_TO non-endocrine_JJ tissue_NN ._.
However_RB ,_, wording_NN of_IN questions_NNS may_MD vary_VB between_IN studies_NNS ._.
However_RB ,_, pathological_JJ neural_JJ processes_NNS and_CC their_PRP$ resulting_VBG changes_NNS in_IN brain_NN network_NN topology_NN with_IN disease_NN progression_NN are_VBP not_RB clearly_RB known_VBN ._.
However_RB ,_, whether_IN it_PRP also_RB has_VBZ direct_JJ impact_NN on_IN cellular_JJ health_NN is_VBZ largely_RB unknown_JJ ._.
However_RB ,_, the_DT effects_NNS of_IN peritumoral_JJ edema_NN pose_VBP a_DT challenge_NN to_TO conventional_JJ tractography_NN using_VBG the_DT standard_JJ diffusion_NN tensor_NN model_NN ._.
However_RB ,_, it_PRP is_VBZ still_RB unknown_JJ the_DT relationship_NN between_IN CXCL13_NN and_CC ITP_NN ._.
However_RB ,_, a_DT rationale_NN for_IN this_DT safe_JJ choice_NN is_VBZ lacking_VBG ,_, while_IN the_DT assumption_NN regarding_VBG applicability_NN of_IN strict_JJ linearity_NN has_VBZ not_RB been_VBN justified_JJ ._.
However_RB ,_, the_DT occurrence_NN of_IN nonspecific_JJ symptoms_NNS and_CC different_JJ malignancies_NNS involving_VBG the_DT same_JJ cancer_NN site_NN may_MD lead_VB to_TO a_DT high_JJ proportion_NN of_IN misclassifications_NNS ._.
However_RB ,_, the_DT results_NNS of_IN these_DT studies_NNS remain_VBP inconclusive_JJ ._.
However_RB ,_, timetable_NN and_CC syllabus_NN often_RB give_VBP little_JJ scope_NN so_IN that_IN alternatives_NNS such_JJ as_IN combined_JJ lessons_NNS in_IN English_NNP and_CC sports_NNS may_MD be_VB suited_VBN to_TO integrate_VB the_DT desire_NN for_IN exercise_NN and_CC leaning_VBG ._.
However_RB ,_, few_JJ data_NNS are_VBP available_JJ on_IN the_DT risk_NN assessment_NN of_IN the_DT potential_JJ reasons_NNS for_IN HFMD_NN in_IN Beijing_NNP ._.
However_RB ,_, factors_NNS concomitant_JJ with_IN cardiovascular_JJ diseases_NNS may_MD confound_VB the_DT relationship_NN between_IN somatic_JJ symptoms_NNS of_IN depression_NN and_CC reduced_VBD HRV_NNP ._.
However_RB ,_, little_JJ research_NN has_VBZ demonstrated_VBN the_DT mental_JJ health_NN issues_NNS associated_VBN with_IN nursing_NN transformational_JJ leadership_NN style_NN under_IN the_DT NHI_NNP system_NN ,_, especially_RB in_IN the_DT quality_NN of_IN nurses_NNS '_POS working_VBG lives_NNS in_IN Taiwan_NNP ._.
However_RB ,_, some_DT recent_JJ studies_NNS have_VBP found_VBN that_IN even_RB normal_JJ range_NN albuminuria_NN was_VBD associated_VBN with_IN MetS_NN and_CC cardiometabolic_JJ risk_NN factors_NNS ._.
However_RB ,_, previous_JJ studies_NNS about_IN the_DT effects_NNS of_IN ATDs_NNS on_IN congenital_JJ anomalies_NNS are_VBP controversial_JJ ._.
However_RB ,_, whether_IN the_DT pharmacologic_JJ blocking_NN of_IN the_DT Wnt_NN signaling_NN pathway_NN could_MD provide_VB therapeutic_JJ possibility_NN remains_VBZ unknown_JJ ._.
However_RB ,_, different_JJ trophoblast_NN models_NNS and_CC a_DT variety_NN of_IN culture_NN conditions_NNS have_VBP been_VBN employed_VBN ,_, resulting_VBG in_IN a_DT myriad_JJ of_IN different_JJ reported_VBN findings_NNS ._.
However_RB ,_, experiences_NNS among_IN adolescents_NNS living_VBG in_IN low_JJ -_: and_CC lower-middle-income_JJ countries_NNS are_VBP yet_RB to_TO be_VB examined_VBN ._.
However_RB ,_, nothing_NN is_VBZ known_VBN about_IN the_DT involvement_NN of_IN HKLM_NN in_IN MMP-9_NN regulation_NN ._.
However_RB ,_, the_DT role_NN of_IN neuropilin_NN INT_CD -LRB-_-LRB- Nrp1_NN -RRB-_-RRB- in_IN osteoblastogenesis_NN remains_VBZ obscure_JJ ._.
However_RB ,_, iA-related_JJ neural_JJ activity_NN in_IN the_DT insula_NN during_IN the_DT acute_JJ state_NN of_IN major_JJ depressive_JJ disorder_NN -LRB-_-LRB- MDD_NN -RRB-_-RRB- and_CC in_IN remission_NN from_IN depression_NN has_VBZ not_RB been_VBN explored_VBN ._.
However_RB ,_, the_DT prognostic_JJ value_NN of_IN NLR_NN in_IN patients_NNS with_IN esophageal_NN cancer_NN -LRB-_-LRB- EC_NN -RRB-_-RRB- is_VBZ still_RB controversial_JJ ._.
However_RB ,_, large-scale_JJ epidemiological_JJ research_NN on_IN this_DT issue_NN is_VBZ lacking_VBG in_IN older_JJR Chinese_JJ adults_NNS ._.
However_RB ,_, patients_NNS with_IN omphalocele_NN may_MD not_RB have_VB adequately_RB protective_JJ postoperative_JJ adhesions_NNS because_IN of_IN difference_NN in_IN the_DT inflammatory_JJ state_NN of_IN the_DT bowel_NN wall_NN and_CC in_IN repair_NN strategy_NN ._.
However_RB ,_, only_RB a_DT limited_JJ number_NN of_IN studies_NNS have_VBP ever_RB investigated_VBN the_DT prevalence_NN of_IN these_DT STDs_NNS ,_, particular_JJ for_IN genital_JJ warts_NNS and_CC its_PRP$ correlates_NNS among_IN heterosexual_JJ males_NNS attending_VBG STD_NN clinics_NNS in_IN China_NNP ._.
However_RB ,_, there_EX is_VBZ no_DT research_NN into_IN the_DT current_JJ role_NN of_IN pharmacists_NNS in_IN this_DT setting_NN ._.
However_RB ,_, unspecified_JJ bilateral_JJ biopsies_NNS are_VBP commonly_RB submitted_VBN in_IN many_JJ centers_NNS ._.
However_RB ,_, clinical_JJ comparison_NN of_IN the_DT INT_CD techniques_NNS is_VBZ lacking_VBG in_IN the_DT literature_NN ._.
However_RB ,_, all_DT commercially_RB available_JJ ARDs_NNS are_VBP designed_VBN with_IN non-locking_JJ fixation_NN ._.
However_RB ,_, as_IN phenotypes_NNS are_VBP often_RB ``_`` hidden_VBN ''_'' within_IN free_JJ text_NN in_IN clinical_JJ records_NNS ,_, clinicians_NNS could_MD benefit_VB from_IN text_NN mining_NN systems_NNS that_WDT facilitate_VBP their_PRP$ prompt_JJ recognition_NN ._.
However_RB ,_, most_JJS of_IN the_DT literature_NN investigates_VBZ stigma_NN from_IN a_DT cultural_JJ conception_NN point_NN of_IN view_NN ,_, experiences_NNS of_IN patients_NNS or_CC public_JJ attitudes_NNS towards_IN mental_JJ illness_NN but_CC little_JJ to_TO none_NN from_IN the_DT standpoint_NN of_IN mental_JJ health_NN professionals_NNS ._.
However_RB ,_, no_DT one_NN has_VBZ documented_VBN the_DT levels_NNS of_IN ceramide_NN itself_PRP in_IN CHF_NN or_CC determined_VBD its_PRP$ potential_JJ prognostic_JJ value_NN ._.
However_RB ,_, estrogens_NNS also_RB directly_RB affect_VB tumor_NN cells_NNS ,_, though_IN the_DT mechanisms_NNS involved_VBN are_VBP not_RB well_RB understood_VBN ._.
However_RB ,_, these_DT studies_NNS only_RB applied_VBD the_DT serum_NN creatinine_NN -LRB-_-LRB- sCr_NN -RRB-_-RRB- criteria_NNS while_IN ignoring_VBG the_DT urine_NN output_NN criteria_NNS ._.
However_RB ,_, this_DT effect_NN seems_VBZ to_TO be_VB dose_NN dependent_JJ ._.
However_RB ,_, recently_RB the_DT expression_NN of_IN FSHR_NN was_VBD found_VBN in_IN tumoral_JJ cells_NNS and_CC intra-tumoral_JJ blood_NN vessels_NNS of_IN many_JJ other_JJ tumours_NNS ,_, including_VBG thyroid_NN tumours_NNS ._.
However_RB ,_, international_JJ reference_NN values_NNS for_IN lung_NN function_NN are_VBP commonly_RB used_VBN ,_, which_WDT may_MD not_RB be_VB appropriate_JJ to_TO correctly_RB identify_VB reduced_VBN lung_NN function_NN ._.
However_RB ,_, the_DT relationship_NN between_IN anthracycline_NN sensitivity_NN and_CC TOP2A_NN amplification_NN in_IN HER2-positive_JJ breast_NN cancers_NNS in_IN neoadjuvant_JJ settings_NNS is_VBZ not_RB known_VBN ._.
However_RB ,_, the_DT number_NN and_CC the_DT suppressive_JJ function_NN of_IN glycoprotein-A_NN repetitions_NNS predominant_JJ -LRB-_-LRB- GARP_NN -RRB-_-RRB- -LRB-_-LRB- +_CC -RRB-_-RRB- CD4_NN -LRB-_-LRB- +_CC -RRB-_-RRB- CD25_NN -LRB-_-LRB- +_CC -RRB-_-RRB- activated_VBN nTregs_NNS were_VBD impaired_JJ in_IN patients_NNS with_IN ACS_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN of_IN the_DT specific_JJ role_NN of_IN different_JJ HDAC_NN ,_, notably_RB Hdac1_NN ,_, in_IN the_DT regulation_NN of_IN inflammatory_JJ gene_NN expression_NN in_IN intestinal_JJ epithelial_JJ cells_NNS -LRB-_-LRB- IEC_NNS -RRB-_-RRB- ._.
However_RB ,_, donor_NN site_NN seroma_NN is_VBZ the_DT most_RBS common_JJ complication_NN of_IN LD_NN flap_NN reconstruction_NN ._.
However_RB ,_, the_DT biomarker_NN CD4_NN protein_NN expression_NN level_NN measured_VBN for_IN T_NN helper_NN cells_NNS from_IN Cyto-Trol_NNP was_VBD about_RB INT_CD %_NN lower_JJR than_IN those_DT for_IN cryopreserved_JJ PBMC_NN and_CC fresh_JJ whole_JJ blood_NN using_VBG flow_NN cytometry_NN and_CC mass_NN cytometry_NN ._.
However_RB ,_, the_DT role_NN of_IN NNMT_NNP in_IN pancreatic_JJ cancer_NN development_NN remains_VBZ elusive_JJ ._.
However_RB ,_, there_EX is_VBZ little_JJ data_NNS to_TO suggest_VB that_IN radiologic_JJ studies_NNS change_VBP the_DT management_NN of_IN complications_NNS ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN patients_NNS '_POS perceptions_NNS of_IN these_DT risks_NNS ,_, and_CC whether_IN these_DT perceptions_NNS relate_VBP to_TO their_PRP$ alcohol_NN consumption_NN ._.
However_RB ,_, the_DT growth_NN inhibitory_JJ activity_NN against_IN human_JJ cancer_NN cells_NNS and_CC the_DT underlying_VBG molecular_JJ mechanisms_NNS have_VBP been_VBN poorly_RB determined_VBN ._.
However_RB ,_, the_DT relationship_NN between_IN serum_NN clusterin_NN expression_NN and_CC esophageal_NN squamous_JJ cell_NN carcinoma_NN -LRB-_-LRB- ESCC_NN -RRB-_-RRB- is_VBZ unclear_JJ ._.
However_RB ,_, only_RB combinations_NNS where_WRB symptoms_NNS are_VBP mutually_RB influential_JJ hold_NN potential_NN for_IN identifying_VBG patient_NN subgroups_NNS at_IN greater_JJR risk_NN ,_, and_CC in_IN some_DT contexts_NNS ,_, interventions_NNS with_IN ``_`` cross-over_JJ ''_'' -LRB-_-LRB- multisymptom_JJ -RRB-_-RRB- effects_NNS ._.
However_RB ,_, there_EX are_VBP no_DT clinical_JJ guidelines_NNS for_IN the_DT prescription_NN of_IN customised_VBN foot_NN orthoses_NNS that_WDT are_VBP specific_JJ to_TO this_DT population_NN ._.
However_RB ,_, review_NN articles_NNS on_IN the_DT cytologic_JJ diagnosis_NN of_IN poorly_RB differentiated_VBN thyroid_NN carcinoma_NN -LRB-_-LRB- PDTC_NN -RRB-_-RRB- are_VBP scarce_JJ as_IN PDTC_NN are_VBP rare_JJ tumors_NNS ._.
However_RB ,_, because_IN normative_JJ data_NNS are_VBP sparsely_RB available_JJ in_IN the_DT literature_NN ,_, we_PRP aimed_VBD to_TO describe_VB the_DT range_NN of_IN V̇CO2_NN and_CC V̇O2_NN values_NNS observed_VBN in_IN mechanically_RB ventilated_VBN children_NNS ._.
However_RB ,_, we_PRP found_VBD that_IN for_IN patients_NNS '_POS daily_JJ assessment_NN ,_, INT_CD categories_NNS were_VBD too_RB many_JJ ._.
However_RB ,_, few_JJ studies_NNS have_VBP focused_VBN on_IN whether_IN glycyrrhizin_NN can_MD potentially_RB improve_VB the_DT outcome_NN of_IN traumatic_JJ pancreatitis_NN -LRB-_-LRB- TP_NN -RRB-_-RRB- by_IN inhibiting_VBG HMGB1_NN ._.
However_RB ,_, minilaparoscopic_JJ surgery_NN has_VBZ been_VBN introduced_VBN to_TO reduce_VB invasiveness_NN and_CC abdominal_JJ wall_NN trauma_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT relation_NN between_IN reoperation_NN rates_NNS and_CC postoperative_JJ mortality_NN rates_NNS at_IN a_DT hospital_NN level_NN ._.
However_RB ,_, there_EX is_VBZ little_JJ evidence_NN of_IN such_PDT an_DT association_NN in_IN young_JJ adults_NNS ,_, particularly_RB from_IN South_NNP America_NNP ,_, where_WRB the_DT burden_NN of_IN CVD_NNP and_CC chronic_JJ obstructive_JJ pulmonary_JJ disease_NN -LRB-_-LRB- COPD_NN -RRB-_-RRB- is_VBZ as_RB high_JJ as_IN that_DT observed_VBN in_IN more_RBR developed_JJ countries_NNS ._.
However_RB ,_, an_DT overwhelming_JJ majority_NN of_IN LGSC_NN patients_NNS do_VBP not_RB respond_VB to_TO conventional_JJ chemotherapy_NN resulting_VBG in_IN a_DT poor_JJ long-term_JJ prognosis_NN comparable_JJ to_TO women_NNS diagnosed_VBN with_IN HGSC_NN ._.
However_RB ,_, besides_IN behavioral_JJ pharmacology_NN studies_NNS ,_, there_EX is_VBZ little_JJ in_FW vivo_FW data_NNS documenting_VBG antidepressant-induced_JJ 5-HT2CR_NN desensitization_NN in_IN specific_JJ brain_NN areas_NNS ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT effect_NN of_IN CCL3_NN on_IN osteoblasts_NNS -LRB-_-LRB- OB_NN -RRB-_-RRB- ._.
However_RB ,_, civilian_JJ public_JJ health_NN and_CC tobacco_NN control_NN advocates_NNS have_VBP been_VBN relatively_RB silent_JJ on_IN the_DT issue_NN ._.
However_RB ,_, the_DT supporting_VBG data_NNS vary_VBP between_IN studies_NNS ,_, and_CC this_DT hypothesis_NN remains_VBZ controversial_JJ ._.
However_RB ,_, in_IN playing_VBG this_DT role_NN ,_, caregivers_NNS may_MD neglect_NN their_PRP$ health_NN and_CC quality_NN of_IN life_NN -LRB-_-LRB- QOL_NN -RRB-_-RRB- ._.
However_RB ,_, hanging-associated_JJ cardiovascular_JJ damage_NN has_VBZ not_RB been_VBN fully_RB established_VBN ._.
However_RB ,_, there_EX are_VBP limited_JJ data_NNS for_IN evaluating_VBG the_DT potential_JJ association_NN of_IN biomarkers_NNS with_IN functional_JJ disability_NN in_IN an_DT extremely_RB longevous_JJ -LRB-_-LRB- INT_CD +_CC -RRB-_-RRB- population_NN ._.
However_RB ,_, the_DT precise_JJ mechanism_NN of_IN bath-related_JJ death_NN remains_VBZ uncertain_JJ ,_, and_CC effective_JJ prevention_NN strategies_NNS have_VBP not_RB been_VBN established_VBN ._.
However_RB ,_, it_PRP is_VBZ unclear_JJ whether_IN a_DT reduction_NN in_IN CRP_NN is_VBZ associated_VBN with_IN a_DT reduction_NN in_IN risk_NN of_IN clinical_JJ events_NNS ._.
However_RB ,_, the_DT majority_NN of_IN TNBCs_NNS express_VBP the_DT membrane_NN bound_VBD estrogen_NN receptor_NN GPR30_NN ._.
However_RB ,_, although_IN parenthood_NN is_VBZ highly_RB desired_VBN ,_, many_JJ parents_NNS are_VBP unaware_JJ of_IN the_DT demands_NNS of_IN parenthood_NN and_CC the_DT strain_NN on_IN their_PRP$ relationship_NN that_IN the_DT arrival_NN of_IN the_DT baby_NN might_MD bring_VB ._.
However_RB ,_, different_JJ options_NNS in_IN biliary_JJ reconstruction_NN must_MD be_VB entertained_VBN in_IN those_DT with_IN abnormal_JJ anatomy_NN ._.
However_RB ,_, methods_NNS developed_VBD to_TO date_NN are_VBP expensive_JJ and_CC extremely_RB time-consuming_JJ ._.
However_RB ,_, few_JJ studies_NNS have_VBP analysed_VBN the_DT effects_NNS of_IN natural_JJ variation_NN within_IN fungal_JJ isolates_NNS on_IN mosquito_NN survival_NN ,_, and_CC the_DT implications_NNS and_CC possible_JJ exploitation_NN for_IN malaria_NN control_NN ._.
However_RB ,_, many_JJ patients_NNS do_VBP not_RB adhere_VB to_TO the_DT treatment_NN ._.
However_RB ,_, there_EX remains_VBZ concern_NN about_IN their_PRP$ efficacy_NN and_CC safety_NN ._.
However_RB ,_, the_DT benefits_NNS and_CC risks_NNS of_IN MMF_NN for_IN the_DT treatment_NN of_IN IgA_NN nephropathy_NN remain_VBP uncertain_JJ ._.
However_RB ,_, there_EX are_VBP few_JJ data_NNS on_IN postnatal_JJ arsenic_JJ exposure_NN via_IN human_JJ milk_NN ._.
However_RB ,_, it_PRP is_VBZ also_RB more_RBR difficult_JJ to_TO learn_VB and_CC has_VBZ a_DT great_JJ potential_JJ for_IN complications_NNS ._.
However_RB ,_, this_DT has_VBZ not_RB been_VBN investigated_VBN in_IN postpartum_JJ women_NNS living_VBG with_IN HIV_NN ._.
However_RB ,_, adverse_JJ effects_NNS of_IN SSRIs_NNS on_IN sexual_JJ function_NN are_VBP common_JJ in_IN the_DT treatment_NN of_IN patients_NNS with_IN MDD_NN ._.
However_RB ,_, the_DT neural_JJ mechanism_NN underlying_VBG these_DT disparate_JJ presentations_NNS is_VBZ uncertain_JJ ._.
However_RB ,_, prospective_JJ studies_NNS on_IN the_DT clinical_JJ benefits_NNS of_IN endogenous_JJ cortisol_NN on_IN clinical_JJ improvements_NNS in_IN naturalistic_JJ exposures_NNS are_VBP lacking_VBG ._.
However_RB ,_, patients_NNS with_IN inoperable_JJ CTEPH_NN or_CC persistent_JJ pulmonary_JJ hypertension_NN -LRB-_-LRB- PH_NN -RRB-_-RRB- after_IN these_DT interventions_NNS continue_VBP to_TO exhibit_VB impaired_JJ exercise_NN capacity_NN and_CC limited_JJ quality_NN of_IN life_NN -LRB-_-LRB- QOL_NN -RRB-_-RRB- ._.
However_RB ,_, it_PRP remains_VBZ elusive_JJ regarding_VBG the_DT risk_NN factors_NNS for_IN RLS_NN onset_NN in_IN dialysis_NN patients_NNS ._.
However_RB ,_, the_DT INT_CD Census_NNP -LRB-_-LRB- which_WDT included_VBD a_DT question_NN on_IN smoking_NN -RRB-_-RRB- showed_VBD a_DT greater_JJR than_IN expected_VBN fall_NN in_IN prevalence_NN ,_, especially_RB for_IN Maori_NNP ._.
However_RB ,_, identification_NN of_IN the_DT most_RBS salient_JJ WM_NN aberrations_NNS to_TO neurocognition_NN and_CC clinical_JJ symptoms_NNS is_VBZ limited_VBN by_IN relatively_RB small_JJ samples_NNS with_IN divergent_JJ results_NNS ._.
However_RB ,_, 24-hour_JJ in-hospital_JJ congenital_JJ cardiac_JJ surgical_JJ coverage_NN -LRB-_-LRB- 24-CCSC_NN -RRB-_-RRB- is_VBZ not_RB available_JJ at_IN all_DT institutions_NNS ._.
However_RB ,_, patient_NN perceptions_NNS about_IN barriers_NNS experienced_VBN while_IN seeking_VBG care_NN for_IN post-discharge_JJ SSI_NNP have_VBP not_RB been_VBN assessed_VBN in_IN depth_NN ._.
However_RB ,_, the_DT exact_JJ entity_NN of_IN these_DT risks_NNS and_CC their_PRP$ causes_NNS are_VBP unknown_JJ ._.
However_RB designing_VBG robust_JJ and_CC scalable_JJ knowledge_NN discovery_NN systems_NNS remains_VBZ a_DT challenge_NN ._.
However_RB ,_, the_DT efficacy_NN of_IN intralesional_JJ bleomycin_NN for_IN the_DT treatment_NN of_IN corns_NNS has_VBZ not_RB been_VBN established_VBN ._.
However_RB ,_, few_JJ studies_NNS have_VBP examined_VBN the_DT intake_NN pattern_NN of_IN these_DT dietary_JJ items_NNS compared_VBN to_TO adequate_JJ control_NN populations_NNS and_CC whether_IN intake_NN levels_NNS may_MD vary_VB by_IN migraine_NN aura_NN status_NN or_CC attack_NN frequency_NN ._.
However_RB ,_, so_RB far_RB very_RB little_JJ experience_NN has_VBZ been_VBN reported_VBN on_IN VATS_NNS management_NN of_IN sulcus_NN superior_JJ tumors_NNS ._.
However_RB ,_, long-term_JJ follow-up_NN data_NNS are_VBP limited_JJ because_IN of_IN the_DT rarity_NN of_IN this_DT tumor_NN ._.
However_RB ,_, this_DT alternative_JJ hinders_VBZ the_DT possibility_NN to_TO quantify_VB every_DT single_JJ P_NN wave_NN ,_, its_PRP$ variability_NN over_IN time_NN ,_, as_RB well_RB as_IN to_TO obtain_VB complimentary_JJ and_CC evolving_VBG information_NN about_IN the_DT arrhythmia_NN ._.
However_RB ,_, absence_NN of_IN Asian_JJ ethnicity_NN in_IN the_DT contemporary_JJ cohorts_NNS and_CC limited_JJ studies_NNS to_TO examine_VB the_DT use_NN of_IN the_DT risk_NN score_NN limit_NN the_DT applicability_NN of_IN the_DT equation_NN in_IN an_DT Asian_JJ population_NN ._.
However_RB ,_, the_DT sensitivity_NN and_CC specificity_NN of_IN leukocyte_NN esterase_NN has_VBZ not_RB been_VBN determined_VBN when_WRB matched_VBN for_IN the_DT current_JJ ,_, most_JJS inclusive_JJ Musculoskeletal_JJ Infection_NN Society_NN -LRB-_-LRB- MSIS_NN -RRB-_-RRB- criteria_NNS for_IN periprosthetic_JJ joint_JJ infection_NN ._.
However_RB ,_, research_NN into_IN these_DT healthcare_NN organizations_NNS is_VBZ limited_VBN by_IN the_DT time_NN constraints_NNS and_CC pressure_NN facing_VBG them_PRP ,_, and_CC the_DT concern_NN by_IN staff_NN that_WDT research_NN is_VBZ peripheral_JJ to_TO their_PRP$ work_NN ._.
However_RB ,_, studies_NNS investigating_VBG the_DT association_NN between_IN dynamics_NNS in_IN remission_NN status_NN in_IN relation_NN to_TO longitudinal_JJ functional_JJ and_CC clinical_JJ outcome_NN are_VBP scarce_JJ ._.
However_RB ,_, patterns_NNS of_IN neurological_JJ abnormalities_NNS that_WDT reflect_VBP brachial_JJ plexus_NN dysfunction_NN are_VBP frequent_JJ in_IN limbs_NNS with_IN pain_NN ,_, weakness_NN and/or_CC numbness/tingling_NN ._.
However_RB ,_, data_NNS on_IN changes_NNS in_IN BMD_NN after_IN discontinuing_VBG tenofovir_NN are_VBP lacking_VBG ._.
However_RB ,_, these_DT organs_NNS are_VBP subjected_VBN to_TO more_RBR ischaemia-reperfusion_JJ injury_NN -LRB-_-LRB- IRI_NN -RRB-_-RRB- ._.
However_RB ,_, the_DT optimum_JJ ratio_NN that_WDT will_MD separate_VB populations_NNS with_IN high_JJ from_IN low_JJ cardiovascular_JJ risk_NN remains_VBZ controversial_JJ ._.
However_RB ,_, these_DT studies_NNS have_VBP used_VBN various_JJ paradigms_NNS and_CC multiple_JJ stimulus_NN sets_NNS ,_, rendering_VBG comparisons_NNS difficult_JJ ._.
However_RB ,_, very_RB few_JJ data_NNS exist_VBP concerning_VBG the_DT impact_NN of_IN such_JJ position_NN stand_NN ._.
However_RB ,_, published_VBN data_NNS are_VBP still_RB conflicting_VBG ._.
However_RB ,_, studies_NNS have_VBP demonstrated_VBN a_DT severe_JJ lack_NN of_IN comprehension_NN of_IN these_DT terms_NNS ,_, particularly_RB in_IN underserved_JJ populations_NNS ._.
However_RB ,_, whether_IN these_DT processes_NNS differ_VBP in_IN peripheral_JJ and_CC cardiac_JJ circulation_NN is_VBZ unknown_JJ ._.
However_RB ,_, little_JJ is_VBZ known_VBN of_IN blood_NN flow_NN in_IN the_DT umbilical_JJ vessels_NNS immediately_RB after_IN birth_NN during_IN DCC_NNP ._.
However_RB ,_, there_EX is_VBZ a_DT risk_NN of_IN adverse_JJ reactions_NNS ,_, especially_RB when_WRB using_VBG cytomegalovirus-controlled_JJ expression_NN ._.
However_RB ,_, there_EX is_VBZ a_DT paucity_NN of_IN evidence_NN about_IN adolescent_JJ parent_NN communication_NN in_IN Ethiopia_NNP ._.
However_RB ,_, Asian_JJ aging_NN populations_NNS are_VBP often_RB underrepresented_JJ in_IN studies_NNS of_IN patient_NN trust_NN in_IN physicians_NNS ._.
However_RB ,_, there_EX is_VBZ no_DT study_NN that_WDT has_VBZ been_VBN conducted_VBN targeting_VBG large_JJ population_NN samples_NNS with_IN the_DT aim_NN of_IN determining_VBG the_DT prevalence_NN of_IN diabetes_NN in_IN TGRR_NN ._.
However_RB ,_, differences_NNS in_IN responsiveness_NN to_TO each_DT treatment_NN among_IN different_JJ groups_NNS remain_VBP unclear_JJ ._.
However_RB ,_, the_DT potential_JJ prognostic_JJ value_NN of_IN miR-21_NN in_IN various_JJ types_NNS of_IN human_JJ malignancy_NN remains_VBZ controversial_JJ ._.
However_RB ,_, the_DT results_NNS from_IN different_JJ studies_NNS remain_VBP inconsistent_JJ ._.
However_RB ,_, even_RB when_WRB patients_NNS receive_VBP maintenance_NN treatment_NN with_IN azathioprine_NN or_CC methotrexate_NN ,_, the_DT relapse_NN rate_NN remains_VBZ high_JJ ._.
However_RB ,_, the_DT contribution_NN of_IN anti-EGFR_JJ MoAbs_NNS to_TO infections_NNS is_VBZ still_RB unknown_JJ ._.
However_RB ,_, the_DT superiority_NN of_IN DF_NN compared_VBN with_IN SF_NN has_VBZ not_RB yet_RB been_VBN demonstrated_VBN during_IN ventilation_NN in_IN small_JJ infants_NNS ._.
However_RB ,_, a_DT sensitive_JJ and_CC specific_JJ isoelectrofocusing_NN -LRB-_-LRB- IEF_NN -RRB-_-RRB- and_CC western_NN blot_NN method_NN was_VBD described_VBN ._.
However_RB ,_, previous_JJ reports_NNS have_VBP shown_VBN that_IN despite_IN universal_JJ coverage_NN ,_, socioeconomic_JJ disparity_NN persists_VBZ in_IN access_NN to_TO high-tech_JJ invasive_JJ care_NN ,_, such_JJ as_IN cardiac_JJ treatment_NN ._.
However_RB ,_, which_WDT currents_NNS are_VBP principally_RB involved_VBN and_CC how_WRB the_DT IFN_NN signaling_NN cascade_NN is_VBZ linked_VBN to_TO the_DT respective_JJ ion_NN channels_NNS remains_VBZ elusive_JJ ._.
However_RB ,_, they_PRP have_VBP not_RB been_VBN assessed_VBN in_IN human_JJ pulmonary_JJ fibrosis_NN ._.
However_RB ,_, no_DT nerve_NN functional_JJ or_CC electrophysiologic_JJ evaluations_NNS were_VBD performed_VBN ._.
However_RB ,_, intracorporeal_JJ knot-tying_NN under_IN direct_JJ laparoscopy_NN is_VBZ difficult_JJ and_CC requires_VBZ proficiency_NN ._.
However_RB ,_, current_JJ timeline_NN representations_NNS have_VBP limitations_NNS in_IN visualizing_VBG narrative_JJ events_NNS ._.
However_RB ,_, the_DT degree_NN to_TO which_WDT RAGE_NN influences_VBZ developing_VBG lungs_NNS when_WRB gestating_VBG mice_NNS are_VBP exposed_VBN to_TO secondhand_JJ smoke_NN -LRB-_-LRB- SHS_NN -RRB-_-RRB- has_VBZ not_RB been_VBN determined_VBN to_TO date_NN ._.
However_RB ,_, its_PRP$ protein_NN expression_NN in_IN human_JJ malignant_JJ tumors_NNS has_VBZ not_RB been_VBN studied_VBN ._.
However_RB ,_, the_DT prognostic_JJ value_NN of_IN CTCs_NNS in_IN gastric_JJ cancer_NN -LRB-_-LRB- GC_NN -RRB-_-RRB- remains_VBZ controversial_JJ ._.
However_RB ,_, there_EX were_VBD no_DT cohort_NN studies_NNS for_IN the_DT effect_NN of_IN treatment_NN of_IN allergic_JJ rhinitis_NN on_IN attention_NN performance_NN in_IN pediatric_JJ population_NN ._.
However_RB ,_, its_PRP$ role_NN and_CC mechanism_NN in_IN myocardial_JJ infarction_NN -LRB-_-LRB- MI_NN -RRB-_-RRB- is_VBZ not_RB fully_RB understood_VBN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT possible_JJ effects_NNS of_IN CNT_NNP on_IN pulmonary_JJ allergic_JJ diseases_NNS ,_, such_JJ as_IN asthma_NN ._.
However_RB ,_, its_PRP$ safety_NN is_VBZ unknown_JJ in_IN patients_NNS with_IN pulmonary_JJ dysfunction_NN ._.
However_RB ,_, wild_JJ poliovirus_NN -LRB-_-LRB- WPV_NN -RRB-_-RRB- transmission_NN was_VBD reestablished_VBN in_IN INT_CD continuing_VBG through_IN INT_CD -LRB-_-LRB- last_JJ WPV_NN case_NN onset_NN INT_CD December_NNP INT_CD -RRB-_-RRB- ,_, and_CC vaccine-derived_JJ poliovirus_NN type_NN INT_CD -LRB-_-LRB- VDPV2_NN -RRB-_-RRB- outbreaks_NNS occurred_VBD during_IN FLOAT_CD -LRB-_-LRB- last_JJ VDPV2_NN case_NN onset_NN INT_CD April_NNP INT_CD -RRB-_-RRB- ._.
However_RB ,_, considering_VBG the_DT potential_JJ influence_NN of_IN scaffolds_NNS on_IN the_DT surrounding_VBG microenvironment_NN ,_, as_RB well_RB as_IN immunological_JJ issues_NNS ,_, it_PRP is_VBZ desirable_JJ to_TO develop_VB a_DT scaffold-free_JJ technique_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT immunological_JJ profile_NN of_IN pilgrims_NNS ._.
However_RB ,_, disjointed_JJ reports_NNS make_VBP the_DT significance_NN of_IN these_DT findings_NNS difficult_JJ to_TO interpret_VB ._.
However_RB ,_, evaluation_NN of_IN this_DT therapy_NN in_IN randomized_VBN multicenter_NN trials_NNS is_VBZ needed_VBN ._.
However_RB ,_, end-points_NNS are_VBP too_RB often_RB imprecisely_RB defined_VBN which_WDT largely_RB contributes_VBZ to_TO a_DT lack_NN of_IN homogeneity_NN across_IN trials_NNS ,_, hampering_VBG comparison_NN between_IN them_PRP ._.
However_RB ,_, DLI_NNP is_VBZ not_RB available_JJ after_IN UCB_NNP transplantation_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT agreement_NN between_IN the_DT two_CD methods_NNS in_IN young_JJ children_NNS ._.
However_RB ,_, it_PRP remains_VBZ unclear_JJ which_WDT kind_NN of_IN preimplant_JJ assessments_NNS could_MD accurately_RB predict_VB outcomes_NNS after_IN CRT_NNP ._.
However_RB ,_, the_DT role_NN of_IN hemostatic_JJ markers_NNS in_IN AF_NN remains_VBZ inconclusive_JJ ._.
However_RB ,_, pandemic_JJ triage_NN predictors_NNS have_VBP not_RB been_VBN validated_VBN ._.
However_RB ,_, the_DT role_NN of_IN miR-155_NN in_IN multiple_JJ myeloma_NN is_VBZ poorly_RB understood_VBN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN their_PRP$ performance_NN in_IN Chinese_JJ men_NNS ._.
However_RB ,_, few_JJ are_VBP known_VBN regarding_VBG the_DT metabolic_JJ factors_NNS that_WDT determine_VBP these_DT abnormalities_NNS ._.
However_RB ,_, with_IN continuing_VBG expansion_NN of_IN novel_JJ therapeutics_NNS ,_, it_PRP is_VBZ important_JJ to_TO understand_VB whether_IN the_DT Gleason_NN system_NN can_MD be_VB effectively_RB utilized_VBN in_IN this_DT setting_NN ._.
However_RB ,_, for_IN the_DT lower_JJR abdominal_JJ wall_NN or_CC groin_NN defects_NNS after_IN malignant_JJ tumor_NN resection_NN ,_, reconstruction_NN with_IN EOMF_NN is_VBZ little_RB reported_VBN ._.
However_RB ,_, few_JJ studies_NNS have_VBP investigated_VBN staging_NN in_IN patients_NNS with_IN radiologically_RB normal_JJ mediastina_NN ,_, and_CC the_DT accuracy_NN of_IN EBUS-TBNA_NN staging_NN for_IN radiologically_RB normal_JJ mediastina_NN and_CC hila_NN is_VBZ unclear_JJ ._.
However_RB ,_, resolution_NN of_IN histologic_JJ disease_NN activity_NN has_VBZ potential_JJ to_TO convey_VB additional_JJ benefit_NN beyond_IN that_DT attained_VBN with_IN endoscopic_JJ healing_NN alone_RB ._.
However_RB ,_, the_DT exact_JJ role_NN of_IN the_DT pedicular_JJ cortical_JJ bone_NN composition_NN and_CC the_DT screw-bone_NN gap_NN on_IN the_DT screw_NN fixation_NN failure_NN has_VBZ yet_RB to_TO be_VB quantitatively_RB documented_VBN ._.
However_RB ,_, bicyclomycin_NN participates_VBZ in_IN bacteriostatic_JJ synergy_NN ,_, which_WDT raises_VBZ the_DT possibility_NN that_IN conditions_NNS for_IN lethal_JJ synergy_NN may_MD exist_VB ,_, perhaps_RB through_IN a_DT suppression_NN of_IN protective_JJ factors_NNS ._.
However_RB ,_, the_DT molecular_JJ mechanisms_NNS involved_VBN with_IN sFlt-1_NN shedding_VBG are_VBP still_RB unidentified_JJ ._.
However_RB ,_, various_JJ bacteria_NNS that_WDT promote_VBP the_DT synthesis_NN of_IN reactive_JJ oxygen_NN and_CC nitrogen_NN species_NNS may_MD be_VB involved_VBN in_IN the_DT later_JJR stages_NNS ._.
However_RB ,_, the_DT precise_JJ mechanisms_NNS have_VBP not_RB been_VBN well_RB defined_VBN ._.
However_RB ,_, it_PRP was_VBD and_CC it_PRP is_VBZ well_RB known_VBN that_IN some_DT inorganic_JJ elements_NNS at_IN high_JJ dosage_NN may_MD have_VB curative_JJ effects_NNS but_CC also_RB serious_JJ toxicity_NN ._.
However_RB its_PRP$ precise_JJ localization_NN in_IN GC_NN has_VBZ yet_RB to_TO be_VB clarified_VBN ._.
However_RB ,_, only_RB INT_CD %_NN of_IN program_NN directors_NNS believed_VBD residents_NNS received_VBD adequate_JJ training_NN in_IN practice_NN management_NN -LSB-_-LRB- INT_CD -RSB-_-RRB- ._.
However_RB ,_, minimal_JJ attention_NN has_VBZ been_VBN given_VBN to_TO driving_VBG under_IN the_DT influence_NN of_IN prescription_NN drugs_NNS used_VBN nonmedically_RB ._.
However_RB ,_, performing_VBG LSG_NNP safely_RB is_VBZ sometimes_RB not_RB possible_JJ during_IN laparoscopy_NN ._.
However_RB ,_, the_DT exact_JJ neural_JJ circuitry_NN implicated_VBN in_IN such_JJ abnormalities_NNS remains_VBZ largely_RB unexplored_JJ ._.
However_RB ,_, its_PRP$ use_NN is_VBZ still_RB doubtful_JJ for_IN Thai_NNP population_NN ._.
However_RB ,_, the_DT utility_NN of_IN screening_VBG advanced_JJ adenomas_NNS for_IN loss_NN of_IN mismatch_NN repair_NN -LRB-_-LRB- MMR_NN -RRB-_-RRB- protein_NN expression_NN to_TO identify_VB suspected_VBN LS_NN remains_VBZ unclear_JJ ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN their_PRP$ fidelity_NN and_CC validity_NN ._.
However_RB ,_, it_PRP also_RB produces_VBZ artifacts_NNS during_IN radiological_JJ imaging_NN ._.
However_RB ,_, few_JJ studies_NNS have_VBP investigated_VBN preanalytical_JJ factors_NNS that_WDT might_MD impact_VB the_DT measurement_NN of_IN fetuin-A_NN in_IN the_DT circulation_NN ._.
However_RB ,_, its_PRP$ sensitivity_NN is_VBZ limited_VBN when_WRB low_JJ amounts_NNS of_IN d-xylose_NN are_VBP to_TO be_VB measured_VBN ,_, such_JJ as_IN in_IN the_DT noninvasive_JJ evaluation_NN of_IN intestinal_JJ lactase_NN with_IN 4-galactosylxylose_NN -LRB-_-LRB- gaxilose_NN -RRB-_-RRB- ._.
However_RB ,_, the_DT degree_NN to_TO which_WDT B7-H3_NN directly_RB affects_VBZ tumor_NN immune_JJ evasion_NN mechanisms_NNS remains_VBZ unclear_JJ ,_, particularly_RB in_IN patients_NNS with_IN breast_NN cancer_NN ._.
However_RB ,_, many_JJ Latino_NN patients_NNS do_VBP not_RB initiate_VB their_PRP$ PCPs_NNS '_POS recommended_JJ treatment_NN ,_, which_WDT likely_RB contributes_VBZ to_TO ethnic_JJ disparities_NNS in_IN depression_NN treatment_NN ._.
However_RB ,_, only_RB a_DT small_JJ minority_NN of_IN adolescents_NNS obtain_VB adequate_JJ amounts_NNS of_IN sleep_NN ._.
However_RB ,_, deformity_NN may_MD result_VB from_IN the_DT excision_NN of_IN significant_JJ amounts_NNS of_IN breast_NN tissue_NN ,_, as_RB well_RB as_IN radiation_NN therapy_NN ._.
However_RB ,_, due_JJ to_TO technical_JJ complexity_NN ,_, this_DT method_NN still_RB presents_VBZ some_DT level_NN of_IN variation_NN between_IN laboratories_NNS ._.
However_RB the_DT safety_NN of_IN in_IN utero_NN ART_NN exposure_NN in_IN newborns_NNS remains_VBZ a_DT concern_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT overall_JJ prevalence_NN of_IN obesity_NN among_IN secondary_JJ students_NNS in_IN China_NNP ,_, the_DT aim_NN of_IN this_DT study_NN was_VBD to_TO evaluate_VB the_DT overall_JJ obesity_NN prevalence_NN of_IN student_NN from_IN Chinese_JJ secondary_JJ school_NN ._.
However_RB ,_, no_DT commonly_RB used_VBN ,_, validated_VBN staging_NN system_NN exists_VBZ for_IN amyotrophic_JJ lateral_JJ sclerosis_NN -LRB-_-LRB- ALS_NN -RRB-_-RRB- ._.
However_RB ,_, no_DT large_JJ population_NN cohort_NN study_NN has_VBZ yet_RB to_TO demonstrate_VB the_DT nature_NN of_IN the_DT relationship_NN between_IN these_DT disorders_NNS ._.
However_RB ,_, at_IN present_JJ ,_, the_DT physiological_JJ function_NN of_IN C9orf72_NN remains_VBZ largely_RB unknown_JJ ._.
However_RB ,_, there_EX are_VBP currently_RB few_JJ simple_JJ ,_, direct_JJ ,_, behavioural_JJ ways_NNS to_TO test_VB this_DT claim_NN ._.
However_RB ,_, the_DT extent_NN to_TO which_WDT the_DT language_NN phenotypes_NNS in_IN SLI_NNP and_CC ALI_NNP can_MD be_VB viewed_VBN as_IN similar_JJ or_CC different_JJ depends_VBZ in_IN part_NN upon_IN the_DT age_NN of_IN the_DT individuals_NNS studied_VBN ._.
However_RB ,_, neither_CC JAM-A_NN expression_NN nor_CC its_PRP$ correlation_NN with_IN clinicopathologic_JJ variables_NNS and_CC patient_NN survival_NN has_VBZ been_VBN defined_VBN in_IN gastric_JJ cancers_NNS ._.
However_RB ,_, the_DT prevalence_NN of_IN cognitive_JJ dysfunction_NN and_CC poor_JJ health_NN literacy_NN among_IN ACS_NN patients_NNS and_CC their_PRP$ association_NN with_IN medication_NN nonadherence_NN are_VBP poorly_RB understood_VBN ._.
However_RB ,_, its_PRP$ direct_JJ correlation_NN with_IN cardiac_JJ iron_NN accumulation_NN has_VBZ never_RB been_VBN investigated_VBN ._.
However_RB ,_, dispersal_NN across_IN the_DT Levant_NNP would_MD better_RB explain_VB the_DT introgression_NN with_IN Neanderthals_NNS ,_, and_CC more_JJR than_IN one_CD exit_NN would_MD fit_VB better_JJR with_IN the_DT different_JJ ancient_JJ genomic_JJ components_NNS discovered_VBN in_IN indigenous_JJ Australians_NNPS and_CC in_IN ancient_JJ Europeans_NNPS ._.
However_RB ,_, cell-to-cell_JJ variability_NN is_VBZ not_RB commonly_RB included_VBN in_IN predictability_NN analyses_NNS ,_, thus_RB relying_VBG on_IN predictive_JJ models_NNS trained_VBN and_CC tested_VBN on_IN central_JJ tendency_NN values_NNS ._.
However_RB ,_, the_DT association_NN between_IN statin_NN use_NN and_CC survival_NN in_IN patients_NNS with_IN colorectal_JJ cancer_NN -LRB-_-LRB- CRC_NN -RRB-_-RRB- remains_VBZ unclear_JJ ._.
However_RB ,_, their_PRP$ role_NN in_IN reproduction_NN is_VBZ unclear_JJ ._.
However_RB ,_, their_PRP$ significance_NN during_IN liver_NN pathogenesis_NN is_VBZ currently_RB not_RB well_RB defined_VBN ._.
However_RB ,_, clinical_JJ criteria_NNS alone_RB may_MD be_VB insufficient_JJ to_TO identify_VB them_PRP correctly_RB ._.
However_RB ,_, the_DT correlation_NN of_IN transcriptome_NN profile_NN with_IN infertility_NN remains_VBZ obscure_JJ ._.
However_RB ,_, the_DT results_NNS were_VBD inconsistent_JJ ._.
However_RB ,_, the_DT association_NN between_IN and_CC clinicopathological_JJ significance_NN of_IN CDH1_NN promoter_NN methylation_NN and_CC lung_NN cancer_NN remains_VBZ unclear_JJ ._.
However_RB ,_, its_PRP$ biological_JJ role_NN is_VBZ not_RB clear_JJ ._.
However_RB ,_, the_DT role_NN of_IN VCE_NNP in_IN patients_NNS with_IN CAP_NN is_VBZ still_RB unclear_JJ ._.
However_RB ,_, to_TO gain_VB a_DT proper_JJ and_CC marketable_JJ chemotype_NN various_JJ factors_NNS during_IN the_DT cultivation_NN should_MD be_VB considered_VBN as_IN the_DT geographical_JJ morphology_NN ,_, climatic_JJ ,_, and_CC farming_NN conditions_NNS ._.
However_RB ,_, the_DT impact_NN of_IN cigarette_NN smoking_NN on_IN patients_NNS with_IN esophageal_NN squamous_JJ cell_NN carcinoma_NN -LRB-_-LRB- ESCC_NN -RRB-_-RRB- remains_VBZ unknown_JJ ._.
However_RB ,_, the_DT efficacy_NN of_IN ankle_NN exercise_NN for_IN improving_VBG cerebral_JJ circulation_NN has_VBZ not_RB been_VBN determined_VBN ._.
However_RB ,_, the_DT intricacies_NNS of_IN making_VBG judgments_NNS about_IN research_NN methodology_NN and_CC evidence_NN make_VBP the_DT GRADE_NN system_NN complex_NN and_CC challenging_VBG to_TO apply_VB without_IN training_NN ._.
However_RB ,_, whether_IN such_PDT a_DT demethylating_JJ effect_NN also_RB applies_VBZ to_TO the_DT TMS1_NN gene_NN in_IN chronic_JJ myeloid_JJ leukemia_NN cell_NN line_NN K562_NN cells_NNS has_VBZ not_RB been_VBN studied_VBN so_RB far_RB ._.
However_RB ,_, the_DT correlation_NN between_IN CXCR4_NN expression_NN and_CC clinicopathological_JJ characteristics_NNS of_IN NSCLC_NN remains_VBZ unclear_JJ ._.
However_RB ,_, the_DT mechanical_JJ effectiveness_NN of_IN the_DT cast_NN material_NN brace_VB as_IN compared_VBN to_TO the_DT TLSO_NN is_VBZ unknown_JJ ,_, thus_RB providing_VBG the_DT objective_NN of_IN this_DT study_NN ._.
However_RB ,_, there_EX is_VBZ very_RB little_JJ information_NN about_RB low_JJ back_RB pain_NN in_IN the_DT general_JJ population_NN in_IN developing_VBG Countries_NNS ._.
However_RB ,_, Heart_NNP Rate_NNP Variability_NN predictive_JJ value_NN for_IN vascular_JJ events_NNS is_VBZ not_RB completely_RB clear_JJ ._.
However_RB ,_, lack_NN of_IN knowledge_NN about_IN oral_JJ contraceptive_JJ use_NN and_CC inconsistent_JJ pill-taking_NN might_MD result_VB in_IN decreased_VBN efficacy_NN ._.
However_RB ,_, the_DT pathways_NNS responsible_JJ for_IN these_DT phenotypic_JJ differences_NNS are_VBP still_RB largely_RB unknown_JJ ._.
However_RB ,_, little_JJ information_NN is_VBZ available_JJ on_IN the_DT effects_NNS of_IN oral_JJ MSG_NN on_IN intestinal_JJ microbiota_NN ,_, and_CC no_DT study_NN was_VBD done_VBN focusing_VBG on_IN the_DT interaction_NN effect_NN of_IN fat_JJ and_CC MSG_NN with_IN respect_NN to_TO intestinal_JJ microbiota_NN ._.
However_RB ,_, the_DT effect_NN of_IN ascariasis_NN on_IN asthma_NN severity_NN has_VBZ not_RB been_VBN sufficiently_RB explored_VBN ._.
However_RB ,_, the_DT uncertainty_NN is_VBZ a_DT major_JJ obstacle_NN in_IN this_DT domain_NN of_IN medical_JJ research_NN ._.
However_RB ,_, few_JJ studies_NNS investigated_VBD the_DT relationship_NN between_IN alcohol_NN consumption_NN and_CC components_NNS of_IN MS._NNP We_PRP examined_VBD association_NN of_IN several_JJ types_NNS of_IN alcoholic_JJ beverage_NN with_IN components_NNS of_IN MS_NN among_IN people_NNS in_IN rural_JJ China_NNP ._.
However_RB ,_, few_JJ studies_NNS have_VBP investigated_VBN the_DT association_NN between_IN serum_NN long-chain_JJ n-3_NN and_CC n-6_JJ PUFA_NN profiles_NNS and_CC renal_JJ function_NN in_IN a_DT Japanese_JJ population_NN with_IN high_JJ marine-derived_JJ long-chain_JJ n-3_NN PUFA_NN intake_NN ._.
However_RB ,_, a_DT role_NN for_IN this_DT protein_NN in_IN papillary_JJ thyroid_NN carcinoma_NN -LRB-_-LRB- PTC_NN -RRB-_-RRB- has_VBZ not_RB yet_RB been_VBN established_VBN ._.
However_RB ,_, all_DT were_VBD derived_VBN from_IN single_JJ high-volume_JJ centers_NNS ._.
However_RB ,_, there_EX is_VBZ concern_NN that_IN providing_VBG information_NN on_IN possible_JJ risks_NNS of_IN screening_NN might_MD prevent_VB deter_VB from_IN participating_VBG ._.
However_RB ,_, quality_NN assurance_NN and_CC quality_NN control_NN of_IN these_DT processed_VBN medicines_NNS remain_VBP challenging_JJ ._.
However_RB ,_, it_PRP is_VBZ unclear_JJ if_IN gender_NN plays_VBZ a_DT role_NN in_IN this_DT pedicle_NN width_NN pattern_NN ._.
However_RB ,_, whether_IN targeted_VBN recipients_NNS are_VBP reached_VBN and_CC willing_JJ and_CC able_JJ to_TO follow_VB the_DT recommendations_NNS has_VBZ significant_JJ impact_NN on_IN the_DT efficacy_NN of_IN guidelines_NNS ._.
However_RB ,_, few_JJ studies_NNS have_VBP focused_VBN on_IN the_DT regional_JJ intensity_NN of_IN spontaneous_JJ fluctuations_NNS during_IN the_DT resting_VBG state_NN and_CC the_DT relationship_NN between_IN the_DT abnormal_JJ properties_NNS and_CC the_DT behavioral_JJ performances_NNS ._.
However_RB ,_, variant_JJ interpretation_NN remains_VBZ challenging_JJ ,_, and_CC tools_NNS that_WDT close_VBP the_DT gap_NN between_IN data_NNS generation_NN and_CC data_NNS interpretation_NN are_VBP urgently_RB required_VBN ._.
However_RB ,_, previous_JJ investigations_NNS have_VBP not_RB evaluated_VBN the_DT various_JJ etiologies_NNS of_IN WRF_NN and_CC its_PRP$ impact_NN on_IN prognosis_NN ._.
However_RB ,_, whether_IN the_DT aberrant_JJ expression_NN of_IN BCL6_NN in_IN ovarian_JJ carcinoma_NN is_VBZ associated_VBN with_IN malignancy_NN ,_, metastasis_NN or_CC prognosis_NN remains_VBZ unknown_JJ ._.
However_RB ,_, the_DT molecular_JJ mechanisms_NNS underlying_VBG these_DT deficits_NNS are_VBP still_RB poorly_RB understood_VBN ._.
However_RB GJH_NN is_VBZ also_RB highly_RB prevalent_JJ amongst_IN healthy_JJ individuals_NNS whereas_IN its_PRP$ consequences_NNS for_IN physical_JJ functioning_VBG are_VBP unclear_JJ ._.
However_RB ,_, the_DT efficacy_NN is_VBZ limited_VBN by_IN the_DT poor_JJ viability_NN of_IN MSCs_NNS in_IN the_DT infarcted_JJ heart_NN ._.
However_RB ,_, as_IN the_DT stem_NN cells_NNS in_IN these_DT studies_NNS were_VBD animal-derived_JJ ,_, little_JJ information_NN is_VBZ available_JJ about_IN the_DT effects_NNS of_IN TMZ_NN on_IN human_JJ MSCs_NNS ._.
However_RB ,_, genetic_JJ and_CC environmental_JJ origins_NNS of_IN DD_NN remain_VBP unclear_JJ ._.
However_RB ,_, the_DT outcomes_NNS associated_VBN with_IN acute_JJ silent_JJ cerebral_JJ infarction_NN -LRB-_-LRB- ASCI_NN -RRB-_-RRB- have_VBP not_RB been_VBN not_RB well_RB established_VBN ._.
However_RB ,_, increased_VBD mortality_NN in_IN CKD_NN patients_NNS is_VBZ a_DT competing_VBG risk_NN scenario_NN not_RB accounted_VBD for_IN in_IN previous_JJ studies_NNS ._.
However_RB ,_, little_JJ is_VBZ known_VBN regarding_VBG the_DT prevalence_NN and_CC related_JJ factors_NNS of_IN CKD_NN among_IN Chinese_JJ LLI_NN over_IN INT_CD years_NNS of_IN age_NN ._.
However_RB ,_, the_DT underlying_VBG mechanism_NN -LRB-_-LRB- s_NNS -RRB-_-RRB- in_IN the_DT up-regulation_NN of_IN IL-6_NN and_CC IL-8_NN are_VBP not_RB clearly_RB understood_VBN ._.
However_RB ,_, the_DT diagnostic_JJ yield_NN obtained_VBN with_IN these_DT platforms_NNS is_VBZ not_RB confirmed_VBN ,_, and_CC the_DT real_JJ clinical_JJ value_NN of_IN LOH_NNP detection_NN has_VBZ not_RB been_VBN established_VBN ._.
However_RB ,_, antibiotics_NNS delivered_VBN intravenously_RB may_MD have_VB poor_JJ tissue_NN penetration_NN and_CC be_VB dose_NN limited_VBN by_IN systemic_JJ side_NN effects_NNS ._.
However_RB ,_, antibiotic_JJ resistance_NN is_VBZ a_DT global_JJ concern_NN ._.
However_RB ,_, Clinical_JJ studies_NNS related_VBN to_TO the_DT SCA_NNP aspects_NNS of_IN NMOSD_NN are_VBP still_RB scarce_JJ ._.
However_RB ,_, its_PRP$ impact_NN is_VBZ not_RB only_RB influenced_VBN by_IN its_PRP$ physical_JJ manifestations_NNS ,_, but_CC also_RB by_IN its_PRP$ subjective_JJ importance_NN to_TO the_DT patient_NN ._.
However_RB ,_, before_IN the_DT objective_NN method_NN can_MD be_VB applied_VBN ,_, it_PRP must_MD be_VB demonstrated_VBN that_IN its_PRP$ ability_NN to_TO estimate_VB the_DT FS_NN ,_, gives_VBZ comparable_JJ results_NNS to_TO those_DT obtained_VBN by_IN subjective_JJ procedures_NNS i.e._FW PTCs_FW ._.
However_RB ,_, its_PRP$ prescription_NN to_TO adults_NNS with_IN ADHD_NN and_CC narcolepsy_NN raises_VBZ the_DT question_NN of_IN how_WRB the_DT brain_NN is_VBZ impacted_VBN by_IN MPH_NN exposure_NN during_IN pregnancy_NN ._.
However_RB ,_, proof_NN of_IN a_DT beneficial_JJ effect_NN on_IN functional_JJ outcome_NN is_VBZ lacking_VBG ._.
However_RB ,_, there_EX is_VBZ limited_VBN information_NN on_IN patients_NNS '_POS views_NNS of_IN their_PRP$ perceived_VBN role_NN in_IN PIP_NN ._.
However_RB ,_, these_DT electrodes_NNS generate_VBP metal_NN artifacts_NNS as_IN silver_NN blocks_VBZ X-rays_NNS ,_, creating_VBG white_JJ radial_JJ lines_NNS on_IN computed_JJ tomography_NN -LRB-_-LRB- CT_NN -RRB-_-RRB- images_NNS during_IN surgery_NN ._.
However_RB ,_, the_DT role_NN of_IN miR-126_NN in_IN EGCG_NN anticancer_JJ remains_NNS unclear_JJ ._.
However_RB ,_, its_PRP$ psychometric_JJ properties_NNS have_VBP been_VBN questioned_VBN ,_, and_CC alternative_JJ measurement_NN models_NNS of_IN the_DT inventory_NN have_VBP been_VBN suggested_VBN ._.
However_RB ,_, drug_NN levels_NNS and_CC the_DT genetic_JJ background_NN may_MD affect_VB this_DT interaction_NN ._.
However_RB ,_, no_DT study_NN has_VBZ addressed_VBN whether_IN this_DT classification_NN has_VBZ advantage_NN in_IN estimating_VBG factors_NNS associated_VBN with_IN the_DT progression_NN of_IN disease_NN severity_NN or_CC dengue_NN pathogenesis_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN predictors_NNS of_IN different_JJ courses_NNS of_IN alcohol_NN use_NN in_IN this_DT context_NN ._.
However_RB ,_, this_DT practice_NN remains_VBZ controversial_JJ ._.
However_RB ,_, whether_IN minocycline_NN can_MD ameliorate_VB cognitive_JJ impairment_NN induced_VBN by_IN ionizing_VBG radiation_NN -LRB-_-LRB- IR_NN -RRB-_-RRB- has_VBZ not_RB been_VBN tested_VBN ._.
However_RB ,_, as_IN with_IN other_JJ disorders_NNS with_IN a_DT language_NN component_NN ,_, we_PRP know_VBP surprisingly_RB little_JJ about_IN the_DT language_NN trajectories_NNS and_CC how_WRB varied_JJ these_DT might_MD be_VB across_IN different_JJ children_NNS ._.
However_RB ,_, few_JJ studies_NNS have_VBP explored_VBN the_DT associations_NNS between_IN urine_NN CC-16_NN levels_NNS and_CC environmental_JJ tobacco_NN smoke_NN -LRB-_-LRB- ETS_NN -RRB-_-RRB- exposure_NN in_IN children_NNS ._.
However_RB ,_, currently_RB no_DT standard_JJ criteria_NNS for_IN the_DT definition_NN of_IN a_DT positive_JJ challenge_NN outcome_NN exists_VBZ and_CC interpretation_NN of_IN food_NN challenges_NNS mainly_RB depends_VBZ on_IN clinical_JJ judgment_NN ._.
However_RB ,_, we_PRP recently_RB showed_VBD it_PRP plays_VBZ a_DT pivotal_JJ role_NN in_IN blood_NN processing_NN ._.
However_RB ,_, laparoscopic_JJ rectal_JJ resection_NN is_VBZ technically_RB demanding_VBG ,_, especially_RB when_WRB performing_VBG a_DT tumor-specific_JJ mesorectal_JJ excision_NN in_IN a_DT difficult_JJ pelvis_NN ._.
However_RB ,_, total_JJ primaquine_NN doses_NNS ,_, or_CC those_DT per_IN body_NN weight_NN ,_, are_VBP also_RB recognized_VBN as_IN important_JJ ._.
However_RB ,_, no_DT study_NN has_VBZ yet_RB indicated_VBN the_DT serum_NN amylase_NN levels_NNS in_IN NAFLD_NN with_IN MS._NNP The_DT aim_NN of_IN the_DT present_JJ study_NN was_VBD to_TO evaluate_VB serum_NN amylase_NN levels_NNS in_IN NAFLD_NN patients_NNS with_IN and_CC without_IN MS_NN ,_, and_CC to_TO explore_VB a_DT possible_JJ association_NN between_IN serum_NN amylase_NN levels_NNS with_IN the_DT components_NNS of_IN MS_NN and_CC the_DT degree_NN of_IN hepatic_JJ fibrosis_NN in_IN NAFLD_NN patients_NNS ._.
However_RB ,_, GIS_NNS data_NNS are_VBP often_RB unavailable_JJ in_IN rural_JJ settings_NNS and_CC village-level_JJ mapping_NN is_VBZ resource-intensive_JJ ._.
However_RB ,_, the_DT exact_JJ contribution_NN of_IN the_DT major_JJ active_JJ components_NNS of_IN S._NNP miltiorrhiza_NNP and_CC P._NNP notoginseng_NN to_TO cardioprotection_NN is_VBZ far_RB from_IN clear_JJ ._.
However_RB ,_, no_DT simulation_NN studies_NNS have_VBP been_VBN conducted_VBN to_TO test_VB the_DT performance_NN of_IN the_DT methods_NNS ._.
However_RB ,_, little_JJ evidence_NN of_IN a_DT correlation_NN between_IN NRP2_NN expression_NN and_CC lymphangiogenesis_NN has_VBZ been_VBN reported_VBN ._.
However_RB ,_, as_IN far_RB as_RB known_VBN ,_, no_DT studies_NNS have_VBP been_VBN conducted_VBN to_TO see_VB how_WRB trips_NNS with_IN combined_JJ purposes_NNS affect_VBP this_DT decision_NN ._.
However_RB ,_, there_EX are_VBP a_DT growing_VBG number_NN of_IN these_DT patients_NNS who_WP develop_VBP an_DT opioid_JJ use_NN disorder_NN and_CC in_IN some_DT cases_NNS require_VBP opioid_JJ replacement_NN therapy_NN ._.
However_RB ,_, TREM-1_NN expression_NN and_CC its_PRP$ direct_JJ effects_NNS on_IN HCC_NN cells_NNS have_VBP not_RB been_VBN previously_RB determined_VBN ._.
However_RB ,_, the_DT role_NN of_IN PAHs_NNS independent_JJ of_IN environmental_JJ tobacco_NN smoke_NN -LRB-_-LRB- ETS_NN -RRB-_-RRB- is_VBZ unclear_JJ ,_, and_CC the_DT interaction_NN between_IN PAHs_NNS and_CC ETS_NN remains_VBZ unknown_JJ ._.
However_RB host_NN genetic_JJ factors_NNS play_VBP a_DT vital_JJ role_NN in_IN the_DT spontaneous_JJ and_CC treatment-induced_JJ clearance_NN of_IN HCV_NN infection_NN from_IN these_DT infected_JJ patients_NNS ._.
However_RB ,_, the_DT onset_NN time_NN of_IN rocuronium_NN for_IN good_JJ intubation_NN condition_NN is_VBZ still_RB slower_JJR than_IN that_DT condition_NN of_IN succinylcholine_NN ._.
However_RB ,_, it_PRP remains_VBZ unsettled_JJ whether_IN sympathetic_JJ cardiovascular_JJ influences_NNS are_VBP potentiated_VBN in_IN true_JJ resistant_JJ hypertension_NN -LRB-_-LRB- RHT_NN -RRB-_-RRB- ._.
However_RB ,_, there_EX are_VBP limited_JJ data_NNS on_IN influence_NN of_IN serum_NN INT_CD -LRB-_-LRB- OH_NN -RRB-_-RRB- D_NN on_IN risk_NN and_CC prognosis_NN of_IN malignant_JJ melanoma_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT association_NN of_IN free_JJ thyroxine_NN -LRB-_-LRB- fT4_NN -RRB-_-RRB- and_CC mortality_NN in_IN patients_NNS on_IN peritoneal_JJ dialysis_NN -LRB-_-LRB- PD_NN -RRB-_-RRB- ._.
However_RB ,_, awareness_NN of_IN stage_NN INT_CD CKD_NN amongst_IN patients_NNS remains_VBZ limited_JJ ._.
However_RB ,_, no_DT studies_NNS have_VBP addressed_VBN CV_NN risk_NN as_IN a_DT function_NN of_IN the_DT route_NN of_IN administration_NN of_IN TRT_NNP ._.
However_RB ,_, the_DT mechanism_NN by_IN which_WDT upstream_JJ signalling_NN regulates_VBZ ANXA2_NN is_VBZ unclear_JJ ._.
However_RB ,_, it_PRP is_VBZ unknown_JJ if_IN these_DT molecules_NNS contribute_VBP to_TO IS_VBZ pathophysiology_NN in_IN humans_NNS ,_, and_CC might_MD be_VB of_IN use_NN as_IN biomarkers_NNS for_IN IS_VBZ risk_NN and_CC severity_NN ._.
However_RB ,_, this_DT is_VBZ still_RB controversial_JJ ._.
However_RB ,_, the_DT mechanical_JJ response_NN of_IN BP_NN variability_NN to_TO the_DT plaque_NN remains_VBZ unclear_JJ ._.
However_RB ,_, the_DT functions_NNS of_IN renal_JJ NCX1_NN have_VBP not_RB been_VBN studied_VBN in_FW vivo_FW ._.
However_RB ,_, the_DT importance_NN in_IN patients_NNS with_IN ruptured_VBN abdominal_JJ aortic_JJ aneurysm_NN -LRB-_-LRB- RAAA_NN -RRB-_-RRB- remains_VBZ unclear_JJ ._.
However_RB ,_, the_DT involvement_NN of_IN central_JJ TRH_NN in_IN this_DT regulation_NN has_VBZ not_RB been_VBN reported_VBN ._.
However_RB ,_, totally_RB laparoscopic_JJ distal_JJ gastrectomy_NN -LRB-_-LRB- TLDG_NN -RRB-_-RRB- has_VBZ recently_RB been_VBN attempted_VBN and_CC is_VBZ expected_VBN to_TO be_VB feasible_JJ and_CC less_RBR invasive_JJ compared_VBN with_IN LADG_NN ._.
However_RB ,_, controversy_NN remains_VBZ regarding_VBG the_DT ideal_JJ technique_NN ;_: therefore_RB ,_, the_DT aim_NN of_IN this_DT study_NN was_VBD to_TO compare_VB closure_NN techniques_NNS and_CC risk_NN of_IN postoperative_JJ pancreatic_JJ fistula_NN -LRB-_-LRB- POPF_NN -RRB-_-RRB- ._.
However_RB ,_, there_EX is_VBZ a_DT lack_NN of_IN scientific_JJ evidence_NN regarding_VBG the_DT training_NN ._.
However_RB ,_, the_DT risk_NN of_IN falling_VBG might_MD prevent_VB this_DT population_NN from_IN showing_VBG interest_NN in_IN physical_JJ activity_NN ._.
However_RB ,_, gaps_NNS exist_VBP in_IN the_DT access_NN of_IN this_DT group_NN to_TO RH_NN services_NNS in_IN China_NNP ._.
However_RB ,_, the_DT suitability_NN of_IN this_DT vector_NN for_IN pulmonary_JJ siRNA_NN delivery_NN has_VBZ not_RB been_VBN assessed_VBN to_TO date_NN ._.
However_RB ,_, many_JJ screening_JJ programmes_NNS for_IN OC_NNP and_CC detection_NN of_IN potentially_RB malignant_JJ disorders_NNS are_VBP described_VBN ._.
However_RB ,_, this_DT association_NN has_VBZ not_RB been_VBN thoroughly_RB documented_VBN in_IN China_NNP ._.
However_RB ,_, its_PRP$ pharmacological_JJ properties_NNS are_VBP still_RB poorly_RB understood_VBN ._.
However_RB ,_, the_DT therapeutic_JJ efficacy_NN of_IN pregabalin_NN for_IN reducing_VBG the_DT incidence_NN of_IN spinal_JJ surgery_NN to_TO treat_VB leg_NN symptoms_NNS in_IN patients_NNS with_IN lumbar_JJ spinal_JJ stenosis_NN remains_VBZ unknown_JJ ._.
However_RB ,_, their_PRP$ impact_NN on_IN healthcare_NN resource_NN utilization_NN is_VBZ not_RB well_RB understood_VBN ._.
However_RB ,_, to_TO the_DT authors_NNS '_POS knowledge_NN ,_, the_DT survival_NN benefits_NNS associated_VBN with_IN AC_NN in_IN these_DT patients_NNS remain_VBP largely_RB unproven_JJ ._.
However_RB ,_, not_RB all_DT patients_NNS respond_VBP equally_RB well_RB ,_, and_CC there_EX are_VBP few_JJ reliable_JJ predictors_NNS of_IN treatment_NN outcome_NN ._.
However_RB ,_, prevention_NN of_IN CAV_NN in_IN this_DT setting_NN required_VBD the_DT depletion_NN of_IN both_CC NK_NN and_CC CD4_NN T_NN cells_NNS ._.
However_RB ,_, recently_RB our_PRP$ group_NN has_VBZ developed_VBN a_DT bolus_NN injection_NN -LRB-_-LRB- BI_NN -RRB-_-RRB- method_NN ,_, which_WDT requires_VBZ an_DT injection_NN of_IN bolus_NN of_IN tracer_NN and_CC can_MD be_VB completed_VBN within_IN INT_CD h_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT impact_NN of_IN tenofovir_NN on_IN renal_JJ function_NN in_IN HIV-infected_JJ Vietnamese_NNS with_IN generally_RB low_JJ weight_NN ._.
However_RB ,_, longer_JJR prospective_JJ studies_NNS are_VBP required_VBN to_TO determine_VB if_IN Aβ-related_JJ memory_NN decline_NN continues_VBZ and_CC whether_IN it_PRP is_VBZ associated_VBN with_IN increased_VBN rate_NN of_IN disease_NN progression_NN ._.
However_RB ,_, few_JJ prospective_JJ studies_NNS have_VBP investigated_VBN the_DT associations_NNS between_IN these_DT macronutrients_NNS and_CC incident_NN Crohn_NN 's_POS disease_NN -LRB-_-LRB- CD_NN -RRB-_-RRB- or_CC ulcerative_JJ colitis_NN -LRB-_-LRB- UC_NN -RRB-_-RRB- ._.
However_RB ,_, its_PRP$ relationship_NN with_IN rhythm_NN outcomes_NNS after_IN catheter_NN ablation_NN in_IN patients_NNS with_IN atrial_JJ fibrillation_NN -LRB-_-LRB- AF_NN -RRB-_-RRB- is_VBZ not_RB well_RB established_VBN ._.
However_RB ,_, the_DT role_NN of_IN AngII_NN in_IN mediating_VBG the_DT stimulation_NN of_IN -LRB-_-LRB- P_NN -RRB-_-RRB- RR_NN during_IN LS_NN conditions_NNS is_VBZ unknown_JJ ._.
However_RB ,_, the_DT neural_JJ underpinnings_NNS of_IN alcohol-induced_JJ impairment_NN of_IN inhibitory_JJ control_NN are_VBP widely_RB unknown_JJ ._.
However_RB ,_, the_DT high_JJ risk_NN of_IN perioperative_JJ complications_NNS associated_VBN with_IN surgery_NN may_MD outweigh_VB the_DT benefits_NNS of_IN improved_VBN pain_NN and/or_CC function_NN ._.
However_RB ,_, glycemic_JJ control_NN -LRB-_-LRB- GC_NN -RRB-_-RRB- protocols_NNS in_IN critically_RB ill_JJ patients_NNS limit_VBP the_DT development_NN of_IN hyperglycemia_NN despite_IN increasing_VBG insulin_NN resistance_NN ._.
However_RB ,_, the_DT complete_JJ lack_NN of_IN information_NN regarding_VBG NT-R_NN in_IN liver_NN metastases_NNS of_IN pancreatic_JJ cancer_NN and_CC pancreatic_JJ intraepithelial_JJ neoplasia_NN -LRB-_-LRB- PanIN_NN -RRB-_-RRB- makes_VBZ an_DT in_FW vitro_FW study_NN of_IN NT-R_NN in_IN these_DT tissues_NNS indispensable_JJ ._.
However_RB ,_, with_IN this_DT approach_NN ,_, the_DT suprascapular_JJ nerve_NN is_VBZ difficult_JJ to_TO visualize_VB by_IN ultrasound_NN ._.
However_RB ,_, with_IN INT_CD items_NNS ,_, its_PRP$ length_NN is_VBZ a_DT disadvantage_NN ._.
However_RB ,_, there_EX is_VBZ a_DT void_NN in_IN the_DT literature_NN assessing_VBG the_DT long-term_JJ retention_NN of_IN anatomical_JJ knowledge_NN by_IN medical_JJ students_NNS following_VBG teaching_NN by_IN whole-body_JJ dissection_NN ._.
However_RB ,_, objective_JJ real-time_JJ measurement_NN of_IN activities_NNS after_IN school_NN among_IN young_JJ school_NN children_NNS is_VBZ seldom_RB described_VBN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN their_PRP$ job_NN satisfaction_NN during_IN economic_JJ recessions_NNS ._.
However_RB ,_, elevated_JJ circulating_VBG endostatin_NN concentrations_NNS have_VBP been_VBN found_VBN in_IN several_JJ human_JJ cancers_NNS including_VBG colorectal_JJ cancer_NN -LRB-_-LRB- CRC_NN -RRB-_-RRB- ._.
However_RB ,_, LTL_NN is_VBZ modified_VBN by_IN age-dependent_JJ attrition_NN ._.
However_RB ,_, grafted_VBN fat_JJ tissue_NN is_VBZ not_RB initially_RB perfused_JJ and_CC relies_VBZ on_IN plasmatic_JJ diffusion_NN from_IN the_DT recipient_JJ bed_NN until_IN revascularization_NN occurs_VBZ ._.
However_RB ,_, reported_VBD optimal_JJ volumes_NNS in_IN literature_NN vary_VBP ,_, and_CC minimal_JJ volume_NN standards_NNS in_IN different_JJ countries_NNS show_VBP considerable_JJ variation_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN its_PRP$ use_NN by_IN young_JJ Africans_NNS in_IN the_DT urban_JJ context_NN ._.
However_RB ,_, the_DT long-term_JJ effects_NNS of_IN such_PDT a_DT protocol_NN were_VBD not_RB yet_RB studied_VBN ._.
However_RB ,_, the_DT mechanism_NN by_IN which_WDT ATF3_NN regulates_VBZ innate_JJ immunity_NN against_IN gram-positive_JJ bacterial_JJ infection_NN ,_, particularly_RB Streptococcus_NN pneumoniae_FW ,_, remains_VBZ unknown_JJ ._.
However_RB ,_, islet_NN infusions_NNS from_IN multiple_JJ donors_NNS are_VBP often_RB required_VBN to_TO achieve_VB insulin_NN independence_NN ._.
However_RB ,_, neurobiological_JJ correlates_NNS of_IN SLC6A4_NN promoter_NN methylation_NN have_VBP never_RB been_VBN studied_VBN or_CC compared_VBN to_TO genotype_NN effects_NNS by_IN means_NNS of_IN human_JJ neuroimaging_NN hitherto_RB
However_RB ,_, children_NNS 's_POS and_CC parents_NNS '_POS reports_NNS often_RB differ_VBP ._.
However_RB ,_, much_JJ suffering_NN is_VBZ not_RB `_`` painful_JJ '_'' and_CC may_MD be_VB under-recognised_JJ ._.
However_RB ,_, there_EX are_VBP no_DT studies_NNS about_IN the_DT impact_NN of_IN a_DT cardiac_JJ rehabilitation_NN -LRB-_-LRB- CR_NN -RRB-_-RRB- on_IN HRV_NN behaviour_NN after_IN OPCAB_NNP ._.
However_RB ,_, data_NNS about_IN the_DT influence_NN of_IN intraperitoneal_JJ fluid_NN on_IN body_NN composition_NN measures_NNS are_VBP conflicting_VBG ,_, and_CC there_EX is_VBZ no_DT clear_JJ consensus_NN about_IN whether_IN the_DT abdomen_NN should_MD be_VB drained_VBN before_IN the_DT procedure_NN ._.
However_RB ,_, recent_JJ clinical_JJ experience_NN demonstrates_VBZ that_IN the_DT ALT_NNP fascia-only_JJ flap_NN is_VBZ a_DT suitable_JJ option_NN for_IN reconstructions_NNS necessitating_VBG thin_JJ and_CC pliable_JJ coverage_NN ._.
However_RB ,_, the_DT extent_NN to_TO which_WDT these_DT processes_NNS might_MD be_VB differentially_RB modified_VBN by_IN psychotherapy_NN and_CC the_DT neural_JJ basis_NN of_IN such_JJ changes_NNS are_VBP unknown_JJ ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT role_NN of_IN this_DT SNP_NN in_IN increasing_VBG MYC_NN activity_NN in_IN colorectal_JJ cancers_NNS -LRB-_-LRB- CRCs_NNS -RRB-_-RRB- ._.
However_RB ,_, tumor_NN behavior_NN in_IN the_DT individual_JJ patient_NN is_VBZ unpredictable_JJ and_CC in_IN spite_NN of_IN treatment_NN advances_NNS ,_, a_DT classification_NN of_IN `_`` advanced_JJ stage_NN '_'' still_RB portends_VBZ a_DT poor_JJ prognosis_NN ._.
However_RB ,_, neural_JJ responses_NNS to_TO smoking_NN and_CC nonsmoking_JJ rewards_NNS are_VBP rarely_RB evaluated_VBN within_IN the_DT same_JJ paradigm_NN ,_, leaving_VBG the_DT extent_NN to_TO which_WDT both_DT processes_NNS operate_VBP simultaneously_RB uncertain_JJ ._.
However_RB ,_, little_JJ about_IN how_WRB miR-30a-3p_JJ functions_NNS in_IN these_DT cancers_NNS has_VBZ been_VBN reported_VBN ,_, and_CC the_DT role_NN of_IN miR-30a-3p_NN in_IN hepatocellular_JJ carcinoma_NN -LRB-_-LRB- HCC_NN -RRB-_-RRB- is_VBZ unknown_JJ ._.
However_RB ,_, research_NN has_VBZ shown_VBN that_IN the_DT inclusion_NN of_IN these_DT codes_NNS leads_VBZ to_TO false_JJ positives_NNS ._.
However_RB ,_, this_DT classic_JJ sequence_NN is_VBZ not_RB always_RB present_JJ and_CC only_RB a_DT few_JJ studies_NNS have_VBP addressed_VBN children_NNS at_IN risk_NN of_IN developing_VBG asthma_NN ._.
However_RB ,_, the_DT effectiveness_NN of_IN this_DT approach_NN has_VBZ not_RB been_VBN established_VBN ._.
However_RB ,_, the_DT relationship_NN between_IN water_NN intake_NN and_CC childhood_NN cognitive_JJ control_NN remains_VBZ inadequately_RB studied_VBN ._.
However_RB ,_, the_DT effects_NNS of_IN M2-AA_NN on_IN the_DT cardiac_JJ function_NN during_IN the_DT process_NN of_IN DCM_NNP and_CC the_DT potential_JJ mechanisms_NNS are_VBP not_RB fully_RB known_VBN ._.
However_RB ,_, no_DT relationship_NN with_IN other_JJ measures_NNS in_IN the_DT Global_JJ Initiative_NNP for_IN Obstructive_JJ Lung_NN Disease_NN -LRB-_-LRB- GOLD_NN -RRB-_-RRB- strategy_NN has_VBZ been_VBN evaluated_VBN ._.
However_RB in_IN recent_JJ studies_NNS ,_, synchronous_JJ and_CC metachronous_JJ metastases_NNS were_VBD always_RB lumped_VBN together_RB ,_, neglecting_VBG their_PRP$ clinical_JJ and_CC molecular_JJ differences_NNS ._.
However_RB ,_, reported_VBD ASD_NN recurrence_NN rates_NNS have_VBP not_RB demonstrated_VBN significantly_RB increased_VBN risk_NN to_TO siblings_NNS of_IN affected_JJ girls_NNS ._.
However_RB ,_, distinct_JJ study_NN cohorts_NNS and_CC different_JJ quantification_NN techniques_NNS allow_VBP only_RB for_IN an_DT indirect_JJ comparison_NN between_IN the_DT different_JJ tracers_NNS ._.
However_RB ,_, there_EX are_VBP few_JJ validated_VBN measures_NNS to_TO assess_VB attitudes_NNS or_CC purchase_NN intentions_NNS toward_IN contraband_NN tobacco_NN -LRB-_-LRB- CT_NN -RRB-_-RRB- ._.
However_RB ,_, whether_IN the_DT dynamic_JJ expression_NN pattern_NN of_IN B7-H3_NN contributes_VBZ to_TO early_JJ invasion_NN of_IN HCC_NNP is_VBZ largely_RB unknown_JJ ._.
However_RB ,_, a_DT pertinent_JJ question_NN is_VBZ how_WRB this_DT new_JJ economic_JJ status_NN has_VBZ impacted_VBN on_IN the_DT wealth_NN and_CC health_NN of_IN her_PRP$ citizens_NNS ._.
However_RB ,_, we_PRP found_VBD few_JJ studies_NNS focusing_VBG on_IN older_JJR patients_NNS '_POS experiences_NNS of_IN cardiac_JJ surgery_NN ._.
However_RB ,_, less_JJR is_VBZ known_VBN about_IN the_DT unique_JJ relationships_NNS between_IN discrete_JJ DSM-IV_NN panic_NN symptoms_NNS and_CC higher_JJR suicidality_NN ._.
However_RB ,_, no_DT study_NN has_VBZ assessed_VBN the_DT association_NN between_IN high-risk_JJ alcohol_NN consumption_NN and_CC the_DT presence_NN of_IN anxiety_NN and_CC depression_NN in_IN individuals_NNS with_IN type_NN INT_CD diabetes_NN mellitus_NN -LRB-_-LRB- 1DM_NN -RRB-_-RRB- ._.
However_RB ,_, it_PRP is_VBZ said_VBN to_TO be_VB difficult_JJ to_TO differentiate_VB pre-existing_JJ type_NN scoliosis_NN from_IN de_FW novo_FW type_NN scoliosis_NN ._.
However_RB ,_, it_PRP is_VBZ often_RB difficult_JJ to_TO find_VB an_DT appropriate_JJ implant_VB for_IN thin_JJ Asian_JJ women_NNS with_IN small_JJ breasts_NNS ._.
However_RB ,_, the_DT precise_JJ relationship_NN between_IN drug_NN resistance_NN in_IN S._NNP pombe_FW and_CC external_JJ potassium_NN concentrations_NNS -LRB-_-LRB- particularly_RB in_IN its_PRP$ natural_JJ habitats_NNS -RRB-_-RRB- remains_VBZ unclear_JJ ._.
However_RB ,_, the_DT association_NN between_IN SIRT1_NN expression_NN and_CC clinicopathological_JJ parameters_NNS and_CC prognosis_NN in_IN breast_NN cancer_NN remains_VBZ inconclusive_JJ ._.
However_RB ,_, current_JJ reference_NN intervals_NNS established_VBN by_IN older_JJR instruments_NNS and_CC technologies_NNS and_CC those_DT from_IN American_JJ and_CC European_JJ populations_NNS are_VBP not_RB suitable_JJ for_IN Chinese_JJ samples_NNS due_JJ to_TO ethnic_JJ ,_, dietary_JJ ,_, and_CC lifestyle_NN differences_NNS ._.
However_RB ,_, it_PRP is_VBZ possible_JJ that_IN repeated_VBN evaluations_NNS of_IN sCr_NN during_IN hospitalization_NN ,_, rather_RB than_IN measuring_VBG sCr_NN value_NN at_IN admission_NN only_RB ,_, might_MD improve_VB risk_NN assessment_NN ._.
However_RB ,_, no_DT randomized_VBN controlled_JJ trials_NNS of_IN DBS_NNP for_IN TRD_NNP have_VBP been_VBN published_VBN ._.
However_RB ,_, the_DT effects_NNS of_IN HPIV3_NN infection_NN on_IN nasal_JJ epithelial_JJ cells_NNS have_VBP not_RB been_VBN well_RB defined_VBN ._.
However_RB ,_, imprecision_NN of_IN the_DT currently_RB available_JJ biomarkers_NNS have_VBP impaired_JJ effective_JJ therapies_NNS in_IN a_DT timely_JJ manner_NN ._.
However_RB ,_, the_DT results_NNS are_VBP inconsistent_JJ ._.
However_RB ,_, ECMO_NNP is_VBZ a_DT highly_RB invasive_JJ and_CC risky_JJ procedure_NN with_IN devastating_VBG complications_NNS such_JJ as_IN intracranial_JJ hemorrhage_NN -LRB-_-LRB- ICH_NN -RRB-_-RRB- ._.
However_RB ,_, risk_NN factors_NNS for_IN developing_VBG severe_JJ liver_NN disease_NN in_IN the_DT morbidly_RB obese_JJ remain_VBP unknown_JJ ._.
However_RB ,_, some_DT case_NN reports_VBZ described_VBN seat_NN belt_NN use_NN as_IN a_DT double-edged_JJ sword_NN because_IN some_DT injuries_NNS are_VBP related_JJ to_TO seat_NN belt_NN use_NN in_IN motor_NN vehicle_NN crashes_NNS ._.
However_RB ,_, several_JJ studies_NNS have_VBP attempted_VBN to_TO determine_VB the_DT value_NN of_IN the_DT Gram_NN stain_VB in_IN the_DT diagnosis_NN and_CC therapy_NN of_IN bacterial_JJ infection_NN in_IN different_JJ populations_NNS of_IN patients_NNS with_IN ventilator-associated_JJ pneumonia_NN -LRB-_-LRB- VAP_NN -RRB-_-RRB- with_IN conflicting_VBG results_NNS ._.
However_RB ,_, the_DT safety_NN and_CC tolerability_NN of_IN -LRB-_-LRB- INT_CD -RRB-_-RRB- I_PRP seed_NN sequential_JJ irradiation_NN therapy_NN remain_VBP unclear_JJ ,_, there_EX is_VBZ no_DT unified_JJ standard_NN of_IN brachytherapy_NN radiation_NN dose_NN ,_, and_CC further_JJ study_NN on_IN the_DT basic_JJ radiobiology_NN of_IN continuous_JJ rate_NN irradiation_NN is_VBZ necessary_JJ ._.
However_RB ,_, the_DT antipsychotic_JJ properties_NNS of_IN repeated_VBN CBD_NN treatment_NN have_VBP been_VBN poorly_RB investigated_VBN ._.
However_RB ,_, there_EX is_VBZ little_JJ data_NNS analyzing_VBG the_DT relative_JJ effectiveness_NN of_IN FOR_IN for_IN radiculopathy_NN due_JJ to_TO soft_JJ disc_NN versus_CC osteophyte_NN disease_NN ._.
However_RB ,_, reasons_NNS for_IN cardiovascular_JJ therapies_NNS discontinuation_NN after_IN hospital_NN discharge_NN are_VBP poorly_RB reported_VBN in_IN previous_JJ studies_NNS ._.
However_RB ,_, its_PRP$ predictive_JJ value_NN has_VBZ not_RB been_VBN fully_RB established_VBN ._.
However_RB ,_, the_DT correlation_NN between_IN T-cadherin_JJ hypermethylation_NN and_CC clinicopathological_JJ characteristics_NNS of_IN NSCLC_NN remains_VBZ unclear_JJ ._.
However_RB ,_, the_DT impact_NN of_IN these_DT therapies_NNS on_IN commensals_NNS -LRB-_-LRB- Corynebacterium_NN -RRB-_-RRB- and_CC on_IN biofilm_NN pathogens_NNS associated_VBN with_IN CRS_NNP -LRB-_-LRB- Staphylococcus_FW aureus_FW and_CC Pseudomonas_FW -RRB-_-RRB- is_VBZ not_RB well_RB characterized_VBN ._.
However_RB ,_, findings_NNS have_VBP not_RB been_VBN consistent_JJ across_IN studies_NNS in_IN this_DT population_NN ._.
However_RB ,_, the_DT role_NN of_IN these_DT cells_NNS in_IN the_DT progression_NN from_IN acute_JJ viral_JJ myocarditis_NN -LRB-_-LRB- AVMC_NN -RRB-_-RRB- to_TO dilated_JJ cardiomyopathy_NN -LRB-_-LRB- DCM_NN -RRB-_-RRB- and_CC myocardial_JJ fibrosis_NN remains_VBZ unknown_JJ ._.
However_RB ,_, no_DT study_NN has_VBZ reported_VBN the_DT efficacy_NN and_CC safety_NN of_IN raltitrexed_VBN in_IN intraperitoneal_JJ chemotherapy_NN ._.
However_RB ,_, it_PRP is_VBZ not_RB clear_JJ whether_IN they_PRP act_VBP simultaneously_RB during_IN illness_NN states_NNS in_IN major_JJ psychiatric_JJ disorders_NNS ._.
However_RB ensuring_VBG adherence_NN and_CC monitoring_NN adverse_JJ effects_NNS is_VBZ more_RBR difficult_JJ ._.
However_RB ,_, hitherto_RB established_VBN questionnaires_NNS did_VBD not_RB focus_VB on_IN these_DT symptoms_NNS ._.
However_RB ,_, the_DT determinants_NNS of_IN exercise_NN capacity_NN reduction_NN in_IN MR_NN have_VBP remained_VBN unclear_JJ ._.
However_RB ,_, induced_VBD growth_NN of_IN cashmere_JJ fleece_NN by_IN melatonin_NN implants_NNS can_MD not_RB be_VB combined_VBN with_IN the_DT typical_JJ growth_NN ,_, resulting_VBG in_IN earlier_JJR shedding_VBG followed_VBN by_IN another_DT cycle_NN of_IN cashmere_JJ growth_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN more_RBR complex_JJ gait_NN tasks_NNS that_WDT require_VBP planning_NN of_IN gait_NN adaptations_NNS to_TO cross_VB over_IN an_DT obstacle_NN in_IN PD_NN ._.
However_RB ,_, technical_JJ questions_NNS remain_VBP ._.
However_RB these_DT may_MD hide_VB many_JJ disparities_NNS dues_NNS to_TO cultural_JJ specificities_NNS which_WDT may_MD differ_VB across_IN geographic_JJ areas_NNS of_IN the_DT country_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN district_NN health_NN managing_NN practices_NNS and_CC time_NN allocation_NN in_IN resource-constrained_JJ health_NN systems_NNS ._.
However_RB ,_, most_JJS of_IN these_DT methods_NNS were_VBD difficult_JJ to_TO operate_VB in_IN real-time_JJ because_IN of_IN their_PRP$ complexity_NN or_CC computational_JJ requirements_NNS ._.
However_RB ,_, this_DT finding_NN has_VBZ never_RB been_VBN studied_VBN with_IN regard_NN to_TO whole-body_JJ insulin-sensitivity_NN as_IN a_DT possible_JJ regulator_NN ._.
However_RB ,_, it_PRP is_VBZ still_RB unclear_JJ whether_IN a_DT chronic_JJ course_NN of_IN these_DT health_NN conditions_NNS is_VBZ also_RB prospectively_RB associated_VBN with_IN incidence_NN of_IN disability_NN ._.
However_RB ,_, the_DT effects_NNS of_IN CrS_NN on_IN systemic_JJ microvascular_JJ reactivity_NN and_CC density_NN have_VBP never_RB been_VBN reported_VBN ._.
However_RB ,_, alternative_JJ prostate-specific_JJ antigen_NN -LRB-_-LRB- PSA_NN -RRB-_-RRB- screening_NN strategies_NNS for_IN the_DT population_NN may_MD exist_VB ,_, optimizing_VBG the_DT effects_NNS on_IN mortality_NN reduction_NN ,_, quality_NN of_IN life_NN ,_, overdiagnosis_NN ,_, and_CC costs_NNS ._.
However_RB ,_, its_PRP$ use_NN in_IN patients_NNS with_IN benign_JJ anastomotic_JJ stricture_NN after_IN laparoscopy-assisted_JJ gastrectomy_NN -LRB-_-LRB- LAG_NN -RRB-_-RRB- is_VBZ not_RB well_RB established_VBN ._.
However_RB ,_, the_DT exact_JJ mechanisms_NNS that_WDT contribute_VBP to_TO the_DT initial_JJ production_NN of_IN precursor_NN IL-1β_NN -LRB-_-LRB- pro-IL-1β_NN -RRB-_-RRB- are_VBP still_RB unclear_JJ ._.
However_RB ,_, both_CC the_DT etiology_NN and_CC mechanisms_NNS associated_VBN with_IN SHS_NN are_VBP still_RB unclear_JJ ._.
However_RB ,_, its_PRP$ adoption_NN rate_NN remains_VBZ low_JJ ,_, especially_RB in_IN developing_VBG countries_NNS due_JJ to_TO technological_JJ ,_, financial_JJ ,_, and_CC organizational_JJ factors_NNS ._.
However_RB ,_, little_JJ is_VBZ known_VBN of_IN the_DT performance_NN of_IN MRI-compatible_JJ ventilators_NNS ._.
However_RB the_DT role_NN of_IN SDHB_NN in_IN ovarian_JJ cancer_NN is_VBZ still_RB unclear_JJ ._.
However_RB ,_, the_DT currently_RB available_JJ studies_NNS on_IN balance_NN in_IN AIS_NN patients_NNS are_VBP not_RB consistent_JJ ._.
However_RB ,_, the_DT specific_JJ method_NN for_IN GDNF_NNP detection_NN is_VBZ also_RB un-discovered_JJ ._.
However_RB ,_, they_PRP were_VBD conducted_VBN in_IN countries_NNS culturally_RB and_CC legally_RB different_JJ from_IN European_JJ countries_NNS and_CC were_VBD limited_VBN to_TO cross-sectional_JJ designs_NNS ._.
However_RB ,_, the_DT role_NN of_IN neurohormones_NNS in_IN orthostatic_JJ intolerance_NN has_VBZ not_RB been_VBN explained_VBN ._.
However_RB ,_, data_NNS concerning_VBG efficacy_NN with_IN anakinra_NN use_NN in_IN different_JJ clinical_JJ trials_NNS has_VBZ not_RB been_VBN evaluated_VBN ,_, and_CC the_DT overall_JJ remission_NN of_IN AoSD_NN with_IN anakinra_NN treatment_NN has_VBZ not_RB been_VBN well_RB defined_VBN ._.
However_RB ,_, the_DT role_NN played_VBN by_IN the_DT mitochondria_NN in_IN the_DT cardioprotective_JJ effects_NNS of_IN therapeutic_JJ hypothermia_NN remains_VBZ unclear_JJ ._.
However_RB ,_, few_JJ studies_NNS have_VBP examined_VBN associations_NNS between_IN inflammatory_JJ markers_NNS and_CC hippocampal_JJ volume_NN ,_, and_CC none_NN have_VBP examined_VBN these_DT associations_NNS in_IN the_DT context_NN of_IN PTSD_NN ._.
However_RB ,_, these_DT BP_NNP criteria_NNS are_VBP quite_RB difficult_JJ for_IN use_NN by_IN professionals_NNS in_IN the_DT clinic_NN or_CC children_NNS and_CC their_PRP$ parents_NNS ._.
However_RB ,_, microbubbles_NNS also_RB suffer_VBP from_IN limitations_NNS such_JJ as_IN low_JJ spatial_JJ selectivity_NN and_CC short_JJ circulation_NN time_NN in_FW vivo_FW ._.
However_RB ,_, the_DT optimal_JJ shape_NN of_IN a_DT radial_JJ head_NN implant_VBP to_TO ensure_VB proper_JJ tracking_NN relative_JJ to_TO the_DT capitellum_NN has_VBZ not_RB been_VBN established_VBN ._.
However_RB ,_, simply_RB applying_VBG a_DT news-trained_JJ entity_NN linker_NN produces_VBZ inadequate_JJ results_NNS ._.
However_RB ,_, the_DT short-term_JJ action_NN of_IN this_DT combination_NN on_IN the_DT nitric_JJ oxide_NN -LRB-_-LRB- NO_NN -RRB-_-RRB- -_: cGMP_NN pathway_NN remains_VBZ to_TO be_VB elucidated_VBN ._.
However_RB ,_, its_PRP$ expression_NN and_CC clinicopathological_JJ significance_NN in_IN hepatocellular_JJ carcinoma_NN -LRB-_-LRB- HCC_NN -RRB-_-RRB- has_VBZ not_RB been_VBN entirely_RB clarified_VBN ._.
However_RB ,_, many_JJ relapse_NN after_IN treatment_NN ._.
However_RB ,_, there_EX is_VBZ concern_NN regarding_VBG the_DT safety_NN of_IN performing_VBG SET_NNP because_IN IC_NN patients_NNS are_VBP at_IN risk_NN for_IN untoward_JJ cardiovascular_JJ events_NNS ._.
However_RB ,_, its_PRP$ role_NN in_IN breast_NN cancer_NN -LRB-_-LRB- BC_NN -RRB-_-RRB- remains_VBZ unknown_JJ ._.
However_RB ,_, the_DT anterior_JJ branch_NN frequently_RB courses_NNS within_IN the_DT lesser_JJR wing_NN of_IN the_DT sphenoid_JJ bone_NN and_CC can_MD easily_RB be_VB damaged_VBN during_IN craniotomy_NN for_IN bypass_NN surgery_NN ._.
However_RB ,_, there_EX is_VBZ currently_RB little_JJ insight_NN into_IN whether_IN adverse_JJ pregnancy_NN outcomes_NNS are_VBP more_RBR common_JJ among_IN migrant_JJ women_NNS of_IN refugee_NN background_NN ,_, compared_VBN to_TO women_NNS who_WP have_VBP migrated_VBN for_IN non-humanitarian_JJ reasons_NNS ._.
However_RB ,_, in_IN clinical_JJ practice_NN ,_, none_NN of_IN the_DT components_NNS are_VBP more_RBR important_JJ than_IN the_DT cannula_NN ._.
However_RB ,_, there_EX are_VBP still_RB many_JJ errors_NNS with_IN INDEL_NN variant_JJ calling_NN ,_, driven_VBN by_IN library_NN preparation_NN ,_, sequencing_NN biases_NNS ,_, and_CC algorithm_NN artifacts_NNS ._.
However_RB ,_, there_EX remains_VBZ a_DT dearth_NN of_IN evidence_NN guiding_VBG treatment_NN in_IN various_JJ stages_NNS of_IN CE_NN ._.
However_RB ,_, it_PRP is_VBZ often_RB used_VBN in_IN patients_NNS with_IN coronary_JJ artery_NN disease_NN -LRB-_-LRB- CAD_NN -RRB-_-RRB- ,_, peripheral_JJ artery_NN disease_NN -LRB-_-LRB- PAD_NN -RRB-_-RRB- ,_, before_IN heart_NN surgery_NN ,_, syncope_NN and_CC non-specific_JJ neurological_JJ symptoms_NNS although_IN its_PRP$ value_NN is_VBZ unclear_JJ ._.
However_RB ,_, there_EX is_VBZ uncertainty_NN about_IN the_DT significance_NN and_CC cause_NN of_IN persistence_NN of_IN high_JJ IgG_NN phase_NN I_PRP antibody_NN titres_NNS in_IN patients_NNS that_WDT do_VBP not_RB have_VB any_DT additional_JJ manifestations_NNS of_IN chronic_JJ Q_NNP fever_NN ._.
However_RB ,_, the_DT direct_JJ role_NN of_IN NPR-A_NN signaling_NN in_IN gastric_JJ cancer_NN remains_VBZ unclear_JJ ._.
However_RB ,_, ICU_NN admission_NN of_IN these_DT patients_NNS might_MD also_RB result_VB in_IN administration_NN of_IN specific_JJ anticancer_JJ treatments_NNS and_CC evaluation_NN of_IN tumor_NN characteristics_NNS ,_, which_WDT could_MD influence_VB long-term_JJ outcomes_NNS ._.
However_RB ,_, it_PRP remains_VBZ unclear_JJ which_WDT comorbidities_NNS are_VBP predictors_NNS of_IN PCs_NNS in_IN patients_NNS who_WP undergo_VBP laparoscopy-assisted_JJ gastrectomy_NN -LRB-_-LRB- LAG_NN -RRB-_-RRB- ._.
However_RB ,_, within_IN an_DT outbreak_NN ,_, it_PRP can_MD be_VB difficult_JJ to_TO identify_VB the_DT routes_NNS of_IN cross-infection_NN rapidly_RB and_CC accurately_RB enough_JJ to_TO inform_VB infection_NN control_NN ._.
However_RB ,_, supporting_VBG data_NNS for_IN such_PDT a_DT service_NN development_NN are_VBP limited_VBN ._.
However_RB ,_, their_PRP$ ability_NN in_IN inhibiting_VBG viral_JJ infections_NNS has_VBZ not_RB yet_RB been_VBN tested_VBN ._.
However_RB ,_, we_PRP do_VBP not_RB have_VB sufficient_JJ information_NN regarding_VBG the_DT medical_JJ care_NN provided_VBN to_TO nonfatal_JJ self-harm_NN episodes_NNS preceding_VBG suicide_NN ._.
However_RB ,_, in_IN our_PRP$ recent_JJ distributed_VBN effects_NNS model_NN of_IN ADHD_NNP ,_, we_PRP surmised_VBD that_IN this_DT phenotype_NN is_VBZ not_RB ADHD_NN specific_JJ ,_, but_CC rather_RB more_RBR broadly_RB reflective_JJ of_IN any_DT circumstance_NN that_WDT disrupts_VBZ the_DT induction_NN and_CC maintenance_NN of_IN an_DT emergent_JJ task-directed_JJ neural_JJ architecture_NN ._.
However_RB ,_, long-term_JJ benefits_NNS of_IN the_DT treatment_NN might_MD be_VB limited_VBN owing_VBG to_TO the_DT occurrence_NN of_IN drug_NN resistance_NN ._.
However_RB ,_, it_PRP is_VBZ not_RB fully_RB understood_VBN how_WRB forebrain_NN activity_NN is_VBZ altered_VBN in_IN FH_NN +_CC individuals_NNS ,_, and_CC ultimately_RB how_WRB these_DT alterations_NNS may_MD contribute_VB to_TO substance_NN use_NN disorder_NN risk_NN ._.
However_RB ,_, since_IN there_EX is_VBZ still_RB no_DT consensus_NN on_IN the_DT real_JJ situation_NN of_IN Chinese_JJ WCH_NN professionals_NNS ,_, we_PRP aim_VBP with_IN this_DT study_NN to_TO compare_VB the_DT actual_JJ and_CC required_JJ amount_NN of_IN WCH_NN professionals_NNS for_IN China_NNP ._.
However_RB ,_, the_DT literature_NN is_VBZ inconclusive_JJ in_IN this_DT regard_NN ._.
However_RB ,_, there_EX is_VBZ limited_VBN information_NN regarding_VBG the_DT relationship_NN between_IN dietary_JJ PI_NN and_CC glomerular_JJ histological_JJ changes_NNS in_IN chronic_JJ kidney_NN disease_NN ._.
However_RB ,_, only_RB a_DT few_JJ studies_NNS have_VBP compared_VBN the_DT complications_NNS and_CC the_DT outcomes_NNS following_VBG pelvic_JJ exenteration_NN between_IN cases_NNS with_IN and_CC without_IN a_DT VRAM_NNP flap_NN ._.
However_RB ,_, the_DT cytokine_NN interactions_NNS that_WDT characterize_VBP PTB_NN coincident_JJ with_IN pre-diabetes_NNS -LRB-_-LRB- PDM_NN -RRB-_-RRB- are_VBP not_RB known_VBN ._.
However_RB ,_, previous_JJ investigations_NNS have_VBP discussed_VBN the_DT role_NN of_IN SUVmax_NN without_IN distinguishing_VBG among_IN the_DT histological_JJ subtypes_NNS of_IN lung_NN cancer_NN ._.
However_RB ,_, the_DT data_NNS regarding_VBG an_DT association_NN between_IN an_DT increased_VBN risk_NN for_IN arthroplasty_NN infection_NN after_IN an_DT intraarticular_JJ steroid_NN injection_NN are_VBP still_RB conflicting_VBG ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN patient_NN filed_VBD compensation_NN claims_NNS related_VBN to_TO the_DT chiropractic_NN consultation_NN process_NN ._.
However_RB ,_, it_PRP is_VBZ unknown_JJ whether_IN UA_NNP relates_VBZ to_TO nigral_JJ iron_NN deposition_NN ,_, which_WDT is_VBZ a_DT characteristic_JJ pathophysiological_JJ alteration_NN in_IN PD_NN ._.
However_RB ,_, additional_JJ knowledge_NN about_IN the_DT in_FW vivo_FW effect_NN in_IN humans_NNS is_VBZ needed_VBN ,_, and_CC reported_VBD associations_NNS with_IN genital_JJ abnormalities_NNS are_VBP inconclusive_JJ ._.
However_RB ,_, the_DT role_NN of_IN SNPs_NNS in_IN chronic_JJ HBV_NN infection_NN in_IN children_NNS remains_VBZ unclear_JJ ._.
However_RB ,_, the_DT effectiveness_NN and_CC safety_NN of_IN tourniquets_NNS are_VBP debated_VBN ._.
However_RB ,_, the_DT majority_NN of_IN SDB_NN patients_NNS remain_VBP undiagnosed_JJ ._.
However_RB ,_, the_DT deployment_NN of_IN the_DT device_NN across_IN the_DT septum_NN using_VBG the_DT conventional_JJ method_NN presents_VBZ difficulties_NNS in_IN large_JJ ASDs_NNS ._.
However_RB there_EX is_VBZ a_DT limited_JJ amount_NN of_IN evidence_NN that_IN some_DT patients_NNS suffer_VBP enduring_VBG consequences_NNS as_IN a_DT result_NN of_IN this_DT `_`` transient_JJ '_'' event_NN ._.
However_RB ,_, both_DT indexes_NNS might_MD be_VB conflicting_VBG as_IN far_RB as_IN grade_NN is_VBZ concerned_VBN ._.
However_RB ,_, there_EX has_VBZ been_VBN limited_VBN research_NN into_IN controlling_VBG such_JJ pain_NN ._.
However_RB ,_, most_JJS of_IN current_JJ methods_NNS are_VBP unsupervised_JJ learning_NN based_VBN methods_NNS which_WDT ca_MD n't_RB utilize_VB the_DT information_NN of_IN the_DT large_JJ amount_NN of_IN available_JJ known_JJ complexes_NNS ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT role_NN of_IN HSPB1_NN in_IN autophagy_NN and_CC apoptosis_NN in_IN the_DT pathogenesis_NN of_IN AKI_NNP ._.
However_RB ,_, there_EX is_VBZ no_DT simple_JJ ,_, convenience_NN scoring_VBG system_NN to_TO identify_VB risk_NN of_IN adverse_JJ outcomes_NNS ._.
However_RB ,_, its_PRP$ acceptability_NN by_IN study_NN participants_NNS is_VBZ unclear_JJ ._.
However_RB ,_, the_DT utilization_NN of_IN SAD_NN requires_VBZ specific_JJ validation_NN for_IN each_DT ethnicity_NN ._.
However_RB ,_, the_DT magnitude_NN of_IN this_DT problem_NN remains_VBZ largely_RB uninvestigated_JJ despite_IN having_VBG the_DT largest_JJS number_NN of_IN population_NN with_IN HIV/AIDS_NN ._.
However_RB ,_, there_EX is_VBZ little_JJ understanding_NN of_IN how_WRB patients_NNS decide_VBP where_WRB to_TO seek_VB cancer_NN care_NN ._.
However_RB ,_, little_JJ information_NN is_VBZ available_JJ regarding_VBG correlations_NNS between_IN platelet_NN count_NN and_CC these_DT complications_NNS ._.
However_RB ,_, the_DT clinical_JJ utility_NN of_IN pedigree_NN development_NN is_VBZ still_RB unknown_JJ ._.
However_RB ,_, the_DT current_JJ classification_NN system_NN fails_VBZ to_TO reflect_VB the_DT heterogeneous_JJ characteristics_NNS of_IN the_DT disease_NN ._.
However_RB ,_, the_DT effectiveness_NN of_IN cisplatin_NN treatment_NN diminishes_VBZ quickly_RB as_IN cancer_NN cells_NNS develop_VBP resistance_NN to_TO the_DT drug_NN ,_, which_WDT eventually_RB results_VBZ in_IN treatment_NN failure_NN ._.
However_RB ,_, randomized_VBN controlled_JJ trials_NNS of_IN selenium_NN supplementation_NN have_VBP reported_VBN conflicting_JJ results_NNS ._.
However_RB ,_, clinical_JJ outcomes_NNS associated_VBN with_IN adoption_NN of_IN this_DT recommendation_NN have_VBP not_RB been_VBN studied_VBN ._.
However_RB ,_, duodenal_JJ biopsy_NN remains_VBZ the_DT gold_JJ standard_NN in_IN adult_JJ coeliac_NN disease_NN ._.
However_RB ,_, to_TO the_DT authors_NNS '_POS knowledge_NN ,_, the_DT effect_NN of_IN radiation_NN therapy_NN -LRB-_-LRB- RT_NN -RRB-_-RRB- on_IN CTCs_NNS in_IN patients_NNS with_IN non-small_JJ cell_NN lung_NN cancer_NN -LRB-_-LRB- NSCLC_NN -RRB-_-RRB- has_VBZ not_RB been_VBN previously_RB explored_VBN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN supplement_NN use_NN in_IN patients_NNS with_IN HCC_NN ._.
However_RB ,_, the_DT effectiveness_NN of_IN the_DT traditional_JJ prophylactic_NN bolus_NN in_IN parturients_NNS undergoing_VBG spinal_JJ anesthesia_NN for_IN cesarean_NN delivery_NN has_VBZ been_VBN questioned_VBN ._.
However_RB ,_, the_DT use_NN of_IN cytostatics_NNS as_IN adjunctive_JJ treatment_NN is_VBZ limited_VBN due_JJ to_TO their_PRP$ adverse_JJ side-effects_NNS ,_, low_JJ biodistribution_NN after_IN intravenous_JJ administration_NN and_CC multidrug_JJ resistance_NN ._.
However_RB ,_, the_DT processes_NNS that_WDT promote_VBP resilience_NN have_VBP not_RB been_VBN well_RB assessed_VBN within_IN the_DT UK_NNP military_NN ._.
However_RB ,_, there_EX are_VBP no_DT published_VBN data_NNS to_TO support_VB this_DT view_NN ._.
However_RB ,_, in_IN FLOAT_CD %_NN of_IN all_DT nipple_JJ discharge_NN ,_, it_PRP is_VBZ caused_VBN by_IN breast_NN cancer_NN ._.
However_RB ,_, the_DT long-term_JJ effect_NN of_IN CA_NNP coverage_NN on_IN foregut_NN perfusion_NN is_VBZ unknown_JJ ._.
However_RB ,_, the_DT importance_NN of_IN psychosocial_JJ factors_NNS for_IN successful_JJ disease_NN management_NN is_VBZ under_IN investigated_VBN ._.
However_RB ,_, structural_JJ alterations_NNS in_IN this_DT region_NN have_VBP not_RB been_VBN a_DT consistent_JJ finding_NN and_CC functional_JJ imaging_NN studies_NNS have_VBP also_RB implicated_VBN additional_JJ areas_NNS ._.
However_RB ,_, evolving_VBG data_NNS indicate_VBP that_IN many_JJ patients_NNS have_VBP persistent_JJ symptoms_NNS and_CC diminished_VBN health-related_JJ quality_NN of_IN life_NN -LRB-_-LRB- HRQOL_NN -RRB-_-RRB- long_RB after_IN acute_JJ attacks_NNS ._.
However_RB ,_, an_DT algorithm_NN to_TO select_VB the_DT most_RBS suitable_JJ treatment_NN option_NN for_IN the_DT individual_JJ patient_NN is_VBZ lacking_VBG ._.
However_RB ,_, little_JJ is_VBZ known_VBN on_IN the_DT relation_NN of_IN these_DT MRI_NNP markers_NNS with_IN daily_JJ functioning_VBG in_IN nondemented_JJ individuals_NNS ._.
However_RB ,_, the_DT treatment_NN is_VBZ often_RB suboptimal_JJ and_CC is_VBZ associated_VBN with_IN adverse_JJ effects_NNS ._.
However_RB ,_, the_DT field_NN of_IN foregut_NN and_CC bariatric_NN surgery_NN is_VBZ still_RB evolving_VBG ._.
However_RB ,_, the_DT full_JJ relationship_NN between_IN gingivitis_NN and_CC COHRQoL_NN has_VBZ been_VBN assessed_VBN by_IN only_RB a_DT small_JJ number_NN of_IN studies_NNS ._.
However_RB ,_, very_RB little_JJ is_VBZ currently_RB known_VBN of_IN the_DT molecular_JJ basis_NN of_IN borderline_JJ Hb_NN A2_NN in_IN Chinese_JJ individuals_NNS ._.
However_RB ,_, they_PRP are_VBP being_VBG increasingly_RB used_VBN as_IN hemodialysis_NN vascular_JJ access_NN ._.
However_RB ,_, data_NNS of_IN QT_NN dispersion_NN in_IN HIV-infected_JJ patients_NNS receiving_VBG a_DT combined_JJ antiretroviral_JJ therapy_NN -LRB-_-LRB- cART_NN -RRB-_-RRB- is_VBZ limited_VBN ._.
However_RB ,_, very_RB little_JJ information_NN is_VBZ available_JJ about_IN its_PRP$ role_NN and_CC underlying_VBG mechanism_NN in_IN innate_JJ immunity_NN ._.
However_RB ,_, this_DT may_MD be_VB subject_JJ to_TO incorrect_JJ interpretation_NN ._.
However_RB ,_, the_DT clinical_JJ value_NN of_IN serum_NN HER2-extracellular_JJ domain_NN -LRB-_-LRB- ECD_NN -RRB-_-RRB- in_IN gastric_JJ cancer_NN has_VBZ not_RB yet_RB been_VBN defined_VBN ._.
However_RB ,_, there_EX is_VBZ a_DT lack_NN of_IN specific_JJ studies_NNS in_IN the_DT literature_NN regarding_VBG the_DT morbidity_NN and_CC mortality_NN of_IN XLA_NN patients_NNS ._.
However_RB ,_, data_NNS on_IN IDVG_NN in_IN children_NNS are_VBP lacking_VBG ._.
However_RB ,_, the_DT role_NN of_IN miR-449a_NN in_IN gastric_JJ cancer_NN -LRB-_-LRB- GC_NN -RRB-_-RRB- remains_VBZ largely_RB unknown_JJ ._.
However_RB ,_, many_JJ patients_NNS with_IN acute_JJ coronary_JJ syndrome_NN -LRB-_-LRB- ACS_NN -RRB-_-RRB- have_VBP low_JJ CAC_NN score_NN ._.
However_RB ,_, the_DT precise_JJ impact_NN of_IN pre-transplant_JJ ATG_NN on_IN immune_JJ recovery_NN after_IN PBSCT_NNP is_VBZ still_RB poorly_RB documented_VBN ._.
However_RB ,_, studies_NNS on_IN its_PRP$ relationship_NN with_IN hypertension_NN ,_, a_DT single_JJ and_CC common_JJ cause_NN of_IN various_JJ chronic_JJ diseases_NNS ,_, are_VBP limited_JJ and_CC their_PRP$ findings_NNS are_VBP not_RB consistent_JJ ._.
However_RB ,_, short_JJ half-life_NN and_CC rapid_JJ degraded_VBN by_IN DPP-IV_NN limits_VBZ the_DT therapeutic_JJ potential_NN of_IN the_DT native_JJ GLP-1_NN ._.
However_RB ,_, there_EX is_VBZ little_JJ metabolic_JJ profile_NN data_NNS available_JJ about_IN Korean_JJ Hanwoo_NNP cows_NNS ._.
However_RB ,_, earlier_JJR markers_NNS as_IN a_DT diagnostic_JJ tool_NN for_IN DN_JJ was_VBD required_VBN for_IN the_DT invalid_JJ of_IN microalbuminuria_NN in_IN some_DT cases_NNS ._.
However_RB ,_, the_DT precise_JJ biological_JJ functions_NNS and_CC underlying_VBG mechanisms_NNS of_IN LCN2_NN in_IN hepatocytes_NNS remains_VBZ unknown_JJ ._.
However_RB ,_, there_EX is_VBZ no_DT consensus_NN which_WDT regimen_NN is_VBZ the_DT most_RBS efficacious_JJ ._.
However_RB ,_, none_NN have_VBP investigated_VBN cutting_VBG error_NN in_IN UKA_NNP ._.
However_RB ,_, its_PRP$ pathophysiology_NN is_VBZ not_RB well_RB understood_VBN ._.
However_RB ,_, primary_JJ healthcare_NN workers_NNS '_POS competence_NN to_TO deliver_VB public_JJ health_NN services_NNS is_VBZ relatively_RB poor_JJ because_IN they_PRP lack_VBP professional_JJ training_NN ._.
However_RB ,_, data_NNS regarding_VBG the_DT risk_NN of_IN TB_NN development_NN in_IN HIV-infected_JJ patients_NNS testing_VBG positive_JJ for_IN IGRAs_NNS remain_VBP sparse_JJ in_IN the_DT era_NN of_IN combination_NN antiretroviral_JJ therapy_NN ._.
However_RB ,_, the_DT outcome_NN of_IN this_DT intervention_NN and_CC the_DT number_NN of_IN children_NNS transitioning_VBG to_TO adult_JJ care_NN as_IN a_DT consequence_NN of_IN longer_JJR survival_NN is_VBZ not_RB yet_RB clear_JJ ._.
However_RB ,_, bibliometric_JJ studies_NNS concerning_VBG the_DT quantity_NN and_CC quality_NN of_IN articles_NNS published_VBN in_IN foot_NN and_CC ankle_NN journals_NNS are_VBP scarce_JJ ._.
However_RB ,_, few_JJ have_VBP yet_RB investigated_VBN possible_JJ association_NN between_IN serum_NN bilirubin_NN level_NN and_CC LVH_NN in_IN essential_JJ hypertension_NN ._.
However_RB ,_, in_IN the_DT past_JJ decade_NN ,_, effective_JJ adjuvant_JJ chemotherapy_NN for_IN lymph_NN node_NN positive_JJ primary_JJ colon_NN cancer_NN was_VBD introduced_VBN ._.
However_RB ,_, the_DT role_NN of_IN its_PRP$ receptor_NN UNC5B_NN in_IN diabetic_JJ kidney_NN disease_NN is_VBZ unknown_JJ ._.
However_RB ,_, as_IN far_RB as_IN we_PRP are_VBP aware_JJ ,_, few_JJ studies_NNS have_VBP described_VBN the_DT risk_NN factors_NNS of_IN undernutrition_NN among_IN HIV-infected_JJ Nigerian_JJ children_NNS ._.
However_RB ,_, previous_JJ studies_NNS focused_VBD only_RB on_IN coagulate-negative_JJ staphylococcus_NN infection_NN ._.
However_RB ,_, the_DT risks_NNS for_IN mortality_NN and_CC atherosclerotic_JJ complications_NNS in_IN incident_NN HD_NN patients_NNS subsequently_RB with_IN bone_NN fractures_NNS are_VBP unknown_JJ ._.
However_RB ,_, there_EX has_VBZ been_VBN little_JJ research_NN on_IN post-trafficking_JJ mental_JJ health_NN and_CC psychosocial_JJ support_NN services_NNS for_IN survivors_NNS ._.
However_RB ,_, the_DT route_NN of_IN action_NN for_IN dexamethasone_NN and_CC its_PRP$ potential_JJ neurotoxicity_NN are_VBP still_RB unclear_JJ ._.
However_RB ,_, some_DT studies_NNS have_VBP reported_VBN differences_NNS in_IN the_DT methylation_NN frequencies_NNS of_IN P16INK4a_NN promoter_NN between_IN cancer_NN and_CC the_DT corresponding_JJ control_NN group_NN ._.
However_RB ,_, few_JJ studies_NNS have_VBP attempted_VBN to_TO identify_VB eQTL_NN in_IN racially_RB admixed_JJ populations_NNS such_JJ as_IN Hispanics_NNPS ._.
However_RB ,_, few_JJ have_VBP yet_RB investigated_VBN possible_JJ association_NN between_IN RDW_NNP and_CC LVH_NNP ._.
However_RB ,_, it_PRP varies_VBZ dynamically_RB ._.
However_RB ,_, its_PRP$ effect_NN on_IN the_DT pulmonary_JJ vascular_JJ functions_NNS related_VBN to_TO PH_NN is_VBZ unknown_JJ ._.
However_RB ,_, individuals_NNS with_IN renal_JJ hypouricemia_NN have_VBP a_DT high_JJ risk_NN of_IN urolithiasis_NN and_CC exercise-induced_JJ acute_JJ kidney_NN injury_NN ,_, both_DT of_IN which_WDT are_VBP risk_NN factors_NNS for_IN reduced_VBN kidney_NN function_NN ._.
However_RB ,_, there_EX is_VBZ a_DT lack_NN of_IN knowledge_NN concerning_VBG the_DT perspectives_NNS of_IN adolescents_NNS in_IN outpatient_NN treatment_NN ,_, whose_WP$ treatment_NN often_RB involves_VBZ family_NN ._.
However_RB ,_, in_IN the_DT last_JJ decade_NN we_PRP have_VBP seen_VBN the_DT increasing_VBG use_NN of_IN predictive_JJ models_NNS that_WDT combine_VBP ,_, in_IN a_DT non-linear_JJ manner_NN ,_, several_JJ predictives_NNS that_WDT are_VBP better_RBR able_JJ to_TO predict_VB prostate_NN cancer_NN -LRB-_-LRB- PC_NN -RRB-_-RRB- ,_, but_CC these_DT fail_VBP to_TO help_VB the_DT clinician_NN to_TO distinguish_VB between_IN PC_NN and_CC benign_JJ prostate_NN hyperplasia_NN -LRB-_-LRB- BPH_NNP -RRB-_-RRB- patients_NNS ._.
However_RB ,_, it_PRP remains_VBZ unknown_JJ whether_IN the_DT spontaneous_JJ brain_NN activity_NN changes_NNS in_IN acute_JJ SCI_NNP ._.
However_RB ,_, their_PRP$ deleterious_JJ gastric_JJ effects_NNS ,_, observed_VBN in_IN both_CC animals_NNS and_CC humans_NNS ,_, dramatically_RB limit_VB their_PRP$ long-term_JJ use_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT relationship_NN between_IN arterial_JJ compliance_NN and_CC cardiovascular_JJ disease_NN risk_NN in_IN children_NNS ._.
However_RB ,_, the_DT available_JJ evidence_NN is_VBZ controversial_JJ ._.
However_RB ,_, there_EX have_VBP been_VBN limited_JJ studies_NNS conducted_VBN regarding_VBG the_DT incidence_NN of_IN rabies_NNP and_CC associated_VBN factors_NNS in_IN Ethiopia_NNP ,_, in_IN general_JJ ,_, and_CC in_IN this_DT study_NN area_NN ,_, in_IN particular_JJ ._.
However_RB ,_, to_TO date_NN ,_, in_IN literature_NN ,_, there_EX have_VBP been_VBN no_DT studies_NNS demonstrating_VBG the_DT relationship_NN between_IN these_DT parameters_NNS in_IN diabetic_JJ patients_NNS together_RB ._.
However_RB ,_, miR-101_NN 's_POS role_NN in_IN the_DT invasion_NN ,_, metastasis_NN ,_, and_CC chemosensitivity_NN of_IN bladder_NN cancer_NN cells_NNS remains_VBZ unclear_JJ ._.
However_RB ,_, consensus_NN program_NN design_NN has_VBZ yet_RB to_TO be_VB established_VBN ,_, and_CC the_DT effectiveness_NN of_IN these_DT programs_NNS in_IN terms_NNS of_IN producing_VBG quality_NN clinician-educator_JJ teaching_NN remains_VBZ unclear_JJ ._.
However_RB ,_, in_IN case_NN of_IN bleeding_VBG there_EX is_VBZ no_DT specific_JJ antidote_NN to_TO reverse_VB their_PRP$ effects_NNS ._.
However_RB ,_, it_PRP is_VBZ not_RB clear_JJ if_IN this_DT is_VBZ causal_JJ for_IN an_DT inability_NN to_TO reject_VB transformed_VBN cells_NNS ,_, or_CC if_IN it_PRP is_VBZ a_DT consequence_NN of_IN tumor_NN growth_NN ._.
However_RB ,_, routine_JJ screening_NN by_IN brain_NN CT_NN and_CC CT_NN angiography_NN -LRB-_-LRB- CTA_NN -RRB-_-RRB- is_VBZ not_RB standard_JJ practice_NN ._.
However_RB ,_, the_DT prognostic_JJ value_NN of_IN LMR_NNP in_IN patients_NNS with_IN esophageal_NN cancer_NN has_VBZ not_RB been_VBN reported_VBN yet_RB ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT roles_NNS of_IN both_DT molecules_NNS in_IN the_DT etiology_NN of_IN CRS_NNP ._.
However_RB ,_, the_DT results_NNS of_IN individual_JJ studies_NNS have_VBP been_VBN inconsistent_JJ ._.
However_RB ,_, no_DT in_FW vitro_FW studies_NNS are_VBP available_JJ that_IN directly_RB assess_VB the_DT sensitivity_NN of_IN Trichomonas_FW vaginalis_FW to_TO boric_JJ acid_NN ._.
However_RB ,_, the_DT effect_NN of_IN HCA_NNP on_IN allogenic_JJ skin_NN graft_NN rejection_NN is_VBZ unknown_JJ ._.
However_RB ,_, no_DT systematic_JJ analysis_NN of_IN suitable_JJ references_NNS in_IN lncRNA_NN studies_NNS in_IN human_JJ glioma_NN has_VBZ been_VBN performed_VBN yet_RB ._.
However_RB ,_, there_EX is_VBZ no_DT published_VBN report_NN focusing_VBG on_IN thyroid_NN cancer_NN mortality_NN in_IN Korea_NNP ._.
However_RB ,_, the_DT clinical_JJ effect_NN of_IN a_DT positive_JJ surgical_JJ margin_NN on_IN the_DT survival_NN of_IN patients_NNS with_IN PCC_NN after_IN hepatectomy_NN still_RB needs_VBZ to_TO be_VB clarified_VBN due_JJ to_TO conflicting_JJ results_NNS ._.
However_RB ,_, such_JJ trauma_NN scoring_VBG systems_NNS reflect_VBP the_DT patient_NN 's_POS physiological_JJ condition_NN ,_, which_WDT can_MD only_RB be_VB determined_VBN to_TO a_DT limited_JJ extent_NN ,_, and_CC are_VBP difficult_JJ to_TO use_VB when_WRB performing_VBG a_DT rapid_JJ initial_JJ assessment_NN ._.
However_RB ,_, ketamine_NN has_VBZ associated_VBN psychotomimetic_JJ effects_NNS and_CC a_DT high_JJ risk_NN of_IN abuse_NN ._.
However_RB ,_, the_DT correlation_NN between_IN postural_JJ changes_NNS and_CC LP_NN determinates_NNS remains_VBZ unknown_JJ ._.
However_RB ,_, the_DT evidence_NN is_VBZ fragmented_JJ as_IN to_TO how_WRB the_DT use_NN of_IN medical_JJ registries_NNS and_CC the_DT like_JJ lead_NN to_TO quality_NN improvement_NN ,_, and_CC little_JJ is_VBZ known_VBN about_IN non-clinical_JJ use_NN ._.
However_RB ,_, how_WRB this_DT is_VBZ achieved_VBN especially_RB in_IN smallholder_NN farming_NN systems_NNS in_IN arid_JJ and_CC semi-arid_JJ areas_NNS is_VBZ rarely_RB documented_VBN ._.
However_RB ,_, such_JJ test_NN systems_NNS may_MD not_RB be_VB sufficient_JJ for_IN testing_VBG nanoparticles_NNS intended_VBN for_IN intravenous_JJ application_NN ._.
However_RB ,_, the_DT cellular_JJ mechanisms_NNS of_IN oxytocin_NN in_IN drug_NN seeking_VBG remain_VBP unknown_JJ ._.
However_RB ,_, the_DT effects_NNS of_IN ginseng_NN on_IN stress_NN in_IN brain_NN cells_NNS are_VBP not_RB well_RB understood_VBN ._.
However_RB ,_, little_JJ is_VBZ currently_RB known_VBN about_IN the_DT barriers_NNS and_CC facilitators_NNS WH-PCPs_JJ face_NN in_IN using_VBG this_DT approach_NN to_TO incorporate_VB gender-specific_JJ services_NNS into_IN women_NNS veterans_NNS '_POS primary_JJ care_NN services_NNS ._.
However_RB ,_, how_WRB patients_NNS with_IN heart_NN failure_NN view_NN participation_NN and_CC which_WDT factors_NNS may_MD be_VB associated_VBN with_IN participation_NN is_VBZ not_RB known_VBN ._.
However_RB ,_, the_DT importance_NN of_IN IL-22_NN in_IN the_DT pathogenesis_NN of_IN allergic_JJ rhinitis_NN -LRB-_-LRB- AR_NN -RRB-_-RRB- remains_VBZ poorly_RB understood_VBN ._.
However_RB ,_, recent_JJ developments_NNS in_IN our_PRP$ understanding_NN of_IN the_DT disease_NN have_VBP resulted_VBN in_IN several_JJ new_JJ therapies_NNS that_WDT show_VBP promise_NN in_IN improving_VBG overall_JJ survival_NN rates_NNS in_IN this_DT patient_NN population_NN ._.
However_RB ,_, these_DT capsules_NNS are_VBP labelled_VBN with_IN same_JJ ingredient_NN levels_NNS ,_, namely_RB EPA_NNP INT_CD mg/g_NN and_CC DHA_NN INT_CD mg/g_NN ._.
However_RB ,_, complete_JJ tumor_NN regression_NN is_VBZ observed_VBN in_IN a_DT significant_JJ proportion_NN of_IN patients_NNS after_IN nCRT_NN ,_, making_VBG them_PRP ideal_JJ candidates_NNS for_IN alternative_JJ treatment_NN strategies_NNS to_TO this_DT considerably_RB morbid_JJ procedure_NN ._.
However_RB ,_, as_IN advancements_NNS in_IN therapies_NNS have_VBP improved_VBN life_NN expectancy_NN ,_, this_DT gender_NN disparity_NN has_VBZ been_VBN challenged_VBN ._.
However_RB ,_, little_JJ evidence_NN is_VBZ available_JJ on_IN how_WRB and_CC to_TO what_WP extent_NN the_DT pollen_NN carryover_NN affects_VBZ the_DT pollen-donor_NN composition_NN and_CC on_IN which_WDT insect_JJ taxa_NN are_VBP effective_JJ outcross-pollen_JJ transporters_NNS under_IN field_NN conditions_NNS ._.
However_RB ,_, if_IN administered_VBN incorrectly_RB ,_, it_PRP can_MD be_VB boring_JJ and_CC useless_JJ ._.
However_RB ,_, whether_IN high_JJ circulating_VBG Scl_NNP is_VBZ also_RB a_DT risk_NN factor_NN for_IN death_NN is_VBZ not_RB well_RB established_VBN ._.
However_RB ,_, data_NNS concerning_VBG memory_NN function_NN in_IN this_DT neurological_JJ vulnerable_JJ patient_NN collective_JJ remain_VBP scarce_JJ and_CC inconclusive_JJ ._.
However_RB ,_, no_DT detailed_JJ descriptions_NNS have_VBP yet_RB been_VBN published_VBN for_IN the_DT measurement_NN of_IN cough_NN strength_NN and_CC associated_VBN outcomes_NNS in_IN AECOPD_NN patients_NNS ._.
However_RB ,_, the_DT incidence_NN of_IN depression_NN after_IN Mycobacterium_NN tuberculosis_NN infection_NN remains_VBZ unknown_JJ ._.
However_RB ,_, the_DT comprehensive_JJ evaluation_NN of_IN HE4_NN combined_VBN with_IN other_JJ markers_NNS is_VBZ still_RB missing_VBG ._.
However_RB ,_, benefit_NN among_IN stable_JJ coronary_JJ artery_NN disease_NN patients_NNS who_WP have_VBP not_RB suffered_VBN an_DT acute_JJ ischemic_JJ event_NN is_VBZ uncertain_JJ ._.
However_RB ,_, risk_NN factors_NNS other_JJ than_IN smoking_NN in_IN never-smokers_NNS have_VBP not_RB been_VBN elucidated_VBN sufficiently_RB ._.
However_RB ,_, the_DT risk_NN of_IN colonization_NN of_IN the_DT stickers_NNS '_POS surface_NN has_VBZ not_RB been_VBN evaluated_VBN ._.
However_RB ,_, the_DT natural_JJ history_NN of_IN dabigatran-related_JJ ICH_NN remains_VBZ unclear_JJ ._.
However_RB a_DT targeted_VBN supplementation_NN regime_NN requires_VBZ a_DT complete_JJ nutritional_JJ assessment_NN ,_, which_WDT includes_VBZ food_NN diaries_NNS ._.
However_RB ,_, other_JJ indicators_NNS may_MD be_VB more_RBR informative_JJ ._.
However_RB ,_, due_JJ to_TO ethical_JJ and_CC methodological_JJ limitations_NNS ,_, few_JJ studies_NNS have_VBP examined_VBN these_DT learning_VBG processes_NNS across_IN development_NN ,_, particularly_RB among_IN anxious_JJ individuals_NNS ._.
However_RB ,_, to_TO the_DT authors_NNS '_POS knowledge_NN ,_, none_NN of_IN these_DT studies_NNS was_VBD conducted_VBN in_IN a_DT US_NNP population_NN ._.
However_RB ,_, its_PRP$ presence_NN in_IN OLP_NNP has_VBZ not_RB been_VBN reported_VBN ._.
However_RB ,_, there_EX are_VBP limited_JJ studies_NNS in_IN developing_VBG countries_NNS ,_, particularly_RB in_IN Ethiopia_NNP ._.
However_RB ,_, specific_JJ aspects_NNS of_IN these_DT social_JJ factors_NNS influencing_VBG dementia_NN are_VBP unknown_JJ ._.
However_RB ,_, research_NN assessing_VBG aerobic_JJ fitness_NN and_CC physical_JJ activity_NN levels_NNS associated_VBN with_IN frailty_NN is_VBZ limited_VBN ._.
However_RB ,_, studies_NNS have_VBP suggested_VBN that_IN differences_NNS exist_VBP regarding_VBG tumor_NN behavior_NN and_CC molecular_JJ biology_NN of_IN these_DT cancers_NNS ,_, comprehensive_JJ investigations_NNS are_VBP needed_VBN to_TO guide_VB the_DT clinical_JJ management_NN of_IN UTUC_NN ._.
However_RB ,_, the_DT relationship_NN between_IN mild_JJ traumatic_JJ brain_NN injury_NN and_CC ischemic_JJ stroke_NN has_VBZ never_RB been_VBN established_VBN ._.
However_RB ,_, more_JJR information_NN is_VBZ needed_VBN from_IN different_JJ populations_NNS ._.
However_RB ,_, prevention_NN of_IN relapse_NN with_IN depressive_JJ symptoms_NNS after_IN the_DT index_NN course_NN of_IN ECT_NNP can_MD be_VB challenging_JJ ._.
However_RB ,_, the_DT optimal_JJ timing_NN for_IN administration_NN of_IN pre-operative_JJ prophylactic_NN antibiotics_NNS is_VBZ unknown_JJ ._.
However_RB ,_, the_DT impact_NN of_IN overweight_JJ on_IN the_DT short-term_JJ outcome_NN after_IN transthoracic_JJ esophagectomy_NN for_IN patients_NNS with_IN esophageal_NN squamous_JJ cell_NN carcinoma_NN -LRB-_-LRB- ESCC_NN -RRB-_-RRB- remains_VBZ unclear_JJ ._.
However_RB ,_, there_EX are_VBP contradictory_JJ results_NNS on_IN these_DT issues_NNS ,_, it_PRP is_VBZ not_RB clear_VB the_DT effect_NN of_IN every_DT major_JJ compound_NN in_IN relation_NN to_TO the_DT whole_JJ effect_NN of_IN the_DT beverages_NNS and_CC there_EX is_VBZ a_DT lack_NN in_IN knowledge_NN about_IN their_PRP$ degree_NN of_IN safety_NN for_IN consumption_NN ._.
However_RB ,_, how_WRB neuroinflammation_NN and_CC TRPA1_NN and_CC TRPV4_NN are_VBP linked_VBN to_TO cause_VB pain_NN in_IN paclitaxel-treated_JJ animals_NNS is_VBZ not_RB known_VBN ._.
However_RB ,_, it_PRP remains_VBZ unknown_JJ whether_IN certain_JJ types_NNS of_IN sex_NN partnerships_NNS were_VBD more_RBR important_JJ to_TO this_DT decline_NN ._.
However_RB ,_, limited_JJ research_NN has_VBZ been_VBN conducted_VBN to_TO understand_VB health_NN literacy_NN levels_NNS among_IN Chinese_JJ American_JJ older_JJR adults_NNS ._.
However_RB ,_, the_DT molecular_JJ mechanism_NN through_IN which_WDT IVBD_NN acts_VBZ on_IN cardiac_JJ function_NN has_VBZ yet_RB to_TO be_VB elucidated_VBN ,_, especially_RB in_IN experimental_JJ diabetic_JJ animals_NNS ._.
However_RB ,_, the_DT sequence_NN of_IN and_CC causal_JJ relation_NN between_IN these_DT events_NNS is_VBZ unclear_JJ ,_, necessitating_VBG a_DT spontaneous_JJ animal_NN model_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT underlying_JJ signaling_NN events_NNS influencing_VBG risk_NN ._.
However_RB ,_, the_DT form_NN of_IN obesity_NN is_VBZ metabolically_RB distinct_JJ from_IN obesity_NN induced_VBN through_IN other_JJ pathways_NNS -LRB-_-LRB- e.g._FW diet-induced_JJ obesity_NN -RRB-_-RRB- ._.
However_RB ,_, the_DT disease_NN causing_VBG gene_NN remains_VBZ unknown_JJ in_IN many_JJ families_NNS ._.
However_RB ,_, its_PRP$ efficacy_NN is_VBZ still_RB controversial_JJ ._.
However_RB ,_, no_DT large_JJ series_NN has_VBZ accurately_RB documented_VBN the_DT incidence_NN of_IN caseating_VBG granulomas_NNS in_IN CL_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT effect_NN of_IN MHC_NN upon_IN clinicians_NNS '_POS decisions_NNS about_IN intensifying_VBG antiglycemic_JJ medications_NNS in_IN diabetic_JJ patients_NNS with_IN poor_JJ glycemic_JJ control_NN ._.
However_RB ,_, differences_NNS in_IN disease_NN presentation_NN and_CC outcomes_NNS between_IN older_JJR and_CC younger_JJR IMN_NN patients_NNS remain_VBP controversial_JJ ._.
However_RB ,_, the_DT amended_VBN insulin-glucose_NN ratio_NN exhibited_VBD excellent_JJ diagnostic_JJ performance_NN in_IN a_DT recent_JJ retrospective_JJ cohort_NN study_NN ,_, although_IN it_PRP has_VBZ not_RB yet_RB been_VBN validated_VBN in_IN other_JJ patient_NN cohorts_NNS ._.
However_RB ,_, its_PRP$ role_NN in_IN renal_JJ cell_NN carcinoma_NN has_VBZ not_RB been_VBN fully_RB investigated_VBN ._.
However_RB ,_, such_PDT an_DT invasion_NN has_VBZ not_RB been_VBN described_VBN in_IN the_DT literature_NN ,_, although_IN reports_NNS on_IN RLN_NN invasion_NN by_IN primary_JJ tumors_NNS have_VBP been_VBN published_VBN ._.
However_RB ,_, the_DT clinicopathologic_JJ characteristics_NNS of_IN missed_VBN or_CC interval_JJ early_JJ gastric_JJ cancer_NN -LRB-_-LRB- EGC_NN -RRB-_-RRB- are_VBP not_RB well_RB known_VBN ._.
However_RB ,_, its_PRP$ regulatory_JJ effect_NN in_IN the_DT pathogenesis_NN of_IN children_NNS allergic_JJ rhinitis_NN -LRB-_-LRB- AR_NN -RRB-_-RRB- needs_VBZ to_TO be_VB further_JJ characterized_VBN ._.
However_RB ,_, its_PRP$ diagnostic_JJ performance_NN in_IN higher-risk_JJ patients_NNS has_VBZ not_RB been_VBN investigated_VBN in_IN a_DT large_JJ international_JJ multicenter_JJ trial_NN ._.
However_RB ,_, previous_JJ studies_NNS have_VBP reported_VBN inconsistent_JJ results_NNS ._.
However_RB ,_, the_DT expression_NN pattern_NN and_CC biologic_JJ significance_NN of_IN TMPRSS4_NN in_IN thyroid_NN cancer_NN are_VBP largely_RB unknown_JJ ._.
However_RB ,_, where_WRB to_TO place_VB the_DT generator_NN may_MD need_VB to_TO be_VB considered_VBN from_IN the_DT mental_JJ ,_, functional_JJ ,_, and_CC cosmetic_JJ standpoints_NNS ._.
However_RB ,_, the_DT effects_NNS of_IN burns_NNS on_IN the_DT corresponding_JJ spinal_JJ dermatome_NN remain_VBP unknown_JJ ._.
However_RB ,_, its_PRP$ ability_NN to_TO detect_VB ischemic_JJ injury_NN during_IN middle_JJ cerebral_JJ artery_NN -LRB-_-LRB- MCA_NNP -RRB-_-RRB- aneurysm_NN surgery_NN remains_VBZ unclear_JJ ._.
However_RB ,_, these_DT fractions_NNS can_MD not_RB be_VB assumed_VBN to_TO be_VB equipotent_JJ ._.
However_RB ,_, reported_VBD rates_NNS of_IN BCT_NNP in_IN predominantly_RB Chinese_JJ populations_NNS are_VBP significantly_RB lower_JJR than_IN those_DT reported_VBN in_IN Western_JJ countries_NNS ._.
However_RB ,_, there_EX is_VBZ a_DT paucity_NN of_IN evidence_NN of_IN the_DT extent_NN to_TO which_WDT patients_NNS recover_VB their_PRP$ activities_NNS of_IN daily_JJ living_NN -LRB-_-LRB- ADL_NN -RRB-_-RRB- ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT relationship_NN between_IN epistaxis_NN and_CC quality_NN of_IN life_NN ._.
However_RB ,_, no_DT reports_NNS in_IN the_DT English_JJ literature_NN have_VBP focused_VBN on_IN the_DT effect_NN of_IN an_DT anterior_JJ vacuum_NN disc_NN in_IN relation_NN to_TO surgical_JJ outcome_NN of_IN same-segment_JJ spondylolisthesis_NN ._.
However_RB ,_, this_DT conclusion_NN may_MD vary_VB depending_VBG on_IN region_NN and_CC culture_NN ._.
However_RB understanding_NN of_IN hospital_NN factors_NNS that_WDT influence_VBP time-to-theatre_JJ -LRB-_-LRB- TTT_NN -RRB-_-RRB- is_VBZ poor_JJ ._.
However_RB ,_, the_DT morbidity_NN associated_VBN with_IN PD_NN remains_VBZ high_JJ ,_, including_VBG frequent_JJ complications_NNS such_JJ as_IN delayed_VBN gastric_JJ emptying_NN and_CC pancreatic_JJ fistulas_NNS ._.
However_RB ,_, the_DT biomarker_NN calprotectin_NN shows_VBZ INT_CD potential_JJ cleavages_NNS sites_NNS for_IN trypsin_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN SOX17_NN expression_NN in_IN acute_JJ myeloid_JJ leukemia_NN -LRB-_-LRB- AML_NN -RRB-_-RRB- ._.
However_RB ,_, the_DT differences_NNS in_IN brain_NN activity_NN between_IN grip_NN type_NN -LRB-_-LRB- i.e._FW power_NN or_CC precision_NN -RRB-_-RRB- and_CC pattern_NN -LRB-_-LRB- i.e._FW dynamic_JJ or_CC static_JJ -RRB-_-RRB- are_VBP not_RB fully_RB understood_VBN ._.
However_RB ,_, no_DT work_NN has_VBZ been_VBN done_VBN to_TO compare_VB these_DT techniques_NNS from_IN a_DT Human_JJ Factors_NNS perspective_NN ._.
However_RB ,_, ESD_NN is_VBZ technically_RB difficult_JJ ,_, hazardous_JJ ,_, and_CC time_NN consuming_NN ._.
However_RB ,_, left_VBD ventricular_JJ -LRB-_-LRB- LV_NN -RRB-_-RRB- diastolic_JJ dysfunction_NN progresses_VBZ with_IN aging_NN and_CC may_MD also_RB influence_VB plasma_NN BNP_NN levels_NNS in_IN elderly_JJ patients_NNS ._.
However_RB ,_, the_DT potential_JJ contributions_NNS of_IN spinal_JJ PKMζ_NN to_TO PPSP_NNP ,_, a_DT condition_NN in_IN which_WDT preoperative_JJ pain_NN is_VBZ prevalent_JJ ,_, are_VBP not_RB known_VBN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT molecular_JJ mechanisms_NNS underlying_VBG nicotine_NN relapse_NN ,_, hampering_VBG development_NN of_IN more_JJR effective_JJ therapies_NNS ._.
However_RB ,_, there_EX is_VBZ no_DT standard_JJ timeline_NN for_IN collecting_VBG blood_NN for_IN storage_NN ._.
However_RB ,_, the_DT association_NN between_IN SVR_NNP and_CC viral_JJ kinetics_NNS earlier_RBR than_IN week_NN INT_CD after_IN initiation_NN of_IN therapy_NN remains_VBZ unclear_JJ ._.
However_RB ,_, few_JJ studies_NNS investigated_VBD its_PRP$ inhibitory_JJ effect_NN against_IN cervical_JJ cancer_NN stem_NN cells_NNS ._.
However_RB ,_, data_NNS variations_NNS affect_VBP statistical_JJ analyses_NNS -LRB-_-LRB- eg_FW ,_, signal_NN detection_NN -RRB-_-RRB- ._.
However_RB ,_, the_DT effect_NN on_IN the_DT acquisition_NN of_IN non-ulcerative_JJ sexually_RB transmitted_VBN infections_NNS -LRB-_-LRB- STIs_NNS -RRB-_-RRB- remains_VBZ unclear_JJ ._.
However_RB ,_, little_JJ relevant_JJ information_NN is_VBZ available_JJ regarding_VBG the_DT role_NN of_IN microvesicles_NNS -LRB-_-LRB- MVs_NNS -RRB-_-RRB- derived_VBN from_IN ATMs_NNS in_IN macrophage-adipocyte_JJ crosstalk_NN ._.
However_RB ,_, the_DT expense_NN and_CC time_NN involved_VBN for_IN vaccination_NN ,_, antibody_NN testing_NN and_CC visiting_VBG a_DT clinic_NN may_MD represent_VB a_DT major_JJ barrier_NN to_TO voluntary_JJ compliance_NN among_IN this_DT busy_JJ demographic_JJ ._.
However_RB ,_, its_PRP$ impact_NN on_IN initially_RB unresectable_JJ ,_, previously_RB untreated_JJ advanced_JJ CRC_NN ,_, regardless_RB of_IN concurrent_JJ metastases_NNS ,_, remains_VBZ to_TO be_VB clarified_VBN ._.
However_RB ,_, studies_NNS that_WDT directly_RB relate_VBP hospitalizations_NNS for_IN exacerbation_NN of_IN COPD_NNP to_TO ambient_JJ temperature_NN are_VBP lacking_VBG ._.
However_RB ,_, how_WRB depressive_JJ symptoms_NNS affect_VBP the_DT different_JJ domains_NNS and_CC facets_NNS of_IN QOL_NN in_IN older_JJR adults_NNS ,_, and_CC whether_IN depressive_JJ symptoms_NNS mediate_VBP the_DT relationship_NN between_IN physical_JJ disability_NN and_CC QOL_NN in_IN older_JJR adults_NNS are_VBP unclear_JJ ._.
However_RB ,_, the_DT specific_JJ role_NN of_IN CD36_NN in_IN podocyte_JJ apoptosis_NN in_IN DN_JJ with_IN hyperlipidemia_NN remains_VBZ poorly_RB investigated_VBN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT way_NN they_PRP predict_VBP each_DT other_JJ over_IN time_NN ._.
However_RB ,_, these_DT approaches_NNS are_VBP only_RB prepared_JJ to_TO discover_VB constant_JJ biclusters_NNS and_CC their_PRP$ underlying_JJ contributions_NNS remain_VBP dispersed_JJ ._.
However_RB ,_, the_DT effect_NN of_IN NSAIDs_NNS on_IN blood_NN pressure_NN -LRB-_-LRB- BP_NN -RRB-_-RRB- in_IN children_NNS has_VBZ not_RB been_VBN rigorously_RB examined_VBN ._.
However_RB ,_, clinical_JJ adoption_NN and_CC use_NN are_VBP still_RB nascent_JJ in_IN health_NN care_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN regarding_VBG the_DT molecular_JJ mechanisms_NNS of_IN its_PRP$ anticancer_JJ effects_NNS ._.
However_RB ,_, little_JJ is_VBZ known_VBN regarding_VBG the_DT extent_NN to_TO which_WDT MCH_NNP nurses_NNS promote_VBP obesity_NN prevention_NN practices_NNS and_CC how_WRB such_JJ practices_NNS could_MD be_VB better_RBR supported_VBN ._.
However_RB ,_, no_DT corresponding_JJ analysis_NN has_VBZ been_VBN done_VBN for_IN patients_NNS who_WP have_VBP undergone_VBN third-line_JJ or_CC later-line_JJ chemotherapy_NN ._.
However_RB ,_, RAS_NN inhibition_NN increases_VBZ the_DT risk_NN of_IN renal_JJ complications_NNS ._.
However_RB ,_, such_JJ studies_NNS are_VBP usually_RB performed_VBN by_IN questionnaires_NNS and_CC ,_, sometimes_RB ,_, by_IN skin_NN prick_NN test_NN or_CC in_FW vitro_FW IgE_NN tests_NNS ,_, while_IN the_DT portion_NN of_IN allergy_NN sustained_VBN by_IN the_DT cell-mediated_JJ mechanism_NN is_VBZ neglected_VBN ,_, because_IN the_DT essential_JJ test_NN ,_, i.e._FW the_DT atopy_NN patch_NN test_NN is_VBZ not_RB performed_VBN ._.
However_RB ,_, there_EX are_VBP some_DT reports_NNS that_IN aluminum_NN can_MD be_VB toxic_JJ to_TO humans_NNS and_CC animals_NNS ._.
However_RB ,_, there_EX is_VBZ a_DT small_JJ group_NN of_IN patients_NNS who_WP are_VBP unable_JJ to_TO tolerate_VB postoperative_JJ complications_NNS and_CC ultimately_RB undergo_VBP reversal_NN procedures_NNS ._.
However_RB ,_, the_DT relationship_NN between_IN intraoperative_JJ blood_NN pressure_NN and_CC PD_NN is_VBZ unclear_JJ ._.
However_RB ,_, the_DT majority_NN of_IN women_NNS with_IN STIs_NNS are_VBP asymptomatic_JJ ._.
However_RB ,_, few_JJ studies_NNS have_VBP investigated_VBN normal_JJ tissue_NN responses_NNS in_FW vivo_FW after_IN -LRB-_-LRB- INT_CD -RRB-_-RRB- At_IN administration_NN ._.
However_RB ,_, few_JJ reports_NNS are_VBP available_JJ on_IN asthma_NN treatment_NN in_IN the_DT athlete_NN population_NN in_IN clinical_JJ practice_NN ._.
However_RB ,_, the_DT role_NN of_IN miR-429_NN in_IN PDAC_NN remained_VBD unknown_JJ ._.
However_RB ,_, the_DT extent_NN to_TO which_WDT alliance_NN predicts_VBZ outcomes_NNS in_IN psychopharmacology_NN is_VBZ yet_RB to_TO be_VB fully_RB investigated_VBN considering_VBG the_DT fact_NN that_IN alliance_NN can_MD be_VB the_DT result_NN ,_, rather_RB than_IN the_DT cause_NN ,_, of_IN symptomatic_JJ change_NN ._.
However_RB ,_, the_DT practical_JJ relevance_NN of_IN such_JJ adjustment_NN is_VBZ not_RB clear_JJ ._.
However_RB ,_, because_IN of_IN its_PRP$ technical_JJ complexity_NN and_CC concerns_NNS for_IN higher_JJR operative_NN and_CC metabolic_JJ complications_NNS ,_, it_PRP has_VBZ not_RB obtained_VBN widespread_JJ acceptance_NN among_IN patients_NNS or_CC bariatric_JJ surgeons_NNS ._.
However_RB ,_, most_JJS of_IN these_DT innovations_NNS require_VBP considerable_JJ time_NN and_CC effort_NN to_TO optimally_RB implement_VB leading_VBG to_TO a_DT biased_VBN ``_`` steady_JJ state_NN ''_'' cost-effectiveness_NN outcome_NN ._.
However_RB ,_, there_EX is_VBZ discrepancy_NN between_IN cytological_JJ and_CC surgical_JJ diagnoses_NNS ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT clinical_JJ characteristics_NNS of_IN aspiration-related_JJ ARDS_NN in_IN acute_JJ stroke_NN patients_NNS ._.
However_RB ,_, no_DT study_NN has_VBZ longitudinally_RB examined_VBN the_DT developmental_JJ trajectory_NN of_IN corpus_NN callosum_NN in_IN autism_NN past_JJ early_JJ childhood_NN ._.
However_RB ,_, the_DT relation_NN between_IN end-organ_JJ damage_NN and_CC the_DT 24-hour_JJ central_JJ SBP_NN profile_NN and_CC variability_NN has_VBZ not_RB so_RB far_RB been_VBN analyzed_VBN ._.
However_RB ,_, the_DT reports_NNS about_IN maternal_JJ BLL_NN changes_NNS during_IN pregnancy_NN are_VBP conflicting_VBG to_TO some_DT extent_NN ._.
However_RB ,_, at_IN present_JJ it_PRP remains_VBZ unclear_JJ how_WRB to_TO reliably_RB assess_VB biological_JJ age_NN in_IN individual_JJ wild_JJ vertebrates_NNS ._.
However_RB ,_, all_DT of_IN these_DT programs_NNS do_VBP not_RB live_VB up_RP to_TO the_DT standards_NNS of_IN scientific_JJ evidence_NN ._.
However_RB ,_, it_PRP is_VBZ clear_JJ that_IN policy_NN drives_NNS to_TO encourage_VB and_CC enable_VB greater_JJR role_NN flexibility_NN among_IN the_DT health_NN professions_NNS may_MD also_RB lead_VB to_TO professional_JJ resistance_NN and_CC inter-professional_JJ role_NN boundary_NN disputes_NNS ._.
However_RB ,_, whether_IN the_DT anabolic_JJ response_NN can_MD be_VB reversed_VBN when_WRB alcohol_NN is_VBZ consumed_VBN after_IN the_DT stimulus_NN is_VBZ unknown_JJ ._.
However_RB ,_, data_NNS on_IN the_DT incidence_NN of_IN occupational_JJ rhinitis_NN are_VBP lacking_VBG ,_, since_IN comprehensive_JJ studies_NNS are_VBP rare_JJ ._.
However_RB ,_, the_DT mechanisms_NNS of_IN radioresistance_NN has_VBZ not_RB been_VBN fully_RB elucidated_VBN ._.
However_RB ,_, the_DT use_NN of_IN MR_NN antagonist_NN is_VBZ limited_VBN by_IN an_DT increased_VBN incidence_NN of_IN hyperkalemia_NN owing_NN to_TO MR_NN blockade_NN in_IN the_DT kidney_NN ._.
However_RB ,_, it_PRP is_VBZ difficult_JJ to_TO make_VB the_DT scintillator_NN so_RB thin_JJ ,_, and_CC additionally_RB thin_JJ scintillator_NN may_MD greatly_RB reduce_VB the_DT efficiency_NN of_IN collecting_VBG photons_NNS ._.
However_RB ,_, the_DT patients_NNS are_VBP not_RB always_RB accompanied_VBN by_IN eosinophilia_NN ,_, so_IN it_PRP is_VBZ necessary_JJ to_TO learn_VB about_IN the_DT clinical_JJ and_CC radiologic_JJ features_NNS that_WDT may_MD predict_VB pulmonary_JJ toxocariasis_NN without_IN eosinophilia_NN ._.
However_RB ,_, it_PRP is_VBZ a_DT neglected_VBN area_NN in_IN the_DT care_NN and_CC treatment_NN of_IN patients_NNS with_IN dementia_NN ._.
However_RB ,_, in_IN RV_NN challenges_NNS ,_, viral_JJ clearance_NN begins_VBZ before_IN de_FW novo_FW adaptive_JJ immune_JJ responses_NNS would_MD develop_VB ._.
However_RB ,_, findings_NNS have_VBP been_VBN inconsistent_JJ ._.
However_RB ,_, it_PRP is_VBZ unknown_JJ whether_IN their_PRP$ initial_JJ negative_JJ inotropic_JJ effect_NN may_MD increase_VB 30-day_JJ all-cause_JJ readmission_NN ,_, a_DT target_NN outcome_NN for_IN Medicare_NNP cost_NN reduction_NN and_CC financial_JJ penalty_NN for_IN hospitals_NNS under_IN the_DT Affordable_NNP Care_NNP Act_NNP ._.
However_RB ,_, the_DT large_JJ bone_NN defect_NN peri-implant_NN has_VBZ a_DT negative_JJ influence_NN on_IN the_DT process_NN of_IN bone_NN healing_NN ._.
However_RB ,_, the_DT function_NN of_IN CDK2-AP1_NN in_IN breast_NN cancer_NN remains_VBZ unclear_JJ ._.
However_RB ,_, possible_JJ advantages_NNS of_IN a_DT liquid_JJ diet_NN over_IN one_CD of_IN normal_JJ consistency_NN are_VBP controversial_JJ ._.
However_RB ,_, implementation_NN of_IN lifestyle_NN interventions_NNS is_VBZ often_RB met_VBN with_IN barriers_NNS ._.
However_RB ,_, the_DT mechanism_NN and_CC function_NN underlying_VBG such_JJ effects_NNS are_VBP not_RB fully_RB elucidated_VBN ,_, especially_RB in_IN human_JJ monocytes_NNS and_CC dendritic_JJ cells_NNS -LRB-_-LRB- DCs_NNS -RRB-_-RRB- ._.
However_RB ,_, whether_IN exogenous_JJ H2S_NN could_MD mitigate_VB the_DT hepatic_JJ steatosis_NN in_IN mice_NNS remains_VBZ unclear_JJ ._.
However_RB medical_JJ trainees_NNS have_VBP many_JJ difficulties_NNS concerning_VBG research_NN ,_, for_IN which_WDT reason_NN potential_JJ remedial_JJ strategies_NNS need_VBP to_TO be_VB constantly_RB developed_VBN and_CC tested_VBN ._.
However_RB ,_, so_RB far_RB ,_, no_DT systematic_JJ review_NN has_VBZ summarized_VBN the_DT available_JJ evidence_NN on_IN the_DT effectiveness_NN and_CC safety_NN of_IN influenza_NN vaccination_NN in_IN this_DT patient_NN group_NN ._.
However_RB ,_, the_DT particular_JJ involvement_NN of_IN the_DT circadian_JJ system_NN in_IN the_DT pathophysiology_NN of_IN depression_NN and_CC its_PRP$ molecular_JJ regulatory_JJ interface_NN is_VBZ incompletely_RB understood_VBN ._.
However_RB ,_, it_PRP is_VBZ an_DT aggressive_JJ entity_NN ,_, and_CC the_DT absence_NN of_IN a_DT standardized_JJ treatment_NN protocol_NN makes_VBZ for_IN an_DT extremely_RB poor_JJ prognosis_NN ._.
However_RB ,_, the_DT effects_NNS of_IN PA_NN on_IN lipopolysaccharide_NN -LRB-_-LRB- LPS_NN -RRB-_-RRB- -_: induced_VBN acute_JJ lung_NN injury_NN -LRB-_-LRB- ALI_NN -RRB-_-RRB- have_VBP not_RB yet_RB been_VBN studied_VBN ._.
However_RB ,_, not_RB much_JJ work_NN has_VBZ been_VBN reported_VBN on_IN comparing_VBG the_DT effect_NN of_IN the_DT different_JJ combinations_NNS of_IN the_DT inlet/outlet_NN boundary_NN conditions_NNS on_IN the_DT quantification_NN of_IN the_DT pressure_NN field_NN and_CC flow_NN distribution_NN patterns_NNS in_IN stenotic_JJ right_JJ coronary_JJ arteries_NNS ._.
However_RB ,_, large_JJ scale_NN population_NN screening_NN is_VBZ of_IN prime_JJ importance_NN and_CC requires_VBZ a_DT simple_JJ ,_, accurate_JJ ,_, and_CC cost_NN effective_JJ technique_NN ._.
However_RB ,_, resection_NN is_VBZ performed_VBN in_IN select_JJ cases_NNS because_IN of_IN involvement_NN of_IN the_DT MT_NNP in_IN the_DT inflammatory_JJ process_NN ,_, obstruction_NN ,_, or_CC instability_NN ._.
However_RB ,_, there_EX have_VBP been_VBN few_JJ scientific_JJ publications_NNS on_IN scientific_JJ collaboration_NN in_IN psychiatry_NN research_NN so_RB far_RB ._.
However_RB ,_, the_DT relationship_NN between_IN early_JJ life_NN exposures_NNS and_CC natural_JJ history_NN of_IN IBD_NN has_VBZ not_RB been_VBN previously_RB examined_VBN ._.
However_RB ,_, the_DT mechanisms_NNS responsible_JJ for_IN the_DT superior_JJ vaccine_NN efficacy_NN of_IN rBCG_NN are_VBP still_RB incompletely_RB understood_VBN ._.
However_RB ,_, several_JJ factors_NNS raise_VBP doubts_NNS to_TO this_DT generalization_NN ._.
However_RB ,_, the_DT timing_NN of_IN liver_NN transplant_NN for_IN these_DT patients_NNS remains_VBZ unclear_JJ ._.
However_RB ,_, few_JJ studies_NNS to_TO date_NN focused_VBD on_IN the_DT association_NN of_IN genetic_JJ variation_NN of_IN CRISPLD2_NN gene_NN with_IN nsCL/P_NN ,_, and_CC the_DT results_NNS are_VBP conflicting_VBG based_VBN on_IN the_DT different_JJ study_NN population_NN ._.
However_RB ,_, the_DT measurement_NN system_NN used_VBN is_VBZ known_VBN to_TO affect_VB FeNO_NN results_NNS ,_, and_CC it_PRP remains_VBZ unknown_JJ whether_IN results_NNS from_IN offline_JJ methods_NNS correlate_VBP with_IN those_DT from_IN traditional_JJ online_JJ methods_NNS ,_, such_JJ as_IN NO_NN breath_NN ®_CD ._.
However_RB ,_, how_WRB early_JJ pain_NN develops_VBZ and_CC whether_IN GJH_NN without_IN pain_NN in_IN childhood_NN is_VBZ a_DT risk_NN factor_NN for_IN pain_NN development_NN in_IN adolescence_NN is_VBZ undetermined_JJ ._.
However_RB ,_, there_EX is_VBZ no_DT information_NN about_IN the_DT effectiveness_NN of_IN azithromycin_NN -LRB-_-LRB- AZM_NN -RRB-_-RRB- for_IN the_DT treatment_NN of_IN aspiration_NN pneumonia_NN ._.
However_RB ,_, the_DT application_NN of_IN sealants_NNS -LRB-_-LRB- composed_VBN of_IN two_CD essential_JJ components_NNS :_: fibrinogen_NN and_CC thrombin_NN -RRB-_-RRB- is_VBZ not_RB without_IN difficulties_NNS ._.
However_RB ,_, only_RB a_DT few_JJ recent_JJ publications_NNS on_IN epidemiologic_JJ data_NNS showing_VBG the_DT trends_NNS in_IN incidence_NN of_IN pediatric_JJ GCTs_NNS are_VBP available_JJ ._.
However_RB ,_, the_DT impact_NN of_IN obesity_NN on_IN LG_NNP still_RB remains_VBZ controversial_JJ ._.
However_RB ,_, primary_JJ or_CC acquired_VBN resistance_NN is_VBZ inevitable_JJ and_CC no_DT second-line_JJ chemotherapy_NN is_VBZ demonstrated_VBN to_TO be_VB effective_JJ ._.
However_RB ,_, the_DT involvement_NN of_IN these_DT factors_NNS in_IN brain_NN damage_NN is_VBZ also_RB demonstrated_VBN systemically_RB ._.
However_RB ,_, in_IN recent_JJ years_NNS ,_, more_JJR women_NNS have_VBP started_VBN smoking_NN ._.
However_RB ,_, almost_RB nothing_NN is_VBZ known_VBN about_IN the_DT function_NN of_IN RIOK-3_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT association_NN between_IN sleep_NN and_CC different_JJ subtypes_NNS of_IN breast_NN cancer_NN defined_VBN by_IN hormone_NN receptor_NN status_NN ._.
However_RB ,_, the_DT association_NN of_IN multifocality_NN with_IN poor_JJ prognosis_NN remains_VBZ controversial_JJ ._.
However_RB ,_, the_DT mechanisms_NNS responsible_JJ are_VBP unknown_JJ ._.
However_RB ,_, posterior_JJ chest_NN tubes_NNS have_VBP a_DT tendency_NN to_TO act_VB as_IN nonfunctional_JJ drains_VBZ for_IN the_DT evacuation_NN of_IN pneumothoraces_NNS ,_, and_CC additional_JJ chest_NN tube_NN may_MD be_VB required_VBN ._.
However_RB ,_, a_DT limitation_NN is_VBZ the_DT willingness_NN of_IN patients_NNS and_CC families_NNS to_TO complete_VB these_DT environmental_JJ questionnaires_NNS ._.
However_RB ,_, there_EX are_VBP still_RB many_JJ contradictions_NNS about_IN their_PRP$ pathogenic_JJ role_NN in_IN NGU_NNP ._.
However_RB ,_, normal_JJ values_NNS and_CC physiologic_JJ limits_NNS of_IN left_JJ ventricular_JJ strain_NN and_CC strain_NN rate_NN in_IN trained_JJ athletes_NNS are_VBP largely_RB undefined_JJ ._.
However_RB ,_, cryobiopsy_NN is_VBZ acquiring_VBG an_DT important_JJ role_NN in_IN the_DT ILD_NNP diagnostic_JJ process_NN ._.
However_RB ,_, genetic_JJ alterations_NNS in_IN genes_NNS encoding_VBG enzymes_NNS involved_VBN in_IN amino_NN acid_NN metabolism_NN are_VBP largely_RB unknown_JJ ._.
However_RB ,_, there_EX is_VBZ a_DT paucity_NN of_IN data_NNS on_IN the_DT long-term_JJ outcome_NN of_IN these_DT patients_NNS in_IN a_DT Canadian_JJ context_NN outside_IN of_IN clinical_JJ trials_NNS ._.
However_RB ,_, the_DT associations_NNS of_IN infant_NN feeding_NN ,_, linear_JJ growth_NN and_CC weight_NN gain_NN relative_JJ to_TO linear_JJ growth_NN with_IN separate_JJ components_NNS of_IN body_NN composition_NN remain_VBP unclear_JJ ._.
However_RB ,_, new_JJ research_NN suggests_VBZ that_IN the_DT RDA_NNP is_VBZ not_RB sufficient_JJ to_TO meet_VB the_DT target_NN biomarker_NN status_NN for_IN individuals_NNS who_WP are_VBP heavy_JJ or_CC who_WP have_VBP dark_JJ skin_NN ._.
However_RB ,_, incidence_NN and_CC prevalence_NN of_IN RTT_NNP are_VBP scarcely_RB reported_VBN ._.
However_RB ,_, the_DT link_NN between_IN leptin_NN and_CC sperm_NN motility_NN is_VBZ yet_RB to_TO be_VB determined_VBN ._.
However_RB ,_, one-third_NN of_IN the_DT cases_NNS do_VBP not_RB respond_VB or_CC relapse_NN and_CC need_VB salvage_NN regimens_NNS ._.
However_RB ,_, increasing_VBG evidence_NN suggests_VBZ that_IN information_NN ,_, that_WDT is_VBZ independent_JJ of_IN the_DT DNA_NN sequence_NN ,_, termed_VBN epigenetic_JJ information_NN ,_, can_MD be_VB inherited_VBN between_IN generations_NNS ._.
However_RB ,_, during_IN that_DT time_NN ,_, mumps_NNS cases_NNS continued_VBD to_TO occur_VB ._.
However_RB ,_, the_DT risk_NN of_IN selecting_VBG resistant_JJ bacteria_NNS ,_, a_DT major_JJ issue_NN especially_RB in_IN critical_JJ care_NN environments_NNS ,_, has_VBZ not_RB been_VBN sufficiently_RB investigated_VBN ._.
However_RB ,_, the_DT expression_NN and_CC function_NN of_IN miR-371-5p_NN in_IN pancreatic_JJ cancer_NN has_VBZ not_RB been_VBN clearly_RB elucidated_VBN ._.
However_RB ,_, the_DT literature_NN has_VBZ not_RB always_RB been_VBN consistent_JJ ._.
However_RB ,_, the_DT association_NN between_IN multimorbidity_NN and_CC PA_NN has_VBZ not_RB been_VBN investigated_VBN in_IN detail_NN ,_, and_CC recent_JJ studies_NNS of_IN this_DT topic_NN yield_NN dissenting_VBG results_NNS ._.
However_RB ,_, definitions_NNS of_IN incident_NN cases_NNS and_CC the_DT population_NN at_IN risk_NN remain_VBP varied_JJ and_CC ambiguous_JJ ._.
However_RB ,_, little_JJ information_NN has_VBZ been_VBN reported_VBN regarding_VBG the_DT expression_NN of_IN Nrf2_NN in_IN skin_NN cancers_NNS ._.
However_RB ,_, they_PRP may_MD be_VB related_VBN to_TO an_DT immune_JJ risk_NN phenotype_NN that_WDT has_VBZ not_RB been_VBN sufficiently_RB studied_VBN ._.
However_RB ,_, currently_RB ,_, animal_NN models_NNS of_IN beige_JJ fat_NN are_VBP restricted_JJ to_TO rodents_NNS ,_, where_WRB subcutaneous_JJ adipose_NN tissue_NN -LRB-_-LRB- sWAT_NN ,_, benign_JJ WAT_NN -RRB-_-RRB- is_VBZ more_RBR liable_JJ to_TO develop_VB into_IN the_DT beige_JJ fat_NN under_IN specific_JJ activators_NNS than_IN the_DT intra-abdominal_JJ adipose_NN tissue_NN -LRB-_-LRB- aWAT_NN ,_, malignant_JJ WAT_NN -RRB-_-RRB- that_WDT is_VBZ the_DT major_JJ source_NN of_IN obesity_NN related_JJ diseases_NNS in_IN humans_NNS ._.
However_RB ,_, this_DT evidence_NN was_VBD not_RB enough_RB for_IN different_JJ populations_NNS ._.
However_RB ,_, previous_JJ studies_NNS reported_VBD confused_JJ risk_NN factors_NNS for_IN catheter-related_JJ Candida_NN bloodstream_NN infection_NN -LRB-_-LRB- CRCBSI_NN -RRB-_-RRB- ._.
However_RB ,_, the_DT risk_NN factors_NNS associated_VBN with_IN long-term_JJ outcomes_NNS in_IN these_DT patients_NNS remain_VBP unclear_JJ ._.
However_RB ,_, most_JJS of_IN them_PRP were_VBD applied_VBN to_TO the_DT gait_NN of_IN healthy_JJ subjects_NNS and/or_CC of_IN a_DT single_JJ pathologic_JJ population_NN ._.
However_RB ,_, some_DT authors_NNS suggest_VBP that_IN T4_NN melanoma_NN patients_NNS could_MD be_VB considered_VBN as_IN a_DT heterogeneous_JJ group_NN that_WDT could_MD benefit_VB from_IN SLNB_NNP ._.
However_RB ,_, each_DT study_NN had_VBD a_DT major_JJ limitation_NN of_IN a_DT small_JJ number_NN of_IN patients_NNS ._.
However_RB ,_, risk_NN factors_NNS ,_, other_JJ than_IN awareness_NN ,_, for_IN symptoms_NNS of_IN posttraumatic_JJ stress_NN disorder_NN -LRB-_-LRB- PTSD_NN -RRB-_-RRB- after_IN surgery_NN are_VBP poorly_RB defined_VBN ,_, and_CC practical_JJ screening_NN methods_NNS have_VBP not_RB been_VBN applied_VBN to_TO a_DT broad_JJ population_NN of_IN surgical_JJ patients_NNS ._.
However_RB ,_, the_DT examination_NN of_IN combined_JJ tumor_NN markers_NNS might_MD improve_VB their_PRP$ sensitivity_NN or_CC specificity_NN in_IN aiding_VBG diagnosis_NN ._.
However_RB ,_, reduced_VBD exposure_NN of_IN anatomical_JJ landmarks_NNS may_MD result_VB in_IN technical_JJ errors_NNS and_CC inferior_JJ implant_VBP survivorships_NNS ._.
However_RB ,_, only_RB a_DT few_JJ studies_NNS have_VBP been_VBN published_VBN on_IN the_DT topic_NN ,_, mainly_RB with_IN retrospective_JJ data_NNS ._.
However_RB ,_, the_DT clinical_JJ utility_NN of_IN common_JJ breast_NN cancer_NN risk_NN markers_NNS may_MD nonetheless_RB differ_VB across_IN strata_NN defined_VBN by_IN known_JJ risk_NN factors_NNS ,_, such_JJ as_IN age_NN ._.
However_RB ,_, the_DT role_NN of_IN oral_JJ hydration_NN has_VBZ not_RB been_VBN well_RB established_VBN ._.
However_RB ,_, less_JJR is_VBZ known_VBN about_IN the_DT effects_NNS of_IN childhood_NN maltreatment_NN on_IN cardiovascular_JJ risk_NN factors_NNS prior_RB to_TO development_NN of_IN cardiovascular_JJ disease_NN ,_, or_CC whether_IN these_DT effects_NNS are_VBP evident_JJ in_IN young_JJ adulthood_NN ._.
However_RB ,_, there_EX are_VBP evidences_NNS that_WDT do_VBP not_RB support_VB the_DT aneuploidy_NN hypothesis_NN ._.
However_RB ,_, it_PRP is_VBZ affected_VBN by_IN many_JJ factors_NNS ._.
However_RB ,_, it_PRP is_VBZ difficult_JJ to_TO inject_VB botulinum_NN toxin_NN type_NN A_NN into_IN the_DT depressor_NN anguli_JJ oris_NN muscle_NN because_IN its_PRP$ medial_JJ border_NN overlaps_VBZ with_IN the_DT depressor_NN labii_NN inferioris_NN ,_, and_CC its_PRP$ lateral_JJ border_NN is_VBZ adjacent_JJ to_TO the_DT risorius_NN ,_, zygomaticus_NN major_JJ ,_, and_CC platysma_NN muscles_NNS ._.
However_RB ,_, to_TO assess_VB the_DT effectiveness_NN of_IN these_DT interventions_NNS ,_, the_DT time_NN from_IN symptom_NN onset_NN to_TO presentation_NN needs_VBZ to_TO be_VB reliably_RB and_CC accurately_RB measured_VBN ._.
However_RB ,_, many_JJ patients_NNS with_IN AMI_NNP present_JJ with_IN very_RB mild_JJ pain_NN or_CC discomfort_NN ._.
However_RB ,_, the_DT effectiveness_NN of_IN audit_NN and_CC feedback_NN has_VBZ shown_VBN inconsistent_JJ results_NNS and_CC the_DT impact_NN of_IN audit_NN and_CC feedback_NN on_IN clinical_JJ performance_NN has_VBZ not_RB been_VBN evaluated_VBN for_IN COPD_NN exacerbations_NNS ._.
However_RB ,_, late_JJ sequelae_NN and_CC safety_NN of_IN non-interventional_JJ management_NN in_IN patients_NNS with_IN asymptomatic_JJ walled-off_JJ necrosis_NN remain_VBP unclear_JJ ._.
However_RB ,_, there_EX are_VBP concerns_NNS about_IN its_PRP$ safety_NN ,_, particularly_RB in_IN view_NN of_IN the_DT increasing_VBG efficacy_NN of_IN less_JJR invasive_JJ strategies_NNS ._.
However_RB ,_, the_DT kinetic_JJ limits_NNS of_IN PCR_NN are_VBP unknown_JJ ._.
However_RB ,_, laparoscopic_JJ total_JJ gastrectomy_NN -LRB-_-LRB- LTG_NN -RRB-_-RRB- with_IN splenectomy_NN is_VBZ seldom_RB performed_VBN ,_, because_IN of_IN its_PRP$ difficulty_NN of_IN removal_NN of_IN station_NN INT_CD lymph_NN nodes_NNS ;_: splenectomy_NN is_VBZ technically_RB essential_JJ for_IN complete_JJ removal_NN of_IN these_DT lymph_NN nodes_NNS ._.
However_RB ,_, research_NN has_VBZ predominantly_RB focused_VBN on_IN depression_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN how_WRB EHR_NNP use_NN relates_VBZ to_TO physicians_NNS '_POS care_NN decisions_NNS ._.
However_RB ,_, BM_NN or_CC PB_NN is_VBZ still_RB preferred_VBN over_IN CB_NNP in_IN Korea_NNP ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN late_JJ outcomes_NNS of_IN hospital_NN survivors_NNS and_CC their_PRP$ ability_NN to_TO progress_VB through_IN subsequent_JJ palliative_JJ stages_NNS ._.
However_RB ,_, these_DT therapies_NNS are_VBP not_RB curative_JJ and_CC simply_RB slow_VB the_DT progression_NN of_IN the_DT disease_NN ._.
However_RB ,_, although_IN life-expectancy_NN has_VBZ increased_VBN considerably_RB ,_, incidence_NN rates_NNS of_IN PD_NN appeared_VBD to_TO be_VB stable_JJ over_IN the_DT last_JJ two_CD decades_NNS ._.
However_RB ,_, this_DT procedure_NN over-uses_NNS medical_JJ resources_NNS ,_, and_CC the_DT cessation_NN of_IN hemofiltration_NN during_IN coronary_JJ angiography_NN results_VBZ in_IN persistent_JJ renal_JJ injury_NN ._.
However_RB ,_, there_EX is_VBZ little_JJ evidence_NN for_IN efficiency_NN of_IN physicians_NNS due_JJ to_TO CDS_NN assistance_NN ._.
However_RB ,_, the_DT precise_JJ molecular_JJ mechanisms_NNS by_IN which_WDT cerebral_JJ vasospasm_NN is_VBZ attenuated_VBN is_VBZ not_RB clear_JJ ._.
However_RB ,_, the_DT DRI_NNP has_VBZ not_RB been_VBN tested_VBN for_IN smaller_JJR cohorts_NNS or_CC cohorts_NNS with_IN shorter_JJR follow-up_NN ._.
However_RB ,_, choice_NN of_IN medications_NNS is_VBZ correlated_VBN with_IN diabetes_NN duration_NN and_CC severity_NN ,_, leading_VBG to_TO confounding_JJ by_IN indication_NN ._.
However_RB ,_, their_PRP$ effects_NNS in_IN different_JJ living_NN environments_NNS or_CC with_IN aging_VBG remain_VBP unclear_JJ ._.
However_RB ,_, whether_IN faster_JJR surgeons_NNS have_VBP better_JJR outcomes_NNS is_VBZ unclear_JJ ,_, as_IN a_DT surgeon_NN ׳_NN s_VBZ speed_NN could_MD reflect_VB skill_NN and_CC efficiency_NN ,_, but_CC may_MD alternatively_RB reflect_VB haste_NN ._.
However_RB ,_, the_DT impact_NN of_IN MRI_NNP evaluation_NN on_IN surgical_JJ treatment_NN decisions_NNS in_IN the_DT neoadjuvant_JJ setting_NN has_VBZ not_RB been_VBN well_RB described_VBN ._.
However_RB ,_, few_JJ data_NNS exist_VBP to_TO characterize_VB the_DT clotting_NN profiles_NNS of_IN these_DT variants_NNS ._.
However_RB ,_, there_EX are_VBP limited_JJ data_NNS on_IN the_DT treatment_NN of_IN these_DT patients_NNS in_IN Argentina_NNP ._.
However_RB ,_, selective_JJ conservatism_NN with_IN gunshot_NN wounds_NNS to_TO the_DT abdomen_NN is_VBZ controversial_JJ ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT relationship_NN between_IN total_JJ PCS_NN level_NN and_CC prolonged_JJ QT_NN interval_NN ._.
However_RB ,_, prior_JJ studies_NNS report_VBP poor_JJ specificity_NN ,_, necessitating_VBG adrenal_JJ vein_NN sampling_NN -LRB-_-LRB- AVS_NN -RRB-_-RRB- prior_RB to_TO surgical_JJ consideration_NN ._.
However_RB ,_, there_EX is_VBZ little_JJ in_IN the_DT medical_JJ literature_NN to_TO guide_NN secondary_JJ therapy_NN when_WRB an_DT initial_JJ treatment_NN strategy_NN is_VBZ insufficient_JJ ._.
However_RB ,_, disadvantages_NNS of_IN these_DT immobilization_NN devices_NNS in_IN terms_NNS of_IN discomfort_NN and_CC tissue-interface_NN pressures_NNS have_VBP guided_VBN the_DT development_NN of_IN soft-layered_JJ long_JJ spineboards_NNS ._.
However_RB ,_, the_DT data_NNS are_VBP less_RBR clear_JJ in_IN regards_VBZ to_TO patients_NNS who_WP undergo_VBP endoscopic_JJ sphincterotomy_NN prior_RB to_TO surgery_NN ._.
However_RB ,_, Aeromonas_NNP infections_NNS are_VBP the_DT most_RBS common_JJ complications_NNS of_IN post-operative_JJ leech_NN application_NN ._.
However_RB ,_, the_DT mechanism_NN of_IN ARBs_NNS is_VBZ unknown_JJ ._.
However_RB ,_, there_EX are_VBP no_DT known_JJ studies_NNS evaluating_VBG the_DT utility_NN of_IN the_DT lymphocyte_NN proliferation_NN test_NN -LRB-_-LRB- LPT_NN -RRB-_-RRB- or_CC specific_JJ antibodies_NNS to_TO avian_JJ antigens_NNS in_IN diagnosing_VBG bird-related_JJ HP_NNP ._.
However_RB ,_, the_DT effects_NNS of_IN antihypertensive_JJ agents_NNS on_IN urinary_JJ ACE2_NN remain_VBP unclear_JJ ._.
However_RB ,_, little_JJ evidence_NN exists_VBZ on_IN professional-parent_JJ interactions_NNS in_IN this_DT context_NN ._.
However_RB ,_, whether_IN more_RBR adapted_VBN electrophysiological_JJ criteria_NNS may_MD allow_VB a_DT single_JJ study_NN to_TO be_VB sufficient_JJ is_VBZ unknown_JJ ._.
However_RB ,_, a_DT traumatic_JJ event_NN can_MD be_VB associated_VBN with_IN several_JJ cues_NNS ,_, and_CC each_DT cue_NN can_MD potentially_RB trigger_VB recollection_NN of_IN the_DT event_NN ._.
However_RB ,_, this_DT may_MD not_RB hold_VB for_IN all_DT patients_NNS with_IN traumatic_JJ experiences_NNS ._.
However_RB ,_, it_PRP is_VBZ unknown_JJ whether_IN the_DT angiotensin_NN II_CD receptor_NN blocker_NN olmesartan_NN synergistically_RB acts_VBZ with_IN statins_NNS to_TO increase_VB the_DT levels_NNS of_IN circulating_VBG EPCs_NNS ._.
However_RB ,_, clinical_JJ experience_NN is_VBZ limited_VBN ,_, and_CC mid-term_JJ results_NNS are_VBP lacking_VBG ._.
However_RB ,_, ring_NN annuloplasty_NN does_VBZ not_RB always_RB prevent_VB the_DT recurrence_NN of_IN tricuspid_NN regurgitation_NN due_JJ to_TO dilation_NN of_IN the_DT septal_JJ annulus_NN ._.
However_RB ,_, a_DT variety_NN of_IN approaches_NNS have_VBP been_VBN used_VBN ,_, especially_RB in_FW vitro_FW and_CC animal_JJ models_NNS ,_, and_CC the_DT findings_NNS are_VBP variable_JJ ._.
However_RB ,_, the_DT optimal_JJ combination_NN regimen_NN is_VBZ not_RB well_RB established_VBN ._.
However_RB ,_, few_JJ reports_NNS have_VBP described_VBN MPCs_NNS in_IN gastric_JJ carcinomas_NNS ,_, and_CC the_DT clinicopathological_JJ features_NNS of_IN MPC_NNP are_VBP unclear_JJ ._.
However_RB ,_, this_DT association_NN could_MD be_VB due_JJ to_TO genetic_JJ factors_NNS influencing_VBG exposure_NN to_TO such_JJ risky_JJ environments_NNS or_CC increasing_VBG sensitivity_NN to_TO the_DT detrimental_JJ impact_NN of_IN abuse_NN ._.
However_RB ,_, present_JJ studies_NNS do_VBP not_RB allow_VB comparative_JJ evidence_NN on_IN indication_NN for_IN surgical_JJ treatment_NN mostly_RB due_JJ to_TO the_DT lack_NN of_IN precise_JJ definitions_NNS and_CC comparable_JJ classifications_NNS ._.
However_RB ,_, the_DT correlation_NN between_IN PD-L1expression_NN and_CC prognosis_NN of_IN solid_JJ tumor_NN is_VBZ still_RB in_IN controversial_JJ ._.
However_RB only_RB a_DT few_JJ reports_NNS showed_VBD the_DT tumor_NN forming_VBG ability_NN of_IN SaOS2_NN cells_NNS on_IN CAM_NNP ._.
However_RB ,_, the_DT health_NN effects_NNS of_IN long_JJ working_VBG hours_NNS on_IN suicidal_JJ thoughts_NNS have_VBP not_RB been_VBN frequently_RB studied_VBN ._.
However_RB ,_, the_DT clinical_JJ manifestations_NNS of_IN syphilitic_JJ chorioretinitis_NN are_VBP still_RB unclear_JJ ,_, particularly_RB during_IN different_JJ stages_NNS ._.
However_RB ,_, the_DT fentanyl_NN concentrations_NNS in_IN the_DT blood_NN of_IN patients_NNS with_IN cachexia_NN have_VBP not_RB been_VBN analyzed_VBN ._.
However_RB ,_, its_PRP$ expression_NN and_CC role_NN in_IN lung_NN cancer_NN has_VBZ not_RB been_VBN well_RB clarified_VBN yet_RB ._.
However_RB ,_, this_DT contention_NN has_VBZ not_RB been_VBN systematically_RB assessed_VBN ._.
However_RB ,_, a_DT comprehensive_JJ profile_NN of_IN Olig2_NN target_NN genes_NNS in_IN pMNs_NNS and_CC oligodendrocyte_JJ progenitor_NN cells_NNS -LRB-_-LRB- OPCs_NNS -RRB-_-RRB- with_IN relevance_NN to_TO the_DT pathogenesis_NN of_IN ALS_NN remains_VBZ to_TO be_VB characterized_VBN ._.
However_RB ,_, the_DT drug_NN resistances_NNS limited_VBD the_DT curative_JJ effect_NN of_IN the_DT doxorubicin_NN therapy_NN in_IN breast_NN cancer_NN patients_NNS ,_, but_CC the_DT molecular_JJ mechanism_NN determinants_NNS of_IN breast_NN cancer_NN resistance_NN to_TO doxorubicin_NN chemotherapy_NN are_VBP not_RB fully_RB understood_VBN ._.
However_RB ,_, prior_JJ studies_NNS have_VBP usually_RB focused_VBN on_IN a_DT limited_JJ illness_NN period_NN and_CC used_VBD a_DT wide_JJ variety_NN of_IN cognitive_JJ instruments_NNS ._.
However_RB ,_, the_DT mechanisms_NNS underlying_VBG IPC_NNP remain_VBP far_RB from_IN complete_JJ ._.
However_RB ,_, little_JJ information_NN exists_VBZ comparing_VBG it_PRP with_IN acarbose_NN which_WDT is_VBZ also_RB commonly_RB used_VBN in_IN China_NNP ._.
However_RB ,_, watching_VBG television_NN may_MD become_VB difficult_JJ when_WRB it_PRP is_VBZ disturbed_VBN by_IN symptoms_NNS of_IN dementia_NN ._.
However_RB ,_, the_DT roles_NNS of_IN PGC-1α_NN in_IN malignant_JJ endometrial_JJ cancer_NN remain_VBP unknown_JJ ._.
However_RB ,_, the_DT self_NN is_VBZ a_DT multimodal_JJ construct_NN ,_, and_CC therefore_RB ,_, it_PRP is_VBZ essential_JJ to_TO test_VB self-recognition_NN in_IN other_JJ sensory_JJ modalities_NNS as_RB well_RB ._.
However_RB ,_, many_JJ patients_NNS suffer_VBP from_IN deterioration_NN of_IN the_DT quality_NN of_IN a_DT postoperative_JJ life_NN ._.
However_RB ,_, the_DT results_NNS have_VBP been_VBN inconclusive_JJ ._.
However_RB ,_, beliefs_NNS about_IN the_DT effectiveness_NN of_IN these_DT interventions_NNS can_MD influence_VB pediatricians_NNS '_POS recommendations_NNS to_TO their_PRP$ patients_NNS ._.
However_RB ,_, its_PRP$ physiological_JJ meaning_NN is_VBZ not_RB clear_JJ during_IN acute_JJ respiratory_JJ distress_NN syndrome_NN -LRB-_-LRB- ARDS_NN -RRB-_-RRB- ._.
However_RB the_DT expression_NN of_IN LAPTM4B-35_NN and_CC its_PRP$ role_NN in_IN the_DT progression_NN of_IN gastric_JJ cancer_NN -LRB-_-LRB- GC_NN -RRB-_-RRB- remains_VBZ unknown_JJ ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN their_PRP$ direct_JJ effects_NNS on_IN coronary_JJ artery_NN disease_NN -LRB-_-LRB- CAD_NN -RRB-_-RRB- ._.
However_RB ,_, the_DT biological_JJ processes_NNS and_CC molecular_JJ pathways_NNS through_IN which_WDT this_DT miRNA_NN exerts_VBZ its_PRP$ positive_JJ effects_NNS are_VBP unknown_JJ ._.
However_RB ,_, although_IN efficacy_NN of_IN surgery_NN has_VBZ been_VBN demonstrated_VBN ,_, evidence_NN supporting_VBG HIPEC_NNP 's_POS role_NN is_VBZ less_RBR certain_JJ ._.
However_RB ,_, knowledge_NN about_IN the_DT diagnosis_NN and_CC management_NN of_IN dementia_NN and_CC memory_NN impairment_NN among_IN immigrants_NNS is_VBZ scarce_JJ in_IN Norway_NNP and_CC elsewhere_RB ._.
However_RB ,_, comparative_JJ studies_NNS of_IN STE_NNP parameters_NNS acquired_VBN from_IN murine_NN are_VBP limited_VBN ._.
However_RB ,_, the_DT regulatory_JJ mechanism_NN still_RB remains_VBZ unclear_JJ ._.
However_RB ,_, the_DT AVR_NN measurements_NNS on_IN radiographs_NNS may_MD underestimate_VB its_PRP$ actual_JJ value_NN ._.
However_RB ,_, it_PRP has_VBZ been_VBN reported_VBN that_IN complications_NNS may_MD arise_VB due_JJ to_TO the_DT closure_NN of_IN mesenteric_JJ defects_NNS ._.
However_RB ,_, few_JJ studies_NNS have_VBP been_VBN conducted_VBN to_TO evaluate_VB anxiety_NN symptoms_NNS of_IN medical_JJ students_NNS in_IN China_NNP ._.
However_RB ,_, until_IN now_RB ,_, the_DT serum_NN level_NN and_CC its_PRP$ diagnostic_JJ and_CC prognostic_JJ potential_NN in_IN breast_NN cancer_NN have_VBP not_RB been_VBN investigated_VBN ._.
However_RB ,_, presentation_NN as_IN fever_NN of_IN unknown_JJ origin_NN -LRB-_-LRB- FUO_NN -RRB-_-RRB- is_VBZ not_RB uncommon_JJ in_IN tropical_JJ countries_NNS ._.
However_RB ,_, the_DT use_NN and_CC uptake_NN of_IN ART_NN has_VBZ resulted_VBN in_IN adverse_JJ reactions_NNS ,_, due_JJ mainly_RB to_TO the_DT medicine_NN 's_POS toxicity_NN and_CC interactions_NNS with_IN other_JJ medicines_NNS ._.
However_RB ,_, recurrent_JJ nature_NN of_IN these_DT data_NNS pose_VBP challenges_NNS in_IN their_PRP$ analyses_NNS ._.
However_RB ,_, data_NNS on_IN the_DT immunogenicity_NN of_IN MMR3_NN are_VBP limited_VBN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT predictors_NNS of_IN maternal_JJ mortality_NN in_IN women_NNS with_IN HDP_NN ._.
However_RB ,_, the_DT validity_NN of_IN participant-reported_JJ medical_JJ diagnoses_NNS is_VBZ unknown_JJ ._.
However_RB ,_, similar_JJ to_TO other_JJ focal_JJ heat_NN ablation_NN techniques_NNS ,_, HIFU_NNP is_VBZ still_RB in_IN need_NN of_IN refinements_NNS due_JJ to_TO tumor_NN recurrence_NN ._.
However_RB ,_, few_JJ researches_VBZ focused_VBN on_IN the_DT obstacles_NNS and_CC factors_NNS facilitating_VBG empowerment_NN in_IN elderly_JJ people_NNS with_IN COPD_NN ;_: and_CC an_DT adequate_JJ determining_NN of_IN these_DT factors_NNS need_VBP an_DT in-depth_JJ understanding_NN of_IN the_DT meaning_NN of_IN these_DT factors_NNS which_WDT influences_VBZ empowerment_NN ._.
However_RB ,_, it_PRP is_VBZ important_JJ that_IN the_DT global_JJ public_JJ health_NN community_NN have_VBP access_NN to_TO information_NN on_IN the_DT basic_JJ epidemiological_JJ features_NNS of_IN the_DT outbreak_NN to_TO date_NN ,_, including_VBG the_DT basic_JJ reproduction_NN number_NN -LRB-_-LRB- R0_NN -RRB-_-RRB- and_CC best_JJS estimates_NNS of_IN case-fatality_NN rates_NNS -LRB-_-LRB- CFR_NNS -RRB-_-RRB- ._.
However_RB ,_, many_JJ unanswered_JJ questions_NNS remain_VBP ,_, and_CC there_EX is_VBZ no_DT consensus_NN as_IN to_TO the_DT optimum_JJ technique_NN ._.
However_RB ,_, information_NN about_IN the_DT level_NN of_IN glycemic_JJ control_NN among_IN patients_NNS in_IN the_DT follow-up_JJ care_NN at_IN the_DT University_NNP of_IN Gondar_NNP Referral_NNP Hospital_NNP is_VBZ scanty_JJ ._.
However_RB ,_, postoperative_JJ pain_NN can_MD be_VB moderate_JJ to_TO severe_JJ for_IN FLOAT_CD days_NNS ._.
However_RB ,_, there_EX are_VBP very_RB few_JJ reports_NNS in_IN the_DT world_NN literature_NN describing_VBG the_DT abdominoplasty_JJ procedure_NN for_IN therapeutic_JJ purposes_NNS rather_RB than_IN for_IN cosmetic_JJ reasons_NNS ._.
However_RB ,_, few_JJ studies_NNS have_VBP been_VBN performed_VBN to_TO assess_VB the_DT relationship_NN between_IN skin_NN inflammation_NN and_CC ASD_NN exposure_NN ._.
However_RB ,_, whether_IN Amino-Nogo_NNP is_VBZ the_DT most_RBS important_JJ functional_JJ domain_NN of_IN Nogo-A_NN remains_VBZ unknown_JJ ._.
However_RB ,_, tumor_NN size_NN has_VBZ not_RB been_VBN incorporated_VBN in_IN tumor_NN -LRB-_-LRB- T_NN -RRB-_-RRB- ,_, nodal_JJ status_NN -LRB-_-LRB- N_NN -RRB-_-RRB- ,_, metastasis_NN -LRB-_-LRB- M_NN -RRB-_-RRB- staging_NN for_IN colon_NN cancer_NN ._.
However_RB ,_, no_DT single_JJ source_NN has_VBZ systematically_RB appraised_VBN and_CC summarised_VBN the_DT literature_NN to_TO evaluate_VB this_DT proposed_VBN relationship_NN ._.
However_RB ,_, complex_JJ LAA_NN anatomy_NN may_MD preclude_VB its_PRP$ use_NN ._.
However_RB ,_, the_DT effect_NN of_IN transcatheter_NN aortic_JJ valve_NN implantation_NN -LRB-_-LRB- TAVI_NN -RRB-_-RRB- on_IN QTd_NN in_IN patients_NNS with_IN aortic_JJ stenosis_NN is_VBZ unknown_JJ ._.
However_RB ,_, differentiation_NN is_VBZ difficult_JJ without_IN specific_JJ diagnostic_JJ tests_NNS ._.
However_RB ,_, measurements_NNS show_VBP that_IN this_DT procedure_NN is_VBZ less_RBR effective_JJ in_IN restoring_VBG upper-pole_JJ fullness_NN ._.
However_RB ,_, the_DT effectiveness_NN of_IN these_DT two_CD methods_NNS has_VBZ not_RB been_VBN compared_VBN before_IN ._.
However_RB ,_, their_PRP$ effects_NNS on_IN myometrial_JJ contractility_NN remain_VBP unknown_JJ ._.
However_RB ,_, there_EX are_VBP few_JJ reports_NNS on_IN the_DT prevalence_NN of_IN SCN_NN disorder_NN and_CC there_EX are_VBP several_JJ reports_NNS only_RB on_IN favorable_JJ outcomes_NNS of_IN treatment_NN of_IN SCN_NN disorder_NN on_IN LBP_NN ._.
However_RB ,_, the_DT regulation_NN of_IN PAPP-A_NN placental_JJ secretion_NN is_VBZ unclear_JJ ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN their_PRP$ toxic_JJ effects_NNS and_CC risks_NNS ._.
However_RB the_DT day/night_NN patterns_NNS of_IN secretion_NN in_IN male_JJ subjects_NNS remain_VBP to_TO be_VB fully_RB elucidated_VBN ._.
However_RB ,_, the_DT neurobiological_JJ alterations_NNS in_IN the_DT brain_NN following_VBG the_DT central_JJ inflammatory_JJ immune_JJ activation_NN remain_VBP elusive_JJ ._.
However_RB ,_, renin-angiotensin-aldosterone_NN system_NN blockade_NN by_IN the_DT angiotensin_NN converting_VBG enzyme_NN inhibitors_NNS -LRB-_-LRB- ACEi_NNS -RRB-_-RRB- can_MD only_RB partially_RB reverse_VB the_DT cardiac_JJ hypertrophy_NN without_IN having_VBG a_DT significant_JJ impact_NN on_IN all-cause_JJ mortality_NN as_IN evidenced_VBN by_IN meta-analyses_NNS from_IN clinical_JJ trials_NNS ._.
However_RB ,_, it_PRP is_VBZ unclear_JJ whether_IN cognitive_JJ impairment_NN of_IN specific_JJ domains_NNS or_CC the_DT degree_NN of_IN severity_NN is_VBZ more_RBR critical_JJ to_TO functional_JJ recovery_NN in_IN patients_NNS with_IN poststroke_JJ disability_NN ._.
However_RB ,_, there_EX is_VBZ a_DT shortage_NN of_IN studies_NNS addressing_VBG CLA_NN from_IN natural_JJ source_NN ._.
However_RB ,_, there_EX is_VBZ no_DT standard_JJ program_NN in_IN LT_NN ,_, and_CC therefore_RB none_NN is_VBZ applied_VBN ._.
However_RB ,_, contradictory_JJ results_NNS have_VBP been_VBN reported_VBN ,_, and_CC small_JJ sample_NN sizes_NNS of_IN the_DT cohorts_NNS and_CC different_JJ definitions_NNS of_IN a_DT microscopic_JJ positive_JJ resection_NN margin_NN -LRB-_-LRB- R1_NN -RRB-_-RRB- hamper_VBP the_DT interpretation_NN of_IN data_NNS ._.
However_RB ,_, in_IN the_DT fields_NNS of_IN data_NNS mining_NN and_CC machine-learning_NN ,_, many_JJ alternative_JJ classification_NN and_CC prediction_NN algorithms_NNS have_VBP been_VBN developed_VBN ._.
However_RB ,_, the_DT effects_NNS of_IN trace_NN amine_NN associated_VBN receptor_NN INT_CD agonists_NNS on_IN addiction-related_JJ behavioral_JJ effects_NNS of_IN methamphetamine_NN are_VBP unknown_JJ ._.
However_RB ,_, the_DT mechanisms_NNS underlying_VBG this_DT pro-oxidative_JJ effect_NN of_IN homocysteine_NN -LRB-_-LRB- Hcy_NN -RRB-_-RRB- in_IN hepatocytes_NNS remain_VBP largely_RB unknown_JJ ._.
However_RB ,_, these_DT comparisons_NNS have_VBP often_RB been_VBN made_VBN between_IN relatively_RB small_JJ groups_NNS of_IN patients_NNS ,_, often_RB with_IN short-term_JJ follow-up_NN ,_, with_IN only_RB small_JJ differences_NNS demonstrated_VBD between_IN the_DT groups_NNS ._.
However_RB ,_, they_PRP used_VBD a_DT limited_JJ number_NN of_IN stages_NNS ._.
However_RB the_DT association_NN between_IN age_NN at_IN time_NN of_IN exposure_NN and_CC the_DT subsequent_JJ development_NN of_IN CD_NNP in_IN South_NNP Africa_NNP is_VBZ unknown_JJ ._.
However_RB ,_, data_NNS on_IN the_DT interactive_JJ effects_NNS of_IN early_JJ life_NN adversity_NN ,_, genetic_JJ factors_NNS -LRB-_-LRB- e.g._FW p.Met66_NN allele_NN of_IN BDNF_NN -RRB-_-RRB- ,_, and_CC alcohol_NN dependence_NN ,_, on_IN brain_NN structure_NN in_IN adolescents_NNS is_VBZ limited_VBN ._.
However_RB ,_, transplant_NN patients_NNS outside_IN the_DT Milan_NNP criteria_NNS have_VBP a_DT high_JJ risk_NN of_IN tumor_NN recurrence_NN ,_, which_WDT has_VBZ been_VBN linked_VBN to_TO standard_JJ immunosuppression_NN regimens_NNS ._.
However_RB ,_, morbidity_NN in_IN survivors_NNS ,_, including_VBG neurodevelopmental_JJ disabilities_NNS ,_, has_VBZ increased_VBN ,_, especially_RB in_IN extremely_RB preterm_JJ infants_NNS born_VBN at_IN ≤_CD INT_CD weeks_NNS '_POS gestation_NN ._.
However_RB ,_, the_DT correlation_NN between_IN RUNX3_NN hypermethylation_NN and_CC the_DT incidence_NN of_IN BC_NN remains_VBZ unclear_JJ ._.
However_RB ,_, there_EX is_VBZ little_JJ mention_NN of_IN the_DT TTE_NNP in_IN the_DT literature_NN ._.
However_RB ,_, gaps_NNS remain_VBP in_IN our_PRP$ understanding_NN of_IN several_JJ fundamental_JJ and_CC applied_VBD questions_NNS ,_, particularly_RB related_JJ to_TO the_DT design_NN of_IN interactive_JJ ,_, personalized_JJ decision_NN aids_NNS ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN CHWs_NNS '_POS perceptions_NNS of_IN barriers_NNS and_CC motivations_NNS ,_, as_RB well_RB as_IN those_DT of_IN the_DT beneficiaries_NNS of_IN CHWs_NNS ._.
However_RB ,_, no_DT study_NN has_VBZ assessed_VBN changes_NNS in_IN body_NN composition_NN -LRB-_-LRB- BC_NN -RRB-_-RRB- in_IN this_DT population_NN ._.
However_RB ,_, the_DT specific_JJ effects_NNS of_IN perceived_VBN parental_JJ acceptance-rejection_NN on_IN diverse_JJ domains_NNS of_IN child_NN adjustment_NN and_CC development_NN have_VBP been_VBN incompletely_RB documented_VBN ,_, and_CC whether_IN these_DT effects_NNS hold_VBP across_RP diverse_JJ populations_NNS and_CC for_IN mothers_NNS and_CC fathers_NNS are_VBP still_RB open_JJ questions_NNS ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT outcome_NN expectations_NNS of_IN HIV-infected_JJ inmates_NNS for_IN release_NN ,_, how_WRB their_PRP$ post-release_JJ lives_NNS align_VBP with_IN pre-release_JJ expectations_NNS ,_, and_CC how_WRB these_DT processes_NNS influence_VBP engagement_NN in_IN HIV_NN care_NN following_VBG release_NN from_IN prison_NN ._.
However_RB ,_, the_DT mechanism_NN for_IN this_DT anti-allodynic_JJ effect_NN of_IN BVA_NN remains_VBZ poorly_RB understood_VBN ._.
However_RB ,_, this_DT priori_FW cost_NN is_VBZ often_RB unknown_JJ and_CC hard_JJ to_TO estimate_VB in_IN medical_JJ decision_NN making_NN ._.
However_RB ,_, use_NN of_IN EEG_NN microstates_NNS as_IN neurophysiological_JJ biomarkers_NNS requires_VBZ assessment_NN of_IN the_DT test-retest_JJ reliability_NN of_IN microstate_NN analysis_NN ._.
However_RB ,_, few_JJ studies_NNS have_VBP reported_VBN the_DT psychometric_JJ properties_NNS of_IN self-report_JJ measures_NNS to_TO assess_VB the_DT frequency_NN and_CC duration_NN of_IN breaks_NNS from_IN sitting_VBG ._.
However_RB ,_, prevention_NN of_IN radiation-induced_JJ damage_NN is_VBZ of_IN great_JJ interest_NN ._.
However_RB ,_, its_PRP$ prognostic_JJ significance_NN in_IN IHCC_NN is_VBZ unclear_JJ ._.
However_RB ,_, patient_NN perceptions_NNS of_IN these_DT relationships_NNS have_VBP not_RB been_VBN investigated_VBN in_IN a_DT military_JJ treatment_NN setting_NN ._.
However_RB ,_, there_EX has_VBZ been_VBN little_JJ focus_NN on_IN evaluating_VBG the_DT implementation_NN of_IN such_JJ policies_NNS ._.
However_RB ,_, studies_NNS have_VBP only_RB occasionally_RB differentiated_VBN CAM_NNP use_NN according_VBG to_TO gender_VB ._.
However_RB ,_, rating_NN discrepancies_NNS have_VBP not_RB been_VBN investigated_VBN ._.
However_RB ,_, the_DT immune_JJ defects_NNS in_IN A-T_NN patients_NNS are_VBP not_RB well_RB characterized_VBN ._.
However_RB ,_, there_EX are_VBP no_DT recent_JJ ,_, systematic_JJ analyses_NNS of_IN the_DT efficacy_NN ,_, safety_NN ,_, or_CC tolerability_NN of_IN these_DT medications_NNS in_IN pediatric_JJ anxiety_NN disorders_NNS ._.
However_RB ,_, relevant_JJ data_NNS on_IN the_DT Taiwanese_JJ population_NN are_VBP lacking_VBG ,_, and_CC most_JJS of_IN the_DT current_JJ literature_NN uses_VBZ global_JJ instead_RB of_IN split_NN renal_JJ function_NN -LRB-_-LRB- SRF_NN -RRB-_-RRB- for_IN postoperative_JJ renal_JJ function_NN follow-up_NN ._.
However_RB ,_, TEA_NN is_VBZ still_RB associated_VBN with_IN a_DT higher_JJR complication_NN rate_NN than_IN total_JJ hip_NN and_CC knee_NN arthroplasty_NN despite_IN advances_NNS in_IN the_DT design_NN and_CC surgical_JJ techniques_NNS ._.
However_RB ,_, `_`` aging_NN ,_, '_'' per_FW se_FW ,_, is_VBZ not_RB a_DT cause_NN of_IN cognitive_JJ decline_NN but_CC rather_RB a_DT variable_JJ that_IN likely_JJ captures_NNS multiple_JJ accumulating_VBG biological_JJ changes_NNS over_IN time_NN that_WDT collectively_RB affect_VBP mental_JJ abilities_NNS ._.
However_RB ,_, eating_VBG them_PRP raw_JJ may_MD pose_VB a_DT great_JJ risk_NN for_IN transmissions_NNS of_IN pathogens_NNS ._.
However_RB ,_, less_JJR evidence_NN is_VBZ available_JJ on_IN the_DT temperature_NN effects_NNS on_IN gender_NN -_: and_CC age-specific_JJ emergency_NN department_NN visits_NNS ,_, especially_RB in_IN developing_VBG countries_NNS ._.
However_RB ,_, we_PRP have_VBP a_DT limited_JJ understanding_NN of_IN the_DT disease_NN transmission_NN dynamics_NNS in_IN these_DT regions_NNS ._.
However_RB ,_, their_PRP$ relative_JJ efficacy_NN in_IN attenuating_VBG cardiac_JJ injury_NN and_CC dysfunction_NN remains_VBZ unknown_JJ ._.
However_RB ,_, the_DT influence_NN of_IN cultivation_NN conditions_NNS on_IN the_DT antioxidant_JJ activity_NN of_IN the_DT fruiting_JJ bodies_NNS remains_VBZ unclear_JJ ._.
However_RB ,_, the_DT risk_NN for_IN long-term_JJ outcomes_NNS after_IN AKI_NNP is_VBZ largely_RB unknown_JJ ._.
However_RB ,_, contrasting_VBG findings_NNS were_VBD reported_VBN based_VBN on_IN the_DT study_NN design_NN ._.
However_RB ,_, there_EX is_VBZ a_DT group_NN of_IN maintained_JJ hyperhydrated_JJ patients_NNS ._.
However_RB ,_, aspects_NNS from_IN a_DT patient_NN 's_POS perspective_NN are_VBP just_RB as_RB important_JJ ._.
However_RB ,_, no_DT systematic_JJ investigations_NNS have_VBP explored_VBN whether_IN this_DT pattern_NN of_IN higher_JJR utilization_NN persists_VBZ after_IN correcting_VBG for_IN a_DT number_NN of_IN factors_NNS in_IN Korea_NNP ._.
However_RB ,_, it_PRP is_VBZ not_RB known_VBN whether_IN the_DT infection_NN modulates_VBZ lung_NN inflammation_NN by_IN regulating_VBG local_JJ immune_JJ response_NN ._.
However_RB ,_, the_DT lack_NN of_IN structural_JJ and_CC experimental_JJ data_NNS for_IN this_DT insect-essential_JJ GPCR_NN family_NN has_VBZ promoted_VBN the_DT development_NN of_IN homology_NN models_NNS that_WDT are_VBP good_JJ representations_NNS of_IN their_PRP$ biological_JJ equivalents_NNS for_IN in_IN silico_NN screening_NN of_IN small_JJ molecules_NNS ._.
However_RB ,_, there_EX are_VBP concerns_NNS about_IN the_DT quality_NN of_IN meta-ethnography_JJ reporting_NN ,_, particularly_RB the_DT analysis_NN and_CC synthesis_NN processes_NNS ._.
However_RB ,_, there_EX is_VBZ a_DT lack_NN of_IN studies_NNS evaluating_VBG the_DT association_NN between_IN visceral_JJ fat_JJ area_NN and_CC the_DT prevalence_NN of_IN CRC_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN regarding_VBG the_DT correlation_NN between_IN epigenetic_JJ regulation_NN and_CC the_DT development_NN of_IN asthma_NN following_VBG IUGR_NN ._.
However_RB ,_, data_NNS supporting_VBG this_DT recommendation_NN are_VBP limited_VBN ._.
However_RB ,_, the_DT cytotoxicity_NN and_CC effects_NNS of_IN sodium_NN dodecyl_NN benzene_NN sulfonate_NN -LRB-_-LRB- SDBS_NN -RRB-_-RRB- ,_, a_DT common_JJ detergent_NN similar_JJ to_TO SLS_NNP ,_, on_IN keratinocytes_NNS are_VBP still_RB not_RB known_VBN ._.
However_RB ,_, whether_IN these_DT genetic_JJ alterations_NNS would_MD impair_VB islet_NN function_NN is_VBZ unknown_JJ ._.
However_RB ,_, data_NNS about_IN possible_JJ relationship_NN between_IN the_DT improvement_NN of_IN clinical_JJ symptoms_NNS and_CC changes_NNS of_IN serum_NN cytokines_NNS are_VBP limited_VBN ._.
However_RB ,_, the_DT impact_NN of_IN SM22α_NN levels_NNS on_IN PECs_NNS is_VBZ not_RB known_VBN ._.
However_RB ,_, evidence_NN on_IN the_DT practice_NN of_IN emergency_NN care_NN and_CC the_DT implementation_NN of_IN triage_NN systems_NNS in_IN such_JJ settings_NNS ,_, is_VBZ scarce_JJ ._.
However_RB ,_, genetic_JJ mutations_NNS are_VBP rarely_RB evaluated_VBN in_IN patients_NNS with_IN adenosquamous_JJ cell_NN carcinoma_NN of_IN the_DT lung_NN ,_, a_DT relatively_RB infrequent_JJ histologic_JJ type_NN of_IN lung_NN cancer_NN ,_, because_IN of_IN limited_JJ knowledge_NN and_CC the_DT unclear_JJ value_NN of_IN assessing_VBG these_DT oncogenic_JJ mutations_NNS in_IN these_DT patients_NNS ._.
However_RB ,_, most_RBS previous_JJ studies_NNS have_VBP not_RB considered_VBN the_DT repeatability_NN of_IN 24-hour_JJ IOP_NN measurements_NNS ._.
However_RB ,_, data_NNS corroborating_VBG any_DT secular_JJ trend_NN in_IN the_DT menarcheal_JJ age_NN of_IN the_DT Indian_JJ population_NN remained_VBD sparse_JJ and_CC inadequately_RB verified_VBN ._.
However_RB ,_, few_JJ researches_VBZ have_VBP focused_VBN on_IN the_DT traditional_JJ Chinese_JJ medicinal_JJ injection_NN due_JJ to_TO the_DT complicated_JJ constituents_NNS and_CC the_DT intricate_JJ mechanism_NN of_IN action_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN how_WRB the_DT two_CD key_JJ players_NNS ,_, patients_NNS and_CC physicians_NNS ,_, view_VBP the_DT current_JJ status_NN of_IN primary_JJ care_NN in_IN Korea_NNP ._.
However_RB ,_, the_DT correlation_NN between_IN dose-volume_JJ effect_NN and_CC chronic_JJ GI_NN complications_NNS of_IN the_DT small_JJ bowel_NN has_VBZ not_RB been_VBN extensively_RB investigated_VBN ._.
However_RB ,_, individuals_NNS with_IN autism_NN spectrum_NN disorders_NNS -LRB-_-LRB- ASD_NN -RRB-_-RRB- have_VBP been_VBN found_VBN to_TO have_VB difficulty_NN in_IN attributing_VBG intentions_NNS to_TO others_NNS ._.
However_RB ,_, its_PRP$ antiplatelet_JJ and_CC antithrombotic_JJ activities_NNS have_VBP not_RB been_VBN described_VBN ._.
However_RB ,_, it_PRP is_VBZ not_RB the_DT only_JJ threat_NN ._.
However_RB ,_, parsimonious_JJ yet_RB reliable_JJ and_CC valid_JJ screening_NN tools_NNS are_VBP scarce_JJ ._.
However_RB there_EX are_VBP no_DT reports_NNS on_IN variability_NN of_IN CAG_NN repeat_NN expansion_NN ,_, phenotype-genotype_JJ association_NN and_CC founder_NN mutations_NNS in_IN a_DT homogenous_JJ population_NN from_IN India_NNP ._.
However_RB ,_, in_IN Spain_NNP ,_, there_EX is_VBZ no_DT reliable_JJ and_CC valid_JJ instrument_NN for_IN the_DT assessment_NN of_IN EI_NN ._.
However_RB ,_, those_DT data_NNS are_VBP based_VBN on_IN retrospective_JJ self-reports_NNS of_IN soldiers_NNS later_RB in_IN their_PRP$ Army_NNP careers_NNS ._.
However_RB ,_, the_DT prognostic_JJ power_NN of_IN VDAC1_NN and_CC its_PRP$ associated_JJ genes_NNS in_IN human_JJ cancers_NNS is_VBZ largely_RB unknown_JJ ._.
However_RB ,_, studies_NNS on_IN maternal_JJ benzene_NN exposure_NN during_IN pregnancy_NN and_CC childhood_NN acute_JJ lymphoblastic_JJ leukemia_NN -LRB-_-LRB- ALL_NN -RRB-_-RRB- have_VBP not_RB been_VBN systematically_RB assessed_VBN ._.
However_RB ,_, no_DT studies_NNS have_VBP investigated_VBN the_DT association_NN between_IN CHRNA5_NN rs3841324_NN ,_, which_WDT has_VBZ been_VBN proven_VBN to_TO have_VB the_DT highest_JJS association_NN with_IN CHRNA5_NN mRNA_NN expression_NN ,_, and_CC the_DT risk_NN of_IN other_JJ smoking-associated_JJ cancers_NNS ,_, except_IN lung_NN cancer_NN ._.
However_RB ,_, conventional_JJ surgical_JJ robots_NNS do_VBP not_RB provide_VB haptic_JJ feedback_NN to_TO surgeons_NNS during_IN surgery_NN ._.
However_RB ,_, these_DT proof_NN of_IN concept_NN studies_NNS showed_VBD fusion_NN rates_NNS comparable_JJ to_TO open_VB approaches_NNS never_RB gaining_VBG wider_JJR acceptance_NN in_IN the_DT clinical_JJ community_NN ._.
However_RB ,_, the_DT detailed_VBN intracellular_JJ signaling_NN mechanisms_NNS of_IN eosinophil_NN exocytosis_NN induced_VBN by_IN LTB4_NN are_VBP poorly_RB understood_VBN ._.
However_RB ,_, a_DT limitation_NN of_IN microarray_NN analysis_NN has_VBZ been_VBN the_DT inability_NN to_TO detect_VB clonal_JJ heterogeneity_NN in_IN a_DT sample_NN ._.
However_RB ,_, during_IN FLOAT_CD ,_, outbreaks_NNS associated_VBN with_IN WPV_NN type_NN INT_CD -LRB-_-LRB- WPV1_NN -RRB-_-RRB- were_VBD widespread_JJ in_IN the_DT DRC_NNP ,_, with_IN >_JJR INT_CD reported_VBD cases_NNS ._.
However_RB ,_, current_JJ reports_NNS are_VBP scarce_JJ on_IN HIV_NN TDR-associated_JJ mutations_NNS and_CC their_PRP$ co-variation_NN among_IN MSM_NNP ._.
However_RB ,_, there_EX is_VBZ a_DT lack_NN of_IN data_NNS regarding_VBG these_DT phenomena_NNS and_CC inflammatory_JJ process_NN of_IN AEP_NNP ._.
However_RB ,_, the_DT role_NN of_IN NK_NN and_CC its_PRP$ subsets_NNS in_IN adults_NNS with_IN GD_NN remains_VBZ unclear_JJ ._.
However_RB ,_, the_DT inhibitory_JJ effect_NN on_IN CYP3A4_NN may_MD vary_VB among_IN CCBs_NNS ._.
However_RB ,_, its_PRP$ effectiveness_NN is_VBZ uncertain_JJ ._.
However_RB ,_, it_PRP is_VBZ unknown_JJ if_IN recurrent_JJ S._FW aureus_FW infections_NNS are_VBP caused_VBN by_IN the_DT same_JJ strain_NN or_CC are_VBP due_JJ to_TO independent_JJ acquisitions_NNS of_IN different_JJ strains_NNS ._.
However_RB ,_, in_IN the_DT acute_JJ period_NN ,_, differentiating_VBG acute_JJ encephalopathy_NN from_IN febrile_JJ seizures_NNS is_VBZ difficult_JJ ._.
However_RB ,_, whether_IN these_DT variables_NNS are_VBP related_JJ to_TO more_RBR basic_JJ neurobiological_JJ factors_NNS ,_, and_CC whether_IN such_JJ associations_NNS have_VBP implications_NNS for_IN the_DT modification_NN of_IN psychosocial_JJ risk_NN factors_NNS in_IN the_DT context_NN of_IN driving_VBG ,_, have_VBP not_RB been_VBN examined_VBN in_IN depth_NN ._.
However_RB ,_, the_DT impact_NN of_IN low_JJ HDL_NN on_IN ST-segment-elevation_NN myocardial_JJ infarction_NN -LRB-_-LRB- STEMI_NN -RRB-_-RRB- compared_VBN with_IN non-ST-segment-elevation_JJ myocardial_JJ infarction_NN -LRB-_-LRB- NSTEMI_NN -RRB-_-RRB- is_VBZ not_RB clear_JJ ._.
However_RB ,_, the_DT current_JJ methods_NNS for_IN measuring_VBG cholesterol_NN efflux_NN require_VBP a_DT radioactive_JJ tracer_NN and_CC involve_VB a_DT variety_NN of_IN cell_NN treatments_NNS ,_, making_VBG the_DT measurement_NN of_IN macrophage_NN cholesterol_NN efflux_NN impractical_JJ for_IN use_NN in_IN clinical_JJ laboratories_NNS ._.
However_RB ,_, outcomes_NNS of_IN mitral_JJ valve_NN repair_NN for_IN commissural_JJ prolapse_NN has_VBZ not_RB been_VBN well_RB defined_VBN ._.
However_RB ,_, most_JJS used_VBN chest_NN X-rays_NNS ,_, which_WDT are_VBP of_IN limited_JJ sensitivity_NN ,_, and_CC the_DT association_NN was_VBD not_RB made_VBN clear_JJ ._.
However_RB ,_, few_JJ longitudinal_JJ studies_NNS have_VBP evaluated_VBN how_WRB the_DT immune_JJ microenvironment_NN effects_NNS shedding_VBG ._.
However_RB ,_, the_DT molecular_JJ pathways_NNS involved_VBN in_IN PpIX-induced_JJ cytotoxicity_NN are_VBP not_RB well-defined_JJ ._.
However_RB ,_, the_DT role_NN of_IN HTG_NN in_IN modulating_VBG disease_NN course_NN remains_VBZ to_TO be_VB cleared_VBN ._.
However_RB ,_, its_PRP$ role_NN in_IN predisposing_VBG to_TO ,_, or_CC modulating_VBG disease_NN severity_NN in_IN ,_, Clostridium_NNP difficile_NN infection_NN -LRB-_-LRB- CDI_NN -RRB-_-RRB- has_VBZ not_RB been_VBN investigated_VBN ._.
However_RB ,_, only_RB limited_JJ information_NN is_VBZ available_JJ concerning_VBG sex_NN differences_NNS in_IN transcatheter_NN aortic_JJ valve_NN implantation_NN -LRB-_-LRB- TAVI_NN -RRB-_-RRB- ._.
However_RB ,_, controversial_JJ findings_NNS have_VBP been_VBN published_VBN on_IN the_DT presence_NN of_IN HCMV_NN in_IN malignant_JJ tumors_NNS ._.
However_RB ,_, detailed_JJ assessments_NNS of_IN glucose_NN metabolism_NN and_CC insulin_NN secretion_NN in_IN a_DT study_NN designed_VBN to_TO minimize_VB confounders_NNS are_VBP lacking_VBG ._.
However_RB ,_, these_DT studies_NNS involved_VBN average-risk_JJ patients_NNS undergoing_VBG lobectomy_NN ._.
However_RB ,_, it_PRP is_VBZ not_RB known_VBN whether_IN genetic_JJ deletion_NN of_IN KOP_NN affects_VBZ the_DT N2O_NN actions_NNS ._.
However_RB ,_, extensive_JJ efforts_NNS to_TO evaluate_VB the_DT central_JJ actions_NNS and_CC therapeutic_JJ efficacy_NN of_IN IN-OT_NN may_MD be_VB marred_VBN by_IN the_DT absence_NN of_IN data_NNS regarding_VBG its_PRP$ temporal_JJ dynamics_NNS and_CC sites_NNS of_IN action_NN in_IN the_DT living_VBG human_JJ brain_NN ._.
However_RB ,_, in_IN patients_NNS with_IN soft_JJ tissue_NN sarcoma_NN -LRB-_-LRB- STS_NN -RRB-_-RRB- ,_, the_DT prognostic_JJ impact_NN of_IN histologic_JJ response_NN to_TO chemotherapy_NN is_VBZ less_RBR clear_JJ ._.
However_RB ,_, the_DT role_NN of_IN the_DT PD-1_NN pathway_NN in_IN xenotransplantation_NN is_VBZ not_RB well_RB defined_VBN yet_RB ._.
However_RB ,_, only_RB a_DT few_JJ of_IN these_DT studies_NNS used_VBD GFR_NN by_IN the_DT Modification_NN of_IN Diet_NNP in_IN Renal_JJ Disease_NN equation_NN in_IN their_PRP$ analysis_NN of_IN long-term_JJ outcome_NN ._.
However_RB ,_, PI_NN use_NN has_VBZ been_VBN associated_VBN with_IN adverse_JJ birth_NN outcomes_NNS ,_, including_VBG preterm_JJ delivery_NN and_CC small-for-gestational-age_NN -LRB-_-LRB- SGA_NN -RRB-_-RRB- births_NNS ._.
However_RB ,_, health-related_JJ quality_NN of_IN life_NN -LRB-_-LRB- HRQOL_NN -RRB-_-RRB- after_IN robotic_JJ thyroidectomy_NN has_VBZ not_RB yet_RB been_VBN evaluated_VBN ._.
However_RB ,_, the_DT clinical_JJ implication_NN of_IN the_DT CIE_NNP for_IN MSSA_NNP bacteremia_NN is_VBZ obscure_JJ ._.
However_RB ,_, the_DT presence_NN of_IN heparin_NN or_CC heparan_NN sulfate_NN accelerates_VBZ its_PRP$ effect_NN by_IN several_JJ magnitudes_NNS ._.
However_RB ,_, as_IN opposed_VBN to_TO other_JJ subtypes_NNS ,_, it_PRP also_RB exists_VBZ in_IN homozygous_JJ form_NN which_WDT represents_VBZ a_DT very_RB high_JJ risk_NN of_IN venous_JJ thromboembolism_NN ._.
However_RB ,_, the_DT US_NNP Food_NNP and_CC Drug_NNP Administration_NNP issued_VBD a_DT warning_VBG about_IN the_DT potential_JJ adverse_JJ events_NNS associated_VBN with_IN DFX_NN in_IN INT_CD ._.
However_RB ,_, this_DT point_NN has_VBZ not_RB been_VBN tested_VBN in_IN some_DT ethnic_JJ groups_NNS ._.
However_RB ,_, surgical_JJ ergonomics_NNS of_IN the_DT conventional_JJ position_NN in_IN the_DT retroperitoneoscopic_NN surgery_NN is_VBZ poor_JJ ._.
However_RB ,_, the_DT expression_NN and_CC functions_NNS of_IN SHARPIN_NNP in_IN prostate_NN cancer_NN -LRB-_-LRB- PCa_NN -RRB-_-RRB- have_VBP not_RB yet_RB been_VBN defined_VBN ._.
However_RB ,_, the_DT interaction_NN between_IN the_DT SLC19A1_NN gene_NN variant_NN and_CC maternal_JJ fever_NN exposure_NN and_CC NTD_NN risk_NN remains_VBZ unknown_JJ ._.
However_RB ,_, these_DT procedures_NNS provide_VBP cosmetic_JJ satisfaction_NN at_IN the_DT cost_NN of_IN possible_JJ maximal_JJ invasiveness_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT relationships_NNS between_IN CAT_NN scores_NNS and_CC quantitative_JJ computed_JJ tomography_NN -LRB-_-LRB- CT_NN -RRB-_-RRB- measurements_NNS of_IN emphysema_NN and_CC airway_NN wall_NN thickness_NN in_IN COPD_NN patients_NNS in_IN the_DT People_NNS 's_POS Republic_NN of_IN China_NNP ._.
However_RB ,_, the_DT potential_NN of_IN gastrointestinal_JJ surgery_NN regarding_VBG diabetes_NN remission_NN in_IN non-severely_JJ obese_JJ diabetic_JJ patients_NNS has_VBZ yet_RB to_TO be_VB defined_VBN ._.
However_RB ,_, there_EX is_VBZ little_JJ direct_JJ evidence_NN to_TO support_VB this_DT claim_NN ._.
However_RB ,_, adipose-derived_JJ stromal_JJ cells_NNS -LRB-_-LRB- ASCs_NNS -RRB-_-RRB- are_VBP a_DT heterogeneous_JJ group_NN and_CC subpopulations_NNS may_MD be_VB identified_VBN with_IN enhanced_VBN osteogenic_JJ potential_NN ._.
However_RB ,_, the_DT effect_NN of_IN age_NN on_IN cortical_JJ thickness_NN has_VBZ not_RB been_VBN assessed_VBN in_IN migraineurs_NNS ._.
However_RB ,_, acute_JJ kidney_NN injury_NN -LRB-_-LRB- AKI_NN -RRB-_-RRB- ,_, a_DT common_JJ serious_JJ complication_NN of_IN lung_NN transplantation_NN ,_, has_VBZ not_RB been_VBN assessed_VBN ._.
However_RB ,_, brittleness_NN and_CC comparatively_RB low_JJ strength_NN restrict_VB the_DT use_NN of_IN CPC_NNP in_IN load-bearing_JJ applications_NNS ._.
However_RB ,_, the_DT hazards_NNS of_IN their_PRP$ coexistence_NN are_VBP not_RB fully_RB understood_VBN in_IN Asian_JJ populations_NNS ._.
However_RB ,_, the_DT association_NN of_IN obesity_NN with_IN cystatin_NN C_NN is_VBZ not_RB known_VBN in_IN industrialized_JJ Asian_JJ populations_NNS ._.
However_RB ,_, few_JJ studies_NNS concern_VBP their_PRP$ trilateral_JJ relationship_NN ._.
However_RB ,_, the_DT high_JJ dimensional_JJ nature_NN of_IN microarray_NN made_VBD feature_NN selection_NN become_VBP time-consuming_JJ ._.
However_RB ,_, severe_JJ complications_NNS -LRB-_-LRB- eg_FW ,_, pneumothorax_NN -RRB-_-RRB- have_VBP been_VBN reported_VBN in_IN association_NN with_IN the_DT insertion_NN of_IN the_DT central_JJ catheter_NN ._.
However_RB ,_, informal_JJ caregiving_NN costs_NNS associated_VBN with_IN heart_NN failure_NN are_VBP largely_RB unknown_JJ ._.
However_RB ,_, delivering_VBG sufficient_JJ radiation_NN dose_NN to_TO the_DT tumor_NN to_TO result_VB in_IN a_DT high_JJ percentage_NN of_IN long-term_JJ tumor_NN remissions_NNS remains_VBZ challenging_JJ because_IN of_IN the_DT limits_NNS imposed_VBN on_IN administered_VBN activity_NN levels_NNS by_IN radiation_NN damage_NN to_TO normal_JJ tissues_NNS ._.
However_RB ,_, there_EX were_VBD still_RB some_DT breast_NN cancer_NN patients_NNS delaying_VBG or_CC refusing_VBG therapy_NN ._.
However_RB ,_, evidence_NN of_IN VT_NN during_IN syncope_NN is_VBZ often_RB missing_VBG ._.
However_RB ,_, there_EX have_VBP been_VBN concerns_NNS regarding_VBG the_DT safety_NN of_IN their_PRP$ use_NN ,_, particularly_RB with_IN regard_NN to_TO possible_JJ oncogenic_JJ transformation_NN ._.
However_RB ,_, its_PRP$ function_NN in_IN identifying_VBG necrotizing_JJ pneumonia_NN ,_, a_DT complication_NN ,_, has_VBZ not_RB been_VBN explored_VBN ._.
However_RB ,_, the_DT correlation_NN between_IN RUNX3_NN hypermethylation_NN and_CC clinicopathological_JJ characteristics_NNS of_IN NSCLC_NN remains_VBZ unclear_JJ ._.
However_RB ,_, the_DT diagnostic_JJ yield_NN of_IN the_DT split_NN pleura_NN sign_NN for_IN complicated_JJ parapneumonic_JJ effusion_NN -LRB-_-LRB- CPPE_NN -RRB-_-RRB- /_: empyema_NN and_CC its_PRP$ utility_NN for_IN differentiating_VBG CPPE/empyema_NN from_IN parapneumonic_JJ effusion_NN -LRB-_-LRB- PPE_NN -RRB-_-RRB- remains_VBZ unclear_JJ ._.
However_RB ,_, there_EX has_VBZ been_VBN very_RB little_JJ focus_NN on_IN the_DT characteristics_NNS of_IN these_DT interventions_NNS and_CC how_WRB effectively_RB they_PRP address_VBP factors_NNS that_WDT predict_VBP non-adherence_NN ._.
However_RB ,_, when_WRB a_DT mutation_NN occurs_VBZ ,_, it_PRP is_VBZ difficult_JJ to_TO determine_VB whether_IN it_PRP will_MD result_VB in_IN a_DT LoF_NN or_CC a_DT GoF_NN ._.
However_RB ,_, health_NN professionals_NNS '_POS perceived_VBN impact_NN and_CC attitude_NN towards_IN health_NN care_NN resource_NN allocation_NN in_IN Sub-Saharan_NNP Africa_NNP is_VBZ unknown_JJ ;_: furthermore_RB ,_, they_PRP occupy_VBP a_DT position_NN which_WDT makes_VBZ them_PRP notice_VB the_DT impact_NN of_IN different_JJ policies_NNS in_IN their_PRP$ health_NN system_NN ._.
However_RB ,_, this_DT therapy_NN has_VBZ led_VBN to_TO an_DT increased_VBN incidence_NN of_IN metabolic_JJ problems_NNS such_JJ as_IN insulin_NN resistance_NN ,_, dyslipidemia_NN ,_, lipodystrophy_NN and_CC impaired_JJ glucose_NN metabolism_NN ._.
However_RB ,_, non-destructive_JJ microstructural_JJ 3D_NN imaging_NN of_IN formalin-fixed_JJ paraffin_NN embedded_JJ -LRB-_-LRB- FFPE_NN -RRB-_-RRB- tissues_NNS would_MD facilitate_VB retrospective_JJ analysis_NN of_IN extensive_JJ tissue_NN archives_NNS of_IN lung_NN FFPE_NN lung_NN samples_NNS with_IN linked_VBN clinical_JJ data_NNS ._.
However_RB ,_, it_PRP is_VBZ not_RB clear_JJ to_TO date_NN as_IN to_TO whether_IN the_DT etiology_NN of_IN NEC_NNP is_VBZ due_JJ to_TO host_NN ,_, environmental_JJ ,_, or_CC yet_RB other_JJ unknown_JJ factors_NNS ._.
However_RB ,_, few_JJ studies_NNS have_VBP examined_VBN NoVs_NNS causing_VBG acute_JJ diarrhea_NN among_IN outpatient_JJ children_NNS worldwide_RB ._.
However_RB ,_, few_JJ studies_NNS have_VBP examined_VBN the_DT safety_NN and_CC efficacy_NN of_IN this_DT therapeutic_JJ approach_NN in_IN patients_NNS with_IN diabetes_NN and_CC renal_JJ impairment_NN ._.
However_RB ,_, several_JJ important_JJ aspects_NNS of_IN the_DT psychometric_JJ properties_NNS of_IN individual_JJ domains_NNS ,_, including_VBG responsiveness_NN ,_, have_VBP not_RB been_VBN addressed_VBN to_TO enable_VB valid_JJ clinical_JJ application_NN ._.
However_RB ,_, the_DT national_JJ data_NNS of_IN INT_CD shows_VBZ a_DT low_JJ delivery_NN of_IN testing_NN ._.
However_RB ,_, standardised_JJ methodologies_NNS for_IN measurement_NN are_VBP lacking_VBG which_WDT has_VBZ limited_VBN its_PRP$ application_NN in_IN clinical_JJ practice_NN ._.
However_RB ,_, the_DT kinetics_NNS of_IN lactate_NN remains_VBZ to_TO be_VB studied_VBN ._.
However_RB ,_, so_RB far_RB there_EX have_VBP neither_RB been_VBN brain_NN structural_JJ studies_NNS investigating_VBG the_DT alterations_NNS related_VBN to_TO BQD_NNP ,_, nor_CC studies_NNS assessing_VBG the_DT brain_NN structural_JJ changes_NNS with_IN clinical_JJ indexes_NNS ._.
However_RB ,_, studies_NNS on_IN the_DT associations_NNS of_IN heavy_JJ metals_NNS and_CC essential_JJ elements_NNS with_IN altered_JJ FPG_NNP and_CC diabetes_NNP risk_NN were_VBD limited_JJ or_CC conflicting_JJ ._.
However_RB ,_, their_PRP$ effects_NNS and_CC mechanisms_NNS of_IN action_NN on_IN ESCs_NNS proliferation_NN remain_VBP to_TO be_VB determined_VBN ._.
However_RB ,_, -LRB-_-LRB- INT_CD -RRB-_-RRB- F-FLT_NN has_VBZ several_JJ limitations_NNS in_IN clinical_JJ use_NN ._.
However_RB ,_, if_IN aspirin_NN fails_VBZ to_TO inhibit_VB platelet_NN function_NN ,_, as_RB is_VBZ expected_VBN in_IN acute_JJ ischemic_JJ stroke_NN -LRB-_-LRB- AIS_NN -RRB-_-RRB- ,_, it_PRP may_MD increase_VB the_DT rate_NN of_IN early_JJ clinical_JJ events_NNS ._.
However_RB significant_JJ disparities_NNS have_VBP been_VBN identified_VBN between_IN the_DT cervical_JJ screening_NN rates_NNS of_IN heterosexual_JJ and_CC lesbian_JJ women_NNS ._.
However_RB ,_, no_DT specific_JJ pharmacological_JJ effects_NNS from_IN A._NN distichum_NN have_VBP been_VBN described_VBN ._.
However_RB ,_, the_DT association_NN of_IN these_DT adipocytokines_NNS with_IN chronic_JJ kidney_NN disease_NN -LRB-_-LRB- CKD_NN -RRB-_-RRB- is_VBZ not_RB clear_JJ ._.
However_RB ,_, in_IN biomedical_JJ literature_NN mining_NN ,_, interaction_NN keywords_NNS have_VBP not_RB been_VBN carefully_RB studied_VBN and_CC used_VBN beyond_IN a_DT collection_NN of_IN keywords_NNS ._.
However_RB ,_, blood_NN pressure_NN and_CC heart_NN rate_NN are_VBP often_RB misleading_JJ ,_, as_IN multiple_JJ variables_NNS may_MD impact_VB these_DT conventional_JJ parameters_NNS ._.
However_RB ,_, oncologists_NNS often_RB defer_VBP the_DT initiation_NN of_IN systemic_JJ therapy_NN for_IN patients_NNS with_IN mRCC_NN ._.
However_RB ,_, evidences_NNS are_VBP lacking_VBG in_IN Ethiopia_NNP particularly_RB in_IN the_DT study_NN area_NN ._.
However_RB ,_, data_NNS are_VBP scarce_JJ related_JJ to_TO substances_NNS that_WDT can_MD protect_VB against_IN the_DT neurotoxicity_NN induced_VBN by_IN formaldehyde_NN ._.
However_RB ,_, there_EX is_VBZ little_JJ information_NN on_IN intraoperative_JJ change_NN of_IN lactate_NN level_NN in_IN pediatric_JJ cardiac_JJ surgery_NN patients_NNS ._.
However_RB ,_, few_JJ studies_NNS that_WDT have_VBP evaluated_VBN a_DT consecutive_JJ series_NN of_IN high-risk_JJ patients_NNS will_MD all_DT types_NNS of_IN microvascular_JJ breast_NN reconstruction_NN ._.
However_RB ,_, it_PRP is_VBZ important_JJ to_TO understand_VB these_DT disparate_JJ dynamics_NNS as_IN trends_NNS of_IN a_DT single_JJ epidemic_JJ spread_NN over_IN regions_NNS with_IN similar_JJ geographic_JJ and_CC cultural_JJ aspects_NNS ,_, with_IN likely_JJ common_JJ parameters_NNS for_IN transmission_NN rates_NNS and_CC reproduction_NN number_NN R0_NN ._.
However_RB ,_, we_PRP aimed_VBD to_TO understand_VB whether_IN the_DT two_CD cancers_NNS could_MD have_VB been_VBN related_VBN ._.
However_RB ,_, these_DT markers_NNS are_VBP neither_DT sufficiently_RB sensitive_JJ ,_, nor_CC specific_JJ enough_RB ,_, for_IN determining_VBG the_DT effects_NNS of_IN alcohol_NN abuse_NN on_IN the_DT central_JJ nervous_JJ system_NN ._.
However_RB ,_, we_PRP were_VBD able_JJ to_TO successfully_RB reconstruct_VB both_DT lateral_JJ and_CC medial_JJ canthal_JJ area_NN defects_NNS by_IN using_VBG orbicularis_NN oculi_NN myocutaneous_JJ island_NN flaps_NNS ._.
However_RB ,_, physical_JJ exercise_NN practice_NN reduces_VBZ some_DT of_IN these_DT risk_NN factors_NNS ._.
However_RB ,_, there_EX have_VBP been_VBN few_JJ reports_NNS about_IN the_DT correlation_NN between_IN serum_NN lipid_NN profile_NN with_IN carotid_NN intima-media_NN thickness_NN -LRB-_-LRB- IMT_NN -RRB-_-RRB- and_CC plaque_NN in_IN Chinese_JJ general_JJ people_NNS ._.
However_RB ,_, these_DT changes_NNS have_VBP not_RB evolved_VBN into_IN a_DT uniform_JJ policy_NN defining_VBG the_DT division_NN of_IN responsibility_NN between_IN physicians_NNS and_CC nurses_NNS ._.
However_RB ,_, no_DT data_NNS are_VBP available_JJ on_IN the_DT effects_NNS of_IN LSD_NN on_IN PPI_NNP in_IN humans_NNS ._.
However_RB ,_, detailed_JJ regulation_NN mechanism_NN of_IN Kupffer_NN cells_NNS activation_NN during_IN ALF_NNP is_VBZ still_RB obscured_VBN ._.
However_RB ,_, the_DT actual_JJ muscle_NN activation_NN and_CC scapular_JJ kinematics_NNS of_IN these_DT exercises_NNS are_VBP not_RB known_VBN ._.
However_RB ,_, the_DT effects_NNS of_IN Berberine_NNP in_IN ovarian_JJ cancer_NN cells_NNS are_VBP unknown_JJ ._.
However_RB ,_, few_JJ studies_NNS have_VBP investigated_VBN built_VBN environment_NN characteristics_NNS in_IN relation_NN to_TO these_DT spatial_JJ clusters_NNS ._.
However_RB ,_, the_DT nude_JJ mouse_NN model_NN is_VBZ not_RB a_DT gut-specific_JJ colon_NN carcinogenesis_NN animal_NN model_NN ._.
However_RB ,_, there_EX is_VBZ emerging_VBG international_JJ evidence_NN of_IN growing_VBG use_NN among_IN young_JJ people_NNS ,_, amid_IN concerns_NNS that_IN this_DT may_MD increase_VB tobacco_NN uptake_NN ._.
However_RB ,_, means_VBZ and_CC standard_JJ deviations_NNS of_IN enhanced_VBN reductions_NNS are_VBP difficult_JJ to_TO translate_VB into_IN clinical_JJ relevant_JJ treatment_NN outcomes_NNS such_JJ as_IN pocket_NN resolution_NN or_CC avoidance_NN of_IN additional_JJ surgical_JJ interventions_NNS ._.
However_RB ,_, studies_NNS have_VBP shown_VBN that_IN two-thirds_NNS of_IN older_JJR cane_NN users_NNS use_VBP a_DT cane_NN that_WDT is_VBZ longer_JJR than_IN the_DT recommended_VBN length_NN ,_, which_WDT may_MD cause_VB unnecessary_JJ muscular_JJ loads_NNS ._.
However_RB ,_, the_DT effect_NN of_IN ART_NN on_IN the_DT resolution_NN of_IN anaemia_NN in_IN patient_NN cohorts_NNS with_IN a_DT high_JJ prevalence_NN and_CC incidence_NN of_IN tuberculosis_NN is_VBZ incompletely_RB defined_VBN and_CC the_DT impact_NN of_IN TB_NN episodes_NNS on_IN haemoglobin_NN recovery_NN has_VBZ not_RB previously_RB been_VBN reported_VBN ._.
However_RB the_DT precision_NN and_CC utility_NN of_IN trending_VBG of_IN continuous_JJ hemoglobin_NN has_VBZ not_RB been_VBN evaluated_VBN in_IN hemorrhaging_VBG humans_NNS ._.
However_RB ,_, the_DT association_NN between_IN severity_NN of_IN CAD_NN and_CC liver_NN transplantation_NN outcomes_NNS remains_VBZ poorly_RB characterized_VBN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN episiotomy_NN characteristics_NNS and_CC pelvic_JJ floor_NN dysfunction_NN ._.
However_RB ,_, the_DT roles_NNS of_IN IFN-λ3_NN in_IN chronic_JJ HCV_NN infection_NN are_VBP still_RB elusive_JJ ._.
However_RB ,_, critically_RB ill_JJ neonates_NNS who_WP are_VBP transferred_VBN often_RB encounter_VBP the_DT risk_NN of_IN complications_NNS ._.
However_RB ,_, foot_NN evaluation_NN using_VBG ultrasonography_NN early_RB in_IN the_DT course_NN of_IN diabetes_NN has_VBZ not_RB gained_VBN due_JJ importance_NN ._.
However_RB ,_, direct_JJ PCR_NN protocols_NNS have_VBP traditionally_RB employed_VBN thermal_JJ cyclers_NNS with_IN slow_JJ ramp_NN rates_NNS and_CC conservative_JJ hold_NN times_NNS that_WDT significantly_RB increase_VBP an_DT assay_NN 's_POS time-to-result_NN ._.
However_RB ,_, Paw_NN comprises_VBZ the_DT endotracheal_JJ tube_NN -LRB-_-LRB- ETT_NN -RRB-_-RRB- -_: related_JJ pressure_NN drop_NN -LRB-_-LRB- ∆_CD PETT_NN -RRB-_-RRB- and_CC thus_RB does_VBZ not_RB reflect_VB the_DT pressure_NN in_IN the_DT patients_NNS '_POS lungs_NNS ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN what_WP characterizes_VBZ this_DT profession_NN and_CC how_WRB it_PRP compares_VBZ to_TO other_JJ chiropractic_NN professions_NNS in_IN Europe_NNP ._.
However_RB its_PRP$ applicability_NN to_TO atherosclerotic_JJ carotid_NN disease_NN has_VBZ not_RB been_VBN established_VBN ._.
However_RB ,_, it_PRP remains_VBZ unclear_JJ whether_IN and_CC how_WRB the_DT expression_NN levels_NNS of_IN AMPK_NNP are_VBP affected_VBN in_IN the_DT COPD_NNP model_NN rats_NNS which_WDT may_MD lead_VB to_TO the_DT dysfunction_NN of_IN the_DT skeletal_JJ muscle_NN in_IN these_DT rats_NNS ._.
However_RB ,_, few_JJ studies_NNS have_VBP explored_VBN multiple_JJ measures_NNS of_IN proximity_NN simultaneously_RB or_CC the_DT specific_JJ facilities_NNS associated_VBN with_IN park_NN use_NN and_CC park-based_JJ PA_NN among_IN adults_NNS ,_, let_VB alone_RB differences_NNS across_IN socio-demographic_JJ characteristics_NNS ._.
However_RB ,_, reports_NNS that_IN suggest_VBP high_JJ rates_NNS of_IN serologic_JJ false_JJ positives_NNS and_CC low_JJ levels_NNS of_IN viremia_NN have_VBP led_VBN to_TO uncertainty_NN regarding_VBG the_DT burden_NN of_IN active_JJ infection_NN in_IN this_DT region_NN ._.
However_RB ,_, there_EX is_VBZ limited_JJ experience_NN with_IN its_PRP$ application_NN in_IN infants_NNS and_CC neonates_NNS ._.
However_RB ,_, knowledge_NN on_IN associations_NNS of_IN cause-specific_JJ DP_NN and_CC premature_JJ death_NN is_VBZ limited_VBN ._.
However_RB ,_, only_RB INT_CD percent_NN of_IN the_DT pregnant_JJ women_NNS living_VBG with_IN HIV_NN have_VBP yet_RB received_VBN the_DT medication_NN needed_VBN to_TO prevent_VB the_DT transmission_NN of_IN HIV_NN ._.
However_RB ,_, because_IN of_IN poor_JJ elution_NN rates_NNS ,_, the_DT clinical_JJ application_NN of_IN this_DT drug_NN delivery_NN mode_NN remains_VBZ challenging_JJ ._.
However_RB ,_, many_JJ complications_NNS ensue_VBP ._.
However_RB ,_, studies_NNS comparing_VBG the_DT efficacy_NN of_IN low-volume_JJ bowel_NN preparations_NNS are_VBP few_JJ ,_, and_CC the_DT results_NNS have_VBP been_VBN controversial_JJ ._.
However_RB ,_, few_JJ have_VBP assessed_VBN the_DT health_NN impacts_NNS at_IN a_DT nation_NN scale_NN in_IN a_DT developing_VBG country_NN ._.
However_RB ,_, no_DT functional_JJ studies_NNS of_IN WNT5A-induced_JJ effects_NNS in_IN OSCC_NN have_VBP been_VBN performed_VBN ._.
However_RB ,_, there_EX are_VBP still_RB questions_NNS regarding_VBG whether_IN rural/urban_NN differences_NNS in_IN adult_JJ POM_NN exist_VBP ,_, and_CC more_RBR important_JJ ,_, which_WDT factors_NNS might_MD be_VB driving_VBG these_DT differences_NNS ._.
However_RB ,_, besides_IN the_DT sporadic_JJ but_CC worrying_JJ reports_NNS of_IN delayed_VBN parasite_JJ clearance_NN after_IN treatment_NN with_IN artemisinins_NNS ,_, there_EX have_VBP been_VBN an_DT increasing_VBG number_NN of_IN reports_NNS of_IN acute_JJ haemolytic_JJ anaemia_NN following_VBG their_PRP$ use_NN and_CC the_DT safety_NN of_IN this_DT class_NN of_IN antimalarials_NNS is_VBZ being_VBG questioned_VBN ._.
However_RB ,_, these_DT effects_NNS have_VBP mainly_RB been_VBN demonstrated_VBN using_VBG animal_NN models_NNS of_IN schizophrenia-like_JJ deficits_NNS in_IN prepulse_NN inhibition_NN -LRB-_-LRB- PPI_NNP -RRB-_-RRB- of_IN the_DT startle_JJ reflex_JJ ._.
However_RB ,_, evidence_NN from_IN Asia_NNP ,_, where_WRB the_DT prevalence_NN of_IN dyslipidemia_NN is_VBZ generally_RB lower_JJR ,_, has_VBZ been_VBN limited_VBN ._.
However_RB ,_, no_DT studies_NNS have_VBP been_VBN carried_VBN out_RP to_TO verify_VB these_DT assumptions_NNS ._.
However_RB ,_, the_DT utility_NN of_IN BVS_NNP was_VBD not_RB sufficiently_RB evaluated_VBN in_IN the_DT setting_NN of_IN acute_JJ thrombotic_JJ lesions_NNS ._.
However_RB ,_, whether_IN cells_NNS of_IN the_DT immune_JJ system_NN -LRB-_-LRB- systemic_JJ -RRB-_-RRB- and/or_CC local_JJ lung_NN cells_NNS are_VBP contributing_VBG to_TO the_DT elevated_JJ IL-17_NN remains_VBZ unclear_JJ ._.
However_RB ,_, dextran_NN SPIO_NN has_VBZ been_VBN associated_VBN with_IN significant_JJ number_NN of_IN complement-related_JJ side_JJ effects_NNS in_IN patients_NNS and_CC some_DT agents_NNS have_VBP been_VBN discontinued_VBN from_IN clinical_JJ use_NN -LRB-_-LRB- e.g._FW ,_, Feridex_NNP ™_CD -RRB-_-RRB- ._.
However_RB ,_, there_EX are_VBP no_DT solid_JJ data_NNS to_TO substantiate_VB this_DT view_NN ._.
However_RB ,_, the_DT sheer_JJ diversity_NN of_IN interventions_NNS represents_VBZ a_DT potentially_RB bewildering_JJ smorgasbord_NN ._.
However_RB ,_, they_PRP often_RB come_VBP at_IN prohibitive_JJ cost_NN and/or_CC lack_VBP the_DT flexibility_NN and_CC scalability_NN needed_VBD to_TO adjust_VB seamlessly_RB to_TO the_DT frequently_RB changing_VBG protocols_NNS employed_VBN ._.
However_RB ,_, the_DT etiology_NN of_IN mathematics_NNS difficulties_NNS in_IN very_RB preterm_JJ children_NNS is_VBZ unknown_JJ ._.
However_RB ,_, accurate_JJ vaccination_NN coverage_NN data_NNS of_IN anthroposophical_JJ schools_NNS are_VBP not_RB widely_RB available_JJ ._.
However_RB ,_, the_DT relationship_NN between_IN regionalized_JJ adiposity_NN and_CC LDL-c_NN is_VBZ unclear_JJ ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT compliance_NN with_IN quality_NN indicators_NNS and_CC the_DT association_NN between_IN process_NN indicators_NNS and_CC in-hospital_JJ mortality_NN in_IN China_NNP ._.
However_RB ,_, only_RB few_JJ studies_NNS have_VBP investigated_VBN hemostatic_JJ effects_NNS after_IN pulmonary_JJ exposure_NN ._.
However_RB ,_, whether_IN such_JJ inhibition_NN reduces_VBZ the_DT risk_NN of_IN coronary_JJ heart_NN disease_NN is_VBZ not_RB known_VBN ._.
However_RB ,_, the_DT concern_NN of_IN opportunistic_JJ bacterial_JJ infections_NNS has_VBZ yet_RB to_TO be_VB addressed_VBN ._.
However_RB ,_, it_PRP is_VBZ still_RB unclear_JJ how_WRB this_DT polymorphism_NN is_VBZ involved_VBN in_IN development_NN of_IN esophageal_JJ squamous_JJ cell_NN carcinoma_NN -LRB-_-LRB- ESCC_NN -RRB-_-RRB- ._.
However_RB ,_, the_DT interactions_NNS between_IN FTO_NNP and_CC FoxO1_NN during_IN the_DT pathogenesis_NN of_IN NAFLD_NNP have_VBP not_RB been_VBN fully_RB elucidated_VBN ._.
However_RB ,_, current_JJ evidence_NN has_VBZ been_VBN largely_RB confined_VBN to_TO adult_JJ populations_NNS ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT direct_JJ association_NN between_IN the_DT volume_NN load_NN and_CC the_DT clustering_NN of_IN CVD_NN risk_NN factors_NNS in_IN general_JJ population_NN ._.
However_RB ,_, few_JJ studies_NNS have_VBP compared_VBN the_DT learning_NN curves_NNS between_IN laparoscopic_JJ and_CC robotic_JJ gastrectomy_NN for_IN gastric_JJ cancer_NN ._.
However_RB ,_, the_DT safety_NN and_CC efficacy_NN of_IN this_DT treatment_NN are_VBP not_RB well_RB established_VBN ._.
However_RB ,_, studies_NNS associating_VBG parasitic_JJ infections_NNS with_IN undernutrition_NN are_VBP scarce_JJ ._.
However_RB ,_, it_PRP remains_VBZ uncertain_JJ whether_IN this_DT pathway_NN also_RB has_VBZ an_DT essential_JJ role_NN in_IN the_DT effector_NN phase_NN ._.
However_RB ,_, whether_IN it_PRP modulates_VBZ dendritic_JJ cells_NNS -LRB-_-LRB- DCs_NNS -RRB-_-RRB- phenotype_NN and_CC regulatory_JJ T_NN cells_NNS -LRB-_-LRB- Treg_NNP -RRB-_-RRB- function_NN is_VBZ incompletely_RB understood_VBN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT combined_JJ impacts_NNS of_IN high_JJ peritoneal_JJ transporters_NNS and_CC diabetes_NNS on_IN mortality_NN ._.
However_RB ,_, the_DT role_NN of_IN eNOS_NN in_IN colitis_NN remains_VBZ controversial_JJ ._.
However_RB ,_, the_DT pathways_NNS between_IN these_DT factors_NNS have_VBP not_RB been_VBN clarified_VBN ._.
However_RB ,_, the_DT involvement_NN and_CC possible_JJ molecular_JJ mechanism_NN of_IN the_DT NLRP3_NN pathway_NN in_IN the_DT context_NN of_IN chronic_JJ periodontitis_NN -LRB-_-LRB- CP_NN -RRB-_-RRB- and_CC diabetes_NN mellitus_NN have_VBP yet_RB to_TO be_VB fully_RB elucidated_VBN ._.
However_RB ,_, its_PRP$ diagnostic_JJ value_NN for_IN endometrial_JJ cancer_NN remains_VBZ unknown_JJ ._.
However_RB ,_, each_DT agent_NN possesses_VBZ unique_JJ drug_NN delivery_NN characteristics_NNS with_IN the_DT former_JJ not_RB requiring_VBG premedication_NN and_CC having_VBG a_DT considerably_RB shorter_JJR recommended_VBD infusion_NN time_NN -LRB-_-LRB- i.e._FW INT_CD min_NN vs._CC FLOAT_CD h_NN -RRB-_-RRB- ._.
However_RB ,_, there_EX is_VBZ a_DT lack_NN of_IN evidence_NN on_IN what_WDT works_NNS ._.
However_RB ,_, saliva_NN and_CC mechanical_JJ activities_NNS quickly_RB remove_VB the_DT PS_NNP from_IN the_DT surface_NN of_IN the_DT buccal_JJ mucosa_NN ._.
However_RB ,_, it_PRP is_VBZ not_RB known_VBN whether_IN trauma_NN can_MD induce_VB activation_NN and_CC iNOS_NN synthesis_NN in_IN inflammatory_JJ cell_NN lines_NNS with_IN microglial_JJ or_CC macrophage_NN lineage_NN ._.
However_RB ,_, their_PRP$ utility_NN for_IN longitudinal_JJ changes_NNS in_IN IADLs_NNS in_IN the_DT transition_NN between_IN MCI_NNP and_CC dementia_NN remains_VBZ unclear_JJ ._.
However_RB ,_, this_DT technique_NN can_MD be_VB especially_RB difficult_JJ in_IN certain_JJ circumstances_NNS and_CC is_VBZ frequently_RB avoided_VBN ._.
However_RB ,_, correlations_NNS have_VBP not_RB been_VBN made_VBN with_IN blood_NN pressure_NN measured_VBN at_IN the_DT cerebral_JJ level_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN whether_IN these_DT deficits_NNS occur_VBP before_IN or_CC after_IN the_DT onset_NN of_IN psychosis_NN ._.
However_RB ,_, frequency_NN of_IN seroreversion_NN remains_VBZ unknown_JJ in_IN human_JJ immunodeficiency_NN virus_NN -LRB-_-LRB- HIV_NN -RRB-_-RRB- /_: HCV-coinfected_JJ patients_NNS ._.
However_RB ,_, few_JJ studies_NNS have_VBP reported_VBN its_PRP$ efficacy_NN in_IN the_DT treatment_NN of_IN acute_JJ repetitive_JJ seizures_NNS ._.
However_RB ,_, diagnosis_NN of_IN AKI_NN with_IN serum_NN creatinine_NN -LRB-_-LRB- SCr_NN -RRB-_-RRB- level_NN change_NN is_VBZ neither_CC highly_RB sensitive_JJ nor_CC specific_JJ ._.
However_RB ,_, the_DT effects_NNS on_IN dentate_NN granule_NN cell_NN morphology_NN and_CC spatial_JJ memory_NN in_IN rats_NNS that_WDT were_VBD given_VBN clinically_RB equivalent_JJ doses_NNS of_IN antenatal_JJ betamethasone_NN remain_VBP unclear_JJ ._.
However_RB ,_, there_EX is_VBZ little_JJ and_CC variable_JJ information_NN on_IN the_DT reference_NN values_NNS obtained_VBN using_VBG these_DT devices_NNS in_IN healthy_JJ children_NNS from_IN different_JJ populations_NNS ._.
However_RB ,_, clinicians_NNS report_VBP difficulty_NN selecting_VBG appropriate_JJ tools_NNS from_IN the_DT wide_JJ range_NN available_JJ ._.
However_RB ,_, microscopically_RB counting_VBG ATL_NN cells_NNS based_VBN on_IN morphology_NN requires_VBZ experience_NN and_CC tends_VBZ to_TO be_VB inaccurate_JJ due_JJ to_TO the_DT rarity_NN of_IN ATL_NN ._.
However_RB ,_, the_DT consequence_NN of_IN HDAC_NN Class_NN III_CD inhibition_NN is_VBZ unknown_JJ in_IN this_DT model_NN ._.
However_RB ,_, the_DT durability_NN of_IN these_DT valve_NN cusps_NNS is_VBZ limited_JJ partly_RB due_JJ to_TO the_DT onset_NN of_IN immune_JJ responses_NNS to_TO the_DT grafts_NNS ._.
However_RB ,_, the_DT presence_NN of_IN other_JJ non-Gal_JJ carbohydrate_NN antigen_NN determinants_NNS as_RB well_RB as_IN the_DT immune_JJ response_NN to_TO these_DT non-Gal_JJ antigens_NNS and_CC the_DT inflammatory_JJ response_NN generated_VBN by_IN their_PRP$ interaction_NN with_IN the_DT immune_JJ system_NN has_VBZ not_RB been_VBN studied_VBN ._.
However_RB ,_, the_DT value_NN of_IN lncRNAs_NNS in_IN the_DT diagnosis_NN of_IN gastric_JJ cancer_NN remains_VBZ unknown_JJ ._.
However_RB ,_, the_DT current_JJ definitions_NNS of_IN the_DT STOPP/START_NN criteria_NNS are_VBP rather_RB non-specific_JJ ,_, allowing_VBG undesirable_JJ variations_NNS in_IN interpretation_NN and_CC thus_RB application_NN ._.
However_RB ,_, post-LT-alone_JJ renal_JJ outcomes_NNS in_IN recipients_NNS who_WP showed_VBD evidence_NN of_IN reversible_JJ renal_JJ injury_NN and_CC limited_JJ chronicity_NN on_IN pre-LT_JJ kidney_NN biopsy_NN are_VBP unclear_JJ ._.
However_RB ,_, although_IN its_PRP$ prognostic_JJ effect_NN on_IN long-term_JJ outcome_NN is_VBZ well-defined_JJ ,_, still_RB unclear_JJ is_VBZ the_DT effect_NN of_IN diabetes_NN on_IN the_DT risk_NN of_IN periprocedural_JJ myocardial_JJ infarction_NN in_IN patients_NNS undergoing_VBG percutaneous_JJ coronary_JJ interventions_NNS ,_, which_WDT was_VBD therefore_RB the_DT aim_NN of_IN our_PRP$ study_NN ._.
However_RB ,_, demonstration_NN of_IN efficacy_NN using_VBG human-use_JJ adjuvants_NNS is_VBZ required_VBN before_IN proceeding_VBG with_IN further_JJ development_NN of_IN an_DT LND_NN vaccine_NN for_IN testing_NN in_IN non-human_JJ primates_NNS and_CC humans_NNS ._.
However_RB ,_, results_VBZ from_IN many_JJ clinical_JJ trials_NNS contradict_VBP this_DT concern_NN ._.
However_RB ,_, the_DT unmet_JJ surgical_JJ burden_NN of_IN these_DT conditions_NNS is_VBZ not_RB known_VBN ,_, because_IN there_EX are_VBP few_JJ population-based_JJ studies_NNS ._.
However_RB ,_, the_DT molecular_JJ mechanisms_NNS of_IN Dicer_NNP in_IN acquired_VBN gefitinib_NN resistance_NN are_VBP still_RB not_RB clear_JJ ._.
However_RB ,_, little_JJ is_VBZ known_VBN of_IN the_DT relationship_NN of_IN serum_NN SAs_NNS concentrations_NNS and_CC the_DT severity_NN of_IN liver_NN disease_NN ._.
However_RB ,_, exposure_NN untraceable_JJ to_TO encephalitis_NN has_VBZ been_VBN repeatedly_RB associated_VBN with_IN impaired_JJ working_VBG memory_NN and_CC executive_NN functions_NNS ,_, particularly_RB among_IN schizophrenia_NN patients_NNS ._.
However_RB ,_, no_DT study_NN has_VBZ used_VBN WBC_NNP cutoff_NN values_NNS to_TO predict_VB MetS_NN in_IN the_DT elderly_JJ ._.
However_RB ,_, the_DT results_NNS of_IN these_DT studies_NNS are_VBP inconsistent_JJ ._.
However_RB ,_, the_DT risk_NN factors_NNS for_IN DM_NN in_IN Qatar_NNP and_CC their_PRP$ prevalence_NN are_VBP not_RB well_RB understood_VBN ._.
However_RB ,_, modern_JJ computer-based_JJ training_NN and_CC simulation_NN systems_NNS rely_VBP on_IN physically_RB unrealistic_JJ models_NNS that_WDT fail_VBP to_TO capture_VB the_DT interplay_NN of_IN the_DT electrical_JJ ,_, mechanical_JJ and_CC thermal_JJ properties_NNS of_IN biological_JJ tissue_NN ._.
However_RB ,_, relatively_RB little_JJ is_VBZ known_VBN on_IN the_DT mechanisms_NNS of_IN action_NN ._.
However_RB ,_, several_JJ studies_NNS have_VBP shown_VBN that_IN these_DT adverse_JJ events_NNS are_VBP underestimated_VBN ._.
However_RB ,_, this_DT response_NN has_VBZ been_VBN difficult_JJ to_TO replicate_VB ._.
However_RB ,_, the_DT process_NN to_TO step_VB up_RP to_TO triple_JJ therapy_NN varies_VBZ for_IN individual_JJ cases_NNS ._.
However_RB ,_, such_JJ systems_NNS have_VBP the_DT disadvantages_NNS of_IN poor_JJ reproducibility_NN and_CC noise_NN ,_, which_WDT can_MD diminish_VB the_DT accuracy_NN of_IN the_DT apparent_JJ diffusion_NN coefficients_NNS -LRB-_-LRB- ADCs_NNS -RRB-_-RRB- provided_VBN by_IN the_DT DWI_NNP process_NN ._.
However_RB ,_, potential_JJ effects_NNS of_IN shift_NN work_NN on_IN metabolic_JJ syndrome_NN -LRB-_-LRB- MetS_NN -RRB-_-RRB- and_CC its_PRP$ components_NNS have_VBP not_RB been_VBN well_RB established_VBN ._.
However_RB ,_, no_DT single_JJ model_NN can_MD perform_VB well_RB in_IN all_DT settings_NNS and_CC available_JJ models_NNS must_MD be_VB tested_VBN before_IN implementation_NN in_IN new_JJ populations_NNS ._.
However_RB ,_, a_DT range_NN of_IN adverse_JJ events_NNS have_VBP been_VBN associated_VBN with_IN its_PRP$ use_NN ._.
However_RB ,_, their_PRP$ impact_NN on_IN public_JJ health_NN is_VBZ equivocal_JJ :_: depending_VBG on_IN the_DT advice_NN 's_POS validity_NN and_CC applicability_NN ,_, celebrity_NN engagements_NNS can_MD benefit_VB or_CC hinder_VB efforts_NNS to_TO educate_VB patients_NNS on_IN evidence-based_JJ practices_NNS and_CC improve_VB their_PRP$ health_NN literacy_NN ._.
However_RB ,_, it_PRP is_VBZ also_RB reported_VBN to_TO possess_VB anti-inflammatory_JJ properties_NNS ._.
However_RB ,_, previous_JJ studies_NNS investigating_VBG music-evoked_JJ ANS_NN effects_NNS produced_VBD inconsistent_JJ results_NNS ._.
However_RB ,_, in_IN most_JJS countries_NNS ,_, the_DT number_NN of_IN people_NNS willing_JJ to_TO donate_VB their_PRP$ body_NN is_VBZ low_JJ ._.
However_RB ,_, the_DT data_NNS on_IN effects_NNS induced_VBN by_IN a_DT long-lasting_JJ treatment_NN with_IN KYNA_NN is_VBZ lacking_VBG ._.
However_RB ,_, there_EX are_VBP insufficient_JJ data_NNS to_TO confirm_VB the_DT incidence_NN and_CC risk_NN factors_NNS for_IN falling_VBG in_IN patients_NNS after_IN TKA_NN compared_VBN with_IN healthy_JJ elderly_JJ counterparts_NNS ._.
However_RB ,_, the_DT signaling_NN mechanisms_NNS remain_VBP unclear_JJ ._.
However_RB ,_, no_DT study_NN has_VBZ examined_VBN the_DT influence_NN of_IN age_NN on_IN cognitive_JJ improvements_NNS after_IN bariatric_JJ surgery_NN ._.
However_RB ,_, few_JJ studies_NNS have_VBP investigated_VBN the_DT proportion_NN of_IN insecure_JJ attachment_NN styles_NNS in_IN different_JJ pain_NN conditions_NNS ,_, and_CC results_VBZ regarding_VBG associations_NNS between_IN attachment_NN ,_, pain_NN severity_NN ,_, and_CC disability_NN in_IN chronic_JJ pain_NN are_VBP inconsistent_JJ ._.
However_RB ,_, the_DT clinical_JJ implications_NNS of_IN Robo4_NN expression_NN in_IN patients_NNS with_IN acute_JJ myeloid_JJ leukemia_NN -LRB-_-LRB- AML_NN -RRB-_-RRB- remain_VBP unclear_JJ ._.
However_RB ,_, the_DT actual_JJ burden_NN has_VBZ rarely_RB been_VBN described_VBN in_IN detail_NN in_IN programmatic_JJ settings_NNS ._.
However_RB ,_, little_JJ research_NN exists_VBZ on_IN neck_NN length_NN associated_VBN with_IN these_DT factors_NNS ._.
However_RB the_DT haemodynamic_JJ effects_NNS of_IN TPE_NN in_IN patients_NNS with_IN severe_JJ ALF_NN requiring_VBG moderate_JJ or_CC high_JJ dose_NN vasopressor_NN therapy_NN has_VBZ not_RB been_VBN reported_VBN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN patients_NNS '_POS characteristics_NNS or_CC program_NN preferences_NNS that_WDT may_MD influence_VB outcomes_NNS ._.
However_RB ,_, the_DT involvement_NN of_IN GP_NN receptors_NNS in_IN human_JJ ischemic_JJ stroke_NN pathophysiology_NN and_CC their_PRP$ utility_NN as_IN biomarkers_NNS for_IN ischemic_JJ stroke_NN risk_NN and_CC severity_NN requires_VBZ elucidation_NN ._.
However_RB ,_, early_JJ invasive_JJ intervention_NN might_MD be_VB constrained_VBN by_IN the_DT need_NN to_TO mobilize_VB the_DT on-call_JJ team_NN on_IN weekends_NNS ._.
However_RB ,_, the_DT question_NN of_IN how_WRB to_TO address_VB self-disorders_NNS psychotherapeutically_RB has_VBZ remained_VBN neglected_VBN ._.
However_RB ,_, patient_NN adherence_NN can_MD be_VB variable_JJ ,_, impacting_VBG health_NN outcomes_NNS ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT effect_NN of_IN miR-144_NN on_IN cell_NN proliferation_NN and_CC apoptosis_NN and_CC how_WRB it_PRP interacts_VBZ with_IN TIGAR_NN ._.
However_RB ,_, this_DT class_NN of_IN antidepressants_NNS is_VBZ freely_RB prescribed_VBN in_IN public_JJ health_NN pharmacies_NNS ,_, while_IN access_NN to_TO other_JJ classes_NNS of_IN antidepressants_NNS is_VBZ restricted_VBN in_IN Brazil_NNP ._.
However_RB ,_, whether_IN AOPPs_NNS induce_VBP tubular-cell_NN hypertrophy_NN and_CC EMT_NN is_VBZ unclear_JJ ._.
However_RB ,_, there_EX were_VBD no_DT data_NNS on_IN the_DT long-term_JJ clinical_JJ and_CC neurocognitive_JJ effect_NN of_IN quetiapine_NN in_IN patients_NNS who_WP had_VBD responded_VBN inadequately_RB to_TO prior_RB antipsychotics_NNS ._.
However_RB ,_, the_DT role_NN of_IN the_DT OX_NN system_NN in_IN excessive_JJ binge-like_JJ EtOH_NN intake_NN remains_VBZ relatively_RB unexplored_JJ ._.
However_RB ,_, there_EX is_VBZ disagreement_NN regarding_VBG the_DT optimal_JJ dosing_NN and_CC duration_NN of_IN anticoagulant_JJ therapy_NN ._.
However_RB ,_, underlying_VBG mechanisms_NNS of_IN action_NN of_IN the_DT different_JJ drugs_NNS on_IN sexual_JJ processing_NN are_VBP still_RB to_TO be_VB explored_VBN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT safety_NN and_CC efficacy_NN of_IN POEM_NN in_IN children_NNS and_CC adolescents_NNS ._.
However_RB ,_, the_DT biological_JJ functions_NNS of_IN PCGF6_NN are_VBP unknown_JJ ._.
However_RB ,_, literature_NN data_NNS about_IN the_DT availability_NN of_IN QRS/T_NNP angle_NN in_IN patients_NNS undergoing_VBG cardiac_JJ surgery_NN has_VBZ not_RB yet_RB been_VBN available_JJ ._.
However_RB ,_, the_DT large_JJ bone_NN defect_NN peri-implant_NN has_VBZ a_DT negative_JJ influence_NN on_IN the_DT process_NN of_IN bone_NN healing_NN ._.
However_RB ,_, the_DT mechanisms_NNS of_IN this_DT effect_NN are_VBP poorly_RB understood_VBN ._.
However_RB ,_, the_DT effect_NN of_IN MEK/ERK_NN pathway_NN in_IN enterovirus_NN INT_CD -LRB-_-LRB- EV71_NN -RRB-_-RRB- -_: infected_JJ immature_JJ dendritic_JJ cells_NNS -LRB-_-LRB- iDCs_NNS -RRB-_-RRB- is_VBZ still_RB unclear_JJ ._.
However_RB ,_, with_IN the_DT exception_NN of_IN left_JJ ventricular_JJ ejection_NN fraction_NN and_CC mass_NN quantifications_NNS in_IN hypertension_NN and_CC heart_NN failure_NN populations_NNS ,_, the_DT prognostic_JJ value_NN of_IN such_JJ imaging_NN techniques_NNS remains_VBZ largely_RB unexplored_JJ ._.
However_RB ,_, whether_IN these_DT deficits_NNS are_VBP present_JJ primarily_RB during_IN psychosis_NN -LRB-_-LRB- i.e._FW ,_, state_NN dependent_JJ -RRB-_-RRB- or_CC an_DT integral_JJ part_NN of_IN the_DT disorder_NN -LRB-_-LRB- i.e._FW ,_, trait_NN dependent_JJ -RRB-_-RRB- remains_VBZ unclear_JJ ._.
However_RB ,_, one_CD hypothesis_NN holds_VBZ that_IN a_DT pharmacologic_JJ strategy_NN aimed_VBN at_IN reducing_VBG amygdala_NN activity_NN while_IN simultaneously_RB augmenting_VBG medial_JJ prefrontal_JJ cortex_NN function_NN could_MD facilitate_VB the_DT extinction_NN of_IN conditioned_JJ fear_NN ._.
However_RB ,_, whether_IN the_DT extracellular_JJ volume_NN status_NN is_VBZ associated_VBN with_IN disease_NN progression_NN is_VBZ unclear_JJ ._.
However_RB ,_, difficulty_NN in_IN predicting_VBG therapeutic_JJ response_NN limits_VBZ the_DT clinical_JJ implementation_NN of_IN PI3K_NN inhibitors_NNS ._.
However_RB ,_, the_DT functional_JJ contribution_NN of_IN ST6GalNAc_NN I_PRP to_TO development_NN or_CC progression_NN of_IN gastric_JJ cancer_NN remains_VBZ unclear_JJ ._.
However_RB ,_, renal_JJ and_CC metabolic_JJ safety_NN of_IN TDF_NN compared_VBN to_TO other_JJ NRTIs_NNS has_VBZ not_RB been_VBN well_RB described_VBN in_IN resource-limited_JJ settings_NNS ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN responses_NNS to_TO thermal_JJ stress_NN in_IN older_JJR adults_NNS ._.
However_RB ,_, efforts_NNS to_TO identify_VB patients_NNS most_RBS vulnerable_JJ to_TO the_DT central_JJ effects_NNS of_IN inflammation_NN are_VBP hindered_VBN by_IN insensitivity_NN of_IN conventional_JJ structural_JJ magnetic_JJ resonance_NN imaging_NN ._.
However_RB ,_, few_JJ studies_NNS have_VBP reported_VBN its_PRP$ relationship_NN with_IN cancer_NN survival_NN ._.
However_RB ,_, diversity_NN in_IN labelling_VBG including_VBG the_DT instructions_NNS for_IN use_NN -LRB-_-LRB- IFU_NN -RRB-_-RRB- limits_VBZ their_PRP$ interchangeability_NN and_CC user-friendliness_NN ._.
However_RB ,_, potential_JJ favorable_JJ long-term_JJ results_NNS and_CC the_DT upcoming_VBG banded_VBN gastric_JJ bypass_NN ,_, with_IN a_DT similar_JJ mechanical_JJ outlet_NN restriction_NN and_CC control_NN of_IN the_DT pouch_NN size_NN ,_, renewed_VBN our_PRP$ interest_NN in_IN the_DT VBG_NNP ._.
However_RB ,_, CIR_NN likely_JJ presents_NNS variations_NNS owing_VBG to_TO different_JJ population_NN characteristics_NNS and_CC intraday_NN variations_NNS not_RB being_VBG taken_VBN into_IN account_NN by_IN most_JJS formulas_NNS ._.
However_RB ,_, the_DT current_JJ diagnostic_JJ criteria_NNS do_VBP not_RB consider_VB subjective_JJ distress_NN elicited_VBN by_IN the_DT symptoms_NNS ,_, thus_RB potentially_RB leading_VBG to_TO overestimated_VBN prevalence_NN rates_NNS ._.
However_RB ,_, whether_IN these_DT modifications_NNS of_IN the_DT prosthesis_NN design_NN lead_NN to_TO improvements_NNS in_IN clinical_JJ results_NNS needs_VBZ further_JJ investigation_NN ._.
However_RB ,_, the_DT effect_NN of_IN these_DT coping_VBG strategies_NNS on_IN the_DT HRQoL_NN of_IN unemployed_JJ people_NNS has_VBZ not_RB been_VBN examined_VBN until_IN now_RB ._.
However_RB ,_, the_DT role_NN of_IN uPA_NN and_CC PAI-1_NN in_IN the_DT context_NN of_IN breast_NN cancer_NN subtypes_NNS and_CC for_IN mRNA_NN expression_NN of_IN these_DT factors_NNS is_VBZ less_RBR clear_JJ ._.
However_RB ,_, because_IN of_IN the_DT rarity_NN of_IN remnant_JJ gastric_JJ cancer_NN ,_, the_DT number_NN of_IN cases_NNS reported_VBD per_IN study_NN has_VBZ been_VBN small_JJ ._.
However_RB ,_, major_JJ questions_NNS remain_VBP about_IN whether_IN widespread_JJ deployment_NN of_IN CT_NN screening_NN can_MD achieve_VB results_NNS similar_JJ to_TO the_DT NLST_NN ,_, especially_RB in_IN the_DT community_NN setting_NN ._.
However_RB ,_, assessment_NN of_IN creatinine_NN clearance_NN -LRB-_-LRB- CrCl_NN -RRB-_-RRB- using_VBG 24-hour_JJ urine_NN collection_NN methods_NNS is_VBZ also_RB prone_JJ to_TO errors_NNS ._.
However_RB ,_, there_EX is_VBZ a_DT lack_NN of_IN data_NNS regarding_VBG the_DT key_JJ biomechanical_JJ contributors_NNS to_TO these_DT accelerations_NNS ._.
However_RB ,_, they_PRP are_VBP inflammatory_JJ and_CC alter_VB the_DT permeability_NN of_IN the_DT blood-brain_JJ barrier_NN ,_, raising_VBG concerns_NNS that_IN their_PRP$ use_NN as_IN a_DT treatment_NN for_IN malaria_NN could_MD lead_VB to_TO cerebral_JJ malaria_NN -LRB-_-LRB- CM_NN -RRB-_-RRB- ,_, a_DT severe_JJ complication_NN of_IN the_DT disease_NN ._.
However_RB ,_, the_DT EPDS_NN has_VBZ not_RB been_VBN validated_VBN in_IN teenager_NN pregnant_JJ women_NNS ._.
However_RB ,_, less_JJR is_VBZ known_VBN about_IN student_NN experience_NN and_CC preference_NN for_IN different_JJ small_JJ groups_NNS teaching_VBG models_NNS ._.
However_RB ,_, the_DT effect_NN of_IN a_DT smaller_JJR baseplate_NN on_IN stability_NN of_IN the_DT glenoid_NN component_NN has_VBZ not_RB been_VBN evaluated_VBN ._.
However_RB ,_, with_IN changes_NNS of_IN disease_NN patterns_NNS and_CC dyspepsia_NN definition_NN ,_, the_DT prevalence_NN of_IN organic_JJ lesions_NNS at_IN endoscopy_NN in_IN dyspepsia_NN patients_NNS and_CC the_DT predictive_JJ values_NNS of_IN alarm_NN features_NNS and_CC age_NN for_IN in_IN malignancy_NN remain_VBP unclear_JJ in_IN Asian_JJ population_NN ._.
However_RB ,_, the_DT cost_NN of_IN a_DT large_JJ scale_NN study_NN using_VBG whole_JJ genome_NN or_CC exome_JJ sequencing_NN is_VBZ still_RB high_JJ ._.
However_RB ,_, the_DT clinical_JJ consequences_NNS of_IN the_DT constitutively_RB increased_VBN dosage_NN of_IN FOXF1_NN are_VBP unknown_JJ ._.
However_RB ,_, few_JJ studies_NNS have_VBP investigated_VBN the_DT associations_NNS between_IN depression_NN and_CC leptin_NN ,_, adiponectin_NN and_CC resistin_NN levels_NNS in_IN patients_NNS with_IN bipolar_JJ disorder_NN ._.
However_RB ,_, there_EX has_VBZ previously_RB been_VBN no_DT physiological_JJ means_NNS of_IN monitoring_VBG cholinergic_JJ activity_NN in_FW vivo_FW ._.
However_RB ,_, ADMSCs_NNS exhibit_VBP resistant_JJ to_TO most_JJS gene_NN transfection_NN techniques_NNS and_CC the_DT use_NN of_IN highly_RB efficient_JJ viral_JJ vectors_NNS has_VBZ several_JJ disadvantages_NNS primarily_RB concerning_VBG safety_NN risk_NN ._.
However_RB ,_, it_PRP remains_VBZ unclear_JJ which_WDT exercise_VBP characteristics_NNS are_VBP most_RBS effective_JJ for_IN improving_VBG peak_JJ VO_NN ₂_NN in_IN coronary_JJ artery_NN disease_NN -LRB-_-LRB- CAD_NN -RRB-_-RRB- patients_NNS ._.
However_RB ,_, there_EX is_VBZ no_DT current_JJ data_NNS on_IN whether_IN identifying_VBG atherosclerosis_NN on_IN CTA_NNP impacts_NNS outcomes_NNS ._.
However_RB ,_, initial_JJ palliation_NN with_IN a_DT superior_JJ cavopulmonary_JJ connection_NN ,_, such_JJ as_IN a_DT bidirectional_JJ Glenn_NNP -LRB-_-LRB- BDG_NNP -RRB-_-RRB- ,_, is_VBZ discouraged_VBN ,_, owing_VBG to_TO potential_JJ for_IN inadequate_JJ pulmonary_JJ blood_NN flow_NN -LRB-_-LRB- PBF_NN -RRB-_-RRB- ._.
However_RB ,_, these_DT reports_NNS neglected_VBN to_TO include_VB several_JJ non-English_JJ language_NN studies_NNS ._.
However_RB ,_, evidence_NN guiding_VBG patients_NNS and_CC surgeons_NNS in_IN shared_JJ decision-making_NN concerning_VBG the_DT optimal_JJ type_NN or_CC timing_NN of_IN surgery_NN is_VBZ lacking_VBG ._.
However_RB ,_, TA_NNP diameter_NN normative_JJ values_NNS and_CC the_DT extent_NN of_IN TA_NNP dynamic_JJ changes_NNS during_IN cardiac_JJ cycle_NN remain_VBP to_TO be_VB established_VBN ._.
However_RB ,_, it_PRP is_VBZ still_RB difficult_JJ to_TO distinguish_VB these_DT two_CD disease_NN entities_NNS by_IN neuroimaging_VBG studies_NNS ._.
However_RB ,_, there_EX is_VBZ a_DT dearth_NN of_IN evidence_NN about_IN the_DT type_NN or_CC the_DT proportion_NN of_IN clinical_JJ time_NN allocated_VBN to_TO preventive_JJ care.The_NN aim_NN of_IN this_DT study_NN is_VBZ to_TO record_VB the_DT proportion_NN and_CC type_NN of_IN preventive_JJ care_NN and_CC clinical_JJ treatment_NN activities_NNS provided_VBN by_IN Therapists_NNPS to_TO adolescents_NNS accessing_VBG the_DT NSW_NNP Public_NNP Oral_NNP Health_NNP Service_NNP ._.
However_RB ,_, the_DT actual_JJ in_FW vivo_FW dynamics_NNS of_IN CMV-CTL_NN clones_NNS after_IN allogeneic_JJ hematopoietic_JJ stem_NN cell_NN transplantation_NN -LRB-_-LRB- alloHCT_NN -RRB-_-RRB- are_VBP still_RB unclear_JJ ._.
However_RB ,_, long-term_JJ disease_NN control_NN in_IN HIV-positive_JJ patients_NNS with_IN head_NN and_CC neck_NN cancer_NN -LRB-_-LRB- HNC_NN -RRB-_-RRB- is_VBZ not_RB well_RB described_VBN ._.
However_RB ,_, heterogeneity_NN exists_VBZ among_IN heart_NN failure_NN patients_NNS and_CC it_PRP is_VBZ possible_JJ that_IN high-risk_JJ subgroups_NNS may_MD benefit_VB from_IN anticoagulation_NN -LRB-_-LRB- warfarin_NN -RRB-_-RRB- ._.
However_RB ,_, limited_JJ data_NNS are_VBP available_JJ on_IN their_PRP$ exact_JJ mechanisms_NNS in_IN HCC_NNP ._.
However_RB ,_, detection_NN and_CC identification_NN of_IN malaria_NN parasites_NNS require_VBP well_RB trained_VBN laboratory_NN personnel.The_NN objective_NN of_IN the_DT study_NN was_VBD to_TO evaluate_VB the_DT performance_NN of_IN laboratory_NN technologists_NNS and_CC technicians_NNS in_IN detecting_VBG and_CC identifying_VBG malaria_NN parasites_NNS in_IN Hawassa_NNP town_NN ,_, Southern_NNP Ethiopia_NNP ._.
However_RB ,_, micro-level_NN -LRB-_-LRB- household_NN and_CC population_NN -RRB-_-RRB- analyses_NNS on_IN the_DT linkages_NNS between_IN malaria_NN and_CC poverty_NN have_VBP often_RB produced_VBN mixed_JJ results_NNS ._.
However_RB ,_, the_DT tolerance_NN to_TO and_CC efficacy_NN of_IN modern_JJ gemcitabine_NN -LRB-_-LRB- GEM_NN -RRB-_-RRB- -_: based_VBN chemotherapy_NN regimens_NNS during_IN adjuvant_JJ ILP_NNP remain_VBP unknown_JJ ._.
However_RB ,_, the_DT distribution_NN in_IN tissue_NN and_CC role_NN of_IN CYP2C8_NN ,_, 2C9_NN ,_, 2J2_NN and_CC sEH_NN in_IN human_JJ breast_NN carcinogenesis_NN remains_VBZ uncertain_JJ ._.
However_RB ,_, much_RB of_IN our_PRP$ understanding_NN of_IN the_DT determinants_NNS of_IN PTSD_NN in_IN these_DT contexts_NNS comes_VBZ from_IN cross-sectional_JJ data_NNS ._.
However_RB ,_, whether_IN risk_NN for_IN subsequent_JJ neoplasms_NNS -LRB-_-LRB- SNs_NNS -RRB-_-RRB- also_RB increases_VBZ is_VBZ unknown_JJ ._.
However_RB ,_, the_DT relationship_NN between_IN smoking_NN and_CC clinical_JJ outcomes_NNS remains_VBZ uncertain_JJ ._.
However_RB ,_, few_JJ studies_NNS have_VBP taken_VBN a_DT genome-wide_JJ approach_NN to_TO investigating_VBG gene_NN expression_NN profiles_NNS in_IN peripheral_JJ leukocytes_NNS between_IN obese_JJ and_CC lean_JJ individuals_NNS with_IN the_DT consideration_NN of_IN obesity-related_JJ shifts_NNS in_IN leukocyte_NN types_NNS ._.
However_RB ,_, the_DT molecular_JJ mechanisms_NNS underlying_VBG the_DT self-renewal_JJ of_IN GCSCs_NNS and_CC their_PRP$ relationship_NN with_IN the_DT microenvironment_NN are_VBP poorly_RB characterized_VBN ._.
However_RB ,_, BDG_NN is_VBZ not_RB thought_VBN to_TO be_VB useful_JJ in_IN diagnosing_VBG cryptococcosis_NN ._.
However_RB ,_, the_DT entire_JJ spectrum_NN of_IN exRNA_NN from_IN saliva_NN has_VBZ not_RB been_VBN fully_RB characterized_VBN ._.
However_RB ,_, the_DT actions_NNS of_IN insulin_NN at_IN the_DT various_JJ stages_NNS of_IN pancreatic_JJ cancer_NN progression_NN remain_VBP poorly_RB defined_VBN ._.
However_RB ,_, it_PRP is_VBZ not_RB a_DT routine_JJ test_NN for_IN all_DT patients_NNS and_CC ,_, as_IN a_DT result_NN ,_, many_JJ patients_NNS are_VBP not_RB aware_JJ of_IN their_PRP$ HIV_NN status_NN ._.
However_RB ,_, the_DT pathway_NN for_IN patients_NNS following_VBG a_DT negative_JJ EBUS-TBNA_NN has_VBZ not_RB been_VBN clearly_RB defined_VBN ._.
However_RB ,_, in_IN order_NN to_TO clarify_VB whether_IN these_DT compounds_NNS can_MD help_VB to_TO objectify_VB the_DT clinical_JJ diagnosis_NN ,_, further_JJ studies_NNS are_VBP needed_VBN ._.
However_RB ,_, it_PRP remains_VBZ largely_RB unknown_JJ whether_IN there_EX is_VBZ an_DT additional_JJ risk_NN of_IN diabetes_NN mellitus_NN -LRB-_-LRB- DM_NN -RRB-_-RRB- in_IN elderly_JJ psychiatric_JJ outpatients_NNS ,_, particularly_RB those_DT with_IN long-term_JJ exposure_NN to_TO atypical_JJ antipsychotics_NNS -LRB-_-LRB- AP_NN -RRB-_-RRB- ._.
However_RB ,_, the_DT neural_JJ substrates_NNS linking_VBG chronic_JJ childhood/adolescent_JJ stress_NN and_CC increased_VBD risk_NN of_IN alcohol_NN addiction_NN are_VBP not_RB well_RB understood_VBN ._.
However_RB ,_, the_DT role_NN of_IN KCs_NNS in_IN inducing_VBG immunity_NN toward_IN HBV_NN is_VBZ poorly_RB understood_VBN ._.
However_RB ,_, there_EX is_VBZ a_DT need_NN for_IN a_DT systematic_JJ global_JJ analysis_NN of_IN the_DT impact_NN of_IN RSV_NN infection_NN in_IN terms_NNS of_IN use_NN of_IN resources_NNS and_CC health_NN impact_NN on_IN both_DT children_NNS and_CC adults_NNS ._.
However_RB ,_, it_PRP is_VBZ not_RB clear_JJ whether_IN young_JJ maternal_JJ age_NN is_VBZ causally_RB associated_VBN with_IN poor_JJ offspring_NN outcomes_NNS or_CC confounded_VBN by_IN familial_JJ factors_NNS ._.
However_RB ,_, no_DT studies_NNS have_VBP analyzed_VBN this_DT epigenetic_JJ marker_NN in_IN cutaneous_JJ lymphomas_NNS ._.
However_RB ,_, treating_VBG HR_NN subjects_NNS within_IN the_DT real-world_JJ setting_NN of_IN prodromal_JJ services_NNS is_VBZ hindered_VBN by_IN several_JJ practical_JJ problems_NNS that_WDT can_MD significantly_RB make_VB an_DT impact_NN on_IN the_DT effect_NN of_IN focused_JJ interventions_NNS ._.
However_RB ,_, the_DT application_NN of_IN such_JJ molecular_JJ analyses_NNS may_MD provide_VB different_JJ results_NNS among_IN different_JJ centers_NNS and_CC populations_NNS in_IN real-life_JJ settings_NNS ._.
However_RB ,_, the_DT questions_NNS with_IN regard_NN to_TO primary_JJ prevention_NN have_VBP been_VBN raised_VBN among_IN patients_NNS with_IN diabetes_NN ._.
However_RB ,_, whether_IN statins_NNS can_MD alter_VB GGT_NN levels_NNS in_IN arterial_JJ atheromatous_JJ plaque_NN has_VBZ not_RB yet_RB been_VBN studied_VBN ._.
However_RB ,_, the_DT role_NN of_IN atheromatosis_NN ,_, its_PRP$ pathogenesis_NN and_CC evolution_NN are_VBP still_RB unclear_JJ ._.
However_RB ,_, it_PRP remains_VBZ untested_JJ whether_IN transplantation_NN of_IN rat_NN AFMSCs_NNS -LRB-_-LRB- rAFMSCs_NNS -RRB-_-RRB- might_MD alleviate_VB lung_NN injury_NN caused_VBN by_IN emphysema_NN by_IN increasing_VBG the_DT expression_NN of_IN surfactant_JJ protein_NN -LRB-_-LRB- SP_NN -RRB-_-RRB- A_NN and_CC SPC_NN and_CC inhibiting_VBG AECII_JJ apoptosis_NN ._.
However_RB ,_, ISBT_NN with_IN Martinez_NNP Universal_NNP Perineal_NNP Interstitial_JJ Template_NN -LRB-_-LRB- MUPIT_NN -RRB-_-RRB- ,_, in_IN which_WDT ~_NN FLOAT_CD needles_NNS are_VBP usually_RB applied_VBN ,_, is_VBZ more_RBR time-consuming_JJ and_CC labor-intensive_JJ than_IN ICBT_NN alone_RB ,_, making_VBG it_PRP a_DT burden_NN on_IN both_DT practitioners_NNS and_CC patients_NNS ._.
However_RB ,_, there_EX is_VBZ no_DT bioassay_NN available_JJ that_DT is_VBZ standardized_JJ with_IN international_JJ reference_NN material_NN ._.
However_RB ,_, since_IN the_DT inception_NN of_IN C-LQAS_NN ,_, questions_NNS have_VBP been_VBN raised_VBN about_IN the_DT optimal_JJ balance_NN between_IN operational_JJ feasibility_NN and_CC precision_NN of_IN classification_NN of_IN lots_NNS to_TO identify_VB areas_NNS with_IN low_JJ SIA_NNP quality_NN that_WDT require_VBP corrective_JJ programmatic_JJ action_NN ._.
However_RB at_IN present_JJ it_PRP remains_VBZ unclear_JJ which_WDT algorithm_NN is_VBZ the_DT most_RBS accurate_JJ ._.
However_RB ,_, the_DT dynamics_NNS of_IN glycocalyx_NN degradation_NN and_CC its_PRP$ association_NN with_IN inflammation_NN remains_VBZ largely_RB unknown_JJ ._.
However_RB ,_, available_JJ evidence_NN is_VBZ based_VBN on_IN a_DT limited_JJ number_NN of_IN trials_NNS ,_, and_CC the_DT outcomes_NNS in_IN routine_JJ clinical_JJ practice_NN and_CC in_IN unselected_JJ patients_NNS are_VBP scarcely_RB reported_VBN ._.
However_RB ,_, it_PRP is_VBZ not_RB known_VBN whether_IN SPT_NNP or_CC sIgE_NN should_MD be_VB the_DT preferred_JJ test_NN ._.
However_RB ,_, it_PRP is_VBZ not_RB known_VBN whether_IN it_PRP is_VBZ feasible_JJ to_TO obtain_VB stool_NN samples_NNS from_IN asymptomatic_JJ individuals_NNS during_IN an_DT appointment_NN in_IN a_DT study_NN center_NN -LRB-_-LRB- SC_NN -RRB-_-RRB- ._.
However_RB ,_, regions_NNS of_IN interest_NN often_RB show_VBP heterogeneous_JJ methylation_NN comprising_VBG multiple_JJ patterns_NNS of_IN methylation_NN -LRB-_-LRB- epialleles_NNS -RRB-_-RRB- on_IN individual_JJ DNA_NN strands_NNS ._.
However_RB ,_, the_DT gait_NN evolution_NN of_IN hereditary_JJ spastic_JJ paraplegia_NN showing_VBG onset_NN symptoms_NNS at_IN an_DT early_JJ age_NN has_VBZ been_VBN described_VBN as_IN stable_JJ ._.
However_RB ,_, these_DT studies_NNS have_VBP been_VBN performed_VBN by_IN using_VBG invasive_JJ coronary_JJ angiography_NN -LRB-_-LRB- ICA_NN -RRB-_-RRB- and_CC in_IN high-risk_JJ patients_NNS for_IN CAD_NN ._.
However_RB ,_, the_DT role_NN of_IN VEGF-C_NN in_IN esophageal_JJ squamous_JJ cell_NN carcinoma_NN -LRB-_-LRB- ESCC_NN -RRB-_-RRB- remains_VBZ unclear_JJ ._.
However_RB ,_, structural_JJ approaches_NNS revealed_VBD weak_JJ but_CC specific_JJ protein-gas_JJ interactions_NNS ._.
However_RB ,_, iNO_NN therapy_NN initiation_NN criteria_NNS have_VBP not_RB been_VBN standardized_JJ ._.
However_RB ,_, many_JJ scientific_JJ uncertainties_NNS ,_, especially_RB concerning_VBG correlates_VBZ to_TO impairment_NN and_CC prognosis_NN remain_VBP ._.
However_RB ,_, few_JJ longitudinal_JJ studies_NNS have_VBP investigated_VBN musculoskeletal_JJ disorders_NNS -LRB-_-LRB- MSDs_NNS -RRB-_-RRB- at_IN other_JJ anatomical_JJ sites_NNS in_IN nurses_NNS ._.
However_RB ,_, postoperative_JJ pain_NN in_IN the_DT operating_NN field_NN after_IN RoT_NN remains_VBZ a_DT concern_NN due_JJ to_TO extensive_JJ tissue_NN dissection_NN and_CC tension_NN during_IN the_DT operation_NN ._.
However_RB ,_, the_DT epidemiology_NN relevant_JJ to_TO this_DT general_JJ outlook_NN remains_VBZ piecemeal_RB ._.
However_RB ,_, CD8_NN -LRB-_-LRB- +_CC -RRB-_-RRB- T_NN cell_NN ,_, as_IN a_DT main_JJ participant_NN in_IN immune-mediated_JJ injuries_NNS and_CC defense_NN against_IN microorganisms_NNS ,_, has_VBZ seldom_RB been_VBN studied_VBN in_IN ACLF_NN ._.
However_RB ,_, despite_IN their_PRP$ potential_JJ interest_NN as_IN biomarkers_NNS of_IN retinal_JJ diseases_NNS ,_, Gunn_NNP 's_POS dots_NNS have_VBP received_VBN little_JJ attention_NN in_IN the_DT scientific_JJ literature_NN ._.
However_RB ,_, a_DT reliable_JJ ,_, practical_JJ indicator_NN of_IN the_DT performance_NN of_IN endoscopists_NNS in_IN screening_VBG esophagogastroduodenoscopy_NN has_VBZ not_RB yet_RB been_VBN identified_VBN ._.
However_RB ,_, to_TO date_NN ,_, there_EX have_VBP been_VBN no_DT investigations_NNS to_TO examine_VB how_WRB well_RB these_DT multidisciplinary_JJ teams_NNS are_VBP performing_VBG ._.
However_RB ,_, the_DT cellularity_NN of_IN an_DT FNA_NN sample_NN may_MD not_RB be_VB high_JJ enough_RB for_IN flow_NN cytometry_NN ,_, leading_VBG to_TO diagnostic_JJ difficulty_NN ._.
However_RB ,_, to_TO the_DT authors_NNS '_POS knowledge_NN ,_, its_PRP$ diagnostic_JJ value_NN for_IN FNA_NN samples_NNS has_VBZ not_RB been_VBN studied_VBN to_TO date_NN ._.
However_RB ,_, the_DT true_JJ incidence_NN of_IN immunoglobulin_NN -LRB-_-LRB- Ig_NN -RRB-_-RRB- E-mediated_JJ cross-reactivity_NN is_VBZ not_RB known_VBN ._.
However_RB ,_, previous_JJ studies_NNS on_IN SPS_NN rates_NNS lack_VBP critical_JJ clinical_JJ characteristics_NNS ,_, rendering_VBG it_PRP unclear_JJ if_IN variation_NN in_IN SPS_NNP rates_NNS is_VBZ due_JJ to_TO unmeasured_JJ case-mix_JJ differences_NNS or_CC surgeons_NNS '_POS selection_NN criteria_NNS ._.
However_RB ,_, few_JJ reports_NNS are_VBP available_JJ regarding_VBG its_PRP$ use_NN in_IN the_DT treatment_NN of_IN benign_JJ peptic_JJ ulcer_NN disease_NN ._.
However_RB ,_, the_DT quality-related_JJ results_NNS were_VBD comparable_JJ to_TO the_DT results_NNS after_IN traditional_JJ open_JJ surgery_NN ._.
However_RB ,_, conveying_VBG a_DT mentor_NN 's_POS directions_NNS using_VBG conventional_JJ methods_NNS ,_, without_IN realistic_JJ on-screen_JJ visual_JJ cues_NNS ,_, can_MD be_VB difficult_JJ and_CC confusing_JJ ._.
However_RB ,_, increasing_VBG coverage_NN with_IN voluntary_JJ health_NN insurance_NN in_IN low_JJ income_NN settings_NNS can_MD prove_VB challenging_JJ ._.
However_RB ,_, most_JJS of_IN these_DT reports_NNS are_VBP based_VBN on_IN Asian_JJ populations_NNS ,_, while_IN European_JJ reports_NNS do_VBP not_RB exist_VB ._.
However_RB ,_, previous_JJ studies_NNS have_VBP obtained_VBN inconclusive_JJ results_NNS regarding_VBG WM_NNP changes_NNS in_IN CH_NN ,_, and_CC WM_NNP variations_NNS between_IN ``_`` in-bout_JJ ''_'' and_CC ``_`` out-of-bout_JJ ''_'' periods_NNS of_IN CH_NN remain_VBP to_TO be_VB determined_VBN ._.
However_RB ,_, results_NNS are_VBP inconsistent_JJ ,_, possibly_RB because_IN of_IN different_JJ patient_NN cohorts_NNS and_CC different_JJ therapies_NNS ._.
However_RB ,_, discussion_NN is_VBZ lacking_VBG on_IN the_DT factors_NNS modifying_VBG that_IN association_NN ._.
However_RB ,_, there_EX is_VBZ limited_JJ evidence_NN demonstrating_VBG their_PRP$ system-wide_JJ effectiveness_NN ._.
However_RB ,_, the_DT question_NN of_IN whether_IN or_CC not_RB GLP-1RA_NN regulates_VBZ osteoblastic_JJ differentiation_NN and_CC calcification_NN of_IN VSMCs_NNS has_VBZ not_RB been_VBN answered_VBN ,_, and_CC the_DT associated_VBN molecular_JJ mechanisms_NNS have_VBP not_RB been_VBN examined_VBN ._.
However_RB ,_, its_PRP$ role_NN in_IN the_DT diagnosis_NN of_IN nodular_JJ ground-glass_JJ opacities_NNS -LRB-_-LRB- nGGOs_NNS -RRB-_-RRB- is_VBZ controversial_JJ ,_, and_CC the_DT necessity_NN of_IN preoperative_JJ histologic_JJ confirmation_NN by_IN PCNA_NN or_CC PCNB_NN in_IN nGGOs_NNP has_VBZ not_RB been_VBN well_RB addressed_VBN ._.
However_RB ,_, its_PRP$ cutoff_JJ score_NN has_VBZ not_RB been_VBN clinically_RB assessed_VBN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT molecular_JJ basis_NN for_IN its_PRP$ potential_NN in_IN immunotherapy_NN ._.
However_RB ,_, anecdotally_RB ,_, patients_NNS with_IN open_JJ neural_JJ tube_NN defects_NNS have_VBP a_DT more_JJR medially_RB oriented_VBN lumbar_JJ pedicle_NN trajectory_NN than_IN the_DT average_JJ population_NN ._.
However_RB ,_, differentiation_NN between_IN acute_JJ cutaneous_JJ GVHD_NN and_CC other_JJ common_JJ skin_NN eruptions_NNS that_WDT develop_VBP in_IN the_DT post-transplantation_JJ period_NN ,_, such_JJ as_IN drug_NN hypersensitivity_NN reaction_NN ,_, can_MD be_VB challenging_JJ clinically_RB and_CC microscopically_RB ._.
However_RB ,_, in_IN immunocompromised_JJ hosts_NNS they_PRP can_MD be_VB virulent_JJ pathogens_NNS and_CC can_MD cause_VB death_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT outcomes_NNS of_IN ADHF_NN patients_NNS on_IN inotropes_NNS and/or_CC vasopressors_NNS who_WP require_VBP continuous_JJ renal_JJ replacement_NN therapy_NN -LRB-_-LRB- CRRT_NN -RRB-_-RRB- for_IN both_DT UF_NN and_CC solute_JJ clearance_NN in_IN severe_JJ acute_JJ kidney_NN injury_NN ._.
However_RB ,_, no_DT data_NNS is_VBZ available_JJ about_IN the_DT miRNA_NN expression_NN pattern_NN for_IN the_DT minimal_JJ deviation_NN adenocarcinoma_NN -LRB-_-LRB- MDA_NN -RRB-_-RRB- of_IN uterine_JJ cervix_NN ._.
However_RB ,_, there_EX is_VBZ little_JJ empirical_JJ evidence_NN that_IN examines_VBZ local_JJ implementation_NN responses_NNS to_TO such_JJ centrally-mandated_JJ collaborations_NNS ._.
However_RB ,_, few_JJ studies_NNS have_VBP been_VBN performed_VBN to_TO address_VB the_DT etiologic_JJ spectrum_NN of_IN severe_JJ SNHL_NN in_IN the_DT population_NN where_WRB there_EX is_VBZ no_DT consanguineous_JJ marriage_NN and_CC the_DT majority_NN of_IN SNHL_NN cases_NNS are_VBP sporadic_JJ in_IN small_JJ sized_VBN families_NNS ._.
However_RB ,_, not_RB all_DT patients_NNS with_IN NSEVA_NN carry_VBP biallelic_JJ mutations_NNS in_IN SLC26A4_NN ._.
However_RB ,_, even_RB when_WRB health_NN services_NNS are_VBP provided_VBN free_JJ of_IN charge_NN ,_, monetary_JJ and_CC time_NN costs_NNS of_IN travel_NN to_TO a_DT local_JJ clinic_NN may_MD pose_VB a_DT significant_JJ barrier_NN for_IN vulnerable_JJ segments_NNS of_IN the_DT population_NN ,_, leading_VBG to_TO overall_JJ poorer_JJR health_NN ._.
However_RB ,_, some_DT studies_NNS have_VBP reported_VBN that_IN anxiety_NN disorders_NNS are_VBP also_RB associated_VBN with_IN perturbations_NNS in_IN reward_NN processing_NN ._.
However_RB ,_, with_IN the_DT aging_NN of_IN these_DT patients_NNS ,_, many_JJ late_JJ complications_NNS have_VBP been_VBN reported_VBN ,_, and_CC this_DT notion_NN must_MD be_VB reevaluated_VBN ._.
However_RB ,_, consumption_NN of_IN proton_NN pump_NN inhibitors_NNS -LRB-_-LRB- PPIs_NNS -RRB-_-RRB- affects_VBZ growth_NN and_CC urease_NN activity_NN of_IN H._NNP pylori_NNP ,_, leading_VBG to_TO false_JJ negative_JJ results_NNS ._.
However_RB ,_, liver_NN metastases_NNS are_VBP common_JJ in_IN NET_NN patients_NNS and_CC the_DT outcome_NN of_IN NET_NN liver_NN metastasis_NN is_VBZ poor_JJ ._.
However_RB ,_, some_DT patients_NNS receiving_VBG IA/IgG_NN experience_NN recurrence_NN of_IN heart_NN failure_NN after_IN an_DT initial_JJ benefit_NN ._.
However_RB ,_, this_DT technique_NN has_VBZ not_RB been_VBN investigated_VBN in_IN recent_JJ onset_NN schizophrenia_NN patients_NNS ._.
However_RB ,_, few_JJ studies_NNS of_IN EDI_NN have_VBP conducted_VBN such_JJ analyses_NNS ._.
However_RB ,_, the_DT prognostic_JJ significance_NN of_IN CXCL1_NN expression_NN in_IN breast_NN cancer_NN has_VBZ not_RB been_VBN fully_RB characterized_VBN ._.
However_RB ,_, there_EX is_VBZ little_JJ information_NN about_IN the_DT influence_NN of_IN periodontitis-associated_JJ bacteria_NNS ,_, Porphyromonas_NN gingivalis_NN -LRB-_-LRB- Pg_NN -RRB-_-RRB- ,_, on_IN pathogenesis_NN of_IN atherosclerosis_NN in_IN obesity_NN ._.
However_RB ,_, no_DT countrywide_NN prevalence_NN data_NNS are_VBP available_JJ ._.
However_RB ,_, there_EX is_VBZ limited_JJ knowledge_NN about_IN international_JJ travel_NN patterns_NNS and_CC travel-related_JJ illnesses_NNS of_IN stem_NN cell_NN transplant_NN recipients_NNS -LRB-_-LRB- SCTRs_NNS -RRB-_-RRB- ._.
However_RB ,_, NB_NN with_IN MYCN_NN amplification_NN is_VBZ less_RBR sensitive_JJ to_TO GANT-61_NN than_IN those_DT without_IN MYCN_NNP amplification_NN ._.
However_RB ,_, because_IN the_DT direct_JJ effects_NNS of_IN 1,25-dihydroxyvitamin_NN D3_NN -LRB-_-LRB- INT_CD -LRB-_-LRB- OH_NN -RRB-_-RRB- 2D3_NN -RRB-_-RRB- on_IN bone_NN formation_NN and_CC resorption_NN are_VBP very_RB complex_JJ ,_, the_DT net_JJ effect_NN of_IN INT_CD -LRB-_-LRB- OH_NN -RRB-_-RRB- 2D3_NN on_IN histomorphometric_JJ parameters_NNS of_IN bone_NN turnover_NN and_CC mineralisation_NN should_MD be_VB investigated_VBN ._.
However_RB ,_, a_DT risk_NN of_IN postoperative_JJ coronal_JJ decompensation_NN after_IN STF_NN has_VBZ also_RB been_VBN reported_VBN ._.
However_RB ,_, information_NN on_IN the_DT geographic_JJ variability_NN of_IN HCMV_NN prevalence_NN in_IN GBM_NNP remains_VBZ scarce_JJ ._.
However_RB ,_, there_EX is_VBZ little_JJ information_NN regarding_VBG the_DT relationship_NN between_IN angiogenesis_NN and_CC NHT_NN ._.
However_RB ,_, because_RB often_RB there_EX is_VBZ not_RB much_RB known_VBN about_IN these_DT human_JJ genes_NNS ,_, an_DT additional_JJ source_NN of_IN data_NNS that_WDT could_MD be_VB used_VBN is_VBZ model_JJ organism_NN phenotype_NN data_NNS ._.
However_RB ,_, evidence_NN demonstrating_VBG this_DT point_NN is_VBZ limited_VBN only_RB to_TO the_DT popliteal_NN sciatic_JJ nerve_NN block_NN ,_, which_WDT is_VBZ relatively_RB easy_JJ to_TO perform_VB by_IN via_IN a_DT high-frequency_VBP linear_JJ transducer_NN ._.
However_RB ,_, no_DT guidance_NN was_VBD provided_VBN as_IN to_TO what_WP ``_`` highly_RB selected_VBN ''_'' meant_VBN ._.
However_RB ,_, the_DT cost-effectiveness_NN of_IN TDM_NN in_IN the_DT management_NN of_IN resistant_JJ hypertension_NN has_VBZ not_RB been_VBN investigated_VBN ._.
However_RB ,_, little_JJ is_VBZ known_VBN on_IN the_DT long-term_JJ effect_NN of_IN screening_NN at_IN the_DT population_NN level_NN in_IN everyday_JJ practice_NN ._.
However_RB ,_, it_PRP is_VBZ necessary_JJ to_TO differentiate_VB from_IN high_JJ confluence_NN of_IN pancreaticobiliary_JJ ducts_NNS -LRB-_-LRB- HCPBD_NN -RRB-_-RRB- with_IN a_DT relatively_RB long_JJ common_JJ channel_NN -LRB-_-LRB- ≥_CD INT_CD mm_NN -RRB-_-RRB- and_CC effect_NN of_IN the_DT sphincter_NN in_IN the_DT pancreaticobiliary_JJ junction_NN ._.
However_RB ,_, the_DT volumetry_NN of_IN the_DT thyroid_NN gland_NN ,_, especially_RB when_WRB enlarged_JJ or_CC abnormally_RB formed_VBN ,_, proves_VBZ to_TO be_VB a_DT challenge_NN in_IN clinical_JJ routine_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT quality_NN of_IN their_PRP$ long-term_JJ survival_NN ._.
However_RB ,_, protease-activated_JJ receptor_NN -LRB-_-LRB- PAR_NN -RRB-_-RRB- that_WDT reacts_VBZ to_TO thrombin_NN stimulation_NN might_MD still_RB be_VB active_JJ in_IN patients_NNS treated_VBN with_IN P2Y12_NN inhibitors_NNS ._.
However_RB ,_, it_PRP is_VBZ unknown_JJ how_WRB brushing_NN behavior_NN observed_VBN at_IN one_CD time_NN relates_VBZ to_TO brushing_NN capabilities_NNS observed_VBN at_IN another_DT time_NN ._.
However_RB ,_, the_DT role_NN of_IN RDW_NN in_IN patients_NNS with_IN Takayasu_NN arteritis_NN -LRB-_-LRB- TA_NNP -RRB-_-RRB- is_VBZ unknown_JJ ._.
However_RB ,_, despite_IN its_PRP$ multifactorial_JJ nature_NN most_RBS studies_NNS in_IN CDI_NNP have_VBP treated_VBN impulsivity_NN monolithically_RB ._.
However_RB ,_, their_PRP$ impact_NN on_IN cognitive_JJ impairment-free_JJ life_NN expectancy_NN -LRB-_-LRB- CIFLE_NN -RRB-_-RRB- has_VBZ not_RB previously_RB been_VBN estimated_VBN ._.
However_RB ,_, there_EX are_VBP still_RB major_JJ gaps_NNS in_IN knowledge_NN related_JJ to_TO access_NN to_TO surgical_JJ care_NN in_IN low-income_JJ countries_NNS ._.
However_RB ,_, surgery_NN is_VBZ not_RB the_DT rule_NN for_IN ATC_NN patients_NNS with_IN distant_JJ metastases_NNS at_IN the_DT time_NN of_IN diagnosis_NN -LRB-_-LRB- stage_NN IV-C_NN -RRB-_-RRB- ,_, regardless_RB of_IN tumor_NN resectability_NN ._.
However_RB ,_, EL_NNP is_VBZ primarily_RB assessed_VBN using_VBG retrospective_JJ self-report_NN ,_, which_WDT is_VBZ subject_JJ to_TO reporting_VBG bias_NN and_CC does_VBZ not_RB consider_VB the_DT potential_JJ influence_NN of_IN positive_JJ and_CC negative_JJ everyday_JJ experiences_NNS ._.
However_RB ,_, there_EX are_VBP limited_JJ case_NN reports_NNS of_IN this_DT phenomenon_NN after_IN radioactive_JJ iodine_NN ablation_NN therapy_NN -LRB-_-LRB- RIAT_NN -RRB-_-RRB- in_IN differentiated_VBN thyroid_NN cancer_NN -LRB-_-LRB- DTC_NN -RRB-_-RRB- ._.
However_RB ,_, previous_JJ studies_NNS are_VBP mixed_VBN as_IN to_TO whether_IN VPI_NNP is_VBZ an_DT independent_JJ prognostic_JJ factor_NN in_IN early-stage_JJ cancers_NNS and_CC whether_IN its_PRP$ effect_NN is_VBZ size_NN dependent_JJ ._.
However_RB ,_, clinical_JJ ,_, molecular_JJ ,_, and_CC prognostic_JJ associations_NNS of_IN SMO_NN expression_NN in_IN colorectal_JJ cancer_NN remain_VBP unclear_JJ ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT distribution_NN of_IN help-seeking_JJ knowledge_NN in_IN the_DT general_JJ population_NN or_CC specific_JJ subpopulations_NNS ._.
However_RB ,_, whether_IN the_DT levels_NNS of_IN inflammatory_JJ alterations_NNS in_IN untreated_JJ HIV-infected_JJ patients_NNS and_CC elderly_JJ individuals_NNS are_VBP similar_JJ is_VBZ unknown_JJ ._.
However_RB gaps_NNS in_IN their_PRP$ nutrition_NN knowledge_NN and_CC education_NN warrant_VBP the_DT need_NN for_IN enhanced_VBN learning_NN as_IN part_NN of_IN their_PRP$ Continued_VBN Professional_NNP Development_NNP -LRB-_-LRB- CPD_NNP -RRB-_-RRB- ._.
However_RB ,_, despite_IN increasing_VBG recognition_NN of_IN the_DT impact_NN of_IN costs_NNS on_IN oncology_NN care_NN ,_, there_EX is_VBZ no_DT patient-reported_JJ outcome_NN measure_NN -LRB-_-LRB- PROM_NN -RRB-_-RRB- that_WDT specifically_RB describes_VBZ the_DT financial_JJ distress_NN experienced_VBN by_IN patients_NNS ._.
However_RB ,_, there_EX are_VBP scarce_JJ data_NNS concerning_VBG laparoscopic_JJ colorectal_JJ surgery_NN -LRB-_-LRB- LCRS_NN -RRB-_-RRB- ._.
However_RB ,_, no_DT research_NN has_VBZ identified_VBN whether_IN adaptations_NNS also_RB exist_VBP in_IN the_DT vasculature_NN of_IN the_DT upper_JJ extremity_NN in_IN the_DT competitive_JJ baseball_NN player_NN ._.
However_RB ,_, few_JJ studies_NNS have_VBP been_VBN performed_VBN on_IN the_DT role_NN of_IN ghrelin_NN and_CC obestatin_NN in_IN middle-aged_JJ and_CC old_JJ adults_NNS ._.
However_RB ,_, there_EX still_RB does_VBZ not_RB exist_VB an_DT ideal_JJ intraneural_JJ microvascular_JJ model_NN ._.
However_RB ,_, no_DT studies_NNS have_VBP assessed_VBN the_DT effects_NNS of_IN TENS_NNS on_IN kidney_NN donors_NNS ._.
However_RB ,_, to_TO our_PRP$ knowledge_NN ,_, few_JJ studies_NNS have_VBP focused_VBN on_IN anesthesia_NN experience_NN during_IN PCTG_NN as_IN treatment_NN for_IN TN_NN so_RB far_RB ._.
However_RB ,_, some_DT patients_NNS who_WP undergo_VBP breast_NN reconstruction_NN with_IN ADMs_NNS develop_VBP postoperative_JJ erythema_NN overlying_VBG their_PRP$ ADM_NNP grafts_NNS ._.
However_RB ,_, there_EX is_VBZ no_DT information_NN about_IN the_DT ability_NN of_IN this_DT fungus_NN to_TO use_VB organic_JJ substrates_NNS other_JJ than_IN cellulose_NN ,_, and_CC its_PRP$ ability_NN to_TO produce_VB different_JJ enzyme_NN systems_NNS ,_, as_RB well_RB as_IN its_PRP$ response_NN to_TO temperature_NN ._.
However_RB ,_, the_DT genetic_JJ and_CC environmental_JJ determinants_NNS behind_IN this_DT phenomenon_NN remain_VBP unclear_JJ ._.
However_RB ,_, impaired_JJ protein_NN synthesis_NN ,_, altered_VBN drug_NN metabolism_NN ,_, and_CC compromised_VBN hepatic_JJ blood_NN flow_NN in_IN patients_NNS with_IN liver_NN cirrhosis_NN might_MD affect_VB the_DT pharmacokinetics_NNS of_IN sedatives_NNS ,_, placing_VBG cirrhotic_JJ patients_NNS undergoing_VBG endoscopy_NN at_IN a_DT greater_JJR risk_NN of_IN adverse_JJ events_NNS ._.
However_RB ,_, no_DT studies_NNS have_VBP screened_VBN for_IN interactions_NNS between_IN general_JJ anesthetics_NNS currently_RB in_IN clinical_JJ use_NN and_CC serotonergic_JJ G-protein-coupled_JJ receptors_NNS -LRB-_-LRB- GPCRs_NNS -RRB-_-RRB- ._.
However_RB ,_, whether_IN these_DT gene_NN expression_NN abnormalities_NNS reflect_VBP disturbances_NNS in_IN postnatal_JJ developmental_JJ processes_NNS before_IN clinical_JJ onset_NN or_CC arise_VB as_IN a_DT consequence_NN of_IN clinical_JJ illness_NN remains_VBZ unclear_JJ ._.
However_RB ,_, carcinogenesis_NN remains_VBZ problematic_JJ in_IN these_DT patients_NNS ._.
However_RB ,_, the_DT functional_JJ roles_NNS of_IN lncRNAs_NNS in_IN hepatocellular_JJ carcinoma_NN -LRB-_-LRB- HCC_NN -RRB-_-RRB- are_VBP not_RB yet_RB well_RB elucidated_VBN ._.
However_RB ,_, there_EX is_VBZ a_DT dearth_NN of_IN studies_NNS addressing_VBG the_DT neural_JJ basis_NN of_IN this_DT association_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT effect_NN of_IN DHA_NN on_IN BBB_NNP dysfunction_NN after_IN cerebral_JJ ischemia-reperfusion_NN injury_NN ._.
However_RB ,_, large-scaled_JJ ,_, population-based_JJ cohort_NN study_NN has_VBZ been_VBN limited_VBN ._.
However_RB ,_, therapeutic_JJ approaches_NNS were_VBD limited_VBN ._.
However_RB ,_, there_EX is_VBZ little_RB known_JJ about_IN the_DT effects_NNS of_IN HS_NN in_IN patients_NNS during_IN neurosurgery_NN ._.
However_RB ,_, the_DT significance_NN of_IN FGFR4_NN in_IN non-small-cell_JJ lung_NN cancer_NN -LRB-_-LRB- NSCLC_NN -RRB-_-RRB- is_VBZ still_RB not_RB well_RB elucidated_VBN ._.
However_RB ,_, the_DT overall_JJ effect_NN of_IN Mefunidone_NNP in_IN renal_JJ fibrosis_NN remains_VBZ unknown_JJ ._.
However_RB ,_, the_DT expression_NN and_CC its_PRP$ potential_JJ biological_JJ roles_NNS of_IN FOXD3_NN in_IN high-grade_JJ gliomas_NNS -LRB-_-LRB- HGGs_NNS -RRB-_-RRB- remain_VBP unknown_JJ ._.
However_RB ,_, the_DT role_NN of_IN hypoxia-inducible_JJ factor_NN 1α_NN -LRB-_-LRB- HIF-1α_NN -RRB-_-RRB- in_IN gynecological_JJ cancer_NN remains_VBZ unclear_JJ ._.
However_RB ,_, varying_VBG measures_NNS of_IN dental_JJ status_NN across_IN different_JJ populations_NNS and_CC low_JJ study_NN sample_NN has_VBZ made_VBN comparison_NN of_IN studies_NNS and_CC conclusion_NN of_IN findings_NNS unclear_JJ ._.
However_RB ,_, due_JJ to_TO a_DT paucity_NN of_IN research_NN on_IN the_DT connection_NN between_IN neuropsychological_JJ difficulties_NNS and_CC the_DT clinical_JJ features_NNS of_IN AN_DT ,_, the_DT link_NN remains_VBZ hypothetical_JJ ._.
However_RB ,_, the_DT precise_JJ mechanism_NN -LRB-_-LRB- s_NNS -RRB-_-RRB- of_IN action_NN of_IN this_DT therapy_NN is_VBZ unclear_JJ ._.
However_RB previous_JJ reliability_NN studies_NNS on_IN diagnostic_JJ ultrasound_NN and_CC LMM_NN have_VBP included_VBN a_DT limited_JJ number_NN of_IN subjects_NNS and_CC few_JJ have_VBP used_VBN Bland-Altman_NNP 's_POS Limits_NNS of_IN Agreement_NN -LRB-_-LRB- LOA_NN -RRB-_-RRB- ._.
However_RB ,_, accurate_JJ measurement_NN of_IN rates_NNS may_MD vary_VB depending_VBG on_IN the_DT data_NNS source_NN used_VBN to_TO determine_VB eligible_JJ sexually-active_JJ women_NNS ._.
However_RB ,_, quantitative_JJ models_NNS that_WDT accurately_RB predict_VBP the_DT up_RP or_CC down_RP regulation_NN of_IN gene_NN expression_NN are_VBP currently_RB lacking_VBG ._.
However_RB ,_, results_VBZ from_IN previous_JJ studies_NNS are_VBP not_RB consistent_JJ ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN its_PRP$ function_NN and_CC mechanism_NN involving_VBG in_IN NPC_NN development_NN and_CC progression_NN ._.
However_RB ,_, very_RB little_JJ information_NN is_VBZ available_JJ with_IN regard_NN to_TO HIV-1_NN infection_NN and_CC treatment_NN outcome_NN in_IN MENA_NN countries_NNS including_VBG the_DT Gulf_NNP Cooperation_NNP Council_NNP -LRB-_-LRB- GCC_NNP -RRB-_-RRB- states_NNS ._.
However_RB ,_, discrepancies_NNS and_CC discordance_NN between_IN different_JJ platforms_NNS targeting_VBG the_DT same_JJ pathogen_NN have_VBP also_RB been_VBN observed_VBN at_IN different_JJ settings_NNS ._.
However_RB ,_, there_EX is_VBZ no_DT clear_JJ evidence_NN that_IN wrapping_VBG in_IN fact_NN provides_VBZ benefits_NNS ._.
However_RB ,_, the_DT magnitude_NN of_IN postpartum_NN CMD_NN in_IN Ethiopia_NNP is_VBZ not_RB well-established_JJ ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT HRQOL_NN of_IN men_NNS who_WP have_VBP sex_NN with_IN men_NNS and_CC women_NNS -LRB-_-LRB- MSMW_NN -RRB-_-RRB- ._.
However_RB ,_, accuracy_NN is_VBZ dependent_JJ on_IN the_DT reading_NN of_IN the_DT CT_NN scans_VBZ ._.
However_RB ,_, like_IN DN_JJ ,_, diffuse_JJ mesangial_JJ sclerosis_NN may_MD occur_VB in_IN this_DT setting_NN without_IN nodules_NNS ._.
However_RB ,_, the_DT association_NN of_IN miRNA-122_NN levels_NNS and_CC hepatic_JJ fibrosis_NN and_CC portal_JJ hypertension_NN remains_VBZ to_TO be_VB explored_VBN in_IN HIV/HCV_NN coinfection_NN ._.
However_RB ,_, there_EX are_VBP limited_JJ data_NNS from_IN recent_JJ ,_, large_JJ international_JJ studies_NNS comparing_VBG risk_NN factors_NNS and_CC clinical_JJ features_NNS in_IN patients_NNS with_IN cervical_JJ artery_NN dissection_NN -LRB-_-LRB- CeAD_NN -RRB-_-RRB- with_IN other_JJ TIA_NNP or_CC ischemic_JJ stroke_NN -LRB-_-LRB- IS_VBZ -RRB-_-RRB- patients_NNS of_IN similar_JJ age_NN and_CC sex_NN ._.
However_RB ,_, no_DT study_NN was_VBD performed_VBN on_IN adults_NNS over_IN INT_CD years_NNS of_IN age_NN and_CC all_DT but_CC two_CD studies_NNS were_VBD based_VBN on_IN parent_NN or_CC teacher_NN ratings_NNS ._.
However_RB ,_, the_DT role_NN of_IN miRNAs_NNS in_IN the_DT cardioprotection_NN by_IN electroacupuncture_JJ pretreatment_NN on_IN myocardial_JJ I/R_NN injury_NN remains_VBZ unknown_JJ ._.
However_RB ,_, few_JJ hip_NN fracture_NN studies_NNS have_VBP specifically_RB examined_VBN the_DT relationship_NN between_IN hip_NN fracture_NN patterns_NNS ,_, sex_NN ,_, and_CC short-term_JJ outcomes_NNS including_VBG hospital_NN length_NN of_IN stay_NN and_CC discharge_NN disposition_NN in_IN geriatric_JJ trauma_NN patients_NNS ._.
However_RB ,_, whether_IN antidepressants_NNS target_VBP neural_JJ progenitor_NN cells_NNS in_IN other_JJ brain_NN regions_NNS has_VBZ not_RB been_VBN examined_VBN ._.
However_RB ,_, maternal_JJ substance_NN use_NN during_IN pregnancy_NN appears_VBZ to_TO occur_VB more_RBR often_RB in_IN those_DT with_IN a_DT family_NN history_NN of_IN alcohol_NN dependence_NN ._.
However_RB ,_, evidence_NN on_IN the_DT comparable_JJ effectiveness_NN of_IN different_JJ ACEIs_NNS is_VBZ scarce_JJ ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT role_NN of_IN orexin_NN in_IN patients_NNS with_IN schizophrenia_NN ._.
However_RB ,_, it_PRP is_VBZ unclear_JJ whether_IN TAP_NN block_NN following_VBG local_JJ anesthetic_JJ infiltration_NN is_VBZ effective_JJ ._.
However_RB ,_, the_DT CMV_NN antigenemia_NN assay_NN is_VBZ still_RB the_DT `_`` gold_JJ standard_NN '_'' assay_NN ._.
However_RB ,_, ways_NNS to_TO measure_VB time_NN lags_VBZ are_VBP under-developed_JJ ,_, with_IN little_JJ attention_NN on_IN where_WRB time_NN lags_VBZ arise_VB within_IN overall_JJ timelines_NNS ._.
However_RB ,_, the_DT relationship_NN between_IN morphological_JJ lesion_NN complexity_NN and_CC FFR_NN has_VBZ not_RB yet_RB been_VBN fully_RB evaluated_VBN ._.
However_RB ,_, the_DT neural_JJ substrates_NNS of_IN non-conscious_JJ processing_NN have_VBP not_RB been_VBN entirely_RB elucidated_VBN ._.
However_RB ,_, it_PRP is_VBZ currently_RB unknown_JJ if_IN dopamine_NN dynamically_RB tracks_VBZ alterations_NNS in_IN expected_VBN reward_NN value_NN online_NN as_IN behavioral_JJ preferences_NNS change_NN and_CC if_IN so_RB ,_, if_IN it_PRP is_VBZ causally_RB linked_VBN to_TO specific_JJ components_NNS of_IN value_NN such_JJ as_IN reward_NN magnitude_NN and/or_CC delay_NN to_TO reinforcement_NN ._.
However_RB ,_, preclinical_JJ studies_NNS focusing_VBG on_IN this_DT matter_NN have_VBP scarcely_RB addressed_VBN abnormal_JJ aversive_JJ memories_NNS and_CC related_JJ outcomes_NNS ._.
However_RB ,_, its_PRP$ effects_NNS on_IN male_JJ reproduction_NN are_VBP not_RB well_RB known_VBN ._.
However_RB ,_, what_WP are_VBP the_DT career_NN choices_NNS of_IN medical_JJ students_NNS ?_.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT use_NN of_IN this_DT procedure_NN for_IN this_DT purpose_NN ._.
However_RB ,_, the_DT prevalence_NN among_IN healthy_JJ children_NNS is_VBZ unknown_JJ ._.
However_RB ,_, it_PRP has_VBZ not_RB yet_RB been_VBN proven_VBN that_IN Stemona_NNP tuberosa_NN has_VBZ positive_JJ effects_NNS on_IN lung_NN inflammation_NN ._.
However_RB ,_, the_DT relationship_NN between_IN methylated_VBN DNA_NN in_IN plasma_NN and_CC colon_NN tissue_NN of_IN the_DT same_JJ subjects_NNS has_VBZ not_RB been_VBN reported_VBN ._.
However_RB ,_, only_RB a_DT few_JJ studies_NNS have_VBP assessed_VBN SSRI-mediated_JJ effects_NNS on_IN autonomic_JJ reactivity_NN in_IN healthy_JJ individuals_NNS using_VBG heart_NN rate_NN variability_NN -LRB-_-LRB- HRV_NN -RRB-_-RRB- ._.
However_RB ,_, these_DT methods_NNS are_VBP inconsistent_JJ with_IN the_DT usual_JJ rigid_JJ segments_NNS assumption_NN ._.
However_RB ,_, CFVADs_NNS have_VBP also_RB been_VBN associated_VBN with_IN certain_JJ complications_NNS thought_VBD to_TO be_VB linked_VBN with_IN decreased_VBN arterial_JJ pulsatility_NN ._.
However_RB ,_, few_JJ community-based_JJ studies_NNS have_VBP been_VBN conducted_VBN to_TO assess_VB the_DT association_NN between_IN the_DT two_CD diseases_NNS ._.
However_RB ,_, despite_IN its_PRP$ role_NN in_IN fall_NN risk_NN ,_, whether_IN SLST_NNP times_NNS around_IN INT_CD seconds_NNS marks_VBZ a_DT clinically_RB important_JJ stage_NN of_IN disease_NN progression_NN has_VBZ largely_RB remained_VBN unexplored_JJ ._.
However_RB ,_, most_RBS immunochromatographic_JJ tests_NNS employ_VBP gold_NN nanoparticles_NNS as_IN reporters_NNS ,_, and_CC these_DT have_VBP only_RB moderate_JJ sensitivity_NN and_CC act_VBP as_IN qualitative_JJ methods_NNS for_IN analyzing_VBG high_JJ biomarker_NN concentrations_NNS ._.
However_RB ,_, current_JJ US_NNP gonorrhea_NN treatment_NN practices_NNS have_VBP not_RB been_VBN well_RB characterized_VBN ._.
However_RB ,_, this_DT association_NN has_VBZ not_RB confirmed_VBN by_IN other_JJ studies_NNS ._.
However_RB ,_, such_JJ surveys_NNS have_VBP not_RB been_VBN performed_VBN in_IN Zimbabwe_NNP over_IN the_DT past_JJ decade_NN ._.
However_RB ,_, the_DT clinical_JJ significance_NN of_IN suPAR_NN in_IN glomerular_JJ diseases_NNS currently_RB remains_VBZ unclear_JJ ._.
However_RB ,_, data_NNS remain_VBP limited_JJ to_TO address_VB the_DT effect_NN of_IN PPIs_NNS alone_RB on_IN the_DT subsequent_JJ risk_NN of_IN myocardial_JJ infarction_NN -LRB-_-LRB- MI_NN -RRB-_-RRB- ._.
However_RB ,_, the_DT effect_NN of_IN age_NN on_IN FFR_NNP has_VBZ not_RB been_VBN well-studied_JJ ._.
However_RB ,_, the_DT role_NN of_IN the_DT corpus_NN callosum_NN in_IN infant_NN development_NN is_VBZ unclear_JJ ._.
However_RB ,_, no_DT such_JJ instrument_NN was_VBD available_JJ in_IN Mexico_NNP at_IN the_DT time_NN of_IN our_PRP$ study_NN ._.
However_RB ,_, there_EX are_VBP still_RB few_JJ clinical_JJ experiences_NNS of_IN SILS_NN in_IN pancreatic_JJ surgery_NN until_IN now_RB ._.
However_RB ,_, no_DT study_NN has_VBZ evaluated_VBN the_DT effects_NNS of_IN the_DT bronchoscope_NN diameter_NN ._.
However_RB ,_, reports_NNS on_IN the_DT concurrence_NN of_IN psoriasis_NN with_IN IBD_NN in_IN the_DT Asian_JJ population_NN in_IN the_DT literature_NN are_VBP scarce_JJ ._.
However_RB when_WRB multiple_JJ abnormalities_NNS are_VBP present_JJ ,_, combining_VBG individual_JJ measurements_NNS can_MD be_VB subjective_JJ ._.
However_RB ,_, the_DT functional_JJ status_NN of_IN central_JJ pain_NN mechanisms_NNS ,_, i.e._FW ,_, central_JJ sensitization_NN and_CC conditioned_VBN pain_NN modulation_NN -LRB-_-LRB- CPM_NN -RRB-_-RRB- ,_, has_VBZ not_RB been_VBN investigated_VBN in_IN this_DT population_NN ._.
However_RB ,_, in_IN cholangiocarcinoma_NN -LRB-_-LRB- CCA_NN -RRB-_-RRB- the_DT correlation_NN between_IN miRNAs_NNS and_CC their_PRP$ potential_JJ roles_NNS in_IN CCA_NN remains_VBZ unclear_JJ ._.
However_RB ,_, in_IN patients_NNS at_IN risk_NN ,_, the_DT highest_JJS levels_NNS of_IN urinary_JJ NGAL_NN are_VBP associated_VBN with_IN AKI_NN severity_NN but_CC the_DT highest_JJS urinary_JJ hepcidin_NN levels_NNS are_VBP associated_VBN with_IN absence_NN of_IN AKI_NNP ._.
However_RB ,_, the_DT dysphagia_NN frequently_RB associated_VBN with_IN this_DT condition_NN may_MD interfere_VB with_IN patient_NN tolerance_NN of_IN this_DT treatment_NN ._.
However_RB ,_, the_DT ideal_JJ recipient_JJ population_NN is_VBZ not_RB fully_RB characterized_VBN ,_, and_CC indications_NNS for_IN helicopter_NN transport_NN in_IN pediatric_JJ trauma_NN vary_VBP dramatically_RB by_IN county_NN ,_, state_NN ,_, and_CC region_NN ._.
However_RB ,_, PubMed_NNP has_VBZ some_DT drawbacks_NNS that_WDT make_VBP it_PRP difficult_JJ to_TO find_VB relevant_JJ publications_NNS pertaining_VBG to_TO users_NNS '_POS individual_JJ intentions_NNS ,_, especially_RB for_IN non-expert_JJ users_NNS ._.
However_RB ,_, previous_JJ studies_NNS have_VBP reported_VBN an_DT uneven_JJ distribution_NN of_IN the_DT disease_NN in_IN Norway_NNP ,_, with_IN a_DT relatively_RB low_JJ prevalence_NN in_IN the_DT most_RBS northern_JJ parts_NNS of_IN the_DT country_NN ._.
However_RB ,_, the_DT application_NN of_IN different_JJ methods_NNS on_IN the_DT same_JJ proteome_NN set_NN can_MD lead_VB to_TO distinct_JJ orthology_NN predictions_NNS ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT role_NN or_CC regulation_NN of_IN BMP_NN signaling_NN in_IN HNSCC_NN CSCs_NNS ._.
However_RB ,_, the_DT detection_NN of_IN occult_NN HBV_NN infection_NN among_IN blood_NN donors_NNS is_VBZ imperative_JJ for_IN improving_VBG blood_NN safety_NN ._.
However_RB ,_, the_DT evidence_NN that_IN transfusions_NNS are_VBP beneficial_JJ is_VBZ contradictory_JJ ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT joint_JJ effects_NNS of_IN phthalate_JJ exposure_NN and_CC filaggrin_NN -LRB-_-LRB- FLG_NN -RRB-_-RRB- gene_NN variants_NNS on_IN atopic_JJ dermatitis_NN -LRB-_-LRB- AD_NN -RRB-_-RRB- ._.
However_RB ,_, the_DT effects_NNS of_IN glenohumeral_JJ abduction_NN on_IN the_DT biomechanical_JJ strength_NN have_VBP seldom_RB been_VBN elucidated_VBN ._.
However_RB ,_, these_DT studies_NNS have_VBP failed_VBN to_TO clarify_VB the_DT nature_NN of_IN the_DT overlap_VBP ._.
However_RB ,_, residual_JJ or_CC recurrent_JJ TR_NN is_VBZ not_RB uncommon_JJ occurring_VBG in_IN INT_CD %_NN to_TO INT_CD %_NN of_IN patients_NNS ._.
However_RB ,_, LPN_NN and_CC RPN_NN are_VBP technically_RB challenging_JJ procedures_NNS ._.
However_RB ,_, the_DT mechanisms_NNS explaining_VBG this_DT relationship_NN are_VBP not_RB well_RB understood_VBN ._.
However_RB ,_, their_PRP$ predictive_JJ ability_NN remains_VBZ controversial_JJ ._.
However_RB ,_, there_EX are_VBP no_DT established_JJ criteria_NNS for_IN selecting_VBG CPT-11_NN dose_NN on_IN the_DT basis_NN of_IN PTB_NN ._.
However_RB it_PRP is_VBZ still_RB not_RB clear_JJ if_IN this_DT trend_NN applies_VBZ to_TO Eastern_NNP Europe_NNP where_WRB high_JJ incidence_NN rate_NN of_IN gastric_JJ cancer_NN is_VBZ observed_VBN ._.
However_RB ,_, dynamic_JJ changes_NNS of_IN microvessels_NNS after_IN stroke_NN still_RB remain_VBP unclear_JJ ,_, and_CC MRI_NNP follow-up_NN could_MD be_VB interesting_JJ as_IN an_DT in_FW vivo_FW biomarker_NN of_IN these_DT ._.
However_RB ,_, it_PRP is_VBZ unclear_JJ whether_IN crackle_VB characteristics_NNS can_MD be_VB used_VBN to_TO identify_VB COPD_NNP ._.
However_RB ,_, the_DT combination_NN of_IN its_PRP$ widespread_JJ use_NN and_CC constant_JJ exchange_NN make_VBP paper_NN currency_NN a_DT likely_JJ agent_NN for_IN disease_NN transmission_NN ._.
However_RB ,_, this_DT method_NN is_VBZ limited_VBN when_WRB there_EX is_VBZ inadequate_JJ vascular_JJ length_NN to_TO work_VB with_IN ._.
However_RB ,_, the_DT delivery_NN of_IN bCPAP_NN requires_VBZ more_RBR resources_NNS than_IN the_DT current_JJ routine_JJ care_NN using_VBG nasal_JJ oxygen_NN ._.
However_RB ,_, relevant_JJ household_NN survey_NN data_NNS ,_, which_WDT is_VBZ traditionally_RB needed_VBN for_IN this_DT analysis_NN is_VBZ not_RB frequently_RB collected_VBN in_IN most_JJS countries_NNS and_CC in_IN some_DT countries_NNS ,_, has_VBZ not_RB been_VBN collected_VBN at_IN all_DT ._.
However_RB ,_, its_PRP$ high_JJ prevalence_NN leads_VBZ to_TO the_DT overdiagnosis_NN of_IN UTI_NNP and_CC unnecessary_JJ antibiotic_JJ use_NN ,_, which_WDT can_MD result_VB in_IN adverse_JJ events_NNS ,_, including_VBG Clostridium_NNP difficile_JJ diarrhea_NN and_CC reinfection_NN with_IN antibiotic-resistant_JJ organisms_NNS ._.
However_RB ,_, data_NNS are_VBP lacking_VBG on_IN the_DT association_NN between_IN use_NN of_IN hypnotics_NNS and_CC the_DT occurrence_NN of_IN bone_NN fracture_NN ._.
However_RB ,_, there_EX is_VBZ no_DT clear_JJ consensus_NN on_IN how_WRB fat_JJ necrosis_NN is_VBZ defined_VBN and_CC classified_VBN in_IN the_DT plastic_NN surgery_NN literature_NN ._.
However_RB ,_, histological_JJ processes_NNS that_WDT occur_VBP during_IN incorporation_NN have_VBP not_RB been_VBN described_VBN ._.
However_RB ,_, spatial_JJ health_NN data_NNS from_IN surveys_NNS are_VBP often_RB incomplete_JJ ,_, ranging_VBG from_IN missing_VBG data_NNS for_IN only_RB a_DT few_JJ variables_NNS ,_, to_TO missing_VBG data_NNS for_IN many_JJ variables_NNS ._.
However_RB ,_, results_VBZ from_IN our_PRP$ observational_JJ and_CC interventional_JJ studies_NNS focusing_VBG on_IN relationships_NNS to_TO understand_VB and_CC improve_VB outcomes_NNS in_IN a_DT variety_NN of_IN healthcare_NN settings_NNS have_VBP been_VBN inconsistent_JJ ._.
However_RB ,_, these_DT concepts_NNS are_VBP not_RB based_VBN on_IN sufficient_JJ evidence_NN ._.
However_RB ,_, preclinical_JJ studies_NNS are_VBP limited_JJ because_IN of_IN the_DT absence_NN of_IN a_DT practical_JJ method_NN of_IN using_VBG CVVHF_NN along_IN with_IN ECPB_NN in_IN rodents_NNS ._.
However_RB ,_, IPC_NN protection_NN is_VBZ ineffective_JJ in_IN aged_JJ hearts_NNS ._.
However_RB ,_, the_DT most_RBS beneficial_JJ approach_NN among_IN these_DT is_VBZ not_RB known_VBN ._.
However_RB ,_, no_DT study_NN provided_VBD within-patient_JJ coefficients_NNS of_IN variation_NN ._.
However_RB ,_, very_RB little_JJ is_VBZ known_VBN about_IN cerebral_JJ hemodynamics_NNS responses_NNS in_IN preterm_JJ infants_NNS during_IN KMC_NNP intervention_NN ._.
However_RB ,_, very_RB little_JJ is_VBZ known_VBN about_IN the_DT role_NN of_IN Tregs_NNP in_IN regulating_VBG antiviral_JJ responses_NNS during_IN acute_JJ encephalitis_NN in_IN resistant_JJ mouse_NN strains_NNS ._.
However_RB ,_, those_DT analyses_NNS did_VBD not_RB consider_VB sources_NNS of_IN uncertainty_NN such_JJ as_IN unbalanced_JJ distributions_NNS or_CC quality_NN of_IN data_NNS ._.
However_RB ,_, there_EX were_VBD little_JJ data_NNS obtained_VBN by_IN validation_NN or_CC demonstration_NN study_NN of_IN the_DT assay_NN in_IN China_NNP ._.
However_RB ,_, these_DT aspects_NNS of_IN the_DT pelvic_JJ injury_NN are_VBP scarcely_RB addressed_VBN in_IN the_DT literature_NN ._.
However_RB ,_, no_DT prognostic_JJ miRNA_NN signature_NN was_VBD reported_VBN in_IN the_DT ER-positive_JJ breast_NN cancer_NN ._.
However_RB ,_, the_DT inhibition_NN of_IN the_DT metastasis_NN mechanism_NN of_IN COE_NNP in_IN gastric_JJ cancer_NN cells_NNS has_VBZ not_RB been_VBN investigated_VBN so_RB far_RB ._.
However_RB ,_, of_IN the_DT SDD_NN components_NNS ,_, whether_IN protocolized_VBN parenteral_JJ antibiotic_JJ prophylaxis_NN -LRB-_-LRB- PPAP_NN -RRB-_-RRB- is_VBZ required_VBN ,_, and_CC whether_IN the_DT topical_JJ antibiotic_JJ actually_RB presents_VBZ a_DT contextual_JJ hazard_NN ,_, remain_VBP unresolved_JJ ._.
However_RB ,_, there_EX is_VBZ still_RB no_DT standardization_NN of_IN the_DT HIPEC_NN regimen_NN ._.
However_RB ,_, only_RB few_JJ studies_NNS examined_VBN emotional_JJ processing_NN in_IN chronic_JJ ,_, heavy_JJ cannabis_NN users_NNS and_CC these_DT studies_NNS were_VBD performed_VBN in_IN cannabis_NN dependent_JJ patients_NNS who_WP were_VBD abstinent_JJ for_IN FLOAT_CD hours_NNS ._.
However_RB ,_, -LRB-_-LRB- a_DT -RRB-_-RRB- associations_NNS with_IN trichoepitheliomas_NNS in_IN Brooke-Spiegler_NN syndrome_NN or_CC with_IN trichoepitheliomas_NNS and_CC milia_NNS in_IN Rasmussen_NN syndrome_NN ,_, -LRB-_-LRB- b_LS -RRB-_-RRB- neoplastic_JJ combinations_NNS with_IN hair_NN follicle_NN tumors_NNS in_IN solitary_JJ cases_NNS ,_, and_CC -LRB-_-LRB- c_LS -RRB-_-RRB- anatomical_JJ considerations_NNS support_VBP a_DT folliculosebaceous-apocrine_JJ lineage_NN ._.
However_RB ,_, identification_NN of_IN allelic_JJ heterogeneity_NN and_CC population-specific_JJ genetic_JJ variants_NNS under_IN consideration_NN of_IN potential_JJ confounding_JJ factors_NNS will_MD be_VB very_RB valuable_JJ for_IN clinical_JJ applicability_NN ._.
However_RB ,_, data_NNS of_IN patients_NNS with_IN low_JJ and_CC high_JJ RecV_NN showed_VBD less_RBR severe_JJ lung_NN disease_NN in_IN high_JJ `_`` recruiters_NNS '_'' ,_, indicating_VBG that_IN RecV_NN may_MD not_RB equal_VB the_DT `_`` potentially_RB recruitable_JJ lung_NN tissue_NN '_'' seen_VBN in_IN computed_JJ tomography_NN scans_NNS ._.
However_RB ,_, the_DT optimal_JJ time_NN to_TO adjuvant_JJ chemotherapy_NN -LRB-_-LRB- TTAC_NN -RRB-_-RRB- in_IN rectal_JJ cancer_NN remains_VBZ unclear_JJ ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN specific_JJ lipid_NN species_NNS in_IN this_DT syndrome_NN and_CC existing_VBG data_NNS are_VBP contradictive_JJ ._.
However_RB ,_, concordance_NN between_IN fasting_JJ plasma_NN glucose_NN -LRB-_-LRB- FPG_NN -RRB-_-RRB- and_CC HbA1c_NN levels_NNS in_IN acutely_RB unwell_JJ patients_NNS is_VBZ unknown_JJ ._.
However_RB ,_, INT_CD %_NN of_IN ER_NN +_CC tumors_NNS develop_VBP resistance_NN to_TO these_DT drugs_NNS -LRB-_-LRB- endocrine_JJ resistance_NN -RRB-_-RRB- ._.
However_RB ,_, threshold_NN values_NNS of_IN these_DT indicators_NNS depend_VBP on_IN many_JJ factors_NNS that_WDT are_VBP influenced_VBN by_IN surgery_NN ,_, including_VBG opening_NN of_IN the_DT abdomen_NN ._.
However_RB ,_, the_DT neuropsychological_JJ effects_NNS of_IN cerebral_JJ microembolism_NN during_IN the_DT procedure_NN remain_VBP unclear_JJ and_CC data_NNS regarding_VBG this_DT issue_NN so_RB far_RB are_VBP inconsistent_JJ ._.
However_RB ,_, their_PRP$ biology_NN is_VBZ still_RB largely_RB unexplored_JJ and_CC there_EX is_VBZ a_DT need_NN for_IN baseline_NN epidemiological_JJ data_NNS ._.
However_RB ,_, availability_NN of_IN PHIs_NNS isunlikely_RB to_TO be_VB adequate_JJ during_IN the_DT early_JJ stages_NNS of_IN a_DT pandemic_NN ._.
However_RB ,_, the_DT potential_NN for_IN preoperative_JJ HCT_NN to_TO be_VB a_DT marker_NN for_IN sicker_JJR patients_NNS was_VBD not_RB well_RB explored_VBN ._.
However_RB ,_, there_EX is_VBZ still_RB no_DT detailed_JJ guidance_NN on_IN the_DT optimal_JJ way_NN to_TO run_VB such_JJ programmes_NNS ._.
However_RB ,_, prediction_NN of_IN successful_JJ T2DM_NN remission_NN after_IN surgery_NN has_VBZ not_RB been_VBN clearly_RB studied_VBN in_IN Chinese_JJ patients_NNS ._.
However_RB ,_, no_DT study_NN has_VBZ been_VBN conducted_VBN thus_RB far_RB to_TO identify_VB alterations_NNS at_IN the_DT molecular_JJ level_NN that_WDT might_MD mediate_VB these_DT changes_NNS in_IN disease_NN risk_NN after_IN migration_NN ._.
However_RB ,_, the_DT impact_NN of_IN Sdc-1_NN shedding_VBG on_IN chemotherapeutic_JJ resistance_NN has_VBZ not_RB been_VBN reported_VBN ._.
However_RB ,_, the_DT molecular_JJ basis_NN of_IN disruptions_NNS in_IN Cu-mediated_JJ ECM_NN formation_NN in_IN CDH_NN remains_VBZ unclear_JJ ._.
However_RB ,_, the_DT high_JJ scanning_NN rate_NN causes_VBZ proportional_JJ decrease_NN of_IN the_DT detector_NN exposure_NN time_NN ,_, resulting_VBG in_IN a_DT reduction_NN of_IN the_DT system_NN signal-to-noise_JJ ratio_NN -LRB-_-LRB- SNR_NN -RRB-_-RRB- ._.
However_RB ,_, term_NN at-risk_JJ infants_NNS ,_, as_IN a_DT distinct_JJ population_NN ,_, are_VBP underrepresented_JJ in_IN the_DT literature_NN ._.
However_RB ,_, data_NNS that_WDT compare_VBP physical_JJ function_NN of_IN patients_NNS who_WP receive_VBP surgery_NN with_IN similar_JJ patients_NNS who_WP do_VBP not_RB are_VBP sparse_JJ ._.
However_RB ,_, the_DT use_NN of_IN frozen_JJ section_NN analysis_NN can_MD assist_VB in_IN the_DT recognition_NN of_IN unique_JJ architecture_NN features_NNS of_IN HTT_NNP ,_, and_CC thus_RB may_MD help_VB prevent_VB the_DT undertaking_NN of_IN an_DT unnecessarily_RB aggressive_JJ operation_NN ._.
However_RB ,_, whether_IN phosphatidylinositol_NN 3-kinase/AKT/mTOR_NN signaling-mediated_JJ VGF_NN participates_VBZ in_IN rapid-acting_JJ antidepressant-like_JJ actions_NNS of_IN GLYX-13_NN is_VBZ unclear_JJ ._.
However_RB ,_, there_EX are_VBP limited_JJ data_NNS on_IN the_DT level_NN of_IN exercise_NN achieved_VBN during_IN exercise_NN SPECT_NNP MPI_NNP among_IN diabetic_JJ patients_NNS and_CC its_PRP$ impact_NN on_IN cardiovascular_JJ outcomes_NNS ._.
However_RB ,_, the_DT pattern_NN of_IN the_DT QT/RR_NN relationship_NN is_VBZ not_RB necessarily_RB linear_JJ ._.
However_RB ,_, systematic_JJ appraisals_NNS of_IN its_PRP$ biological_JJ characteristics_NNS are_VBP not_RB available_JJ ._.
However_RB ,_, many_JJ patients_NNS with_IN distant_JJ metastases_NNS can_MD have_VB very_RB long_JJ periods_NNS of_IN progression-free_JJ survival_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT relationship_NN between_IN hemoglobin_NN level_NN and_CC survival_NN according_VBG to_TO age_NN ._.
However_RB ,_, whether_IN syncopal_JJ symptoms_NNS are_VBP associated_VBN with_IN pathological_JJ cardiac_JJ autonomic_JJ modulation_NN is_VBZ not_RB fully_RB known_VBN ._.
However_RB ,_, screening_VBG guidelines_NNS for_IN TC_NN in_IN these_DT patients_NNS are_VBP not_RB well_RB established_VBN ._.
However_RB ,_, when_WRB iron_NN balance_NN collapses_VBZ ,_, such_JJ as_IN in_IN prolonged_JJ transfusion_NN ,_, transferrin_NN -LRB-_-LRB- Tf_NN -RRB-_-RRB- is_VBZ fully_RB saturated_VBN and_CC non-Tf-bound_JJ iron_NN -LRB-_-LRB- NTBI_NN -RRB-_-RRB- appears_VBZ in_IN the_DT serum_NN ._.
However_RB ,_, the_DT value_NN of_IN routine_JJ screening_NN of_IN infants_NNS with_IN this_DT test_NN has_VBZ not_RB been_VBN determined_VBN ._.
However_RB ,_, it_PRP is_VBZ not_RB known_VBN whether_IN these_DT distinctions_NNS can_MD be_VB refined_VBN by_IN added_VBN information_NN about_IN co-morbid_JJ conditions_NNS ._.
However_RB ,_, since_IN most_JJS DBS_NNS patients_NNS only_RB show_VBP a_DT partial_JJ response_NN ,_, the_DT treatment_NN still_RB needs_VBZ to_TO be_VB improved_VBN ._.
However_RB ,_, clinical_JJ evidence_NN demonstrating_VBG the_DT effectiveness_NN of_IN pharmacological_JJ thromboprophylaxis_NN ,_, including_VBG fondaparinux_NN ,_, is_VBZ limited_JJ because_IN the_DT occurrence_NN of_IN postoperative_JJ PE_NN after_IN hemiarthroplasty_NN is_VBZ very_RB low_JJ ._.
However_RB ,_, the_DT optimal_JJ size_NN ratio_NN of_IN donor_NN to_TO recipient_JJ nerve_NN has_VBZ yet_RB to_TO be_VB elucidated_VBN ._.
However_RB ,_, no_DT data_NNS are_VBP available_JJ on_IN the_DT oxidative_JJ stress_NN status_NN and_CC antioxidant_JJ enzyme_NN activity_NN in_IN these_DT patients_NNS ._.
However_RB ,_, the_DT clinical_JJ significance_NN of_IN STAT4_NN expression_NN in_IN patients_NNS with_IN hepatocellular_JJ carcinoma_NN -LRB-_-LRB- HCC_NN -RRB-_-RRB- remains_VBZ virtually_RB unknown_JJ ._.
However_RB ,_, the_DT mechanisms_NNS of_IN ketamine_NN action_NN at_IN a_DT systems_NNS level_NN remain_VBP unclear_JJ ._.
However_RB ,_, some_DT argue_VBP that_IN it_PRP should_MD be_VB performed_VBN in_IN INT_CD stages_NNS to_TO improve_VB safety_NN ._.
However_RB ,_, leptin_NN concentrations_NNS in_IN the_DT saliva_NN of_IN patients_NNS with_IN chronic_JJ periodontitis_NN -LRB-_-LRB- CP_NN -RRB-_-RRB- has_VBZ not_RB been_VBN explored_VBN despite_IN the_DT potential_JJ role_NN of_IN salivary_JJ biomarkers_NNS in_IN determining_VBG the_DT presence_NN ,_, risk_NN ,_, and_CC progression_NN of_IN periodontal_JJ disease_NN ._.
However_RB its_PRP$ determination_NN in_IN ventilated_VBN patients_NNS is_VBZ cumbersome_JJ and_CC needs_VBZ special_JJ equipment_NN ._.
However_RB ,_, there_EX remains_VBZ no_DT established_JJ nonsurgical_JJ process_NN to_TO rationally_RB select_JJ patients_NNS for_IN this_DT management_NN ,_, either_CC for_IN inclusion/stratification_NN in_IN clinical_JJ trials_NNS or_CC as_IN a_DT component_NN of_IN standard_NN of_IN care_NN ._.
However_RB ,_, the_DT relationship_NN between_IN single_JJ nucleotide_NN polymorphism_NN -LRB-_-LRB- SNP_NN -RRB-_-RRB- c._VBP 2518A/G_NN -_: rs1024611_NN in_IN the_DT MCP-1_NN gene_NN with_IN diabetic_JJ retinopathy_NN remains_VBZ controversial_JJ ._.
However_RB ,_, there_EX is_VBZ a_DT lack_NN of_IN clearly_RB defined_VBN measures_NNS of_IN quality_NN pain_NN management_NN to_TO identify_VB problems_NNS and_CC monitor_VB changes_NNS in_IN improvement_NN initiatives_NNS ._.
However_RB ,_, the_DT role_NN of_IN miR-373_NN in_IN the_DT characteristics_NNS of_IN cancer_NN cells_NNS is_VBZ not_RB still_RB well_RB known_VBN ._.
However_RB ,_, no_DT study_NN investigated_VBD to_TO what_WP extent_NN language_NN impairment_NN could_MD affect_VB patients_NNS '_POS behavioral_JJ responses_NNS ._.
However_RB ,_, the_DT factors_NNS that_WDT inhibit_VBP linkage_NN to_TO care_VB among_IN MSM_NNP remain_VBP unclear_JJ ._.
However_RB ,_, it_PRP is_VBZ unknown_JJ whether_IN cortical_JJ thickness_NN abnormalities_NNS reflect_VBP early_JJ adverse_JJ effects_NNS of_IN genetic_JJ and_CC environmental_JJ risk_NN factors_NNS predisposing_VBG to_TO mood_NN disorders_NNS or_CC emerge_VB at_IN illness_NN onset_NN ._.
However_RB ,_, there_EX is_VBZ a_DT paucity_NN of_IN data_NNS on_IN upper_JJ arm_NN composition_NN of_IN children_NNS from_IN African_JJ countries_NNS ,_, including_VBG Nigeria_NNP ._.
However_RB ,_, in_IN Japan_NNP ,_, there_EX have_VBP been_VBN no_DT epidemiological_JJ studies_NNS on_IN NET_NN since_IN INT_CD ;_: thus_RB ,_, the_DT prevalence_NN of_IN NET_NN remains_VBZ unknown_JJ ._.
However_RB ,_, this_DT figure_NN varied_VBD widely_RB between_IN services_NNS ,_, with_IN better_JJR outcomes_NNS associated_VBN with_IN higher_JJR ``_`` step-up_JJ ''_'' rates_NNS between_IN low_JJ and_CC high_JJ intensity_NN treatments_NNS ._.
However_RB ,_, single_JJ incision_NN laparoscopic_JJ surgery_NN -LRB-_-LRB- SILS_NN -RRB-_-RRB- requires_VBZ more_RBR compact_JJ robotic_JJ arms_NNS with_IN sufficient_JJ dexterity_NN and_CC output_NN ._.
However_RB ,_, the_DT effective_JJ rates_NNS of_IN these_DT two_CD regimens_NNS were_VBD only_RB FLOAT_CD %_NN and_CC FLOAT_CD %_NN ,_, respectively_RB ._.
However_RB ,_, a_DT systematic_JJ evaluation_NN of_IN the_DT performance_NN of_IN microRNA-21_NN as_IN a_DT diagnostic_JJ marker_NN for_IN HCC_NNP has_VBZ yet_RB to_TO be_VB conducted_VBN ._.
However_RB ,_, non-contact_JJ methods_NNS like_IN scanning_NN slit_JJ topography_NN -LRB-_-LRB- Orbscan_NN II_CD -RRB-_-RRB- ,_, slit-lamp_JJ optical_JJ coherence_NN tomography_NN -LRB-_-LRB- SL-OCT_NN -RRB-_-RRB- ,_, and_CC specular_JJ microscopy_NN are_VBP also_RB used_VBN ._.
However_RB ,_, it_PRP is_VBZ not_RB clear_JJ whether_IN the_DT deficits_NNS are_VBP related_JJ to_TO global_JJ impaired_JJ performance_NN or_CC to_TO specific_JJ decrease_NN in_IN ankle_NN motor-control_JJ ._.
However_RB ,_, individual-level_JJ dietary_JJ data_NNS which_WDT allow_VBP direct_JJ comparison_NN across_IN the_DT two_CD regions_NNS are_VBP rare_JJ ._.
However_RB ,_, little_JJ research_NN has_VBZ focused_VBN on_IN understanding_VBG the_DT organized_VBN sports_NNS implementation_NN context_NN ,_, including_VBG factors_NNS facilitating_VBG and_CC impeding_VBG implementation_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT effectiveness_NN of_IN these_DT group_NN therapies_NNS for_IN people_NNS with_IN schizophrenia_NN across_IN different_JJ treatments_NNS with_IN varying_VBG therapeutic_JJ orientations_NNS ._.
However_RB ,_, risk_NN scoring_VBG systems_NNS that_WDT solely_RB use_VBP office-based_JJ data_NNS ,_, not_RB including_VBG laboratory_NN markers_NNS ,_, may_MD be_VB advantageous_JJ ._.
However_RB ,_, its_PRP$ effect_NN on_IN the_DT cardiovascular_JJ system_NN remains_VBZ unknown_JJ ._.
However_RB ,_, this_DT method_NN has_VBZ raised_VBN safety_NN concerns_NNS due_JJ to_TO a_DT possible_JJ increased_VBN risk_NN of_IN malaria_NN or_CC other_JJ mosquito-borne_JJ diseases_NNS among_IN the_DT mosquito_NN collectors_NNS ._.
However_RB ,_, from_IN one_CD ontology_NN version_NN to_TO another_DT ,_, a_DT further_JJ understanding_NN of_IN ontology_JJ changes_NNS relevant_JJ for_IN supporting_VBG mapping_NN adaptation_NN is_VBZ typically_RB lacking_VBG ._.
However_RB ,_, the_DT results_NNS have_VBP been_VBN inconsistent_JJ ._.
However_RB ,_, emotion_NN recognition_NN -LRB-_-LRB- ER_NN -RRB-_-RRB- studies_NNS have_VBP focused_VBN mostly_RB on_IN recognition_NN of_IN the_DT six_CD `_`` basic_JJ '_'' emotions_NNS ,_, usually_RB using_VBG still_RB pictures_NNS of_IN faces_NNS ._.
However_RB ,_, CHA2DS2-VASc_JJ score_NN is_VBZ not_RB recommended_VBN in_IN the_DT INT_CD Japanese_JJ Circulation_NN Society_NN -LRB-_-LRB- JCS_NN -RRB-_-RRB- guidelines_NNS for_IN patients_NNS with_IN NVAF_NN ._.
However_RB ,_, the_DT role_NN of_IN IMP3_NN in_IN RCC_NN progression_NN was_VBD poorly_RB understood_VBN ._.
However_RB ,_, these_DT tests_NNS are_VBP relatively_RB time-consuming_JJ and_CC expensive_JJ ._.
However_RB ,_, the_DT molecular_JJ mechanisms_NNS by_IN which_WDT genistein_NN elicit_VBP its_PRP$ effects_NNS on_IN colorectal_JJ cancer_NN -LRB-_-LRB- CRC_NN -RRB-_-RRB- cells_NNS have_VBP not_RB been_VBN fully_RB elucidated_VBN ._.
However_RB ,_, the_DT results_NNS remain_VBP controversial_JJ so_RB far_RB ._.
However_RB ,_, there_EX are_VBP still_RB some_DT controversies_NNS ._.
However_RB ,_, only_RB a_DT very_RB limited_JJ number_NN of_IN chemical_NN entity_NN recognition_NN systems_NNS are_VBP publically_RB available_JJ ,_, probably_RB due_JJ to_TO the_DT lack_NN of_IN large_JJ manually_RB annotated_JJ corpora_NN ._.
However_RB ,_, it_PRP is_VBZ not_RB known_VBN whether_IN risk_NN for_IN psychiatric_JJ symptoms_NNS amongst_IN individuals_NNS with_IN ID_NN due_JJ to_TO MAGUK_NN gene_NN mutations_NNS is_VBZ higher_JJR than_IN expected_VBN for_IN the_DT degree_NN of_IN general_JJ intellectual_JJ impairment_NN ,_, nor_CC whether_IN specific_JJ cognitive_JJ differences_NNS are_VBP associated_VBN with_IN disruption_NN to_TO this_DT gene_NN functional_JJ network_NN ._.
However_RB ,_, these_DT findings_NNS come_VBP from_IN studies_NNS including_VBG active_JJ smokers_NNS ,_, while_IN results_NNS in_IN ex-smokers_NNS are_VBP scarce_JJ and_CC contradictory_JJ ._.
However_RB ,_, different_JJ results_NNS produced_VBN by_IN previous_JJ studies_NNS make_VBP the_DT role_NN of_IN a_DT common_JJ genetic_JJ variant_NN in_IN the_DT COL11A1_NN gene_NN -LRB-_-LRB- rs3753841_NN -RRB-_-RRB- remains_VBZ elusive_JJ ._.
However_RB ,_, as_IN traffic_NN noise_NN has_VBZ been_VBN associated_VBN with_IN both_CC cardiovascular_JJ disease_NN and_CC diabetes_NN ,_, and_CC health-issues_NNS including_VBG sleeping_VBG problems_NNS ,_, annoyance_NN ,_, and_CC stress_NN ,_, it_PRP seems_VBZ plausible_JJ that_IN traffic_NN noise_NN is_VBZ associated_VBN with_IN health-related_JJ quality_NN of_IN life_NN ._.
However_RB ,_, due_JJ to_TO their_PRP$ limited_JJ statistical_JJ sizes_NNS ,_, some_DT discrepancies_NNS were_VBD discovered_VBN in_IN these_DT studies_NNS ._.
However_RB ,_, the_DT risk_NN factors_NNS ,_, treatment_NN approach_NN ,_, and_CC outcomes_NNS of_IN the_DT disease_NN are_VBP not_RB clearly_RB characterized_VBN ._.
However_RB ,_, the_DT role_NN of_IN CCL2_NN on_IN Th17_NN cells_NNS and_CC Tc17_NN cells_NNS in_IN asthma_NN has_VBZ not_RB been_VBN illuminated_VBN ._.
However_RB ,_, there_EX are_VBP limited_JJ data_NNS examining_VBG the_DT clinical_JJ experience_NN of_IN patients_NNS with_IN low_JJ -LRB-_-LRB- <_JJR FLOAT_CD mmol/L_NN -RRB-_-RRB- or_CC very_RB low_JJ -LRB-_-LRB- <_JJR FLOAT_CD mmol/L_NN -RRB-_-RRB- levels_NNS of_IN LDL-C_NN ._.
However_RB ,_, there_EX is_VBZ scanty_JJ data_NNS on_IN sustained_JJ viral_JJ response_NN -LRB-_-LRB- SVR_NN -RRB-_-RRB- rate_NN with_IN conventionally_RB recommended_VBN dual_JJ therapy_NN with_IN PEG-IFN_NN and_CC ribavirin_NNP ._.
However_RB ,_, the_DT impact_NN of_IN diastolic_JJ dysfunction_NN on_IN CV_NN outcomes_NNS has_VBZ not_RB been_VBN studied_VBN in_IN incident_NN dialysis_NN patients_NNS with_IN preserved_JJ systolic_JJ function_NN ._.
However_RB ,_, in_IN the_DT ART_NN era_NN ,_, there_EX is_VBZ increasing_VBG evidence_NN for_IN the_DT involvement_NN of_IN CD8_NN +_CC T-cells_NNS in_IN CNS_NN pathogenesis_NN ._.
However_RB ,_, young-onset_JJ T2D_NN has_VBZ become_VBN increasingly_RB prevalent_JJ ._.
However_RB ,_, sometimes_RB the_DT temporal_JJ horn_NN is_VBZ difficult_JJ to_TO localize_VB ,_, especially_RB without_IN neuronavigation_NN ._.
However_RB ,_, original_JJ studies_NNS were_VBD conducted_VBN with_IN an_DT approach_NN that_WDT does_VBZ not_RB seem_VB to_TO be_VB aligned_VBN with_IN the_DT present_JJ methodologies_NNS ._.
However_RB ,_, there_EX are_VBP men_NNS with_IN normal_JJ semen_NN tests_NNS but_CC with_IN impaired_JJ fertilizing_VBG ability_NN ,_, as_RB well_RB as_IN fertile_JJ men_NNS with_IN poor_JJ sperm_NN characteristics_NNS ._.
However_RB little_JJ information_NN is_VBZ available_JJ on_IN LA_NNP changes_NNS during_IN hypertension_NN ._.
However_RB ,_, its_PRP$ role_NN in_IN low_JJ risk_NN subgroups_NNS ,_, particularly_RB non-smoking_JJ ,_, non-drinking_JJ patients_NNS and_CC patients_NNS presenting_VBG with_IN early_JJ stage_NN oral_JJ cavity_NN lesions_NNS ,_, is_VBZ debatable_JJ ._.
However_RB ,_, whether_IN a_DT specific_JJ environmental_JJ factor_NN is_VBZ important_JJ for_IN phenotypic_JJ variation_NN is_VBZ still_RB unknown_JJ ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN LAAFV_NN in_IN sinus_NN rhythm_NN -LRB-_-LRB- SR_NN -RRB-_-RRB- after_IN catheter_NN ablation_NN ._.
However_RB ,_, the_DT effects_NNS of_IN extinction_NN are_VBP often_RB transient_JJ ,_, as_IN evidenced_VBN by_IN postextinction_NN return_NN of_IN defensive_JJ behaviors_NNS ._.
However_RB ,_, no_DT studies_NNS have_VBP determined_VBN the_DT characteristics_NNS of_IN the_DT large_JJ population_NN of_IN elderly_JJ patients_NNS with_IN colorectal_JJ tumors_NNS ._.
However_RB ,_, the_DT cellular_JJ and_CC molecular_JJ changes_NNS induced_VBN by_IN such_JJ treatment_NN remain_VBP largely_RB unknown_JJ ._.
However_RB ,_, there_EX is_VBZ only_RB limited_JJ knowledge_NN of_IN pH_NN dependency_NN on_IN the_DT antibacterial_JJ efficacy_NN of_IN common_JJ antimicrobial_JJ substances_NNS ._.
However_RB ,_, few_JJ empirical_JJ data_NNS was_VBD available_JJ with_IN respect_NN to_TO the_DT different_JJ effect_NN on_IN patients_NNS '_POS outcome_NN of_IN the_DT two_CD antihypertensive_JJ strategies_NNS ._.
However_RB with_IN each_DT novel_JJ form_NN of_IN creatine_NN that_WDT emerges_VBZ ,_, its_PRP$ safety_NN must_MD be_VB verified_VBN ._.
However_RB ,_, children_NNS could_MD experience_VB stress_NN from_IN being_VBG constantly_RB moving_VBG and_CC potentially_RB exposed_VBN to_TO parental_JJ conflicts_NNS ._.
However_RB ,_, the_DT mechanisms_NNS of_IN anti-inflammatory_JJ of_IN baicalin_NN in_IN ulcerative_JJ colitis_NN is_VBZ not_RB clear_JJ ._.
However_RB ,_, staple_NN line_NN leak_NN -LRB-_-LRB- SLL_NN -RRB-_-RRB- remains_VBZ a_DT significant_JJ complication_NN of_IN this_DT procedure_NN with_IN reported_VBN incidence_NN ranging_VBG from_IN INT_CD %_NN FLOAT_CD %_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT effect_NN of_IN NRG1_NN on_IN schizophrenia-relevant_JJ behavior_NN and_CC neurotransmission_NN -LRB-_-LRB- particularly_RB GABAergic_JJ and_CC glutamatergic_JJ -RRB-_-RRB- in_IN adult_JJ animals_NNS ._.
However_RB ,_, estimating_VBG chronological_JJ age_NN by_IN means_NNS of_IN the_DT dental_JJ mineralization_NN stage_NN is_VBZ not_RB a_DT straightforward_JJ analysis_NN ,_, and_CC it_PRP is_VBZ fundamental_JJ to_TO test_VB the_DT validity_NN of_IN these_DT methods_NNS and_CC their_PRP$ applicability_NN to_TO populations_NNS ._.
However_RB ,_, little_JJ is_VBZ known_VBN regarding_VBG the_DT effects_NNS of_IN mobile_JJ application-mediated_JJ training_NN on_IN nursing_NN ._.
However_RB ,_, these_DT studies_NNS have_VBP all_DT been_VBN based_VBN on_IN maternal_JJ report_NN of_IN sleeping_VBG position_NN ._.
However_RB ,_, data_NNS about_IN the_DT magnitude_NN of_IN the_DT problem_NN are_VBP rare_JJ and_CC in_IN some_DT countries_NNS such_JJ as_IN Haiti_NNP completely_RB lacking_VBG ._.
However_RB ,_, the_DT role_NN of_IN EMT_NN phenotype_NN in_IN malignant_JJ pleural_JJ effusions_NNS in_IN predicting_VBG prognosis_NN is_VBZ unknown_JJ in_IN lung_NN adenocarcinoma_NN patients_NNS ._.
However_RB ,_, nearly_RB half_NN of_IN patients_NNS with_IN DLB_NNP remain_VBP undiagnosed_JJ thus_RB depriving_VBG many_JJ of_IN them_PRP from_IN an_DT early_JJ and_CC adequate_JJ treatment_NN of_IN their_PRP$ distressing_JJ symptoms_NNS ._.
However_RB ,_, the_DT benefit_NN of_IN mobile-bearing_JJ total_JJ knee_NN arthroplasty_NN remains_VBZ unproven_JJ ._.
However_RB ,_, few_JJ studies_NNS have_VBP aimed_VBN to_TO verify_VB whether_IN there_EX is_VBZ a_DT significant_JJ relationship_NN between_IN forefoot_NN alignment_NN and_CC subtalar_JJ hyperpronation_NN ._.
However_RB ,_, due_JJ to_TO a_DT number_NN of_IN factors_NNS ,_, such_JJ as_IN ,_, the_DT majority_NN of_IN those_DT infected_VBN are_VBP from_IN low-income_JJ backgrounds_NNS and_CC the_DT limitation_NN in_IN experimental_JJ models_NNS for_IN studying_VBG human_JJ S._NNP stercoralis_NNS ,_, strongyloidiasis_NN remains_VBZ neglected_VBN ._.
However_RB ,_, placement_NN of_IN some_DT disorders_NNS is_VBZ uncertain_JJ ._.
However_RB ,_, research_NN into_IN health_NN care_NN handoffs_NNS lacks_VBZ a_DT unifying_JJ foundational_JJ structure_NN ._.
However_RB ,_, the_DT results_NNS remained_VBD controversial_JJ ._.
However_RB ,_, there_EX are_VBP little_JJ available_JJ data_NNS about_IN peritonitis_NN related_JJ to_TO this_DT method_NN ._.
However_RB ,_, the_DT complex_JJ interactions_NNS among_IN prognostic_JJ factors_NNS may_MD lead_VB to_TO a_DT poor_JJ estimate_NN of_IN behaviour_NN ,_, causing_VBG unbalanced_JJ groups_NNS at_IN baseline_NN ,_, which_WDT may_MD introduce_VB accidental_JJ bias_NN ._.
However_RB ,_, the_DT proportion_NN of_IN neonatal_JJ deaths_NNS continues_VBZ to_TO rise_VB and_CC recent_JJ studies_NNS reported_VBD low_JJ coverage_NN of_IN the_DT essential_JJ interventions_NNS saving_VBG newborn_JJ lives_NNS ._.
However_RB ,_, the_DT association_NN between_IN indoor_JJ stove/fireplace_NN use_NN and_CC breast_NN cancer_NN risk_NN is_VBZ unknown_JJ ._.
However_RB ,_, relatively_RB few_JJ studies_NNS have_VBP examined_VBN the_DT relationship_NN between_IN the_DT social_JJ connectedness_NN of_IN people_NNS with_IN intellectual_JJ disabilities_NNS and_CC their_PRP$ health_NN ._.
However_RB ,_, concerns_NNS over_IN added_VBN expenditure_NN may_MD limit_VB its_PRP$ widespread_JJ implementation_NN ._.
However_RB ,_, nothing_NN is_VBZ known_VBN regarding_VBG the_DT association_NN of_IN PDM_NN with_IN possible_JJ brain_NN anomalies_NNS or_CC abnormalities_NNS ._.
However_RB concerns_NNS remain_VBP that_IN the_DT use_NN of_IN traditional_JJ treatments_NNS for_IN HIV-related_JJ disease_NN may_MD lead_VB to_TO pharmacokinetic_JJ interactions_NNS between_IN herbal_JJ remedies_NNS and_CC ART_NN drugs_NNS and_CC delay_NN ART_NN initiation_NN ._.
However_RB ,_, detailed_JJ signaling_NN of_IN mesangial_JJ CXCL1_NN expression_NN induced_VBN by_IN viral_JJ or_CC ``_`` pseudoviral_JJ ''_'' immunity_NN remains_VBZ to_TO be_VB determined_VBN ._.
However_RB ,_, its_PRP$ evidence_NN base_NN for_IN adolescents_NNS is_VBZ scarce_JJ ._.
However_RB ,_, to_TO define_VB the_DT suitability_NN of_IN legumain_NN for_IN such_JJ purposes_NNS ,_, detailed_JJ knowledge_NN of_IN cell_NN type-specific_JJ and_CC subcellular_JJ expression_NN together_RB with_IN proteolytic_JJ activity_NN patterns_NNS in_IN tumour_NN tissue_NN is_VBZ necessary_JJ ._.
However_RB ,_, tumor_NN modification_NN for_IN luciferase_NN has_VBZ the_DT potential_NN for_IN evoking_VBG host_NN immune_JJ response_NN against_IN otherwise_RB syngeneic_JJ tumor_NN cells_NNS ,_, thereby_RB mitigating_VBG the_DT tumor_NN cells_NNS '_POS value_NN for_IN tumor_NN immunology_NN and_CC immunotherapy_NN studies_NNS ._.
However_RB ,_, the_DT underlying_VBG pathophysiological_JJ mechanisms_NNS are_VBP poorly_RB understood_VBN ._.
However_RB ,_, most_RBS studies_NNS were_VBD population-based_JJ studies_NNS ,_, with_IN single_JJ cortisol_NN measurements_NNS ,_, lacking_VBG insight_NN into_IN diurnal_JJ patterns_NNS of_IN HPA-axis_JJ functioning_NN ._.
However_RB ,_, clinical_JJ experience_NN with_IN this_DT condition_NN is_VBZ still_RB insufficient_JJ ._.
However_RB ,_, actual_JJ costs_NNS of_IN treatment_NN have_VBP never_RB been_VBN studied_VBN ._.
However_RB ,_, currently_RB none_NN of_IN P-gp_NN inhibitors_NNS has_VBZ been_VBN approved_VBN by_IN Food_NNP and_CC Drug_NNP Administration_NNP not_RB only_RB due_JJ to_TO toxicity_NN but_CC also_RB lack_NN of_IN efficacy_NN in_IN clinical_JJ trials_NNS ._.
However_RB ,_, whether_IN human_JJ dental_JJ pulp_NN cells_NNS -LRB-_-LRB- DPCs_NNS -RRB-_-RRB- could_MD be_VB reprogrammed_VBN into_IN iPSCs_NN remains_VBZ an_DT open_JJ question_NN ._.
However_RB ,_, literature_NN evidence_NN for_IN stimulant_NN treatment_NN is_VBZ minimal_JJ ._.
However_RB ,_, few_JJ studies_NNS have_VBP evaluated_VBN the_DT role_NN of_IN adjunct_NN exercise_NN in_IN the_DT treatment_NN of_IN severely_RB major_JJ depressed_JJ inpatients_NNS ._.
However_RB ,_, the_DT majority_NN of_IN cancer_NN care_NN takes_VBZ place_NN in_IN the_DT community_NN hospital_NN ._.
However_RB ,_, a_DT recent_JJ study_NN using_VBG the_DT US_NNP SEER_NN database_NN showed_VBD that_IN the_DT proportion_NN of_IN ER-negative_JJ BC_NN is_VBZ comparable_JJ between_IN US-born_JJ blacks_NNS and_CC West-African_JJ born_VBN blacks_NNS but_CC substantially_RB lower_JJR in_IN East_NNP African-born_JJ blacks_NNS ,_, with_IN over_IN INT_CD %_NN of_IN patients_NNS Ethiopians_NNPS or_CC Eritreans_NNPS ._.
However_RB ,_, although_IN deleterious_JJ consequences_NNS of_IN anger_NN on_IN physical_JJ health_NN have_VBP been_VBN well_RB reported_VBN ,_, there_EX are_VBP no_DT studies_NNS that_WDT have_VBP analysed_VBN the_DT effects_NNS of_IN anger_NN on_IN the_DT HRQoL_NN in_IN patients_NNS with_IN MS._NNP Our_PRP$ purpose_NN was_VBD to_TO assess_VB the_DT extent_NN to_TO which_WDT anger_NN impacts_NNS on_IN the_DT HRQoL_NN of_IN a_DT cohort_NN of_IN MS_NN patients_NNS ._.
However_RB ,_, it_PRP is_VBZ unclear_JJ which_WDT approach_NN for_IN assessing_VBG diabetes_NN risk_NN in_IN pharmacies_NNS is_VBZ best_JJS ._.
However_RB ,_, there_EX has_VBZ been_VBN very_RB limited_JJ coverage_NN of_IN interpretation_NN of_IN the_DT personal_JJ genome_NN sequencing_NN data_NNS in_IN terms_NNS of_IN diseases_NNS ._.
However_RB ,_, it_PRP has_VBZ been_VBN suggested_VBN that_IN the_DT inclusion_NN of_IN human_JJ papillomavirus_NN -LRB-_-LRB- HPV_NN -RRB-_-RRB- vaccination_NN for_IN young_JJ adolescent_JJ women_NNS may_MD be_VB the_DT best_JJS prospect_NN to_TO further_RBR reduce_VB the_DT burden_NN of_IN cervical_JJ cancer_NN ._.
However_RB ,_, rapid_JJ molecular_JJ diagnostic_JJ tests_NNS -LRB-_-LRB- RmDT_NN -RRB-_-RRB- are_VBP becoming_VBG increasingly_RB important_JJ and_CC will_MD ,_, most_RBS likely_RB ,_, be_VB the_DT diagnostic_JJ techniques_NNS of_IN choice_NN in_IN the_DT next_JJ years_NNS ._.
However_RB ,_, there_EX are_VBP some_DT conflicting_JJ conclusions_NNS ._.
However_RB ,_, in_IN some_DT malaria-endemic_JJ areas_NNS ,_, such_JJ as_IN Southeast_NNP Asia_NNP and_CC South_NNP America_NNP ,_, malaria_NN vectors_NNS primarily_RB bite_VBP outdoors_RB meaning_VBG that_IN LLINs_NNS and_CC IRS_NNP may_MD be_VB less_RBR effective_JJ ._.
However_RB ,_, a_DT negative_JJ sacral_JJ slope_NN can_MD be_VB found_VBN in_IN some_DT patients_NNS with_IN ankylosing_VBG spondylitis_NNS with_IN thoracolumbar_JJ kyphosis_NN ._.
However_RB ,_, it_PRP is_VBZ not_RB clear_JJ whether_IN this_DT is_VBZ the_DT case_NN in_IN male_JJ patients_NNS ,_, too_RB ._.
However_RB ,_, few_JJ modeling_NN studies_NNS have_VBP taken_VBN into_IN account_NN China_NNP 's_POS context_NN ._.
However_RB ,_, whether_IN asthma_NN occurrence_NN rates_NNS were_VBD higher_JJR in_IN late_JJ ages_NNS than_IN in_IN younger_JJR ages_NNS was_VBD inconclusive_JJ ._.
However_RB ,_, the_DT FAM_NN does_VBZ not_RB take_VB into_IN account_NN broader_JJR aspects_NNS of_IN adolescence_NN ,_, such_JJ as_IN social_JJ functioning_NN ,_, which_WDT could_MD be_VB negatively_RB impacted_VBN by_IN anxiety_NN ._.
However_RB ,_, research_NN has_VBZ shown_VBN contradictory_JJ results_NNS regarding_VBG the_DT suitability_NN of_IN pharmacological_JJ treatment_NN for_IN certain_JJ groups_NNS of_IN schizophrenia_NN patients_NNS ._.
However_RB ,_, there_EX is_VBZ still_RB considerable_JJ uncertainty_NN about_IN the_DT optimal_JJ radiation_NN treatment_NN ._.
However_RB ,_, the_DT symbolic_JJ models_NNS used_VBN in_IN CSSMs_NNS potentially_RB suffer_VBP from_IN combinatorial_JJ explosion_NN ,_, rendering_VBG inference_NN intractable_JJ outside_NN of_IN the_DT limited_JJ experimental_JJ settings_NNS investigated_VBN in_IN present_JJ research_NN ._.
However_RB ,_, anti-EGFR_JJ therapies_NNS have_VBP not_RB been_VBN effective_JJ in_IN these_DT patients_NNS ._.
However_RB ,_, the_DT tumor_NN promoting_VBG activity_NN of_IN AGR2_NN has_VBZ not_RB yet_RB been_VBN determined_VBN in_IN biliary_JJ tract_NN cancers_NNS ._.
However_RB ,_, little_JJ is_VBZ known_VBN regarding_VBG the_DT role_NN of_IN this_DT pathway_NN in_IN human_JJ islet_NN cells_NNS ._.
However_RB ,_, there_EX is_VBZ no_DT consensus_NN on_IN the_DT optimal_JJ methods_NNS to_TO be_VB used_VBN ._.
However_RB ,_, IT-IEM_NN still_RB require_VBP intense_JJ patient_NN and_CC caregiver_NN effort_NN in_IN terms_NNS of_IN strict_JJ dietetic_JJ and_CC pharmacological_JJ treatment_NN ,_, and_CC the_DT threat_NN of_IN metabolic_JJ crises_NNS is_VBZ always_RB present_JJ ._.
However_RB ,_, information_NN on_IN health_NN utility_NN weights_NNS -LRB-_-LRB- HUWs_NNS -RRB-_-RRB- for_IN pre-diabetic_JJ states_NNS and_CC T2D_NN are_VBP essential_JJ to_TO estimate_VB the_DT effect_NN of_IN prevention_NN initiatives_NNS ._.
However_RB ,_, there_EX has_VBZ been_VBN relatively_RB little_JJ research_NN focused_VBD on_IN this_DT topic_NN ._.
However_RB ,_, their_PRP$ role_NN in_IN chronic_JJ pain_NN states_NNS remains_VBZ unknown_JJ ._.
However_RB ,_, its_PRP$ potential_JJ utility_NN as_IN an_DT aid_NN to_TO disease_NN surveillance_NN and_CC to_TO identify_VB patients_NNS likely_JJ to_TO benefit_VB from_IN HGF/Met-targeted_JJ therapies_NNS provide_VBP the_DT rationale_NN for_IN this_DT preliminary_JJ retrospective_JJ study_NN comparing_VBG sMet_NN levels_NNS between_IN benign_JJ conditions_NNS and_CC primary_JJ BCa_NN ,_, and_CC in_IN BCa_NN cases_NNS ,_, between_IN different_JJ disease_NN stages_NNS ._.
However_RB ,_, many_JJ medical_JJ students_NNS interact_VBP poorly_RB with_IN nurses_NNS during_IN clinical_JJ clerkships_NNS ,_, and_CC less_JJR is_VBZ known_VBN about_IN their_PRP$ relationships_NNS with_IN other_JJ healthcare_NN professionals_NNS -LRB-_-LRB- HCPs_NNS -RRB-_-RRB- ._.
However_RB ,_, morphological_JJ identification_NN is_VBZ challenging_VBG when_WRB the_DT expertise_NN is_VBZ limited_JJ and_CC external_JJ characters_NNS are_VBP damaged_VBN because_IN of_IN improper_JJ specimen_NN handling_NN ._.
However_RB ,_, most_RBS self-management_JJ support_NN -LRB-_-LRB- SMS_NN -RRB-_-RRB- evaluations_NNS still_RB focus_VB on_IN particular_JJ elements_NNS or_CC outcomes_NNS of_IN a_DT sub-system_NN ._.
However_RB the_DT mechanisms_NNS of_IN such_JJ dysfunctions_NNS are_VBP as_RB yet_RB poorly_RB explained_VBN ._.
However_RB ,_, the_DT relationship_NN between_IN LINE-1_NN hypomethylation_NN and_CC clinical_JJ outcome_NN in_IN hepatocellular_JJ carcinoma_NN -LRB-_-LRB- HCC_NN -RRB-_-RRB- remains_VBZ unclear_JJ ._.
However_RB ,_, previous_JJ studies_NNS of_IN chronic_JJ HCV_NN and_CC circulating_VBG T-cell_NN subsets_NNS -LRB-_-LRB- activation_NN and_CC differentiation_NN phenotypes_NNS -RRB-_-RRB- in_IN HIV_NN negatives_NNS used_VBN general_JJ population_NN controls_NNS ,_, rather_RB than_IN a_DT risk-appropriate_JJ comparison_NN group_NN ._.
However_RB ,_, the_DT biochemical_JJ basis_NN of_IN abnormal_JJ connectivity_NN remains_VBZ undefined_JJ ._.
However_RB ,_, as_IN in_IN free_JJ tissue_NN transfer_NN ,_, postoperative_JJ revisions_NNS are_VBP necessary_JJ to_TO achieve_VB optimal_JJ functional_JJ and_CC aesthetic_JJ results_NNS ._.
However_RB ,_, no_DT conclusive_JJ data_NNS have_VBP been_VBN published_VBN regarding_VBG the_DT incidence_NN of_IN ,_, and_CC possible_JJ risk_NN factors_NNS for_IN ,_, this_DT complication_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT difference_NN in_IN anesthesia-controlled_JJ time_NN between_IN propofol-based_JJ total_JJ IV_CD anesthesia_NN -LRB-_-LRB- TIVA_NN -RRB-_-RRB- and_CC desflurane_NN anesthesia_NN -LRB-_-LRB- DES_NN -RRB-_-RRB- techniques_NNS for_IN ophthalmic_JJ surgery_NN under_IN general_JJ anesthesia_NN ._.
However_RB ,_, the_DT results_NNS remain_VBP inconclusive_JJ ._.
However_RB ,_, the_DT response_NN to_TO adalimumab_JJ dose_NN escalation_NN and_CC long-term_JJ outcomes_NNS after_IN escalation_NN have_VBP not_RB been_VBN well_RB evaluated_VBN ._.
However_RB ,_, few_JJ studies_NNS have_VBP focused_VBN on_IN the_DT clinical_JJ factors_NNS predicting_VBG the_DT major_JJ postoperative_JJ complications_NNS ._.
However_RB ,_, our_PRP$ observations_NNS highlighted_VBD case_NN of_IN a_DT patient_NN incurring_VBG severe_JJ adverse_JJ reactions_NNS due_JJ to_TO application_NN of_IN the_DT cream_NN ,_, although_IN the_DT treatment_NN proved_VBD successful_JJ in_IN curing_VBG recalcitrant_JJ warts_NNS which_WDT had_VBD developed_VBN on_IN the_DT external_JJ auditory_JJ canal_NN and_CC external_JJ ear_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN what_WP drives_NNS variation_NN in_IN hospital_NN VTE_NN imaging_NN rates_NNS ._.
However_RB ,_, self-stigma_NN has_VBZ not_RB yet_RB been_VBN investigated_VBN in_IN patients_NNS with_IN type_NN INT_CD diabetes_NN ._.
However_RB ,_, this_DT diagnostic_JJ strategy_NN is_VBZ slow_JJ and_CC yields_NNS few_JJ tuberculosis_NN diagnoses_NNS ._.
However_RB ,_, nasal_JJ side_JJ effects_NNS are_VBP rarely_RB described_VBN ._.
However_RB ,_, there_EX is_VBZ a_DT lack_NN of_IN literature_NN on_IN the_DT feasibility_NN of_IN HHD_NN in_IN older_JJR patients_NNS with_IN end-stage_JJ renal_JJ disease_NN -LRB-_-LRB- ESRD_NN -RRB-_-RRB- ._.
However_RB ,_, the_DT underlying_VBG mechanism_NN -LRB-_-LRB- s_NNS -RRB-_-RRB- and_CC targeted_VBN intervention_NN -LRB-_-LRB- s_NNS -RRB-_-RRB- remain_VBP largely_RB to_TO be_VB determined_VBN ._.
However_RB ,_, the_DT relationship_NN between_IN processing_NN speed_NN impairment_NN and_CC white_JJ matter_NN -LRB-_-LRB- WM_NN -RRB-_-RRB- integrity_NN in_IN schizophrenia_NN is_VBZ unclear_JJ ._.
However_RB ,_, obtaining_VBG adequate_JJ training_NN during_IN and_CC postfellowship_NN can_MD be_VB difficult_JJ ._.
However_RB ,_, no_DT measures_NNS of_IN person-centered_JJ care_NN in_IN this_DT context_NN exist_VBP ._.
However_RB ,_, few_JJ reports_NNS are_VBP available_JJ on_IN the_DT clinical_JJ implications_NNS of_IN this_DT comorbidity_NN ._.
However_RB ,_, it_PRP remains_VBZ unclear_JJ what_WP physiological_JJ and_CC molecular_JJ mechanisms_NNS this_DT treatment_NN induces_VBZ inside_IN cells_NNS ._.
However_RB ,_, the_DT disease_NN is_VBZ refractory_JJ to_TO steroids_NNS in_IN about_RB INT_CD %_NN FLOAT_CD %_NN of_IN patients_NNS ,_, for_IN whom_WP currently_RB there_EX is_VBZ no_DT standardized_JJ treatment_NN ._.
However_RB ,_, the_DT malignant_JJ features_NNS of_IN anaplastic_JJ gliomas_NNS without_IN IDH_NN mutation_NN are_VBP not_RB well_RB understood_VBN ._.
However_RB ,_, the_DT underlying_VBG mechanism_NN of_IN the_DT relationship_NN between_IN asthma_NN and_CC depression_NN is_VBZ still_RB unclear_JJ ._.
However_RB ,_, the_DT bioactive_JJ fractions_NNS and_CC the_DT pharmacological_JJ mechanism_NN of_IN analgesic_JJ activity_NN are_VBP not_RB clearly_RB known_VBN ._.
However_RB ,_, the_DT role_NN of_IN Ang_NNP -LRB-_-LRB- FLOAT_CD -RRB-_-RRB- in_IN spinal_JJ nociceptive_JJ transmission_NN remains_VBZ unclear_JJ ._.
However_RB ,_, the_DT SBP_NNP target_NN provides_VBZ no_DT suggested_VBD lower_JJR limit_NN ,_, and_CC some_DT studies_NNS indicate_VBP that_IN a_DT lower_JJR SBP_NN target_NN may_MD be_VB harmful_JJ ._.
However_RB ,_, no_DT systematic_JJ research_NN on_IN the_DT detection_NN of_IN levamisole_NN in_IN hair_NN samples_NNS has_VBZ been_VBN published_VBN ._.
However_RB ,_, reports_NNS on_IN diagnostic_JJ accuracy_NN have_VBP been_VBN limited_VBN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN their_PRP$ relationship_NN among_IN mothers_NNS of_IN young_JJ children_NNS with_IN disabilities_NNS in_IN the_DT Chinese_JJ context_NN ._.
However_RB ,_, little_JJ is_VBZ currently_RB known_VBN about_IN the_DT role_NN of_IN ARID3A_NN in_IN colorectal_JJ cancer_NN -LRB-_-LRB- CRC_NN -RRB-_-RRB- ._.
However_RB ,_, knowledge_NN on_IN expression_NN and_CC function_NN of_IN sex_NN hormone_NN receptors_NNS in_IN juvenile_JJ angiofibromas_NNS is_VBZ still_RB sparse_JJ and_CC inconsistent_JJ ._.
However_RB ,_, there_EX have_VBP been_VBN few_JJ studies_NNS comparing_VBG the_DT quality_NN or_CC efficacy_NN of_IN granules_NNS with_IN those_DT of_IN herbal_JJ formulations_NNS ._.
However_RB ,_, when_WRB LC_NN is_VBZ followed_VBN by_IN hemorrhagic_JJ shock_NN -LRB-_-LRB- HS_NN -RRB-_-RRB- ,_, healing_NN is_VBZ impaired_JJ ._.
However_RB ,_, the_DT efficacy_NN and_CC safety_NN of_IN using_VBG the_DT retroflexed_JJ view_NN for_IN colorectal_JJ endoscopic_JJ submucosal_JJ dissection_NN -LRB-_-LRB- ESD_NN -RRB-_-RRB- are_VBP poorly_RB understood_VBN ._.
However_RB ,_, the_DT functional_JJ role_NN of_IN MMPs_NNS in_IN muscle_NN hypertrophy_NN remains_VBZ largely_RB unknown_JJ ._.
However_RB ,_, damage_NN to_TO normal_JJ tissues_NNS and_CC radioresistance_NN of_IN tumor_NN cells_NNS are_VBP major_JJ obstacles_NNS to_TO successful_JJ radiotherapy_NN ._.
However_RB ,_, no_DT study_NN has_VBZ directly_RB evaluated_VBN the_DT change_NN in_IN lordosis_NN during_IN active_JJ PLKF_NN test_NN in_IN subjects_NNS with_IN low_JJ back_RB pain_NN -LRB-_-LRB- LBP_NN -RRB-_-RRB- ._.
However_RB ,_, the_DT direct_JJ anti-HCC_JJ effects_NNS of_IN metformin_NN have_VBP hardly_RB been_VBN studied_VBN in_IN patients_NNS ,_, but_CC have_VBP been_VBN extensively_RB investigated_VBN in_IN animal_NN models_NNS of_IN HCC_NNP ._.
However_RB ,_, the_DT findings_NNS are_VBP varied_JJ or_CC even_RB contradictory_JJ ._.
However_RB ,_, due_JJ to_TO endemicity_NN of_IN polio_NNP in_IN neighboring_VBG countries_NNS of_IN Iran_NNP ,_, the_DT risk_NN of_IN polio_NNP importation_NN and_CC re-emergence_NN of_IN wild_JJ polio_NNP virus_NN is_VBZ high_JJ ._.
However_RB ,_, the_DT active_JJ ingredients_NNS of_IN the_DT herb_NN and_CC the_DT underlying_JJ mechanisms_NNS are_VBP poorly_RB understood_VBN ._.
However_RB ,_, given_VBN that_IN ILI_NN attack_NN rates_NNS vary_VBP significantly_RB across_IN ages_NNS ,_, in_IN terms_NNS of_IN both_DT magnitude_NN and_CC timing_NN ,_, little_JJ is_VBZ known_VBN about_IN whether_IN the_DT association_NN between_IN ILI_NN morbidity_NN and_CC ILI-related_JJ queries_NNS is_VBZ comparable_JJ across_IN different_JJ age-groups_NNS ._.
However_RB ,_, there_EX are_VBP few_JJ data_NNS on_IN the_DT prevalence_NN of_IN ,_, or_CC risk_NN factors_NNS for_IN ,_, dyslipidaemia_NN in_IN Africa_NNP ._.
However_RB ,_, their_PRP$ neurobiological_JJ basis_NN is_VBZ poorly_RB understood_VBN ._.
However_RB ,_, in_IN India_NNP ,_, data_NNS on_IN their_PRP$ rates_NNS stratified_VBN by_IN surgical_JJ procedure_NN are_VBP not_RB available_JJ ._.
However_RB ,_, the_DT identification_NN of_IN patients_NNS with_IN SBHF_NN is_VBZ difficult_JJ ._.
However_RB ,_, sustainability_NN of_IN these_DT changes_NNS over_IN time_NN remains_VBZ debated_VBN ._.
However_RB ,_, the_DT biologically_RB inactive_JJ counterpart_NN of_IN BNP_NNP ,_, NT-proBNP_NN ,_, was_VBD found_VBN to_TO be_VB a_DT more_RBR stable_JJ and_CC accurate_JJ analyte_NN ._.
However_RB ,_, some_DT studies_NNS have_VBP reported_VBN the_DT ``_`` obesity_NN paradox_NN ''_'' after_IN percutaneous_JJ coronary_JJ intervention_NN -LRB-_-LRB- PCI_NN -RRB-_-RRB- ._.
However_RB ,_, drug_NN resistance_NN occurs_VBZ in_IN a_DT significant_JJ proportion_NN of_IN patients_NNS due_JJ to_TO EGFR_NN mutations_NNS ._.
However_RB ,_, the_DT association_NN between_IN IFN-γ_NN polymorphisms_NNS and_CC HBV-related_JJ liver_NN cirrhosis_NN -LRB-_-LRB- HBV-LC_NN -RRB-_-RRB- risk_NN is_VBZ still_RB unclear_JJ ._.
However_RB ,_, few_JJ have_VBP been_VBN studied_VBN in_IN an_DT intensive_JJ care_NN unit_NN setting_NN ._.
However_RB ,_, the_DT neural_JJ substrates_NNS of_IN response_NN inhibition_NN to_TO sad_JJ faces_NNS across_IN explicit_JJ and_CC implicit_JJ tasks_NNS in_IN general_JJ anxiety_NN disorder_NN -LRB-_-LRB- GAD_NN -RRB-_-RRB- patients_NNS remain_VBP unclear_JJ ._.
However_RB ,_, their_PRP$ reciprocal_JJ relationships_NNS have_VBP not_RB been_VBN systematically_RB reviewed_VBN so_RB far_RB ._.
However_RB ,_, there_EX are_VBP restricted_JJ data_NNS in_IN the_DT literature_NN that_WDT compare_VBP the_DT serum_NN BDNF_NN levels_NNS in_IN patients_NNS with_IN deficit_NN and_CC nondeficit_JJ syndromes_NNS ._.
However_RB ,_, such_JJ expectations_NNS were_VBD never_RB realized_VBN ._.
However_RB ,_, whether_IN quantitative_JJ lung_NN computed_VBD tomography_NN -LRB-_-LRB- CT_NN -RRB-_-RRB- can_MD be_VB useful_JJ in_IN predicting_VBG the_DT outcome_NN of_IN PQ_NN poisoning_NN remains_VBZ unknown_JJ ._.
However_RB ,_, there_EX is_VBZ concern_NN that_IN medical_JJ care_NN provided_VBN at_IN home_NN may_MD negatively_RB affect_VB survival_NN ._.
However_RB ,_, it_PRP is_VBZ obvious_JJ that_IN the_DT NCDs_NNS are_VBP recently_RB taking_VBG over_RP and_CC becoming_VBG the_DT major_JJ health_NN care_NN concerns_NNS in_IN the_DT developing_VBG countries_NNS ._.
However_RB ,_, the_DT role_NN of_IN early_JJ intravenous_JJ initiation_NN of_IN ketogenic_JJ diet_NN in_IN the_DT acute_JJ phase_NN of_IN super-refractory_JJ status_NN epilepticus_NN is_VBZ not_RB well-described_JJ ._.
However_RB ,_, the_DT effect_NN of_IN fish_NN oil_NN and_CC spirulina_NN on_IN hypercholesterolemia_NN has_VBZ not_RB been_VBN studied_VBN ._.
However_RB ,_, there_EX is_VBZ substantial_JJ lung_NN disease_NN heterogeneity_NN within_IN and_CC between_IN patients_NNS that_IN likely_JJ impacts_NNS deposition_NN patterns_NNS of_IN inhaled_VBN antibiotics_NNS ._.
However_RB ,_, its_PRP$ use_NN is_VBZ associated_VBN with_IN toxicity_NN to_TO normal_JJ cells_NNS and_CC development_NN of_IN resistance_NN due_JJ to_TO overexpression_NN of_IN drug_NN efflux_NN pumps_NNS ._.
However_RB ,_, low_JJ survival_NN rate_NN of_IN five_CD years_NNS after_IN clinical_JJ treatments_NNS mainly_RB due_JJ to_TO recurrence_NN of_IN stress-resistant_JJ cancer_NN cells_NNS calls_VBZ for_IN better_JJR understanding_NN and_CC new_JJ ideas_NNS ._.
However_RB ,_, in_IN hand_NN surgery_NN ,_, 3D_NN photography_NN is_VBZ not_RB yet_RB being_VBG used_VBN in_IN clinical_JJ settings_NNS ._.
However_RB ,_, the_DT role_NN of_IN NPM1_NN in_IN endometrial_JJ carcinogenesis_NN remains_VBZ to_TO be_VB elucidated_VBN ._.
However_RB ,_, few_JJ studies_NNS have_VBP examined_VBN the_DT relationship_NN between_IN OPN_NN expression_NN and_CC gastric_JJ precancerous_JJ diseases_NNS ,_, and_CC the_DT potential_JJ role_NN of_IN OPN_NNP in_IN the_DT formation_NN and_CC development_NN of_IN GC_NN ._.
However_RB ,_, isopropanol_NN may_MD reduce_VB precipitate_NN formation_NN ._.
However_RB ,_, its_PRP$ role_NN in_IN gastric_JJ cancer_NN -LRB-_-LRB- GC_NN -RRB-_-RRB- remains_VBZ unclear_JJ ._.
However_RB ,_, it_PRP is_VBZ unclear_JJ to_TO what_WP extent_NN different_JJ commuting_VBG behaviors_NNS are_VBP a_DT source_NN of_IN air_NN pollution_NN compared_VBN to_TO non-commuters_NNS ,_, and_CC if_IN air_NN pollution_NN exposure_NN actually_RB differs_VBZ by_IN the_DT mode_NN of_IN commuting_VBG ._.
However_RB ,_, extended_VBD surgery_NN accompanying_VBG bony_JJ pelvic_JJ resection_NN is_VBZ technically_RB demanding_VBG and_CC is_VBZ still_RB challenging_JJ ._.
However_RB ,_, the_DT results_NNS of_IN previous_JJ studies_NNS are_VBP inconsistent_JJ ._.
However_RB ,_, its_PRP$ role_NN in_IN epithelial_JJ ovarian_JJ carcinoma_NN -LRB-_-LRB- EOC_NN -RRB-_-RRB- remains_VBZ unknown_JJ ._.
However_RB ,_, it_PRP is_VBZ unclear_JJ whether_IN children_NNS like_IN non-nutritively_JJ sweetened_VBN beverages_NNS as_RB much_RB as_IN sugar-sweetened_JJ beverages_NNS ._.
However_RB ,_, the_DT clinical_JJ significance_NN of_IN dual_JJ high_JJ expression_NN of_IN these_DT two_CD proteins_NNS in_IN esophageal_JJ squamous_JJ cell_NN carcinoma_NN -LRB-_-LRB- ESCC_NN -RRB-_-RRB- has_VBZ yet_RB to_TO be_VB determined_VBN ._.
However_RB ,_, high_JJ annual_JJ rate_NN of_IN discontinuation_NN for_IN loss_NN of_IN response_NN or_CC intolerance_NN may_MD lead_VB to_TO a_DT switch_NN to_TO another_DT anti-tumor_JJ necrosis_NN factor_NN agent_NN ._.
However_RB ,_, they_PRP require_VBP validation_NN before_IN they_PRP can_MD be_VB used_VBN with_IN confidence_NN ,_, ideally_RB using_VBG independently_RB collected_VBN data_NNS from_IN a_DT different_JJ source_NN to_TO that_DT used_VBN to_TO develop_VB the_DT model_NN ._.
However_RB ,_, their_PRP$ associations_NNS with_IN susceptibility_NN to_TO HIV_NN and_CC its_PRP$ co-infections_NNS among_IN intravenous_JJ drug_NN users_NNS -LRB-_-LRB- IDUs_NNS -RRB-_-RRB- are_VBP largely_RB unknown_JJ ._.
However_RB ,_, the_DT genome-wide_JJ gene_NN networks_NNS and_CC associated_VBN biological_JJ processes_NNS regulated_VBN by_IN FoxO_NN during_IN cancer_NN cachexia_NN are_VBP unknown_JJ ._.
However_RB ,_, there_EX is_VBZ a_DT paucity_NN of_IN evidence-based_JJ guidelines_NNS to_TO direct_VB management_NN ._.
However_RB ,_, as_IN many_JJ factors_NNS influence_VBP the_DT SRB_NNP ,_, this_DT hypothesis_NN is_VBZ difficult_JJ to_TO test_VB empirically_RB ._.
However_RB ,_, another_DT explanation_NN might_MD be_VB that_IN the_DT low_JJ SRB_NN in_IN INT_CD stems_VBZ from_IN increased_VBN random_JJ variation_NN in_IN the_DT East_JJ German_JJ SRB_NN due_JJ to_TO a_DT drastically_RB reduced_VBN number_NN of_IN births_NNS during_IN the_DT crisis_NN ._.
However_RB ,_, the_DT potential_NN for_IN microbial_JJ shedding_VBG in_IN patients_NNS with_IN MDRO-positive_JJ microbiological_JJ reports_NNS from_IN their_PRP$ respiratory_JJ tract_NN and_CC factors_NNS justifying_VBG the_DT need_NN for_IN single_JJ room_NN isolation_NN are_VBP viewed_VBN controversially_RB ._.
However_RB ,_, it_PRP remains_VBZ unclear_JJ whether_IN the_DT pathology_NN indicated_VBD SV_NN extent_NN is_VBZ included_VBN into_IN the_DT CTV_NNP defined_VBN by_IN current_JJ guidelines_NNS ._.
However_RB ,_, peripheral_JJ mechanisms_NNS underlying_VBG orofacial_JJ pain_NN abnormalities_NNS following_VBG IAN_NNP regeneration_NN are_VBP not_RB fully_RB understood_VBN ._.
However_RB ,_, whether_IN milnacipran_NN could_MD suppress_VB elevated_JJ impulsive_JJ action_NN in_IN rats_NNS with_IN lesions_NNS of_IN the_DT ventromedial_JJ prefrontal_JJ cortex_NN ,_, which_WDT is_VBZ functionally_RB comparable_JJ with_IN the_DT human_JJ prefrontal_JJ cortex_NN ,_, remains_VBZ unknown_JJ ._.
However_RB ,_, it_PRP is_VBZ not_RB known_VBN how_WRB small_JJ intestinal_JJ permeability_NN modulates_VBZ disease_NN in_IN the_DT colon_NN ._.
However_RB ,_, the_DT choice_NN of_IN fluid_NN has_VBZ been_VBN a_DT hot_JJ topic_NN of_IN discussion_NN ._.
However_RB ,_, the_DT relationship_NN between_IN the_DT pendulum_NN test_NN scores_NNS and_CC other_JJ objective_JJ measures_NNS of_IN spasticity_NN has_VBZ not_RB been_VBN studied_VBN ._.
However_RB ,_, few_JJ studies_NNS have_VBP investigated_VBN the_DT epigenetic-OA_NN process_NN within_IN a_DT hypoxic_JJ environment_NN ._.
However_RB ,_, fat_JJ grafting_NN has_VBZ not_RB been_VBN thoroughly_RB understood_VBN and_CC has_VBZ not_RB been_VBN conclusively_RB standardized_JJ to_TO ensure_VB superior_JJ clinical_JJ results_NNS ._.
However_RB ,_, the_DT use_NN of_IN nerve_NN autograft_NN has_VBZ associated_VBN donor_NN site_NN morbidity_NN and_CC limited_JJ availability_NN ._.
However_RB ,_, the_DT conclusions_NNS are_VBP controversial_JJ ._.
However_RB ,_, there_EX is_VBZ lack_NN of_IN sustained_JJ improvement_NN in_IN INT_CD to_TO INT_CD %_NN of_IN infants_NNS ._.
However_RB ,_, data_NNS on_IN HMV_NNP come_VBP exclusively_RB from_IN the_DT developed_JJ countries_NNS of_IN Europe_NNP and_CC North_NNP America_NNP ._.
However_RB ,_, the_DT contribution_NN of_IN S._NNP mutans_NNS with_IN Cnm_NN in_IN the_DT development_NN of_IN IgAN_NN has_VBZ not_RB been_VBN reported_VBN ._.
However_RB ,_, whether_IN health-related_JJ QOL_NN -LRB-_-LRB- HRQOL_NN -RRB-_-RRB- might_MD be_VB adversely_RB affected_VBN by_IN exposure_NN to_TO dioxin-like_JJ chemicals_NNS INT_CD years_NNS ago_RB is_VBZ unknown_JJ ._.
However_RB ,_, ST_JJ is_VBZ not_RB common_JJ practice_NN ,_, particularly_RB in_IN Low_JJ -_: and_CC Middle-Income_NNP Countries_NNP -LRB-_-LRB- LMICs_NNS -RRB-_-RRB- ._.
However_RB there_EX is_VBZ a_DT gap_NN in_IN the_DT literature_NN on_IN how_WRB THPs_NNS understand_VBP HIV-related_JJ opportunistic_JJ infections_NNS -LRB-_-LRB- OIs_NNS -RRB-_-RRB- ,_, i.e._FW tuberculosis_FW ,_, candidiasis_NN and_CC herpes_NN zoster_NN ._.
However_RB ,_, an_DT additional_JJ surgery_NN is_VBZ often_RB difficult_JJ to_TO consider_VB if_IN the_DT surgical_JJ approach_NN itself_PRP is_VBZ challenging_JJ or_CC the_DT patient_NN refuses_VBZ surgery_NN ._.
However_RB ,_, obtaining_VBG pathologist_NN input_NN is_VBZ often_RB difficult_JJ ,_, time_NN consuming_NN and_CC expensive_JJ ._.
However_RB the_DT relationship_NN between_IN trust_NN and_CC well-being_NN outcomes_NNS has_VBZ not_RB been_VBN comprehensively_RB examined_VBN ,_, particularly_RB in_IN socially_RB and_CC economically_RB transitioning_VBG countries_NNS such_JJ as_IN Iran_NNP and_CC among_IN young_JJ women_NNS ._.
However_RB ,_, the_DT clinico-pathological_JJ characteristics_NNS and_CC prognostic_JJ factors_NNS of_IN PBL_NN versus_CC SBL_NN have_VBP not_RB yet_RB been_VBN well_RB defined_VBN ._.
However_RB ,_, adenosine_NN has_VBZ also_RB been_VBN reported_VBN to_TO inhibit_VB tumor_NN growth_NN acting_VBG via_IN A1_NN and_CC A3_NN receptors_NNS ._.
However_RB ,_, few_JJ studies_NNS have_VBP explored_VBN the_DT effects_NNS of_IN PBDEs_NNS on_IN sexual_JJ and_CC reproductive_JJ behaviors_NNS in_IN animals_NNS ._.
However_RB ,_, recent_JJ observations_NNS indicate_VBP that_IN even_RB advanced_JJ fibrosis_NN is_VBZ still_RB reversible_JJ by_IN removing_VBG the_DT causative_JJ agents_NNS ._.
However_RB ,_, data_NNS on_IN the_DT occurrence_NN of_IN acute_JJ kidney_NN injury_NN -LRB-_-LRB- AKI_NN -RRB-_-RRB- during_IN everolimus_NN treatment_NN in_IN clinical_JJ practice_NN are_VBP sparse_JJ ._.
However_RB ,_, direct_JJ damage_NN by_IN PA_NN to_TO astrocytes_NNS is_VBZ relatively_RB unexplored_JJ ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT epidemiology_NN of_IN this_DT condition_NN ._.
However_RB ,_, other_JJ studies_NNS found_VBD that_IN resveratrol_NN treatment_NN for_IN a_DT longer_JJR period_NN of_IN time_NN failed_VBD to_TO regress_VB cardiac_JJ hypertrophy_NN ._.
However_RB there_EX are_VBP no_DT data_NNS on_IN HB_NN vaccination_NN uptake_NN by_IN Batswana_NNP HCWs_NNS ._.
However_RB ,_, inverse_JJ relationships_NNS between_IN NT-proBNP_NN and_CC obesity_NN have_VBP been_VBN reported_VBN ._.
However_RB ,_, no_DT studies_NNS have_VBP investigated_VBN the_DT association_NN between_IN coronary_JJ calcium_NN scores_NNS and_CC cardiovascular_JJ complications_NNS after_IN liver_NN transplantation_NN -LRB-_-LRB- LT_NN -RRB-_-RRB- ._.
However_RB ,_, the_DT effectiveness_NN and_CC efficacy_NN of_IN PSM_NNP in_IN clinical_JJ practice_NN and_CC whether_IN outcomes_NNS are_VBP different_JJ for_IN females_NNS and_CC males_NNS has_VBZ been_VBN sparsely_RB investigated.The_JJ objective_NN is_VBZ to_TO evaluate_VB the_DT sex-dependent_JJ effectiveness_NN of_IN PSM_NN of_IN oral_JJ anticoagulant_JJ therapy_NN in_IN everyday_JJ clinical_JJ practice_NN ._.
However_RB ,_, this_DT phenomenon_NN is_VBZ still_RB controversial_JJ in_IN TEVAR_NN patients_NNS treated_VBN for_IN acute_JJ type_NN B_NN aortic_JJ dissection_NN ._.
However_RB ,_, results_NNS have_VBP been_VBN inconsistent_JJ ,_, and_CC this_DT association_NN has_VBZ never_RB been_VBN examined_VBN longitudinally_RB ._.
However_RB ,_, little_JJ is_VBZ known_VBN of_IN patient-reported_JJ outcomes_NNS alongside_IN ART_NN rollout_NN ._.
However_RB ,_, the_DT association_NN between_IN periodontitis_NN measures_NNS and_CC increased_VBD leukocytosis_NN in_IN the_DT context_NN of_IN CKD_NNP has_VBZ not_RB been_VBN well_RB described_VBN ._.
However_RB ,_, these_DT results_NNS are_VBP controversial_JJ ._.
However_RB ,_, as_IN there_EX are_VBP conflicting_VBG results_NNS between_IN studies_NNS ,_, we_PRP re-evaluated_VBD its_PRP$ role_NN in_IN cluster_NN headache_NN ._.
However_RB ,_, clinical_JJ observations_NNS indicate_VBP that_IN a_DT subgroup_NN suffer_VBP from_IN sleep_NN lengths_NNS frequently_RB exceeding_VBG INT_CD hours_NNS ,_, coupled_VBN with_IN great_JJ daytime_JJ sleepiness_NN ._.
However_RB ,_, factors_NNS that_WDT consistently_RB predict_VBP medication_NN adherence_NN are_VBP unclear_JJ and_CC the_DT literature_NN lacks_VBZ patient_NN perspectives_NNS on_IN how_WRB health_NN care_NN systems_NNS affect_VBP adherence_NN to_TO oral_JJ hypoglycemic_JJ agents_NNS -LRB-_-LRB- OHAs_NNS -RRB-_-RRB- ._.
However_RB ,_, simple_JJ ray_NN resection_NN does_VBZ not_RB always_RB give_VB a_DT natural_JJ postoperative_JJ appearance_NN ,_, especially_RB for_IN short-type_JJ polydactyly_NN ._.
However_RB ,_, the_DT results_NNS were_VBD still_RB in_IN controversy_NN ._.
However_RB ,_, there_EX exists_VBZ limited_JJ empirical_JJ evaluation_NN of_IN the_DT statistical_JJ benefits_NNS of_IN Stated_NNP Choice_NNP -LRB-_-LRB- SC_NNP -RRB-_-RRB- experimental_JJ designs_NNS that_WDT employ_VBP non-zero_JJ prior_JJ estimates_NNS in_IN constructing_VBG non-orthogonal_JJ constrained_VBN designs_NNS ._.
However_RB ,_, there_EX are_VBP no_DT prospective_JJ RCTs_NNS demonstrating_VBG the_DT advantages_NNS of_IN H_NN compared_VBN to_TO the_DT conventional_JJ monopolar_JJ diathermy_NN -LRB-_-LRB- MD_NN -RRB-_-RRB- during_IN laparoscopic_JJ cholecystectomy_NN -LRB-_-LRB- LC_NN -RRB-_-RRB- in_IN cases_NNS of_IN acute_JJ cholecystitis_NN -LRB-_-LRB- AC_NN -RRB-_-RRB- ._.
However_RB ,_, it_PRP is_VBZ unclear_JJ whether_IN resilience_NN is_VBZ a_DT relatively_RB stable_JJ personality_NN trait_NN or_CC has_VBZ a_DT relational_JJ character_NN whose_WP$ protective_JJ strength_NN changes_NNS over_IN the_DT course_NN of_IN life_NN ._.
However_RB ,_, many_JJ researchers_NNS are_VBP not_RB familiar_JJ with_IN working_VBG with_IN PBRNs_NNS ._.
However_RB ,_, no_DT similar_JJ study_NN has_VBZ investigated_VBN this_DT issue_NN among_IN patients_NNS diagnosed_VBN with_IN major_JJ depressive_JJ disorder_NN in_IN Saudi_NNP Arabia_NNP ._.
However_RB ,_, the_DT limited_JJ amount_NN of_IN SF-MDSCs_NN precluded_VBD investigations_NNS into_IN their_PRP$ therapeutic_JJ potential_NN ._.
However_RB ,_, the_DT plasma_NN levels_NNS of_IN chemerin_NN in_IN patients_NNS with_IN ACS_NN have_VBP yet_RB to_TO be_VB investigated_VBN ._.
However_RB ,_, factors_NNS underlying_VBG its_PRP$ malignant_JJ behavior_NN are_VBP still_RB poorly_RB understood_VBN ._.
However_RB ,_, various_JJ tumors_NNS involving_VBG the_DT oculomotor_NN nerve_NN may_MD mimic_VB RPON_NNP ._.
However_RB ,_, this_DT is_VBZ often_RB delayed_VBN and_CC frequently_RB involves_VBZ referral_NN to_TO specialists_NNS ._.
However_RB ,_, the_DT exact_JJ mechanism_NN remains_VBZ to_TO be_VB elucidated_VBN and_CC need_VB to_TO be_VB investigated_VBN ._.
However_RB ,_, the_DT zoonotic_JJ potential_NN of_IN this_DT pathogen_NN ,_, phylogenetically_RB closely_RB related_JJ to_TO Chlamydia_NN trachomatis_NN ,_, is_VBZ still_RB uninvestigated_JJ ._.
However_RB ,_, the_DT associations_NNS between_IN these_DT traits_NNS -LRB-_-LRB- HA_NN ,_, NS_NN ,_, and_CC RD_NN -RRB-_-RRB- with_IN endogenous_JJ analgesia_NN revealed_VBN by_IN CPM_NNP have_VBP not_RB yet_RB been_VBN explored_VBN ._.
However_RB ,_, it_PRP has_VBZ not_RB been_VBN known_VBN on_IN MIA_NN expression_NN of_IN cutaneous_JJ mastocytosis_NN ._.
However_RB ,_, the_DT challenge_NN of_IN acquiring_VBG sufficient_JJ anatomical_JJ knowledge_NN in_IN undergraduate_JJ medical_JJ education_NN for_IN safe_JJ and_CC competent_JJ clinical_JJ practice_NN remains_VBZ ._.
However_RB ,_, a_DT few_JJ decades_NNS ago_IN it_PRP became_VBD more_RBR common_JJ for_IN women_NNS with_IN ID_NN to_TO give_VB birth_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT prognostic_JJ significance_NN of_IN those_DT components_NNS ,_, independent_JJ of_IN various_JJ tumor_NN molecular_JJ features_NNS ._.
However_RB ,_, they_PRP are_VBP critical_JJ for_IN the_DT delivery_NN of_IN education_NN and_CC affect_VB students_NNS '_POS learning_NN outcomes_NNS ._.
However_RB ,_, knowledge_NN on_IN antigenic_JJ diversity_NN of_IN key_JJ antigens_NNS ,_, the_DT impact_NN of_IN polymorphism_NN on_IN potential_JJ vaccine_NN escape_NN ,_, and_CC how_WRB sequence_NN polymorphism_NN relates_VBZ to_TO antigenic_JJ differences_NNS is_VBZ very_RB limited_JJ ,_, yet_RB crucial_JJ for_IN vaccine_NN development_NN ._.
However_RB ,_, AMA1_NN has_VBZ extensive_JJ allelic_JJ diversity_NN with_IN more_JJR than_IN INT_CD polymorphic_JJ amino_NN acid_NN residues_NNS and_CC more_JJR than_IN INT_CD haplotypes_NNS in_IN a_DT single_JJ population_NN ._.
However_RB ,_, the_DT role_NN of_IN contaminated_VBN surfaces_NNS in_IN pathogen_NN acquisition_NN in_IN this_DT setting_VBG generally_RB is_VBZ considered_VBN negligible_JJ ,_, as_IN most_JJS SSIs_NNS are_VBP believed_VBN to_TO originate_VB from_IN patients_NNS '_POS or_CC healthcare_NN workers_NNS '_POS flora_NN ._.
However_RB ,_, the_DT risk_NN of_IN prolonged_JJ or_CC chronic_JJ excretion_NN is_VBZ not_RB well_RB characterized_VBN in_IN developing_VBG countries_NNS ._.
However_RB ,_, there_EX have_VBP been_VBN no_DT epidemiological_JJ studies_NNS investigating_VBG help-seeking_JJ status_NN in_IN individuals_NNS with_IN PLEs_NNS and_CC elevated_JJ risk_NN of_IN suicide_NN ._.
However_RB ,_, transposition_NN of_IN the_DT nasolabial_JJ flap_NN to_TO lower_JJR nasal_JJ defects_NNS may_MD be_VB challenging_JJ because_IN of_IN functional_JJ and_CC aesthetic_JJ concerns_NNS ._.
However_RB ,_, no_DT study_NN has_VBZ compared_VBN NOACs_NNS with_IN each_DT other_JJ head-to-head_NN ._.
However_RB ,_, in_IN children_NNS ,_, this_DT predictive_JJ value_NN is_VBZ unresolved_JJ ._.
However_RB ,_, the_DT role_NN of_IN CD4_NN -LRB-_-LRB- +_CC -RRB-_-RRB- CD25_NN -LRB-_-LRB- +_CC -RRB-_-RRB- Treg_NN cells_NNS ,_, which_WDT play_VBP critical_JJ roles_NNS in_IN maintaining_VBG peripheral_JJ tolerance_NN and_CC preventing_VBG autoimmunity_NN ,_, has_VBZ not_RB yet_RB been_VBN defined_VBN in_IN IgAN_NN ._.
However_RB ,_, the_DT prognostic_JJ impact_NN of_IN histone_NN biomarkers_NNS as_IN surrogates_NNS of_IN MFC_NNP in_IN MCC_NNP is_VBZ unknown_JJ ._.
However_RB ,_, few_JJ studies_NNS have_VBP established_VBN the_DT prevalence_NN and_CC characteristics_NNS of_IN colorectal_JJ polyps_NNS in_IN this_DT population_NN ._.
However_RB ,_, its_PRP$ molecular_JJ mechanism_NN of_IN anti-inflammatory_JJ activity_NN on_IN ulcerative_JJ colitis_NN -LRB-_-LRB- UC_NN -RRB-_-RRB- remains_VBZ unknown_JJ ._.
However_RB ,_, the_DT pathological_JJ mechanism_NN of_IN brain_NN lesion_NN development_NN is_VBZ not_RB fully_RB understood_VBN ._.
However_RB ,_, it_PRP is_VBZ unclear_JJ whether_IN this_DT also_RB applies_VBZ for_IN non-Asian_JJ patients_NNS ._.
However_RB ,_, many_JJ patients_NNS die_VB after_IN the_DT 30-day_JJ mark_NN or_CC are_VBP transferred_VBN to_TO other_JJ facilities_NNS or_CC to_TO home_NN and_CC die_VB there_RB ,_, leading_VBG to_TO the_DT underreporting_NN of_IN surgically_RB related_JJ deaths_NNS ._.
However_RB ,_, a_DT robust_JJ systematic_JJ review_NN of_IN this_DT neurophysiological_JJ data_NNS has_VBZ not_RB yet_RB been_VBN undertaken_VBN ._.
However_RB ,_, there_EX is_VBZ no_DT consensus_NN on_IN the_DT best_JJS method_NN to_TO evaluate_VB pain_NN in_IN endometriosis_NN and_CC many_JJ scales_NNS have_VBP been_VBN used_VBN ._.
However_RB ,_, we_PRP know_VBP little_JJ about_IN how_WRB they_PRP function_VBP within_IN the_DT classroom_NN once_IN they_PRP start_VBP school_NN ._.
However_RB ,_, an_DT important_JJ problem_NN is_VBZ missed_VBN polyps_NNS ._.
However_RB ,_, the_DT sequencing_NN results_NNS of_IN the_DT DNA_NN from_IN a_DT 100-year-old_JJ tissue_NN contained_VBD some_DT uncertainties_NNS ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT outcomes_NNS of_IN DCD_NNP in_IN SLK_NNP ._.
However_RB no_DT data_NNS are_VBP available_JJ assessing_VBG chairs_NNS of_IN surgery_NN ._.
However_RB ,_, patellofemoral_JJ chondral_JJ status_NN after_IN this_DT reconstruction_NN has_VBZ not_RB been_VBN elucidated_VBN ._.
However_RB ,_, little_JJ information_NN is_VBZ available_JJ on_IN net_JJ survival_NN among_IN Yusho_JJ patients_NNS ,_, who_WP were_VBD accidentally_RB exposed_VBN to_TO PCBs_NNS and_CC other_JJ dioxin-related_JJ compounds_NNS ._.
However_RB ,_, the_DT minute_NN volumes_NNS of_IN GCF_NN harvested_VBN in_IN healthy_JJ sites_NNS are_VBP a_DT serious_JJ drawback_NN ._.
However_RB ,_, few_JJ data_NNS are_VBP available_JJ in_IN non-small_JJ cell_NN lung_NN cancer_NN -LRB-_-LRB- NSCLC_NN -RRB-_-RRB- ._.
However_RB ,_, the_DT economic_JJ effects_NNS of_IN such_JJ infections_NNS remain_VBP unclear_JJ particularly_RB in_IN developing_VBG countries_NNS ._.
However_RB ,_, the_DT potential_JJ effects_NNS of_IN ATX_NN on_IN neuroinflammation_NN in_IN SAH_NNP remain_VBP uninvestigated_JJ ._.
However_RB ,_, whether_IN baseline_NN levels_NNS of_IN these_DT makers_NNS are_VBP associated_VBN with_IN subsequent_JJ cancer_NN risk_NN in_IN the_DT general_JJ population_NN remains_VBZ unknown_JJ ._.
However_RB ,_, the_DT role_NN of_IN donor-specific_JJ HLA_NN antibody_NN -LRB-_-LRB- DSA_NN -RRB-_-RRB- responses_NNS as_IN a_DT risk_NN factor_NN for_IN poor_JJ outcomes_NNS remains_VBZ controversial_JJ ._.
However_RB ,_, laparoscopic_JJ surgery_NN in_IN cirrhotic_JJ patients_NNS remains_VBZ challenging_JJ ._.
However_RB ,_, it_PRP is_VBZ unclear_JJ how_WRB symptoms_NNS of_IN depression_NN and_CC anxiety_NN influence_VBP the_DT development_NN of_IN reward-processing_NN over_IN adolescence_NN and_CC whether_IN variation_NN in_IN the_DT severity_NN of_IN parental_JJ depression_NN is_VBZ associated_VBN with_IN hyposensitivity_NN to_TO reward_VB in_IN a_DT high-risk_JJ sample_NN ._.
However_RB ,_, few_JJ data_NNS deriving_VBG from_IN breast_NN surgery_NN have_VBP been_VBN published_VBN ._.
However_RB ,_, they_PRP have_VBP not_RB been_VBN largely_RB adopted_VBN ,_, possibly_RB because_IN of_IN their_PRP$ lack_NN of_IN sensitivity_NN and_CC specificity_NN ._.
However_RB ,_, misuse_NN of_IN MPH_NN has_VBZ been_VBN associated_VBN with_IN an_DT increased_VBN risk_NN of_IN aggression_NN and_CC psychosis_NN ._.
However_RB ,_, the_DT extant_JJ research_NN shows_VBZ conflicts_NNS about_IN the_DT direction_NN of_IN the_DT bias_NN that_WDT target_VBP gender_NN exerts_VBZ on_IN pain_NN perception_NN ._.
However_RB ,_, clinical_JJ factors_NNS associated_VBN with_IN HRCT_NN scan_VBP fibroproliferation_NN are_VBP incompletely_RB characterized_VBN ._.
However_RB ,_, movement_NN experiences_NNS have_VBP long_RB been_VBN considered_VBN important_JJ to_TO children_NNS 's_POS learning_NN and_CC have_VBP received_VBN increased_VBN attention_NN because_IN of_IN the_DT obesity_NN epidemic_JJ ._.
However_RB ,_, in_IN rare_JJ cases_NNS involving_VBG additional_JJ multilevel_JJ epidural_JJ abscess_NN formation_NN ,_, the_DT appropriate_JJ surgical_JJ strategy_NN remains_VBZ controversial_JJ ._.
However_RB ,_, the_DT molecular_JJ mechanisms_NNS and_CC enzymatic_JJ pathways_NNS involved_VBN in_IN the_DT interaction_NN between_IN the_DT two_CD agents_NNS are_VBP not_RB fully_RB understood_VBN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN how_WRB the_DT lymphatic_JJ and_CC blood_NN systems_NNS develop_VBP in_IN humans_NNS ._.
However_RB ,_, the_DT vast_JJ majority_NN of_IN these_DT studies_NNS were_VBD carried_VBN out_RP on_IN native_JJ English-speaking_JJ participants_NNS ._.
However_RB ,_, when_WRB mixed_VBN with_IN normal_JJ pooled_JJ plasma_NN -LRB-_-LRB- NPP_NN -RRB-_-RRB- at_IN physiologically_RB relevant_JJ dilutions_NNS ,_, HTX_NN demonstrates_VBZ accelerated_VBN coagulation_NN ._.
However_RB ,_, few_JJ studies_NNS have_VBP examined_VBN the_DT relationship_NN between_IN early_JJ stages_NNS of_IN chronic_JJ kidney_NN disease_NN -LRB-_-LRB- CKD_NN -RRB-_-RRB- and_CC sarcopenia_NN ._.
However_RB ,_, the_DT critical_JJ target_NN genes_NNS of_IN EZH2_NN and_CC their_PRP$ regulatory_JJ roles_NNS remain_VBP unclear_JJ ._.
However_RB ,_, controversy_NN still_RB exists_VBZ regarding_VBG the_DT advantages_NNS and_CC disadvantages_NNS of_IN pleural_JJ abrasion_NN compared_VBN with_IN other_JJ interventions_NNS in_IN preventing_VBG the_DT recurrence_NN of_IN PSP_NN ._.
However_RB ,_, unemployment_NN remains_VBZ an_DT unsolved_JJ issue_NN worldwide_RB ._.
However_RB ,_, paradoxical_JJ protective_JJ effects_NNS have_VBP also_RB been_VBN described_VBN depending_VBG of_IN IH_NN patterns_NNS and_CC durations_NNS applied_VBN in_IN studies_NNS ._.
However_RB ,_, PD-1_NN /_: PD-L1_NN blockade-treated_JJ mice_NNS eventually_RB succumb_VBP to_TO disease_NN due_JJ to_TO selection_NN of_IN PD-L1_NN mAb-resistant_JJ tumor_NN cells_NNS ._.
However_RB ,_, the_DT association_NN between_IN the_DT IFN-γ_NN +874_CD T/A_NN gene_NN polymorphism_NN and_CC hepatitis_NN virus-related_JJ diseases_NNS is_VBZ heterogeneous_JJ ._.
However_RB ,_, questionnaires_NNS should_MD meet_VB specific_JJ criteria_NNS ,_, to_TO minimize_VB error_NN and_CC ensure_VB reproducibility_NN of_IN results_NNS ._.
However_RB ,_, the_DT specific_JJ antibiotic_JJ use_NN in_IN the_DT Chinese_JJ food_NN animal_NN production_NN sector_NN is_VBZ unclear_JJ ._.
However_RB ,_, the_DT effects_NNS of_IN BDNF_NN on_IN diabetic_JJ nephropathy_NN are_VBP unknown_JJ ._.
However_RB ,_, there_EX have_VBP been_VBN few_JJ reports_NNS on_IN the_DT relationship_NN between_IN the_DT duration_NN of_IN illness_NN and_CC HRV_NN in_IN AN_DT ._.
However_RB ,_, its_PRP$ potential_JJ value_NN as_IN a_DT prognostic_JJ marker_NN in_IN atrial_JJ fibrillation_NN -LRB-_-LRB- AF_NN -RRB-_-RRB- is_VBZ unknown_JJ ._.
However_RB ,_, despite_IN decreasing_VBG the_DT need_NN for_IN intubation_NN in_IN some_DT patients_NNS ,_, there_EX are_VBP no_DT data_NNS regarding_VBG the_DT risk_NN of_IN intubation-related_JJ complications_NNS associated_VBN with_IN delayed_VBN intubation_NN in_IN adult_JJ patients_NNS who_WP fail_VBP NIPPV_NN ._.
However_RB ,_, the_DT regulatory_JJ functions_NNS of_IN the_DT Th2_NN inflammatory_JJ response_NN in_IN asthma_NN have_VBP not_RB been_VBN studied_VBN in_IN detail_NN ._.
However_RB ,_, this_DT association_NN has_VBZ not_RB been_VBN studied_VBN in_IN Indians_NNPS ._.
However_RB ,_, distribution_NN and_CC frequencies_NNS of_IN mutations_NNS in_IN PAM_NNS pathway_NN are_VBP unclear_JJ in_IN breast_NN cancer_NN patients_NNS from_IN the_DT mainland_NN of_IN China_NNP and_CC the_DT correlation_NN between_IN these_DT mutations_NNS and_CC breast_NN cancer_NN outcome_NN remains_VBZ to_TO be_VB identified_VBN ._.
However_RB ,_, the_DT functional_JJ significance_NN and_CC molecular_JJ mechanism_NN of_IN HNF1A_NN in_IN pancreatic_JJ carcinogenesis_NN remains_VBZ unclear_JJ ._.
However_RB ,_, it_PRP is_VBZ unclear_JJ whether_IN it_PRP offers_VBZ any_DT survival_NN benefits_NNS if_IN combined_VBN with_IN adjuvant_JJ tamoxifen_NN treatment_NN in_IN premenopausal_JJ women_NNS ._.
However_RB ,_, the_DT mortality_NN attributed_VBN to_TO birth_NN defects_NNS remains_VBZ constant_JJ ._.
However_RB ,_, the_DT relationship_NN between_IN nutritional_JJ consumption_NN and_CC performance_NN measures_NNS are_VBP less_RBR obvious_JJ for_IN athletes_NNS competing_VBG in_IN Polar_NNP conditions_NNS ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN adventitial_JJ fibroblast_NN subpopulations_NNS ._.
However_RB ,_, previous_JJ research_NN results_NNS are_VBP inconsistent_JJ ._.
However_RB ,_, this_DT information_NN is_VBZ essential_JJ for_IN appropriate_JJ clinical_JJ and_CC nutritional_JJ management_NN ._.
However_RB ,_, in_IN patients_NNS with_IN acute_JJ heart_NN failure_NN -LRB-_-LRB- AHF_NN -RRB-_-RRB- ,_, an_DT increased_VBN BMI_NN could_MD represent_VB a_DT protective_JJ marker_NN ._.
However_RB ,_, this_DT has_VBZ never_RB been_VBN scientifically_RB proven_VBN and_CC positive_JJ effects_NNS of_IN targeting_VBG the_DT sympathetic_JJ system_NN in_IN AR_NN has_VBZ been_VBN demonstrated_VBN in_IN several_JJ studies_NNS ._.
However_RB ,_, because_IN of_IN the_DT difference_NN in_IN chemical_NN structure_NN between_IN BPA-fr_NN and_CC FBPA_NN and_CC the_DT difference_NN in_IN the_DT dose_NN administered_VBN between_IN BPA-fr_NN -LRB-_-LRB- therapeutic_JJ dose_NN -RRB-_-RRB- and_CC FBPA_NN -LRB-_-LRB- tracer_NN dose_NN -RRB-_-RRB- ,_, the_DT predictive_JJ value_NN of_IN FBPA_NNP PET_NNP for_IN BPA-fr_NNP accumulation_NN in_IN the_DT tumor_NN and_CC normal_JJ tissues_NNS is_VBZ not_RB yet_RB clearly_RB proven_VBN ._.
However_RB ,_, because_IN of_IN medical_JJ ,_, logistic_JJ ,_, and_CC ethical_JJ issues_NNS ,_, the_DT use_NN of_IN hearts_NNS from_IN DCD_NNP donors_NNS for_IN transplantation_NN is_VBZ not_RB generally_RB considered_VBN to_TO be_VB feasible_JJ ._.
However_RB ,_, the_DT reasons_NNS for_IN the_DT knee_NN revisions_NNS have_VBP not_RB been_VBN compared_VBN ._.
However_RB ,_, these_DT effects_NNS have_VBP not_RB been_VBN entirely_RB clarified_VBN in_FW vivo_FW in_IN the_DT subventricular_JJ zone_NN -LRB-_-LRB- SVZ_NN -RRB-_-RRB- of_IN neonatal_JJ rats_NNS ._.
However_RB ,_, its_PRP$ anticancer_JJ activity_NN has_VBZ not_RB yet_RB been_VBN completely_RB studied_VBN ._.
However_RB ,_, almost_RB half_NN of_IN ambulatory_JJ providers_NNS with_IN an_DT EHR_NN do_VBP not_RB use_VB the_DT full_JJ functionality_NN ._.
However_RB ,_, CHMI_NN studies_NNS have_VBP not_RB been_VBN routinely_RB performed_VBN in_IN malaria-endemic_JJ countries_NNS or_CC used_VBN to_TO investigate_VB mechanisms_NNS of_IN naturally-acquired_JJ immunity_NN -LRB-_-LRB- NAI_NN -RRB-_-RRB- to_TO Plasmodium_NN falciparum_NN ._.
However_RB ,_, except_IN for_IN the_DT location_NN at_IN control_NN points_NNS ,_, RPM_NNP can_MD not_RB estimate_VB the_DT consistent_JJ correspondence_NN between_IN two_CD images_NNS because_IN RPM_NNP is_VBZ a_DT unidirectional_JJ image_NN matching_VBG approach_NN ._.
However_RB ,_, their_PRP$ association_NN with_IN the_DT severity_NN of_IN NAFLD_NNP has_VBZ not_RB been_VBN fully_RB evaluated_VBN ._.
However_RB the_DT relationship_NN between_IN these_DT two_CD functions_NNS remains_VBZ unclear_JJ ._.
However_RB ,_, the_DT prognostic_JJ value_NN of_IN CD64_NN in_IN predicting_VBG the_DT likelihood_NN of_IN survival_NN for_IN patients_NNS in_IN intensive_JJ care_NN unit_NN -LRB-_-LRB- ICU_NN -RRB-_-RRB- is_VBZ unclear_JJ ._.
However_RB ,_, empirical_JJ data_NNS on_IN the_DT relationship_NN between_IN disease-related_JJ knowledge_NN and_CC health_NN behaviours_NNS in_IN this_DT population_NN is_VBZ lacking_VBG ._.
However_RB ,_, the_DT prognostic_JJ significance_NN of_IN the_DT current_JJ TNM_NNP staging_NN system_NN in_IN RGC_NNP has_VBZ not_RB been_VBN studied_VBN ._.
However_RB ,_, recent_JJ data_NNS suggest_VBP an_DT increased_VBN rate_NN of_IN neoplasms_NNS in_IN these_DT cases_NNS ._.
However_RB ,_, data_NNS on_IN the_DT relationship_NN between_IN bilirubin_NN and_CC blood_NN pressure_NN are_VBP scarce_JJ and_CC inconclusive_JJ ._.
However_RB ,_, the_DT long-term_JJ outcome_NN of_IN INT_CD different_JJ types_NNS of_IN nitinol_NN stents_NNS for_IN AI_NN lesions_NNS is_VBZ unknown_JJ ._.
However_RB ,_, the_DT function_NN and_CC prognostic_JJ indicators_NNS of_IN PTHLH/PTHrP_NN in_IN OSCC_NN remain_VBP obscure_JJ ._.
However_RB ,_, little_JJ or_CC no_DT data_NNS is_VBZ available_JJ on_IN integration_NN of_IN cancer_NN screening_NN guidelines_NNS in_IN clinics_NNS ._.
However_RB ,_, the_DT resulting_VBG samples_NNS have_VBP perceived_VBN limitations_NNS in_IN the_DT oncology_JJ community_NN ,_, and_CC most_JJS commercially_RB available_JJ tests_NNS have_VBP not_RB been_VBN validated_VBN for_IN these_DT sample_NN types_NNS ._.
However_RB ,_, randomized_VBN controlled_JJ trials_NNS have_VBP not_RB demonstrated_VBN this_DT benefit_NN ._.
However_RB ,_, the_DT molecular_JJ mechanism_NN mediating_VBG the_DT brain-derived_JJ neurotrophic_JJ factor_NN effect_NN on_IN cocaine-induced_JJ alterations_NNS in_IN extracellular_JJ glutamate_NN levels_NNS is_VBZ unknown_JJ ._.
However_RB ,_, the_DT short-term_JJ prognostic_JJ value_NN of_IN identifying_VBG an_DT S3_NN on_IN admission_NN in_IN patients_NNS with_IN acute_JJ heart_NN failure_NN -LRB-_-LRB- AHF_NN -RRB-_-RRB- is_VBZ not_RB well_RB established_VBN ._.
However_RB ,_, the_DT detailed_JJ mechanism_NN of_IN the_DT enhancement_NN of_IN viral_JJ infectivity_NN by_IN Nef_NN remains_VBZ unclear_JJ ._.
However_RB ,_, it_PRP is_VBZ unclear_JJ whether_IN hepatic_JJ resection_NN is_VBZ essential_JJ for_IN peritoneal-side_JJ gallbladder_NN cancer_NN ._.
However_RB the_DT population_NN distribution_NN of_IN under-reporting_NN is_VBZ not_RB well_RB understood_VBN ._.
However_RB ,_, response_NN rates_NNS with_IN single-agent_JJ DTIC_NN are_VBP low_JJ ._.
However_RB ,_, concerns_NNS remain_VBP regarding_VBG the_DT downstream_JJ resource_NN utilization_NN and_CC the_DT clinical_JJ impact_NN of_IN such_JJ strategy_NN ._.
However_RB ,_, the_DT risk_NN factors_NNS for_IN different_JJ types_NNS of_IN BKV_NN infection_NN under_IN the_DT impact_NN of_IN intensive_JJ monitoring_NN and_CC reduction_NN of_IN maintenance_NN immunosuppression_NN are_VBP not_RB well_RB understood_VBN ._.
However_RB there_EX are_VBP no_DT clear_JJ guidelines_NNS on_IN how_WRB to_TO effectively_RB screen_VB for_IN anal_JJ cancer_NN ._.
However_RB ,_, the_DT extent_NN to_TO which_WDT frailty_NN is_VBZ associated_VBN with_IN the_DT CVD_NN risk_NN profile_NN has_VBZ been_VBN little_JJ studied_VBN ._.
However_RB ,_, the_DT effects_NNS of_IN nanoparticles_NNS on_IN plants_NNS have_VBP been_VBN seldom_RB studied_VBN ._.
However_RB ,_, in_IN allergic_JJ airways_NNS disease_NN ,_, the_DT role_NN of_IN SP-D_NN in_IN airway_NN remodeling_NN remains_VBZ unknown_JJ ._.
However_RB ,_, failed_VBD osseous_JJ flaps_NNS due_JJ to_TO inadequate_JJ perfusion_NN can_MD lead_VB to_TO significant_JJ morbidity_NN ._.
However_RB ,_, it_PRP has_VBZ not_RB been_VBN determined_VBN yet_RB whether_IN low-normal_JJ ALT_NN values_NNS might_MD be_VB predictive_JJ of_IN frailty_NN and_CC mortality_NN in_IN younger_JJR ,_, middle-aged_JJ adults_NNS ._.
However_RB ,_, there_EX are_VBP few_JJ methods_NNS researched_VBN and_CC shown_VBN beneficial_JJ for_IN treatment_NN of_IN hypertension_NN ._.
However_RB ,_, there_EX are_VBP only_RB a_DT few_JJ studies_NNS on_IN the_DT clinical_JJ course_NN of_IN ARE_VBP ._.
However_RB ,_, whether_IN specific_JJ cognitive_JJ abilities_NNS -LRB-_-LRB- eg_FW ,_, memory_NN vs_CC executive_NN function_NN -RRB-_-RRB- are_VBP impaired_JJ in_IN heart_NN failure_NN has_VBZ not_RB been_VBN fully_RB examined_VBN ._.
However_RB ,_, there_EX are_VBP multiple_JJ mechanisms_NNS through_IN which_WDT people_NNS who_WP inject_VBP drugs_NNS -LRB-_-LRB- PWID_NN -RRB-_-RRB- can_MD acquire_VB and_CC transmit_VB HIV_NN ._.
However_RB ,_, few_JJ studies_NNS have_VBP addressed_VBN methods_NNS for_IN predicting_VBG a_DT patient_NN 's_POS preferred_JJ cervical_JJ pillow_NN size_NN ._.
However_RB ,_, relationship_NN between_IN different_JJ forms_NNS of_IN vitamin_NN D_NN and_CC fibroblast_NN growth_NN factor_NN INT_CD -LRB-_-LRB- FGF-23_NN -RRB-_-RRB- remains_VBZ unclear_JJ in_IN this_DT population_NN ._.
However_RB ,_, there_EX is_VBZ a_DT lack_NN of_IN clinical_JJ data_NNS about_IN the_DT correlation_NN of_IN minimum_JJ inhibitory_JJ concentrations_NNS -LRB-_-LRB- MICs_NNS -RRB-_-RRB- and_CC clinical_JJ outcome_NN ._.
However_RB ,_, the_DT best_JJS age_NN group_NN for_IN this_DT operation_NN is_VBZ still_RB unknown_JJ ._.
However_RB ,_, the_DT findings_NNS might_MD be_VB group-specific_JJ ._.
However_RB ,_, the_DT knowledge_NN of_IN psychiatric_JJ disorders_NNS ,_, related_JJ risk_NN and_CC protective_JJ factors_NNS is_VBZ of_IN great_JJ significance_NN for_IN treatment_NN and_CC prevention_NN ._.
However_RB ,_, the_DT correlation_NN between_IN URG4_NN expression_NN and_CC clinicopathological_JJ significance_NN in_IN human_JJ cancer_NN remains_VBZ unclear_JJ ._.
However_RB ,_, very_RB few_JJ reports_NNS were_VBD available_JJ regarding_VBG level_NN II_CD dissection_NN performed_VBN via_IN the_DT breast_NN approach_NN ._.
However_RB ,_, the_DT efficacy_NN of_IN DPCP_NN immunotherapy_NN remains_VBZ subject_JJ to_TO much_JJ controversy_NN ._.
However_RB ,_, current_JJ data_NNS on_IN MBC_NN are_VBP largely_RB derived_VBN from_IN small_JJ case_NN series_NN or_CC population-based_JJ reports_NNS ._.
However_RB ,_, traditional_JJ techniques_NNS for_IN the_DT detection_NN of_IN acid-fast_JJ bacilli_NNS have_VBP limitations_NNS ._.
However_RB ,_, large_JJ scale_NN population_NN screening_NN is_VBZ of_IN prime_JJ importance_NN and_CC requires_VBZ a_DT simple_JJ ,_, accurate_JJ and_CC cost_NN effective_JJ technique_NN ._.
However_RB ,_, much_JJ remains_VBZ to_TO be_VB known_VBN about_IN the_DT underlying_JJ mechanisms_NNS ._.
However_RB ,_, safety_NN ,_, tolerability_NN and_CC efficacy_NN data_NNS in_IN connection_NN with_IN functional_JJ brain_NN activity_NN from_IN larger_JJR samples_NNS are_VBP lacking_VBG ._.
However_RB ,_, the_DT signaling_NN pathways_NNS and_CC mechanisms_NNS that_WDT regulate_VBP STAT3_NN activation_NN remain_VBP to_TO be_VB elucidated_VBN ._.
However_RB ,_, recent_JJ studies_NNS have_VBP indicated_VBN that_IN the_DT development_NN differ_VBP between_IN different_JJ socio-economic_JJ groups_NNS and_CC different_JJ geographic_JJ regions_NNS ._.
However_RB ,_, between_IN INT_CD and_CC INT_CD ,_, the_DT daily_JJ consumption_NN of_IN neuroleptic_JJ drugs_NNS has_VBZ increased_VBN by_IN INT_CD %_NN in_IN Belgium_NNP !_.
However_RB ,_, the_DT performance_NN of_IN clinical_JJ exome_JJ methods_NNS for_IN reporting_VBG small_JJ subsets_NNS of_IN genes_NNS has_VBZ not_RB been_VBN previously_RB reported_VBN ._.
However_RB ,_, it_PRP remains_VBZ to_TO be_VB investigated_VBN if_IN the_DT fall_NN frequency_NN and_CC the_DT consequences_NNS of_IN the_DT falls_VBZ have_VB an_DT impact_NN on_IN the_DT risk_NN for_IN subsequent_JJ injurious_JJ falls_VBZ in_IN the_DT long_JJ term_NN ._.
However_RB ,_, the_DT detailed_JJ mechanism_NN of_IN how_WRB the_DT macrosomia_NN happened_VBD remains_VBZ unknown_JJ ._.
However_RB ,_, different_JJ from_IN the_DT case_NN of_IN children_NNS diagnosed_VBN with_IN ASD_NN in_IN childhood_NN ,_, it_PRP is_VBZ difficult_JJ in_IN adults_NNS to_TO identify_VB the_DT ASD_NN symptoms_NNS underlying_VBG psychopathology_NN and_CC to_TO differentiate_VB ASD_NN from_IN other_JJ psychiatric_JJ disorders_NNS in_IN general_JJ psychiatric_JJ practice_NN ._.
However_RB ,_, the_DT pathophysiology_NN between_IN the_DT clinical_JJ severity_NN of_IN SAH_NNP and_CC the_DT sBNP_NN secretion_NN is_VBZ still_RB not_RB clear_JJ ._.
However_RB ,_, evidence_NN is_VBZ mainly_RB based_VBN on_IN studies_NNS that_WDT recorded_VBD falls_VBZ retrospectively_RB and/or_CC did_VBD not_RB determine_VB medication_NN use_NN at_IN the_DT time_NN of_IN the_DT fall_NN ._.
However_RB ,_, in_IN DRV-sensitive_JJ patients_NNS at_IN baseline_NN in_IN the_DT POWER_NN 1/2_CD trials_NNS ,_, similar_JJ rates_NNS of_IN HIV_NN RNA_NN suppression_NN -LRB-_-LRB- INT_CD log_NN reduction_NN -RRB-_-RRB- were_VBD achieved_VBN with_IN doses_NNS ranging_VBG from_IN 400/100_CD mg_NN once_RB daily_JJ to_TO 600/100_CD mg_NN twice_RB daily_RB ._.
However_RB ,_, abdominal_JJ wall_NN weakness_NN and_CC herniation_NN commonly_RB occur_VBP postoperatively_RB at_IN the_DT donor_NN site_NN ._.
However_RB ,_, despite_IN good_JJ theoretical_JJ and_CC epidemiological_JJ reasons_NNS for_IN hypothesising_VBG that_IN insecure_JJ attachment_NN may_MD be_VB specifically_RB implicated_VBN in_IN paranoid_JJ delusions_NNS ,_, few_JJ studies_NNS have_VBP considered_VBN the_DT role_NN it_PRP plays_VBZ in_IN specific_JJ symptoms_NNS ._.
However_RB ,_, mental_JJ health_NN of_IN workers_NNS in_IN SMEs_NNS is_VBZ largely_RB neglected_VBN in_IN occupational_JJ health_NN research_NN and_CC practice_NN in_IN China_NNP ._.
However_RB ,_, minority_NN aging_NN populations_NNS are_VBP often_RB underrepresented_JJ in_IN most_JJS studies_NNS on_IN cardiovascular_JJ and_CC pulmonary_JJ symptoms_NNS ._.
However_RB ,_, survival_NN rates_NNS and_CC causes_NNS of_IN death_NN in_IN CHB_NN patients_NNS either_CC treated_VBN or_CC not_RB treated_VBN with_IN NA_NN therapy_NN are_VBP unclear_JJ ._.
However_RB ,_, few_JJ studies_NNS have_VBP been_VBN performed_VBN to_TO evaluate_VB the_DT effects_NNS of_IN MC-LR_NN on_IN HPG_NN axis_NN ._.
However_RB ,_, to_TO the_DT best_JJS of_IN our_PRP$ knowledge_NN ,_, no_DT standard_JJ protocol_NN or_CC external_JJ survey_NN program_NN to_TO measure_VB the_DT ABO_NNP Ab_NN titer_NN has_VBZ been_VBN established_VBN in_IN Korea_NNP ._.
However_RB ,_, the_DT role_NN of_IN miR-200c_NN in_IN bladder_NN cancer_NN cells_NNS and_CC its_PRP$ mechanism_NN has_VBZ not_RB been_VBN well_RB studied_VBN ._.
However_RB ,_, in_IN the_DT previous_JJ studies_NNS ,_, up_RB to_TO INT_CD %_NN of_IN patients_NNS are_VBP compelled_VBN to_TO modify_VB their_PRP$ regimen_NNS in_IN middle_JJ and_CC low-income_JJ countries_NNS where_WRB salvage_NN drug_NN is_VBZ still_RB limited_VBN ._.
However_RB ,_, sustained_JJ expression_NN and_CC function_NN of_IN the_DT androgen_NN receptor_NN -LRB-_-LRB- AR_NN -RRB-_-RRB- gene_NN contribute_VBP to_TO the_DT progression_NN of_IN castration_NN resistant_JJ prostate_NN cancers_NNS -LRB-_-LRB- CRPC_NN -RRB-_-RRB- ._.
However_RB whether_IN these_DT inhibitors_NNS have_VBP any_DT impacts_NNS on_IN the_DT expressions_NNS of_IN full_JJ length_NN AR_NN -LRB-_-LRB- AR-FL_NN -RRB-_-RRB- and_CC its_PRP$ splice_NN variant_NN -LRB-_-LRB- AR-V7_NN -RRB-_-RRB- remains_VBZ unclear_JJ ._.
However_RB ,_, due_JJ to_TO the_DT inevitable_JJ experimental_JJ error_NN and_CC noisy_JJ data_NNS ,_, biological_JJ network_NN data_NNS represented_VBN as_IN the_DT probability_NN model_NN could_MD better_RBR reflect_VB the_DT authenticity_NN and_CC biological_JJ significance_NN ,_, therefore_RB ,_, it_PRP is_VBZ more_RBR biological_JJ meaningful_JJ to_TO discover_VB probability_NN motif_NN in_IN uncertain_JJ biological_JJ networks_NNS ._.
However_RB ,_, clinical_JJ trials_NNS testing_VBG anti-FOLR1_JJ therapies_NNS in_IN OvCa_NN show_VBP mixed_JJ results_NNS and_CC require_VB better_JJR understanding_NN of_IN the_DT prognostic_JJ relevance_NN of_IN FOLR1_NN expression_NN ._.
However_RB ,_, the_DT presence_NN of_IN a_DT patient_NN subset_NN that_WDT fails_VBZ to_TO respond_VB to_TO aspirin_NN despite_IN reduced_VBN TxA2_NN concentrations_NNS suggests_VBZ that_IN the_DT effect_NN of_IN aspirin_NN might_MD be_VB more_RBR complex_JJ than_IN exclusive_JJ COX-1_NN inhibition_NN ._.
However_RB ,_, no_DT previous_JJ studies_NNS have_VBP investigated_VBN whether_IN this_DT relationship_NN depends_VBZ on_IN sex_NN and_CC smoking_NN status_NN in_IN Chinese_JJ adults_NNS ._.
However_RB ,_, the_DT interaction_NN between_IN AII_NNP and_CC reduced_VBD glutathione_NN -LRB-_-LRB- GSH_NN -RRB-_-RRB- redox_NN status_NN in_IN cardiovascular_JJ remodeling_NN remains_VBZ unknown_JJ ._.
However_RB ,_, only_RB a_DT few_JJ quantitative_JJ studies_NNS have_VBP been_VBN performed_VBN to_TO compare_VB upper_JJ and_CC lower_JJR extremity_NN weight_NN bearing_NN ._.
However_RB ,_, the_DT pathogenesis_NN of_IN OA_NN is_VBZ still_RB unclear_JJ ._.
However_RB ,_, less_JJR than_IN INT_CD %_NN of_IN skin_NN grafts_NNS persist_VBP beyond_IN INT_CD days_NNS ._.
However_RB ,_, no_DT consensus_NN exists_VBZ regarding_VBG how_WRB far_RB an_DT optimal_JJ safety_NN margin_NN should_MD be_VB set_VBN in_IN determining_VBG the_DT resection_NN area_NN by_IN endoscopy_NN ._.
However_RB ,_, their_PRP$ role_NN in_IN governing_VBG the_DT response_NN to_TO allergen_NN is_VBZ not_RB fully_RB understood_VBN ._.
However_RB ,_, T1_NN rectal_JJ cancers_NNS may_MD be_VB at_IN low_JJ risk_NN for_IN metastases_NNS and_CC are_VBP therefore_RB treatable_JJ with_IN local_JJ resection_NN ._.
However_RB ,_, it_PRP is_VBZ unknown_JJ if_IN RKIP_NN expression_NN can_MD impact_VB the_DT progression_NN of_IN cancer_NN in_IN an_DT autochthonous_JJ model_NN of_IN cancer_NN ._.
However_RB ,_, clinical_JJ reports_NNS addressing_VBG this_DT issue_NN in_IN patients_NNS with_IN peritoneal_JJ dialysis_NN -LRB-_-LRB- PD_NN -RRB-_-RRB- peritonitis_NN are_VBP rare_JJ ._.
However_RB ,_, these_DT trials_NNS were_VBD performed_VBN at_IN sites_NNS where_WRB conventional_JJ mammographic_JJ screening_NN was_VBD concurrently_RB performed_VBN ,_, possibly_RB leading_VBG to_TO selection_NN biases_NNS or_CC with_IN complex_NN ,_, multireader_JJ algorithms_NNS not_RB reflecting_VBG general_JJ clinical_JJ practice_NN ._.
However_RB ,_, there_EX are_VBP few_JJ studies_NNS in_IN the_DT young_JJ and_CC essentially_RB none_NN in_IN those_DT with_IN CHD_NN ._.
However_RB ,_, nationally_RB ,_, data_NNS are_VBP routinely_RB collected_VBN on_IN hospital_NN admissions_NNS ,_, surgery_NN ,_, radiotherapy_NN and_CC chemotherapy_NN ._.
However_RB ,_, the_DT spectrum_NN of_IN drug-resistance_JJ mutations_NNS -LRB-_-LRB- DRMs_NNS -RRB-_-RRB- in_IN antiretroviral_JJ experienced_JJ patients_NNS with_IN this_DT variant_NN has_VBZ not_RB been_VBN studied_VBN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN their_PRP$ roles_NNS in_IN CRSwNP_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT nature_NN of_IN this_DT association_NN in_IN older_JJR adults_NNS ._.
However_RB ,_, very_RB few_JJ studies_NNS have_VBP examined_VBN the_DT comorbidity_NN between_IN nicotine_NN dependence_NN and_CC psychiatric_JJ and_CC substance_NN use_VBP disorders_NNS within_IN this_DT population_NN ._.
However_RB ,_, it_PRP is_VBZ the_DT fourth_JJ most_RBS common_JJ cause_NN of_IN death_NN in_IN China_NNP ._.
However_RB ,_, the_DT INT_CD methods_NNS currently_RB used_VBN to_TO determine_VB HDL-P_NN yield_NN concentrations_NNS that_WDT differ_VBP >_JJR 5-fold_RB ._.
However_RB ,_, data_NNS evaluating_VBG the_DT long-term_JJ impact_NN of_IN cancer_NN treatment_NN on_IN HIV_NN course_NN are_VBP sparse_JJ ._.
However_RB ,_, the_DT best_JJS method_NN for_IN LTBI_NN detection_NN before_IN initiation_NN of_IN anti-TNF_JJ therapy_NN remains_VBZ to_TO be_VB determined_VBN ._.
However_RB ,_, there_EX have_VBP been_VBN few_JJ reports_NNS on_IN the_DT long-term_JJ outcomes_NNS of_IN LG_NNP for_IN gastric_JJ cancer_NN ._.
However_RB ,_, the_DT inability_NN to_TO assess_VB cellularity_NN before_IN cell_NN block_NN preparation_NN is_VBZ a_DT pitfall_NN of_IN their_PRP$ use_NN ._.
However_RB ,_, it_PRP is_VBZ not_RB clear_JJ whether_IN these_DT differences_NNS influence_VBP patients_NNS '_POS survival_NN ._.
However_RB ,_, few_JJ studies_NNS have_VBP evaluated_VBN if_IN this_DT association_NN is_VBZ altered_VBN in_IN dual_JJ gait_NN tasks_NNS given_VBN gait_NN speed_NN changes_NNS with_IN complexity_NN and_CC nature_NN of_IN task_NN ._.
However_RB ,_, whether_IN such_JJ dichotomy_NN depends_VBZ on_IN the_DT genetic_JJ make-up_NN of_IN individual_JJ cancers_NNS is_VBZ not_RB known_VBN yet_RB ._.
However_RB ,_, the_DT impact_NN of_IN routine_JJ ,_, planned_JJ reexploration_NN performed_VBN in_IN the_DT intensive_JJ care_NN unit_NN -LRB-_-LRB- ICU_NN -RRB-_-RRB- remains_VBZ poorly_RB defined_VBN ._.
However_RB ,_, not_RB all_DT patients_NNS are_VBP suitable_JJ for_IN this_DT procedure_NN ._.
However_RB ,_, less_JJR evidence_NN is_VBZ available_JJ on_IN the_DT variation_NN in_IN the_DT associations_NNS between_IN temperature_NN and_CC mortality_NN in_IN multiple_JJ countries_NNS ,_, analyzed_VBN simultaneously_RB ._.
However_RB ,_, amine-induced_JJ OR/OA_NN may_MD be_VB underreported_VBN ._.
However_RB ,_, morphologic_JJ thresholds_NNS to_TO identify_VB significant_JJ stenoses_NNS are_VBP variable_JJ and_CC exploration_NN of_IN this_DT correlation_NN in_IN patients_NNS with_IN diabetes_NN mellitus_NN -LRB-_-LRB- DM_NN -RRB-_-RRB- remains_VBZ currently_RB incomplete_JJ ._.
However_RB ,_, formal_JJ communication_NN protocols_NNS are_VBP uncommon_JJ in_IN healthcare_NN teams_NNS ._.
However_RB ,_, hormones_NNS of_IN the_DT sympathetic_JJ adrenal_JJ medullary_JJ system_NN complement_NN endocrine_JJ regulation_NN of_IN inflammatory_JJ responses_NNS ._.
However_RB ,_, its_PRP$ therapeutic_JJ strategies_NNS and_CC technical_JJ risk_NN factors_NNS have_VBP not_RB been_VBN well_RB established_VBN ._.
However_RB ,_, whether_IN this_DT same_JJ mechanism_NN exists_VBZ in_IN T2DM_NN is_VBZ unclear_JJ ._.
However_RB ,_, research_NN has_VBZ shown_VBN that_IN these_DT assumptions_NNS are_VBP often_RB violated_VBN ._.
However_RB ,_, long-term_JJ results_NNS of_IN such_JJ treatments_NNS are_VBP rarely_RB reported_VBN ._.
However_RB ,_, no_DT human_JJ histologic_JJ data_NNS are_VBP available_JJ to_TO document_VB the_DT tissue_NN reactions_NNS to_TO this_DT bone_NN augmentation_NN procedure_NN ._.
However_RB ,_, many_JJ patients_NNS choose_VB to_TO have_VB subsequent_JJ cosmetic_NN surgery_NN ._.
However_RB ,_, empowerment_NN questionnaires_NNS that_WDT have_VBP been_VBN validated_VBN for_IN the_DT cancer_NN setting_NN are_VBP lacking_VBG ._.
However_RB ,_, there_EX was_VBD an_DT early_JJ glucose-lowering_NN effect_NN of_IN the_DT trial_NN ._.
However_RB ,_, few_JJ studies_NNS have_VBP evaluated_VBN YAP_NN protein_NN expression_NN in_IN lung_NN cancer_NN ,_, and_CC the_DT results_NNS have_VBP lacked_VBN consistency_NN ._.
However_RB ,_, the_DT effect_NN of_IN resveratrol_NN exerts_VBZ on_IN the_DT metastasis_NN of_IN oral_JJ cancer_NN cells_NNS remains_VBZ unclear_JJ ._.
However_RB ,_, it_PRP is_VBZ difficult_JJ to_TO perform_VB reliable_JJ chromatographic_JJ analysis_NN due_JJ to_TO peak_VB interference_NN of_IN such_JJ serum_NN compounds_NNS as_IN uric_JJ acid_NN and_CC bilirubin_NN ._.
However_RB ,_, the_DT origins_NNS of_IN processes_NNS that_WDT mediate_VBP inflammation_NN are_VBP unknown_JJ ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT use_NN and_CC wastage_NN of_IN distributed_VBN naloxone_NN ampoules_NNS ._.
However_RB ,_, the_DT results_NNS of_IN studies_NNS on_IN this_DT relationship_NN have_VBP been_VBN inconsistent_JJ ._.
However_RB ,_, the_DT contributions_NNS of_IN Sox2ot_NN to_TO hepatocellular_JJ carcinoma_NN -LRB-_-LRB- HCC_NN -RRB-_-RRB- remain_VBP largely_RB unknown_JJ ._.
However_RB ,_, it_PRP may_MD be_VB the_DT net_JJ biological_JJ activity_NN of_IN multiple_JJ androgens_NNS and_CC estrogens_NNS that_WDT influences_VBZ postnatal_JJ effects_NNS of_IN prenatal_JJ sex_NN steroids_NNS ._.
However_RB ,_, little_JJ evidence_NN is_VBZ available_JJ on_IN when_WRB ,_, where_WRB ,_, and_CC who_WP were_VBD infected_VBN with_IN HCV_NN ._.
However_RB ,_, previous_JJ studies_NNS have_VBP yielded_VBN conflicting_VBG evidence_NN for_IN linkage_NN to_TO chromosome_NN Xq28_NN ._.
However_RB ,_, it_PRP remains_VBZ unclear_JJ which_WDT diabetes-associated_JJ factors_NNS are_VBP involved_VBN in_IN overexpression_NN of_IN SGLT2_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN regarding_VBG the_DT cellular_JJ basis_NN of_IN these_DT functional_JJ deficits_NNS in_IN ASD_NN ._.
However_RB ,_, most_RBS clinicians_NNS are_VBP aware_JJ of_IN exceptional_JJ cases_NNS where_WRB survival_NN defies_VBZ the_DT notion_NN of_IN futility_NN ._.
However_RB ,_, it_PRP is_VBZ sometimes_RB difficult_JJ for_IN obtain_VB IO_JJ access_NN with_IN conventional_JJ manual_JJ bone_NN puncture_NN needle_NN ._.
However_RB ,_, the_DT perinatal_JJ period_NN represents_VBZ a_DT unique_JJ situation_NN in_IN which_WDT care_NN of_IN the_DT fetus_NN is_VBZ initiated_VBN by_IN an_DT obstetrician_NN and_CC then_RB assumed_VBN by_IN either_CC a_DT pediatrician_NN or_CC a_DT family_NN practice_NN physician_NN after_IN birth_NN ._.
However_RB ,_, their_PRP$ roles_NNS in_IN terms_NNS of_IN causing_VBG disease_NN have_VBP not_RB been_VBN well_RB discovered_VBN yet_RB ._.
However_RB ,_, they_PRP mostly_RB utilize_VBP complicated_JJ heterogeneous_JJ networks_NNS which_WDT are_VBP constructed_VBN based_VBN on_IN an_DT out-of-date_NN database_NN of_IN phenotype_NN similarity_NN network_NN collected_VBN from_IN literature_NN ._.
However_RB ,_, absence_NN of_IN a_DT well-developed_JJ universal_JJ cancer_NN registry_NN system_NN in_IN India_NNP ,_, institution_NN based_VBN secondary_JJ data_NN analysis_NN can_MD generate_VB useful_JJ information_NN ._.
However_RB ,_, vaccine_NN efficacy_NN has_VBZ been_VBN variable_JJ ,_, in_IN part_NN because_IN of_IN antigenic_JJ shift_NN and_CC drift_NN in_IN circulating_VBG influenza_NN viruses_NNS ._.
However_RB ,_, studies_NNS assessing_VBG students_NNS '_POS outlook_NN towards_IN their_PRP$ first_JJ injection_NN were_VBD limited_VBN ._.
However_RB ,_, the_DT relationship_NN between_IN hyperglycemia_NN and_CC serum_NN NO_NN level_NN was_VBD not_RB clear_JJ ._.
However_RB ,_, AT1002_NN is_VBZ not_RB stable_JJ in_IN neutral_JJ pH_NN or_CC after_IN incubation_NN under_IN physiological_JJ conditions_NNS ,_, which_WDT is_VBZ necessary_JJ to_TO fully_RB uncover_VB its_PRP$ permeation-enhancing_JJ effect_NN ._.
However_RB ,_, few_JJ of_IN knowledge_NN resources_NNS cover_VBP the_DT severity_NN information_NN of_IN ADEs_NNS that_WDT is_VBZ critical_JJ for_IN prioritizing_VBG the_DT medical_JJ need_NN ._.
However_RB ,_, the_DT actual_JJ correction_NN force_NN during_IN the_DT correction_NN maneuver_NN and_CC safety_NN margin_NN of_IN pull_NN out_RP force_NN on_IN each_DT screw_NN were_VBD not_RB well_RB known_VBN ._.
However_RB ,_, establishing_VBG a_DT pathoanatomic_JJ diagnosis_NN does_VBZ not_RB seem_VB possible_JJ in_IN most_JJS LBP_NN patients_NNS and_CC clinical_JJ tests_NNS may_MD potentially_RB be_VB more_RBR relevant_JJ as_IN prognostic_JJ factors_NNS ._.
However_RB ,_, the_DT role_NN of_IN IL-10-producing_JJ B_NN cells_NNS in_IN acute_JJ viral_JJ myocarditis_NN -LRB-_-LRB- AVMC_NN -RRB-_-RRB- remains_VBZ unknown_JJ ._.
However_RB ,_, dedicated_JJ cost_NN analyses_NNS of_IN such_JJ programs_NNS have_VBP not_RB yet_RB been_VBN published_VBN ._.
However_RB ,_, the_DT results_NNS are_VBP inconsistent_JJ ._.
However_RB ,_, regional_JJ signals_NNS about_IN increased_VBN number_NN of_IN hepatitis_NN B_NN cases_NNS raised_VBD the_DT question_NN how_WRB hepatitis_NN B_NN incidence_NN was_VBD distributed_VBN over_IN the_DT country_NN ._.
However_RB ,_, recent_JJ studies_NNS have_VBP raised_VBN concerns_NNS regarding_VBG both_CC the_DT effectiveness_NN and_CC safety_NN of_IN PAC_NN ._.
However_RB ,_, most_JJS patients_NNS develop_VBP an_DT acquired_VBN resistance_NN after_IN a_DT period_NN of_IN about_IN INT_CD months_NNS ._.
However_RB ,_, in_IN all_DT these_DT techniques_NNS ,_, the_DT temporal_JJ vein_NN is_VBZ sacrificed_VBN to_TO allow_VB posterior_JJ retraction_NN of_IN the_DT temporal_JJ lobe_NN ,_, which_WDT may_MD cause_VB venous_JJ infarction_NN in_IN the_DT temporal_JJ lobe_NN ._.
However_RB ,_, when_WRB it_PRP occurs_VBZ ,_, a_DT process_NN to_TO recognize_VB and_CC manage_VB the_DT issues_NNS compassionately_RB must_MD be_VB put_VBN in_IN place_NN ._.
However_RB ,_, in_IN cancer_NN tissues_NNS ,_, both_CC the_DT detailed_JJ characteristics_NNS of_IN Ct-OATP1B3_NN mRNA_NN expression_NN and_CC its_PRP$ biological_JJ functions_NNS remain_VBP unclear_JJ ._.
However_RB ,_, a_DT prediction_NN model_NN to_TO calculate_VB appropriate_JJ opioid_JJ analgesic_JJ requirements_NNS has_VBZ not_RB yet_RB been_VBN established_VBN ._.
However_RB ,_, while_IN women_NNS may_MD find_VB injectables_NNS acceptable_JJ ,_, they_PRP may_MD not_RB always_RB find_VB them_PRP accessible_JJ due_JJ to_TO stock-outs_NNS and_CC difficulties_NNS with_IN returning_VBG to_TO the_DT clinic_NN for_IN reinjections_NNS ._.
However_RB ,_, few_JJ data_NNS was_VBD available_JJ as_IN to_TO the_DT anatomic_JJ relationship_NN between_IN valve_NN stent_NN and_CC aortic_JJ root_NN anatomic_JJ structures_NNS including_VBG the_DT coronary_JJ arterial_JJ ostia_NN ,_, aortic_JJ leaflets_NNS ._.
However_RB ,_, there_EX is_VBZ a_DT paucity_NN of_IN data_NNS that_WDT would_MD provide_VB an_DT evidence_NN basis_NN for_IN recommendations_NNS to_TO hypothyroid_JJ patients_NNS ._.
However_RB ,_, they_PRP are_VBP not_RB widely_RB available_JJ ,_, have_VBP limited_VBN sensitivity_NN and_CC specificity_NN ,_, and_CC can_MD be_VB confounded_VBN by_IN concomitant_JJ cardiovascular_JJ disease_NN and_CC medications_NNS ._.
However_RB ,_, of_IN the_DT estimated_VBN FLOAT_CD million_CD adults_NNS with_IN serious_JJ thoughts_NNS of_IN suicide_NN in_IN the_DT past_JJ year_NN ,_, only_RB half_NN had_VBD a_DT major_JJ depressive_JJ episode_NN -LRB-_-LRB- MDE_NN -RRB-_-RRB- ._.
However_RB ,_, it_PRP is_VBZ difficult_JJ to_TO precisely_RB determine_VB the_DT boundary_NN of_IN the_DT brain_NN tumors_NNS and_CC normal_JJ brain_NN tissues_NNS because_IN the_DT MR_NN image_NN resolution_NN is_VBZ low_JJ ,_, especially_RB when_WRB using_VBG a_DT low-field_JJ open_JJ MRI_NNP scanner_NN ._.
However_RB ,_, mutagenic_JJ polymerase_NN chain_NN reaction-restriction_NN fragment_NN length_NN polymorphism_NN -LRB-_-LRB- PCR-RFLP_NN -RRB-_-RRB- is_VBZ still_RB a_DT choice_NN of_IN genotyping_NN method_NN in_IN molecular_JJ epidemiological_JJ research_NN ._.
However_RB ,_, limited_JJ literature_NN exists_VBZ on_IN the_DT economic_JJ burden_NN of_IN NeP_NN ,_, including_VBG its_PRP$ impact_NN on_IN productivity_NN ._.
However_RB ,_, little_JJ was_VBD known_VBN about_IN the_DT effects_NNS of_IN hypoxia_NN on_IN lupus_NN nephritis_NN -LRB-_-LRB- LN_NN -RRB-_-RRB- ._.
However_RB ,_, the_DT factors_NNS involved_VBN in_IN delaying_VBG treatment_NN contact_NN after_IN the_DT first_JJ onset_NN of_IN lifetime_NN depression_NN are_VBP not_RB fully_RB understood_VBN ._.
However_RB ,_, complications_NNS of_IN both_DT HIV_NN and_CC ART_NN ,_, such_JJ as_IN peripheral_JJ neuropathy_NN currently_RB affect_VBP PLHIV_NN ._.
However_RB ,_, donations_NNS are_VBP sometimes_RB made_VBN without_IN an_DT understanding_NN of_IN the_DT recipient_JJ 's_POS needs_NNS ,_, practical_JJ constraints_NNS or_CC sustainability_NN of_IN supplies_NNS ._.
However_RB ,_, few_JJ prospective_JJ studies_NNS apply_VBP broad_JJ untargeted_JJ metabolite_NN profiling_NN to_TO reveal_VB the_DT comprehensive_JJ metabolic_JJ alterations_NNS preceding_VBG the_DT onset_NN of_IN T2D_NN ._.
However_RB ,_, the_DT failure_NN associated_VBN with_IN metal-on-metal_JJ head_NN size_NN is_VBZ not_RB consistently_RB documented_VBN and_CC needs_VBZ to_TO be_VB communicated_VBN to_TO patients_NNS and_CC surgeons_NNS ._.
However_RB ,_, there_EX are_VBP several_JJ indications_NNS that_WDT increasing_VBG age_NN is_VBZ associated_VBN with_IN more_JJR biological_JJ complexity_NN ,_, resulting_VBG in_IN differences_NNS in_IN DLBCL_NN biology_NN depending_VBG on_IN age_NN ._.
However_RB ,_, few_JJ studies_NNS have_VBP examined_VBN the_DT impact_NN of_IN different_JJ drug_NN use_NN patterns_NNS on_IN mortality_NN among_IN polysubstance_NN using_VBG populations_NNS ._.
However_RB ,_, almost_RB all_DT existing_VBG methods_NNS exhibit_VBP rather_RB low_JJ power_NN or_CC have_VB inappropriate_JJ type_NN I_CD error_NN rates_NNS ._.
However_RB ,_, the_DT resources_NNS available_JJ to_TO country-level_JJ policy_NN makers_NNS to_TO create_VB such_JJ policies_NNS are_VBP limited_VBN ._.
However_RB ,_, urinary_JJ excretion_NN of_IN FABP4_NN has_VBZ not_RB been_VBN investigated_VBN ._.
However_RB ,_, volumetry_NN has_VBZ recently_RB been_VBN increasingly_RB conducted_VBN as_RB well_RB ,_, especially_RB in_IN giant_JJ intracranial_JJ aneurysms_NNS -LRB-_-LRB- GIAs_NNS -RRB-_-RRB- ._.
However_RB ,_, its_PRP$ clinical_JJ value_NN is_VBZ still_RB unclear_JJ ._.
However_RB ,_, trial_NN participants_NNS differ_VBP from_IN patients_NNS in_IN the_DT general_JJ population_NN ._.
However_RB ,_, its_PRP$ reproducibility_NN between_IN different_JJ raters_NNS and_CC between_IN test_NN occasions_NNS has_VBZ yet_RB to_TO be_VB investigated_VBN in_IN a_DT clinical_JJ context_NN ._.
However_RB ,_, the_DT real_JJ reasons_NNS for_IN this_DT phenomenon_NN are_VBP uncertain_JJ ._.
However_RB ,_, the_DT mechanisms_NNS involved_VBN in_IN these_DT changes_NNS are_VBP not_RB well_RB understood_VBN ._.
However_RB ,_, such_JJ data_NNS are_VBP characterized_VBN by_IN high_JJ signal_NN correlation_NN and_CC are_VBP difficult_JJ to_TO interpret_VB using_VBG univariate_JJ data_NN analysis_NN techniques_NNS ._.
However_RB ,_, understanding_VBG the_DT metabolic_JJ consequences_NNS of_IN environmental_JJ predisposing_VBG factors_NNS could_MD shed_VB light_NN on_IN disorders_NNS such_JJ as_IN autism_NN and_CC schizophrenia_NN ._.
However_RB ,_, the_DT association_NN between_IN progression_NN of_IN BP_NN changes_NNS and_CC cerebral_JJ infarction_NN is_VBZ not_RB currently_RB well_RB understood_VBN ._.
However_RB ,_, the_DT evidence_NN base_NN for_IN the_DT validity_NN and_CC reliability_NN of_IN the_DT World_NNP Health_NNP Organisation-endorsed_JJ Global_JJ Physical_JJ Activity_NN Questionnaire_NN -LRB-_-LRB- GPAQ_NN -RRB-_-RRB- is_VBZ limited_VBN ._.
However_RB ,_, CR_NN is_VBZ dramatically_RB underutilized_VBN ._.
However_RB ,_, few_JJ studies_NNS have_VBP reported_VBN the_DT clinical_JJ impact_NN of_IN EGFR_NN gene_NN copy_NN number_NN -LRB-_-LRB- GCN_NN -RRB-_-RRB- and_CC its_PRP$ correlation_NN with_IN EGFR_NN overexpression_NN ._.
However_RB ,_, few_JJ studies_NNS have_VBP specifically_RB examined_VBN this_DT association_NN in_IN births_NNS resulting_VBG from_IN in_FW vitro_FW fertilisation_NN -LRB-_-LRB- IVF_NN -RRB-_-RRB- ._.
However_RB ,_, such_JJ information_NN may_MD not_RB be_VB adequately_RB tailored_VBN to_TO the_DT patient_NN 's_POS perspective_NN ,_, particularly_RB if_IN healthcare_NN professionals_NNS do_VBP not_RB sufficiently_RB engage_VB patient_NN groups_NNS when_WRB developing_VBG online_JJ information_NN ._.
However_RB ,_, fear_NN for_IN increasing_VBG multi_NNS drug_NN resistance_NN might_MD prevent_VB wide_JJ acceptance_NN ._.
However_RB ,_, there_EX is_VBZ limited_JJ knowledge_NN on_IN early_JJ risk_NN factors_NNS of_IN intensive_JJ care_NN unit_NN -LRB-_-LRB- ICU_NN -RRB-_-RRB- requirement_NN ._.
However_RB ,_, few_JJ studies_NNS have_VBP examined_VBN the_DT relation_NN of_IN both_CC individual_JJ and_CC community_NN socioeconomic_JJ status_NN -LRB-_-LRB- SES_NN -RRB-_-RRB- with_IN incident_NN ESRD_NN ._.
However_RB ,_, nausea_NN occurs_VBZ as_IN a_DT premonitory_JJ symptom_NN in_IN about_IN a_DT quarter_NN of_IN patients_NNS ,_, suggesting_VBG that_IN a_DT primary_JJ brain_NN alteration_NN unrelated_JJ to_TO the_DT experience_NN of_IN pain_NN may_MD be_VB the_DT reason_NN for_IN nausea_NN ._.
However_RB ,_, extraction_NN of_IN active_JJ fixation_NN leads_VBZ is_VBZ a_DT complex_JJ procedure_NN that_WDT bears_VBZ potential_JJ fatal_JJ risks_NNS for_IN patients_NNS ._.
However_RB ,_, it_PRP is_VBZ unknown_JJ whether_IN lower_JJR concentrations_NNS of_IN lidocaine_NN ,_, usually_RB found_VBN in_IN patients_NNS managed_VBD with_IN continuous_JJ infusions_NNS ,_, also_RB impair_VBP the_DT function_NN of_IN NK_NN cells_NNS ._.
However_RB ,_, there_EX is_VBZ limited_JJ evidence_NN on_IN the_DT availability_NN of_IN mobile_JJ phones_NNS among_IN people_NNS in_IN substance_NN use_NN treatment_NN ,_, as_RB well_RB as_IN usage_NN patterns_NNS ,_, contact_NN preferences_NNS and_CC willingness_NN to_TO use_VB phone_NN functions_NNS such_JJ as_IN geo-location_NN for_IN treatment_NN purposes_NNS ._.
However_RB ,_, these_DT techniques_NNS are_VBP likely_JJ to_TO have_VB limited_VBN success_NN ,_, due_JJ to_TO insufficiently_RB effective_JJ means_NNS to_TO address_VB the_DT damaged_VBN anulus_NN fibrosus_NN -LRB-_-LRB- AF_NN -RRB-_-RRB- ._.
However_RB ,_, the_DT bidirectional_JJ association_NN between_IN the_DT risk_NN of_IN comorbidities_NNS and_CC the_DT diagnosis_NN of_IN RVO_NN in_IN this_DT population_NN is_VBZ uncertain_JJ ._.
However_RB ,_, whether_IN LDL-C_NN is_VBZ an_DT independent_JJ risk_NN factor_NN of_IN CI-AKI_NN in_IN patients_NNS undergoing_VBG percutaneous_JJ coronary_JJ intervention_NN -LRB-_-LRB- PCI_NN -RRB-_-RRB- is_VBZ unknown_JJ ._.
However_RB ,_, it_PRP is_VBZ still_RB largely_RB unknown_JJ how_WRB to_TO identify_VB CR_NN in_IN NCIS_NN patients_NNS by_IN laboratory_NN and_CC genetic_JJ characteristics_NNS ._.
However_RB ,_, some_DT in-house_JJ systems_NNS are_VBP currently_RB developed_VBN for_IN a_DT more_RBR flexible_JJ and_CC customized_VBN dosimetry_NN calculation_NN at_IN voxel-level_NN ._.
However_RB ,_, management_NN of_IN peripheral_JJ lung_NN nodules_NNS by_IN uniportal_JJ VATS_NNS without_IN tracheal_JJ intubation_NN has_VBZ rarely_RB been_VBN attempted_VBN ._.
However_RB ,_, the_DT role_NN of_IN CoNS_NNS in_IN CRS_NNP remains_VBZ controversial_JJ ._.
However_RB ,_, the_DT random_JJ use_NN of_IN BGAs_NNS to_TO measure_VB blood_NN gases_NNS ,_, electrolytes_NNS and_CC metabolites_NNS increases_VBZ the_DT variability_NN in_IN test_NN results_NNS ._.
However_RB ,_, IFT_NNP is_VBZ a_DT subjective_JJ method_NN requiring_VBG an_DT experienced_JJ investigator_NN ._.
However_RB ,_, because_IN of_IN the_DT diversity_NN of_IN methods_NNS and_CC variables_NNS used_VBN ,_, the_DT results_NNS are_VBP difficult_JJ to_TO compare_VB in_IN the_DT sports_NNS sciences_NNS ._.
However_RB ,_, it_PRP is_VBZ unknown_JJ whether_IN treatment_NN with_IN lanthanum_NN affects_VBZ survival_NN ._.
However_RB ,_, the_DT incidence_NN of_IN miscarriage_NN is_VBZ lower_JJR in_IN in-vitro_FW fertilization_NN twin_NN versus_CC singleton_NN pregnancies_NNS ._.
However_RB ,_, further_JJ studies_NNS are_VBP needed_VBN to_TO accumulate_VB sufficient_JJ evidence_NN on_IN the_DT oncological_JJ outcome_NN of_IN LLR_NN for_IN CLM_NNP ._.
However_RB ,_, the_DT association_NN of_IN complicated_JJ grief_NN with_IN cognitive_JJ and_CC biological_JJ risk_NN factors_NNS is_VBZ unclear_JJ ._.
However_RB ,_, the_DT correlation_NN between_IN radiographic_JJ evaluation_NN of_IN septal_JJ deviation_NN with_IN physical_JJ examination_NN findings_NNS is_VBZ unknown_JJ ._.
However_RB ,_, the_DT exact_JJ mechanism_NN by_IN which_WDT the_DT picornaviruses_NNS induce_VBP SG_NN formation_NN is_VBZ unknown_JJ ._.
However_RB ,_, the_DT cellular_JJ and_CC molecular_JJ mechanisms_NNS underlying_VBG new_JJ bone_NN formation_NN in_IN bone_NN grafting_NN have_VBP yet_RB to_TO be_VB fully_RB elucidated_VBN ._.
However_RB ,_, no_DT systematic_JJ assessment_NN of_IN cost-effectiveness_NN of_IN interventions_NNS addressing_VBG behavioural_JJ risk_NN factors_NNS in_IN the_DT region_NN exists_VBZ ._.
However_RB ,_, there_EX are_VBP very_RB little_JJ data_NNS on_IN nicotine_NN intake_NN associated_VBN with_IN NRT_NNP use_NN in_IN representative_JJ population_NN samples_NNS ._.
However_RB ,_, there_EX is_VBZ debate_NN that_IN some_DT interventions_NNS may_MD pathologize_VB normal_JJ ,_, adaptive_JJ responses_NNS to_TO stressors_NNS ._.
However_RB ,_, this_DT procedure_NN has_VBZ been_VBN insufficiently_RB investigated_VBN ._.
However_RB ,_, our_PRP$ knowledge_NN of_IN the_DT distribution_NN of_IN Diplostomum_NNP spp_NN ._.
However_RB ,_, few_JJ A20_NN mutations_NNS and_CC polymorphisms_NNS have_VBP been_VBN reported_VBN in_IN T-ALL_NN ._.
However_RB ,_, this_DT method_NN systematically_RB underestimates_VBZ cardiopulmonary_JJ fitness_NN in_IN obese_JJ individuals_NNS ._.
However_RB ,_, the_DT relationship_NN between_IN the_DT response_NN by_IN these_DT biomarkers_NNS and_CC clinical_JJ outcomes_NNS has_VBZ not_RB been_VBN validated_VBN with_IN novel_JJ compounds_NNS in_IN the_DT phase_NN INT_CD setting_NN ._.
However_RB ,_, the_DT molecular_JJ mechanisms_NNS responsible_JJ for_IN its_PRP$ anti-proliferative_JJ effects_NNS on_IN the_DT ovarian_JJ cancer_NN have_VBP not_RB been_VBN fully_RB elucidated_VBN ._.
However_RB ,_, a_DT nationally_RB representative_JJ estimate_NN for_IN dyslipidemia_NN prevalence_NN is_VBZ lacking_VBG ._.
However_RB ,_, few_JJ have_VBP been_VBN implemented_VBN in_IN patients_NNS with_IN COPD_NN at_IN all_DT stages_NNS in_IN a_DT community_NN setting_NN ._.
However_RB ,_, few_JJ studies_NNS have_VBP investigated_VBN the_DT phenotypes_NNS and_CC functions_NNS of_IN NK_NN cells_NNS involved_VBN in_IN hepatitis_NN B_NN related_JJ liver_NN failure_NN -LRB-_-LRB- LF_NN -RRB-_-RRB- ,_, and_CC the_DT precise_JJ mechanism_NN underlying_VBG NK_NN cell_NN regulation_NN is_VBZ not_RB fully_RB understood_VBN ._.
However_RB ,_, evidence_NN is_VBZ lacking_VBG concerning_VBG how_WRB these_DT healthcare_NN franchises_NNS should_MD be_VB designed_VBN to_TO actually_RB deliver_VB the_DT promised_VBN benefits_NNS ._.
However_RB ,_, there_EX is_VBZ limited_JJ research_NN on_IN the_DT use_NN of_IN VC_NNP for_IN psychiatric_JJ emergencies_NNS ._.
However_RB ,_, the_DT relationship_NN between_IN HSC70_NN dysfunction_NN and_CC nephrotoxicity_NN has_VBZ not_RB been_VBN clarified_VBN yet_RB ._.
However_RB ,_, the_DT evidence_NN for_IN this_DT in_IN human_JJ alcohol_NN dependence_NN is_VBZ as_RB yet_RB inconclusive_JJ ._.
However_RB ,_, the_DT association_NN between_IN genetic_JJ variations_NNS of_IN FGF21_NN and_CC NAFLD_NN remains_VBZ unknown_JJ ._.
However_RB ,_, the_DT existence_NN of_IN the_DT `_`` CpG_NN island_NN methylator_NN phenotype_NN '_'' -LRB-_-LRB- CIMP_NN -RRB-_-RRB- in_IN human_JJ breast_NN cancer_NN is_VBZ still_RB controversial_JJ ._.
However_RB ,_, although_IN the_DT FMR1_NN gene_NN undergoes_VBZ alternative_JJ splicing_NN ,_, it_PRP is_VBZ unknown_JJ whether_IN all_DT or_CC only_RB some_DT of_IN the_DT isoforms_NNS are_VBP overexpressed_VBN in_IN premutation_NN carriers_NNS and_CC which_WDT isoforms_NNS may_MD contribute_VB to_TO the_DT premutation_NN pathology_NN ._.
However_RB ,_, at_IN the_DT same_JJ time_NN ,_, the_DT increasing_VBG use_NN has_VBZ also_RB raised_VBN many_JJ ethical_JJ challenges_NNS ._.
However_RB ,_, few_JJ investigations_NNS have_VBP been_VBN made_VBN on_IN the_DT applicability_NN of_IN CS_JJ qPCR_NN in_IN particular_JJ cases_NNS such_JJ as_IN dogs_NNS with_IN borderline_JJ IFAT_NNP titres_NNS ,_, suspected_VBN disease_NN relapse_NN with_IN comorbidity_NN and_CC therapy_NN monitoring_NN ._.
However_RB ,_, the_DT effectiveness_NN of_IN this_DT approach_NN in_IN routine_JJ care_NN needs_VBZ more_RBR research_NN ._.
However_RB ,_, the_DT clear_JJ association_NN between_IN MxA_NN expression_NN and_CC cancer_NN remains_VBZ unknown_JJ ._.
However_RB ,_, the_DT limitations_NNS of_IN current_JJ ethical_JJ and_CC regulatory_JJ frameworks_NNS in_IN sub-Saharan_NNP Africa_NNP to_TO govern_VB the_DT collection_NN ,_, export_NN ,_, storage_NN and_CC reuse_NN of_IN these_DT samples_NNS have_VBP resulted_VBN in_IN inconsistencies_NNS in_IN practice_NN and_CC a_DT number_NN of_IN ethical_JJ concerns_NNS for_IN sample_NN donors_NNS ,_, researchers_NNS and_CC research_NN ethics_NNS committees_NNS ._.
However_RB ,_, most_JJS adjuvants_NNS have_VBP limited_VBN uses_NNS in_IN clinical_JJ practice_NN due_JJ to_TO their_PRP$ toxicity_NN ._.
However_RB ,_, much_JJ is_VBZ not_RB documented_VBN ;_: school-absenteeism_NN and_CC dropout_NN are_VBP a_DT common_JJ problem_NN among_IN girls_NNS in_IN rural_JJ Ethiopia_NNP ._.
However_RB ,_, many_JJ of_IN these_DT studies_NNS have_VBP been_VBN confined_VBN to_TO urban_JJ centres_NNS ,_, with_IN few_JJ focusing_VBG on_IN rural_JJ settings_NNS and_CC even_RB fewer_JJR studies_NNS carried_VBD out_RP at_IN a_DT national_JJ level_NN ._.
However_RB ,_, there_EX is_VBZ still_RB little_JJ experience_NN with_IN this_DT technique_NN for_IN the_DT treatment_NN of_IN colorectal_JJ cancer_NN ._.
However_RB ,_, the_DT potential_NN of_IN atorvastatin_NN to_TO inhibit_VB HCC_NN formation_NN is_VBZ controversially_RB discussed_VBN ._.
However_RB ,_, this_DT line_NN of_IN research_NN has_VBZ yet_RB to_TO examine_VB etiological_JJ associations_NNS of_IN affective-interpersonal_JJ -LRB-_-LRB- factor_NN INT_CD ,_, F1_NN -RRB-_-RRB- features_NNS of_IN psychopathy_NN with_IN BPD_NN tendencies_NNS ._.
However_RB ,_, the_DT effect_NN of_IN metformin_NN in_IN ischemic_JJ stroke_NN is_VBZ unclear_JJ ._.
However_RB ,_, no_DT report_NN was_VBD found_VBN on_IN the_DT neuropharmacological_JJ and_CC analgesic_JJ activity_NN of_IN this_DT plant_NN to-date_NN ._.
However_RB ,_, the_DT developmental_JJ mechanism_NN of_IN SSA/P_NN remains_VBZ unknown_JJ ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN brain_NN functional_JJ connectivity_NN in_IN SD_NN ._.
However_RB ,_, the_DT molecular_JJ mechanism_NN and_CC the_DT effect_NN of_IN daphnetin_NN on_IN demethylating_VBG proapoptotic_JJ genes_NNS in_IN the_DT synovial_JJ cells_NNS remains_VBZ further_JJ clarified_VBN ._.
However_RB ,_, research_NN has_VBZ not_RB been_VBN conducted_VBN to_TO assess_VB these_DT behaviors_NNS in_IN SA_NNP preschools_NNS and_CC how_WRB these_DT might_MD differ_VB across_IN income_NN settings_NNS ._.
However_RB ,_, whether_IN a_DT reliable_JJ pedicled_JJ perforator_NN flap_NN could_MD be_VB harvested_VBN from_IN the_DT medial_JJ arm_NN remains_VBZ unanswered_JJ ._.
However_RB ,_, acantholysis_NN can_MD occasionally_RB be_VB observed_VBN in_IN unusual_JJ locations_NNS ._.
However_RB ,_, the_DT sample_NN sizes_NNS of_IN these_DT studies_NNS were_VBD usually_RB small_JJ ._.
However_RB ,_, such_JJ models_NNS are_VBP largely_RB dependent_JJ on_IN accurate_JJ input_NN data_NNS ._.
However_RB ,_, there_EX is_VBZ growing_VBG recognition_NN that_IN individuals_NNS with_IN ARMS_NNS may_MD function_VB poorly_RB regardless_RB of_IN whether_IN they_PRP develop_VBP psychosis_NN ._.
However_RB ,_, information_NN about_IN its_PRP$ distribution_NN in_IN lymph_NN node_NN positive_JJ prostate_NN cancers_NNS and_CC the_DT prognostic_JJ significance_NN in_IN these_DT advanced_JJ tumors_NNS is_VBZ unknown_JJ ._.
However_RB ,_, after_IN the_DT clinical_JJ onset_NN of_IN AD_NN ,_, patients_NNS with_IN HE_PRP levels_NNS show_VBP more_RBR rapid_JJ cognitive_JJ decline_NN than_IN patients_NNS with_IN lower_JJR education_NN -LRB-_-LRB- LE_NN -RRB-_-RRB- levels_NNS ._.
However_RB ,_, there_EX were_VBD limited_VBN data_NNS available_JJ on_IN studying_VBG the_DT effect_NN of_IN interleg_NN ABI_NN difference_NN ._.
However_RB ,_, a_DT clear_JJ definition_NN is_VBZ not_RB available_JJ to_TO date_NN for_IN the_DT paediatric_JJ population_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN impaired_JJ functioning_VBG in_IN youth_NN with_IN mood_NN disorders_NNS ._.
However_RB ,_, transplantation_NN is_VBZ inefficient_JJ ,_, and_CC it_PRP is_VBZ thought_VBN that_IN transplanted_VBN hepatocytes_NNS have_VBP a_DT shortened_VBN lifespan_NN because_IN of_IN inflammation_NN involving_VBG excess_JJ nitric_JJ oxide_NN -LRB-_-LRB- NO_NN -RRB-_-RRB- ._.
However_RB ,_, epidemiological_JJ data_NNS are_VBP scarce_JJ and_CC inconclusive_JJ ._.
However_RB ,_, two-dimensional_JJ angiography_NN may_MD not_RB accurately_RB reflect_VB the_DT extent_NN of_IN residual_JJ stenosis_NN ._.
However_RB ,_, few_JJ systematic_JJ reviews_NNS or_CC meta-analyses_NNS have_VBP synthesized_VBN these_DT results_NNS ._.
However_RB ,_, neither_DT of_IN these_DT equations_NNS has_VBZ been_VBN tested_VBN in_IN a_DT large_JJ Asian_JJ population_NN ._.
However_RB ,_, several_JJ patients_NNS must_MD undergo_VB surgical_JJ treatment_NN due_JJ to_TO treatment_NN failure_NN and_CC there_EX is_VBZ a_DT potential_JJ risk_NN that_IN preoperative_JJ IFX_NN treatment_NN may_MD have_VB a_DT negative_JJ effect_NN on_IN the_DT healing_NN process_NN in_IN intestinal_JJ anastomosis_NN ._.
However_RB ,_, the_DT detection_NN of_IN those_DT preoperative_JJ patients_NNS who_WP will_MD develop_VB AKI_NNP is_VBZ still_RB difficult_JJ ._.
However_RB ,_, the_DT clinical_JJ relevance_NN of_IN CTNNA1_NN methylation_NN remains_VBZ rarely_RB known_VBN in_IN myelodysplastic_JJ syndrome_NN -LRB-_-LRB- MDS_NN -RRB-_-RRB- ._.
However_RB ,_, there_EX is_VBZ currently_RB no_DT evidence_NN from_IN randomized_VBN ,_, controlled_JJ studies_NNS investigating_VBG the_DT possible_JJ benefits_NNS of_IN continuous_JJ TAP_NN blocks_NNS ._.
However_RB ,_, the_DT prognostic_JJ role_NN of_IN a_DT GRAF_NN transcript_NN has_VBZ not_RB been_VBN studied_VBN in_IN patients_NNS with_IN AML_NN ._.
However_RB ,_, the_DT current_JJ failure_NN rate_NN of_IN endovascular_JJ recanalization_NN remains_VBZ at_IN approximately_RB INT_CD %_NN ,_, resulting_VBG in_IN the_DT need_NN for_IN surgical_JJ rescue_NN treatment_NN ._.
However_RB ,_, the_DT relationship_NN between_IN the_DT timing_NN of_IN adjuvant_JJ chemotherapy_NN and_CC survival_NN has_VBZ not_RB been_VBN investigated_VBN ._.
However_RB ,_, the_DT monetary_JJ cost_NN of_IN consuming_VBG such_PDT a_DT diet_NN can_MD be_VB a_DT perceived_VBN barrier_NN ._.
However_RB ,_, the_DT determinant_NN of_IN therapeutic_JJ outcomes_NNS for_IN this_DT complication_NN has_VBZ not_RB yet_RB been_VBN fully_RB clarified_VBN ._.
However_RB ,_, development_NN of_IN hypotension/shock_NN in_IN TTC_NN is_VBZ not_RB closely_RB related_JJ to_TO extent_NN of_IN left_JJ ventricular_JJ -LRB-_-LRB- LV_NN -RRB-_-RRB- hypokinesis_NN ._.
However_RB ,_, it_PRP remains_VBZ unclear_JJ whether_IN gender_NN differences_NNS in_IN smoking_NN outcome_NN expectancies_NNS for_IN negative_JJ smoking_NN reinforcement-an_NN important_JJ theoretical_JJ and_CC clinical_JJ target_NN defined_VBN as_IN beliefs_NNS that_WDT smoking_NN alleviates_VBZ negative_JJ affect-exist_NN above_IN and_CC beyond_IN gender_NN differences_NNS in_IN depression_NN and/or_CC other_JJ outcome_NN expectancies_NNS ._.
However_RB ,_, it_PRP is_VBZ unclear_JJ whether_IN DSA_NNP monitoring_NN is_VBZ necessary_JJ and_CC could_MD predict_VB graft_NN outcome_NN after_IN antirejection_JJ treatment_NN ._.
However_RB ,_, chylothorax_NN after_IN lung_NN cancer_NN surgery_NN performed_VBN solely_RB by_IN video-assisted_JJ thoracoscopic_JJ surgery_NN -LRB-_-LRB- VATS_NNS -RRB-_-RRB- has_VBZ rarely_RB been_VBN investigated_VBN ._.
However_RB ,_, young_JJ HIV-infected_JJ children_NNS remain_VBP at_IN high_JJ risk_NN of_IN TB_NN disease_NN following_VBG mycobacterial_JJ infection_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN about_IN the_DT role_NN of_IN TLR4_NN in_IN the_DT pathogenesis_NN of_IN low-grade_JJ polymicrobial_JJ sepsis_NN ,_, which_WDT is_VBZ often_RB associated_VBN with_IN immunosuppression_NN ._.
However_RB there_EX is_VBZ a_DT lack_NN of_IN information_NN about_IN toxicity_NN of_IN those_DT nanoparticles_NNS as_RB well_RB as_IN their_PRP$ excretion_NN from_IN the_DT body_NN ._.
However_RB ,_, little_JJ is_VBZ known_VBN regarding_VBG the_DT regulation_NN of_IN ADAM17_NN expression_NN in_IN the_DT cardiovascular_JJ system_NN ._.
However_RB ,_, the_DT exact_JJ prevalence_NN ,_, severity_NN and_CC timing_NN of_IN development_NN of_IN ocular_JJ hypertension_NN have_VBP yet_RB to_TO be_VB fully_RB explored_VBN in_IN this_DT pediatric_JJ patient_NN group_NN ._.
However_RB ,_, to_TO date_NN ,_, no_DT evidence_NN has_VBZ been_VBN presented_VBN to_TO confirm_VB this_DT correlation_NN ._.
However_RB ,_, the_DT ECG_NN patterns_NNS of_IN patients_NNS with_IN acute_JJ pulmonary_JJ embolism_NN during_IN hemodynamic_JJ instability_NN are_VBP not_RB fully_RB described_VBN ._.
However_RB ,_, the_DT magnitude_NN of_IN this_DT drug_NN interaction_NN remains_VBZ unclear_JJ ._.
However_RB ,_, despite_IN INT_CD years_NNS of_IN discourse_NN on_IN pain_NN and_CC dementia_NN ,_, pain_NN is_VBZ still_RB undetected_JJ or_CC misinterpreted_VBN in_IN people_NNS with_IN dementia_NN in_IN residential_JJ aged_JJ care_NN facilities_NNS ,_, particularly_RB those_DT with_IN communication_NN difficulties_NNS ._.
However_RB ,_, the_DT evidence_NN of_IN SM_NN effectiveness_NN in_IN CLBP_NN remains_VBZ unclear_JJ ._.
However_RB ,_, a_DT lack_NN of_IN PCSK9_NN could_MD also_RB lead_VB to_TO cholesterol_NN accumulation_NN in_IN pancreatic_JJ islet_NN beta_NN cells_NNS ,_, impairing_VBG insulin_NN secretion_NN ._.
However_RB ,_, the_DT concentration_NN of_IN hippocampal_JJ glutamate_NN in_IN DS_NN individuals_NNS with_IN and_CC without_IN dementia_NN has_VBZ not_RB previously_RB been_VBN directly_RB investigated_VBN ._.
However_RB ,_, the_DT diversity_NN of_IN methods_NNS applied_VBN ,_, such_JJ as_IN in_IN the_DT mode_NN of_IN data_NNS collection_NN ,_, make_VBP it_PRP difficult_JJ to_TO compare_VB results_NNS across_IN surveys_NNS ,_, time_NN ,_, or_CC countries_NNS ._.
However_RB ,_, knowledge_NN concerning_VBG the_DT genetic_JJ basis_NN of_IN sexually_RB dimorphic_JJ traits_NNS is_VBZ limited_VBN in_IN any_DT organism_NN ,_, including_VBG mosquitoes_NNS ,_, especially_RB with_IN respect_NN to_TO differences_NNS in_IN the_DT developing_VBG nervous_JJ system_NN ._.
However_RB ,_, worries_NNS about_IN the_DT development_NN of_IN malignancies_NNS in_IN ustekinumab-treated_JJ patients_NNS have_VBP not_RB been_VBN completely_RB resolved_VBN because_IN of_IN the_DT major_JJ role_NN of_IN IL-12_NN and_CC IL-23_NN in_IN tumor_NN immunity_NN ._.
However_RB ,_, the_DT counting_NN of_IN the_DT number_NN of_IN host_NN cells_NNS in_IN the_DT protocol_NN is_VBZ usually_RB performed_VBN by_IN manual_JJ observation_NN with_IN microscopy_NN ,_, which_WDT is_VBZ time_NN consuming_JJ and_CC labor_NN intensive_JJ work_NN ,_, and_CC prone_JJ to_TO errors_NNS for_IN one_CD person_NN or_CC between_IN different_JJ individuals_NNS ._.
However_RB ,_, ethical_JJ standards_NNS in_IN relation_NN to_TO digital_JJ photography_NN for_IN teaching_NN and_CC learning_NN have_VBP not_RB always_RB been_VBN of_IN the_DT highest_JJS standard_NN ._.
However_RB ,_, it_PRP is_VBZ uncertain_JJ if_IN this_DT `_`` obesity_NN survival_NN paradox_NN '_'' is_VBZ also_RB observed_VBN in_IN kidney_NN transplant_NN recipients_NNS ._.
However_RB ,_, there_EX is_VBZ no_DT effective_JJ cytokine_NN delivery_NN system_NN available_JJ for_IN clinic_NN application_NN ,_, in_IN particular_JJ for_IN myocardial_JJ regeneration_NN ._.
However_RB ,_, whether_IN the_DT site_NN of_IN PAOD_NN can_MD provide_VB additional_JJ contribution_NN to_TO predicting_VBG mortality_NN have_VBP not_RB been_VBN investigated_VBN yet_RB ._.
However_RB ,_, plasma_NN fructose_NN is_VBZ typically_RB 1/1000th_NN of_IN glucose_NN levels_NNS and_CC it_PRP is_VBZ unclear_JJ to_TO what_WP extent_NN fructose_NN crosses_VBZ the_DT blood-brain_JJ barrier_NN ._.
However_RB ,_, they_PRP are_VBP often_RB considered_VBN separately_RB in_IN clinical_JJ settings_NNS ._.
However_RB ,_, TB_NN program_NN reports_NNS are_VBP often_RB compiled_VBN and_CC reported_VBN at_IN higher_JJR administrative_JJ units_NNS that_WDT do_VBP not_RB show_VB the_DT burden_NN at_IN lower_JJR units_NNS ,_, so_RB there_EX is_VBZ limited_VBN information_NN about_IN the_DT spatial_JJ distribution_NN of_IN the_DT disease_NN ._.
However_RB ,_, the_DT unclearness_NN of_IN the_DT risk-benefit_JJ ratio_NN of_IN this_DT method_NN has_VBZ led_VBN to_TO an_DT interest_NN in_IN less_JJR invasive_JJ modalities_NNS ._.
However_RB ,_, the_DT experience_NN of_IN patients_NNS of_IN this_DT procedure_NN has_VBZ been_VBN very_RB seldom_RB evaluated_VBN ._.
However_RB ,_, there_EX have_VBP been_VBN no_DT reports_NNS of_IN myocardiotoxicity_NN following_VBG treatment_NN with_IN EGCG_NN ._.
However_RB ,_, the_DT incidence_NN and_CC risk_NN factors_NNS of_IN HBV_NN reactivation_NN in_IN patients_NNS with_IN acute_JJ myeloid_JJ leukemia_NN -LRB-_-LRB- AML_NN -RRB-_-RRB- are_VBP rarely_RB investigated_VBN ._.
However_RB ,_, CB_NNP frequently_RB lack_VBP adequate_JJ cellularity_NN even_RB when_WRB the_DT direct_JJ smears_NNS are_VBP cellular_JJ ._.
However_RB ,_, the_DT molecular_JJ mechanism_NN of_IN miR-138_NN involvement_NN in_IN gallbladder_NN carcinoma_NN still_RB remains_VBZ unknown_JJ ._.
However_RB ,_, the_DT mechanisms_NNS involved_VBN in_IN E2_NN signaling_NN are_VBP not_RB completely_RB understood_VBN ._.
However_RB ,_, hookworm_NN infection_NN decreases_VBZ the_DT immune_JJ response_NN to_TO hookworm_NN and_CC bystander_NN antigens_NNS ._.
However_RB ,_, it_PRP is_VBZ unknown_JJ whether_IN these_DT factors_NNS predict_VBP treatment_NN outcome_NN ._.
However_RB ,_, clinical_JJ observations_NNS studying_VBG the_DT BDNF_NN polymorphism_NN and_CC the_DT risk_NN of_IN PTSD_NN yielded_VBD contradictory_JJ results_NNS ._.
However_RB ,_, the_DT mechanisms_NNS underlying_VBG the_DT regulation_NN of_IN MCP-1_NN are_VBP not_RB fully_RB understood_VBN ._.
However_RB ,_, current_JJ barriers_NNS to_TO its_PRP$ adoption_NN include_VBP suboptimal_JJ amenability_NN for_IN low_JJ clinical_JJ throughputs_NNS and_CC uncertainty_NN over_IN data_NNS accuracy_NN and_CC analytical_JJ procedures_NNS ._.
However_RB ,_, there_EX is_VBZ limited_VBN information_NN about_IN genotypes_NNS of_IN O._NNP turkestanicum_NN in_IN Iran_NNP ._.
However_RB ,_, RSV_NN infection_NN has_VBZ been_VBN reported_VBN to_TO be_VB affected_VBN by_IN flavonoids_NNS ._.
However_RB ,_, the_DT exact_JJ mechanisms_NNS underlying_VBG the_DT different_JJ effects_NNS of_IN berberine_NN on_IN MM_NN cells_NNS have_VBP not_RB been_VBN fully_RB elucidated_VBN ._.
However_RB ,_, there_EX are_VBP no_DT effective_JJ rating_NN scales_NNS to_TO predict_VB recurrent_JJ stroke_NN following_VBG a_DT minor_JJ one_CD ._.
However_RB ,_, data_NNS with_IN longer_JJR follow-up_NN in_IN this_DT age_NN group_NN are_VBP scarce_JJ ._.
However_RB ,_, there_EX are_VBP few_JJ clinical_JJ studies_NNS on_IN the_DT effect_NN of_IN orally_RB administered_VBN A._NN vera_NN gel_NN on_IN the_DT skin_NN ._.
However_RB ,_, their_PRP$ influence_NN on_IN dermal_JJ fibroblasts_NNS has_VBZ not_RB been_VBN investigated_VBN ._.
However_RB ,_, no_DT previous_JJ studies_NNS have_VBP examined_VBN the_DT effect_NN of_IN neighborhood_NN socioeconomic_JJ conditions_NNS on_IN the_DT risk_NN of_IN stroke_NN in_IN Asian_JJ countries_NNS ._.
However_RB ,_, the_DT exact_JJ mechanisms_NNS through_IN which_WDT CLA_NN mediates_VBZ this_DT effect_NN remain_VBP to_TO be_VB elucidated_VBN ._.
However_RB ,_, there_EX is_VBZ some_DT debate_NN in_IN regard_NN to_TO a_DT statistical_JJ approach_NN to_TO test_VB this_DT hypothesis_NN ._.
However_RB ,_, a_DT recently_RB published_VBN meta-analysis_NN suggested_VBD that_IN the_DT risk-benefit_JJ ratio_NN of_IN current_JJ thromboprophylaxis_NN regimens_NNS administered_VBN to_TO all_DT cancer_NN patients_NNS admitted_VBD for_IN medical_JJ illness_NN is_VBZ unclear_JJ ._.
However_RB there_EX is_VBZ growing_VBG evidence_NN for_IN an_DT elevated_JJ non_JJ stimulus-driven_JJ neural_JJ activity_NN ,_, or_CC neuronal_JJ background_NN noise_NN ,_, as_IN underlying_VBG pathophysiological_JJ correlate_NN ._.
However_RB ,_, the_DT specific_JJ brain_NN regions_NNS that_IN most_JJS accurately_RB differentiate_VBP the_DT migraine_NN brain_NN from_IN the_DT healthy_JJ brain_NN have_VBP yet_RB to_TO be_VB determined_VBN ._.
However_RB ,_, it_PRP 's_VBZ unclear_JJ whether_IN RAPN_NNP is_VBZ more_RBR efficacious_JJ than_IN the_DT standard_JJ laparoscopic_JJ partial_JJ nephrectomy_NN -LRB-_-LRB- LPN_NN -RRB-_-RRB- ._.
However_RB ,_, dosing_NN ,_, duration_NN of_IN expression_NN ,_, and_CC tissue_NN specificity_NN are_VBP challenges_NNS to_TO VEGF_NN gene_NN therapy_NN ,_, and_CC recombinant_JJ VEGF_NN delivery_NN suffers_VBZ from_IN extremely_RB rapid_JJ plasma_NN clearance_NN ,_, necessitating_VBG continuous_JJ infusion_NN and/or_CC direct_JJ injection_NN at_IN the_DT site_NN of_IN interest_NN ._.
However_RB ,_, no_DT previous_JJ studies_NNS have_VBP been_VBN done_VBN in_IN a_DT fast-track_JJ setting_NN with_IN optimized_VBN perioperative_JJ care_NN ,_, including_VBG spinal_JJ anesthesia_NN ,_, multimodal_JJ opioid-sparing_JJ analgesia_NN ,_, early_JJ mobilization_NN ,_, and_CC discharge_NN to_TO home_NN ,_, which_WDT improved_VBD postoperative_JJ outcome_NN ._.
However_RB ,_, few_JJ authors_NNS have_VBP investigated_VBN this_DT injury_NN in_IN all_DT age_NN groups_NNS or_CC performed_VBN follow-up_JJ visit_NN after_IN repair_NN ._.
However_RB ,_, pre-treatment_NN prognostication_NN is_VBZ increasingly_RB warranted_VBN ,_, considering_VBG the_DT follow-up_NN strategy_NN recently_RB admitted_VBD for_IN expectedly_RB low-risk_JJ tumours_NNS and_CC the_DT possible_JJ distinctive_JJ molecular_JJ features/spontaneous_JJ regression_NN of_IN some_DT small_JJ cases_NNS ._.
However_RB ,_, there_EX is_VBZ also_RB clinical_JJ and_CC basic_JJ science/laboratory_JJ literature_NN indicating_VBG a_DT dose-response_JJ relationship_NN between_IN BMP_NN signaling_NN and_CC the_DT evolution_NN of_IN PAH_NN -LRB-_-LRB- e.g._FW ,_, increased_VBD endothelial_JJ ,_, smooth_JJ muscle_NN ,_, and_CC progenitor_NN cell_NN production_NN ,_, with_IN calcifications_NNS -RRB-_-RRB- ._.
However_RB ,_, there_EX are_VBP emerging_VBG examples_NNS of_IN confirmed_VBN infectious_JJ viral_JJ infection_NN of_IN the_DT brain_NN followed_VBN by_IN secondary_JJ inflammation_NN or_CC autoimmunity_NN that_WDT is_VBZ amenable_JJ to_TO immune_JJ suppressive_JJ therapies_NNS ._.
However_RB ,_, the_DT expression_NN and_CC roles_NNS of_IN miR-212_NN in_IN osteosarcoma_NN remain_VBP largely_RB undefined_JJ ._.
However_RB ,_, to_TO the_DT best_JJS of_IN our_PRP$ knowledge_NN ,_, no_DT clinical_JJ results_NNS pertaining_VBG to_TO this_DT technique_NN have_VBP been_VBN reported_VBN from_IN other_JJ institutions_NNS ._.
However_RB ,_, it_PRP is_VBZ unclear_JJ whether_IN PCP_NNP disrupts_VBZ the_DT structural_JJ integrity_NN of_IN brain_NN areas_NNS relevant_JJ to_TO the_DT profile_NN of_IN cognitive_JJ impairment_NN in_IN schizophrenia_NN ._.
However_RB ,_, evidence_NN to_TO support_VB a_DT causal_JJ relationship_NN between_IN preoperative_JJ H._NN pylori_NN status_NN and_CC postoperative_JJ anastomotic_JJ ulceration_NN is_VBZ weak_JJ ._.
However_RB ,_, no_DT previous_JJ systematic_JJ review_NN has_VBZ examined_VBN travel_NN behaviours_NNS among_IN African_JJ children_NNS and_CC youth_NN or_CC the_DT psychometric_JJ properties_NNS of_IN measurement_NN tools_NNS used_VBN among_IN children_NNS and_CC youth_NN worldwide_RB ._.
However_RB ,_, their_PRP$ pathological_JJ mechanism_NN remains_VBZ largely_RB unknown_JJ ._.
However_RB ,_, the_DT efficacy_NN of_IN treatment_NN based_VBN on_IN the_DT type_NN of_IN ICP_NNP monitor_NN used_VBN for_IN improving_VBG patient_NN outcome_NN has_VBZ not_RB been_VBN assessed_VBN prospectively_RB ._.
However_RB ,_, family_NN planning_NN and_CC reproductive_JJ health_NN for_IN WLHIV_NNP are_VBP under-addressed_JJ in_IN Mozambique_NNP ._.
However_RB ,_, only_RB a_DT few_JJ review_NN articles_NNS have_VBP dealt_VBN with_IN this_DT relation_NN in_IN recent_JJ years_NNS ,_, and_CC none_NN of_IN them_PRP have_VBP focused_VBN on_IN the_DT analysis_NN of_IN subgroups_NNS such_JJ as_IN age_NN ,_, gender_NN ,_, and_CC marital_JJ status_NN ._.
However_RB ,_, data_NNS comparing_VBG these_DT procedures_NNS present_JJ conflicting_VBG results_NNS ._.
However_RB ,_, the_DT presence_NN and_CC extent_NN of_IN coronary_JJ artery_NN disease_NN -LRB-_-LRB- CAD_NN -RRB-_-RRB- is_VBZ usually_RB not_RB considered_VBN to_TO tailor_VB AF_NN ablation_NN strategies_NNS ._.
However_RB ,_, building_VBG a_DT model_NN with_IN interactions_NNS that_WDT are_VBP not_RB specified_VBN a_DT priori_FW ,_, in_IN the_DT presence_NN of_IN missing_VBG data_NNS ,_, presents_VBZ a_DT challenge_NN ._.
However_RB ,_, these_DT methods_NNS behave_VBP badly_RB with_IN small_JJ sample_NN sizes_NNS in_IN the_DT three_CD arms_NNS ._.
However_RB ,_, there_EX are_VBP no_DT studies_NNS showing_VBG the_DT effects_NNS of_IN SKF83959_NNS in_IN a_DT chronic_JJ stress_NN model_NN of_IN depression_NN and_CC the_DT role_NN of_IN phospholipase_NN C/inositol_NN phosphate_NN 3/calmodulin-dependent_JJ kinase_NN IIα_NN /_: brain-derived_JJ neurotrophic_JJ factor_NN pathway_NN in_IN SKF83959-mediated_JJ antidepressant_JJ effects_NNS ._.
However_RB ,_, the_DT underlying_JJ mechanisms_NNS have_VBP not_RB been_VBN fully_RB elucidated_VBN ._.
However_RB ,_, less_JJR than_IN a_DT third_JJ of_IN the_DT liver_NN samples_NNS had_VBD detectable_JJ HBRV_NN ,_, whereas_IN others_NNS were_VBD unable_JJ to_TO detect_VB betaretrovirus_NN infection_NN or_CC noted_VBD the_DT presence_NN of_IN virus_NN in_IN the_DT liver_NN of_IN patients_NNS with_IN other_JJ diagnoses_NNS ._.
However_RB ,_, no_DT information_NN is_VBZ available_JJ regarding_VBG the_DT effect_NN of_IN femoral_JJ head_NN size_NN on_IN the_DT survivorship_NN of_IN HXLPE_NN hip_NN prostheses_NNS ._.
However_RB ,_, since_IN then_RB ,_, alternative_JJ explanations_NNS have_VBP been_VBN proposed_VBN ,_, including_VBG the_DT increased_VBN burden_NN of_IN chronic_JJ diseases_NNS ,_, immigration_NN ,_, and_CC the_DT increase_NN in_IN the_DT use_NN of_IN immune_JJ suppressant_NN medications_NNS ._.
However_RB ,_, little_JJ data_NNS exist_VBP concerning_VBG the_DT effects_NNS of_IN the_DT usefulness_NN of_IN oxygen_NN supply_NN during_IN exercise_NN training_NN for_IN >_JJR INT_CD months_NNS in_IN patients_NNS with_IN COPD_NN who_WP are_VBP normoxemic_JJ at_IN rest_NN and_CC during_IN exercise_NN ._.
However_RB ,_, the_DT role_NN of_IN improved_VBN emotion_NN regulation_NN in_IN predicting_VBG treatment_NN outcome_NN in_IN BED_NN is_VBZ uncertain_JJ ._.
However_RB ,_, the_DT specific_JJ function_NN of_IN miR-22_NN in_IN ESCC_NN is_VBZ unclear_JJ at_IN this_DT point_NN ._.
However_RB ,_, patients_NNS required_VBN to_TO undergo_VB two_CD open_JJ operations_NNS in_IN a_DT short_JJ period_NN of_IN time_NN -LSB-_-LRB- FLOAT_CD -RSB-_-RRB- ._.
However_RB ,_, the_DT predictive_JJ accuracy_NN of_IN these_DT variables_NNS during_IN gastrointestinal_JJ surgery_NN remains_VBZ uncertain_JJ ._.
However_RB ,_, most_RBS low_JJ -_: and_CC middle-income_JJ countries_NNS -LRB-_-LRB- LMICs_NNS -RRB-_-RRB- are_VBP unable_JJ to_TO provide_VB this_DT essential_JJ surgery_NN to_TO the_DT general_JJ public_NN ,_, resulting_VBG in_IN considerable_JJ morbidity_NN and_CC mortality_NN ._.
However_RB ,_, the_DT effect_NN of_IN chloroquine_NN selection_NN on_IN parasite_JJ population_NN ,_, which_WDT may_MD affect_VB the_DT efficacy_NN of_IN lumefantrine_NN or_CC other_JJ partner_NN drugs_NNS of_IN artemisinin_NN ,_, has_VBZ not_RB been_VBN well_RB assessed_VBN ._.

